Staying healthy this winter: expert advice on prevention, wellbeing and liver health
As winter approaches, taking steps to protect our health becomes particularly important. In a recent feature in The Guardian, ten medical experts share practical, evidence-based advice on preventing and managing common winter ailments, highlighting the importance of vaccination, healthy lifestyle habits, good nutrition and responsible self-care.
We are pleased to see Professor Debbie Shawcross, EASL Secretary General, featured in the article, sharing her expertise on the gut microbiome, nutrition and liver health.
Professor Shawcross highlights the role of a fibre-rich diet in supporting a diverse and healthy gut microbiome. She also emphasises the importance of mindful alcohol consumption, reminding readers that alcohol is a toxin and that no level of consumption is entirely risk-free. Her advice includes incorporating alcohol-free days into the week and avoiding binge drinking, particularly during the festive season.
Her contribution reinforces an important message: prevention and informed lifestyle choices play a key role in protecting our overall health, including our liver health.
At EASL, we remain committed to advancing liver health through scientific excellence, education and awareness, and to making evidence-based knowledge accessible to healthcare professionals and the wider public.
Read the full article in The Guardian:
www.theguardian.com/lifeandstyle/2026/nov/18/get-vaccinat…
@DebbieShawcros1
#livertwitter #liverx
European Association for the Study of the Liver
The European Association for the Study of the Liver (EASL), founded in 1966, is a medical association concerned with liver research, the clinical practice of liver disorders, and providing education to all those interested in hepatology. As of 2024, EASL serves 7,000 members from 112 countries. More on Wikipedia
-
EASLnews
@EASLnews
-
EASLnews
@EASLnews
🚀 Ready to take the next step in your research career?
The 2027 EASL Emerging Leader Award celebrates promising liver researchers and supports their journey towards becoming leaders in hepatology.
Eligible applicants must be aged 40 or under (parental leave allowances apply) and active EASL members. Full professors are not eligible.
Less than a week left to apply!
🔗 Apply by 24 November: easl.eu/about-us/awards/ -
EASLnews
@EASLnews
Join leading experts for an EASL DeepDive exploring the natural history of AATD-associated liver disease, approaches to fibrosis staging, and the clinical challenges of managing paediatric and adult patients.
📅 9 December, 18:00-19:00 CET
Register now: easl-eu.zoom.us/webinar/register/2317917948171/WN_pCwCiui… -
EASLnews
@EASLnews
No elimination without trust.
With just four years left to reach the 2030 viral hepatitis elimination targets, Europe is still falling behind. And stigma remains one of the barriers we cannot afford to overlook.
We are pleased to share No Elimination Without Trust: Hepatitis B, Stigma and Liver Cancer in Europe, an ECO Policy Action Report led by PPHA’s Patrizia Carrieri, highlighting how hepatitis B-related stigma undermines prevention, testing, treatment and long-term care—and ultimately, liver cancer prevention.
The findings are striking:
💠 46% of respondents living with hepatitis B found it difficult to tell others about their diagnosis.
💠15% had avoided healthcare they needed because they expected to be treated differently.
💠15% had experienced delays in treatment or medical procedures due to stigma in healthcare settings.
💠 Stigma is not just a social issue. It is a barrier to care, a driver of health inequalities, and an obstacle to elimination.
The report calls for concrete action, including better monitoring of stigma, more inclusive testing, community-led interventions, healthcare professional training, and policies that protect people from discrimination.
👉 Read it here: easl.eu/wp-content/uploads/2026/11/08014-Hepatitis-paper.pdf
We will not eliminate hepatitis B without addressing stigma and building trust.
Congratulations to Patrizia and all contributors on this important work!
#easl #viralhepatitis #livercancer #stigma #publichealth #cancerprevention #eco @EuropeanCancer -
EASLnews
@EASLnews
You can still register for today's EASL Genetic Grand Round webinar! Our faculty will explore the challenges of interpreting emerging genetic findings through a clinical case presentation and expert discussion, focusing on their relevance for diagnosis and patient management.
📅 TODAY Wednesday, 18 November, 18:00 CET
Register here: easl-eu.zoom.us/webinar/register/4917931770986/WN_qQV37H8… -
EASLnews
@EASLnews
Are you a Young Investigator with a recent publication in JHEP or JHEP Reports? We want to hear from you!
Have you published an article in either journal within the past 12 months as the first or corresponding author? This is your opportunity to showcase your research through our YI Paper of the Month initiative!
We invite Young Investigators to present their work and share their findings with the wider EASL Young Investigator community.
How to get involved?
Simply email us at yi@easloffice.eu and send us:
🎥 A short video (maximum 1 minute), recorded in front of a green screen or plain wall, including:
• A brief introduction of yourself.
• A short presentation of your article and its key findings.
📄 Your supporting information:
• Proof of your Young Investigator status (Trainee members can simply provide their membership ID).
• A link to your published article.
Why take part?
Showcase your research, share your findings with fellow Young Investigators, and give your work greater visibility across the EASL community! We look forward to featuring your research!This media couldn't be displayed. See it on the original post. -
EASLnews
@EASLnews
Last week, on 12–13 November 2026, Module 3 of the EASL MASLD Guidelines Academy brought healthcare professionals together in Aarhus, Denmark, to explore this question.
Through expert-led discussions and clinical cases, participants examined evidence-based therapies, integrated metabolic and hepatic care, HCC surveillance and multidisciplinary decision-making, with a focus on implementing coordinated models of MASLD care across healthcare settings.
#livertwitter #liverx -
EASLnews
@EASLnews
🚨 Abstract submissions close tomorrow and early fee registation the next day!
This is your final opportunity to secure your participation at the EASL Steatotic Liver Disease Summit 2027.
Share your findings, contribute to scientific discussions and connect with researchers and clinicians advancing the field.
📍 Berlin, 10-13 February 2027
⏰ Abstract deadline: 17 November
⏰ Early registration deadline: 18 November
easl.eu/event/easl-sld-summit-2027/
#sldsummit -
EASLnews
@EASLnews
🩺 LIVER MATTERS: LET'S PUT LIVER HEALTH ON THE PRIMARY CARE AGENDA!
Liver disease is a growing healthcare challenge, yet it is often under-recognised and diagnosed too late.
How can we change this? And how can primary care professionals play a greater role in improving liver health?
🎥 Discover the Liver Matters Webinar: Clinical Basics in Primary Care
Developed in partnership with WONCA, this educational initiative brings together experts from primary care and hepatology, alongside patient representatives, to explore practical ways to improve the recognition and management of liver disease.
In this introductory episode, meet our experts:
🔹 Dr. Kush Abeysekera – Consultant Hepatologist and Senior Lecturer, University of Bristol.
🔹 Dr. Helen Jarvis – General Practitioner and Academic Clinical Lecturer, Newcastle University.
Get a first look at the topics, challenges and practical insights that will shape this educational series.
📅 The webinar series starts on 26 November 2026 at 12:00 CET.
Don't miss out – register now and be part of the conversation!
👉 Explore the introductory episode and register here:
easlcampus.eu/videos/liver-matters-intro-episode
Whether you work in primary care, hepatology or another area of healthcare, this is an opportunity to strengthen your knowledge and contribute to better liver health.
Better awareness. Earlier recognition. Better liver health. -
EASLnews
@EASLnews
Latvia is showing that alcohol policy can save lives. But the work is far from over.
A recent report in The Lancet highlights encouraging early results from Latvia, where new restrictions on alcohol sales and advertising are already showing a measurable impact.
Introduced in August 2025, the measures include:
🔹Shorter hours for alcohol sales.
🔹Restrictions on online and app-based alcohol delivery.
🔹Restrictions on alcohol sales in gambling venues.
🔹A ban on advertising alcohol prices and discounts.
The preliminary findings are striking: a 27% reduction in deaths from causes 100% attributable to alcohol during the first five months following implementation.
This is an important signal of what comprehensive, evidence-based alcohol policy can achieve.
But there is a bigger lesson here.
Alcohol harm cannot be addressed through individual behaviour change alone. It also requires action on the environments in which alcohol is sold, marketed, promoted and consumed.
EASL supports stronger action, including:
🔹Comprehensive restrictions on alcohol marketing and advertising, including digital and social media.
🔹Restrictions on alcohol availability and sales hours.
🔹Effective pricing and taxation policies.
🔹Mandatory health warnings and ingredient labelling.
🔹Greater public awareness of alcohol-related health risks, including its link to at least seven types of cancer.
The experience of Lithuania offers further evidence: its comprehensive alcohol marketing ban was associated with a 35% reduction in the frequency of adolescent intoxication and a 12% reduction in overall alcohol use among adolescents one year after implementation.
The message for European policymakers is clear: protecting liver health starts with prevention. We need to move from evidence to action.
📖 Read the report in The Lancet:
www.thelancet.com/journals/lancet/article/PIIS0140-6736(2…
Latvia has taken an important step. Now the challenge is to build on that progress.
Public health policy should be ambitious enough to match the scale of the problem. -
EASLnews
@EASLnews
⏳ Four days left!
Your opportunity to share research at the EASL Steatotic Liver Disease Summit 2027 is nearly over.
Join the scientific exchange in Berlin and contribute to discussions connecting fundamental discoveries with clinical advances.
📅 Abstract deadline: 17 November
📅 Early registration deadline: 18 November
Don't miss your chance to be part of the Summit.
Submit your abstract: easl.eu/event/easl-sld-summit-2027/
#sldsummit -
EASLnews
@EASLnews
🏆 Celebrate an outstanding member of the liver community!
The 2027 EASL Community Award honours individuals making a lasting impact on hepatology through teaching, advocacy, innovation and more.
Nominees must have 10+ years of EASL membership. Self-nominations are not accepted.
Submit your nomiation by 24 November here: easl.eu/awards-2027/ -
EASLnews
@EASLnews
🧬 From genetic discovery to clinical relevance: how do we connect the dots in cholestasis?
Our upcoming #easlggr will use a clinical case to explore the challenges of evaluating newly identified cholestasis-associated genes and their potential implications for patient care.
📅 Wednesday, 18 November, 18:00 CET
Register here: easl-eu.zoom.us/webinar/register/4917931770986/WN_qQV37H8… -
EASLnews
@EASLnews
How should we approach the risk of cholangiocarcinoma in patients with PSC?
Who should undergo surveillance? What should that surveillance involve? And which changes should trigger concern?
🎙️ In this episode of Talk Liver To Me, experts tackle the practical challenges of translating CCA risk into everyday clinical care, including how to discuss that risk with patients without creating unnecessary anxiety.
Listen now on EASL Campus: easlcampus.eu/tltm/episode-21
Spotify: open.spotify.com/episode/2lo6bqaxRei4LgZrLBp2Ci
Apple Podcasts: podcasts.apple.com/us/podcast/talk-liver-to-me-cholangioc… -
EASLnews
@EASLnews
Module 2 of the EASL MASLD Guidelines Academy – A deeper dive into MASLD took place last month, on 8–9 October 2026 in Antwerp, Belgium, bringing together healthcare professionals for two days of advanced, interactive learning.
Through expert-led discussions and clinical cases, participants explored MASLD pathophysiology, metabolic dysfunction, cardiovascular complications and the role of non-invasive tests in clinical decision-making, strengthening their understanding of this complex disease.
Students are now preparing for Module 3, which is taking place this week in Aarhus, Denmark!
#livertwitter #liverxThis media couldn't be displayed. See it on the original post. -
EASLnews
@EASLnews
Cholangiocarcinoma surveillance in PSC remains one of the most challenging areas of clinical practice.
In the latest Talk Liver To Me, experts discuss:
👉 Who should undergo surveillance
👉 The roles and limitations of imaging
👉 What should trigger referral or further investigation
👉 How to manage inconclusive findings
Tune in this Wednesday to catch up on this discussion!
🔗 easl.eu/event/cholangiocarcinoma-surveillance-in-psc/
Register for the EASL Liver Cancer Summit: easl.eu/event/easl-liver-cancer-summit-2027/This media couldn't be displayed. See it on the original post. -
EASLnews
@EASLnews
📍 EASL is delighted to be in Denver, Colorado, for The Liver Meeting 2026! Come and meet us at Booth #1138!
🤝 We are grateful for the inspiring conversations, meaningful exchanges and opportunities to strengthen our collaborations with our sister societies AASLD, ALEH, APASL, and SOLDA, as well as our valued partners across the globe.
💙 Together, we continue to build bridges across continents, foster scientific collaboration and advance liver health worldwide.
🤝 A heartfelt thank you to AASLD for organising this outstanding congress and bringing together the global liver community to exchange knowledge and share insights.
@AASLDtweets @alehlatam @APASLnews @Solda_Society @DebbieShawcros1 @analleo @amhmx -
EASLnews
@EASLnews
💙 Putting people at the heart of liver care deserves recognition!
The 2027 EASL Excellence in Liver Care Award celebrates liver nurses and Allied Health Professionals who go above and beyond to improve patient care and outcomes.
🌟 Know someone making a difference? Nominate them, or yourself!
📅 Deadline: 24 November 2026
📩 Send nominations to nurses.ahp@easloffice.eu
🔗 Find out more: easl.eu/easl/leadership-and-governance/nurse-and-ahps-tas… -
EASLnews
@EASLnews
How do we determine the clinical significance of newly identified cholestasis-associated genes?🤔
Join the next EASL Genetic Grand Round as experts tackle this challenge through a clinical case presentation and interactive discussion.
📅 Wednesday, 18 November, 18:00 CET
Register here: easl-eu.zoom.us/webinar/register/4917931770986/WN_qQV37H8… -
EASLnews
@EASLnews
Can AI help bridge the gap between clinical trials and real-world evidence?🤖
Join today's EASL DeepDive to explore how AI can leverage electronic health records, registries, and other real-world data to support external controls, assess long-term outcomes, and improve the generalisability of clinical trial findings.
📅 TODAY, Wedneday, 4 November, 18:00 CET
You can still register here: easl-eu.zoom.us/webinar/register/8617907590629/WN_2VrH88s… -
EASLnews
@EASLnews
Today’s EASL Quiz, developped in collaboration with ERN, tests your guidelines knowledge on rare liver diseases. What do you know about Sjögren syndrome? Find out now!
Play here: easlcampus.eu/quiz/question/q152 -
EASLnews
@EASLnews
🧬 A major milestone in gene therapy for liver disease!
For the first time, researchers have published a peer-reviewed clinical case demonstrating successful in vivo base editing in a patient with alpha-1 antitrypsin deficiency.
🔬 Published in the @JHepatology, the study reports:
💠First peer-reviewed publication of a successfully treated PiZZ AATD patient with in vivo gene therapy
💠High correction efficiency, precise editing, and promising safety profile
💠Conversion of homozygous to heterozygous genotype – a major therapeutic achievement
💠Potential to treat numerous hereditary liver diseases and rare variants
These promising findings mark an important step towards precise, minimally invasive treatments for inherited liver diseases.
While further research is needed to establish long-term safety and efficacy, the study highlights the transformative potential of gene editing in hepatology.
🔗 Read the press release: easl.eu/gene-correction-therapy-successfully-treats-alpha…
👉Read the article: www.journal-of-hepatology.eu/article/S0168-8278(26)02935-…
@DebbieShawcros1 @analleo #mhh -
EASLnews
@EASLnews
A significant milestone in global hepatology: five international liver societies establish a unified definition of acute-on-chronic liver failure (ACLF).
Published in the Journal of Hepatology, this landmark consensus brings together EASL, AASLD, APASL, ALEH and SOLDA to establish a common framework for ACLF diagnosis, staging and clinical trial design.
The consensus addresses longstanding regional differences in definitions and aims to support more consistent clinical practice, international research collaboration and the development of effective therapies.
“The publication of this landmark global consensus represents a historic moment in hepatology, bringing together five major international liver societies for the first time to speak with one unified voice on acute-on-chronic liver failure,” said Professor Debbie Shawcross, Professor of Hepatology & Chronic Liver Failure at the Roger Williams Institute of Liver Studies, Kings College London, and EASL Secretary General.
By establishing a shared, evidence-based framework, this collaboration represents an important step towards more equitable patient care and improved outcomes for patients with ACLF worldwide.
Read the full consensus: www.journal-of-hepatology.eu/article/S0168-8278(26)02898-…
Read the press release: easl.eu/easl-and-global-liver-societies-establish-unified…
#easl #hepatology #aclf #liverdisease #liverresearch
@JHepatology @AASLDtweets @APASLnews @alehlatam @Solda_Society @DebbieShawcros1 -
EASLnews
@EASLnews
🌟 Applications are open for the 2027 EASL Emerging Leader Award!
Are you an early-career liver researcher making an impact? 🧬 This award recognises outstanding research achievements and supports the next generation of leaders in hepatology.
✅ 40 years old or younger (parental leave allowances apply)
✅ Active EASL member
📍 Attendance at EASL Congress 2027 is mandatory.
🔗 Apply by 24 November: easl.eu/about-us/awards/ -
EASLnews
@EASLnews
🧬A newly identified cholestasis-associated gene, but is it clinically significant?
Join our next EASL Genetic Grand Round for a case-based discussion exploring how to interpret emerging genetic findings and assess their relevance in clinical practice.
📅 Wednesday, 18 November, 18:00 CET
Register here: easl-eu.zoom.us/webinar/register/4917931770986/WN_qQV37H8… -
EASLnews
@EASLnews
📢 It’s not too late to register!
Our Molecular Tumour Board on hepatocellular carcinoma arising in the absence of underlying liver disease is happening today, 18:00 CET!
Join leading experts for a case-based discussion exploring molecular characteristics, recurrence management, adjuvant therapy, and the potential role of liver transplantation in selected patients.
🔬 Register now and don’t miss this opportunity to gain valuable clinical insights!
👉 easl-eu.zoom.us/webinar/register/7517912027060/WN_nRVLJgk… -
EASLnews
@EASLnews
📊 How should HCC surveillance evolve as risk profiles change?
This new episode of #talklivertome explores the evidence behind patient selection, surveillance timing and modality choice, while addressing persistent variation between guidelines and the limitations of current surveillance strategies.
Now on EASL Campus: easlcampus.eu/tltm/episode-20
Also on Spotify: open.spotify.com/episode/5THbZ6hncsbaceUsnS1UAO
and Apple Podcasts: podcasts.apple.com/ch/podcast/talk-liver-to-me-hepatocell… -
EASLnews
@EASLnews
What new insights could your research bring to Steatotic Liver Disease?
From disease mechanisms and metabolic dysfunction to diagnosis and emerging therapies, the EASL Steatotic Liver Disease Summit 2027 is an opportunity to share findings with an international scientific community.
📅 10-13 February 2027
📍 Berlin, Germany
Abstract submissions close 17 November.
Register with early fees by 18 November.
Submit your research: easl.eu/event/easl-sld-summit-2027/
Register now: easl.eu/event/easl-sld-summit-2027/
#sldsummit -
EASLnews
@EASLnews
From optimising patient stratification to simulating treatment responses using digital twins, AI offers new possibilities for clinical research.
Register for the next EASL DeepDive to examine the evidence behind these approaches, their clinical applications, and their limitations.
📅 Wedneday, 4 November, 18:00 CET
Register here: easl-eu.zoom.us/webinar/register/8617907590629/WN_2VrH88s… -
EASLnews
@EASLnews
Nominations and applications are now invited for the 2027 EASL awards, recognising excellence and impact across the hepatology community:
🏆EASL Community Award 2027
🏆EASL Emerging Leader Award 2027
🏆EASL Excellence in Liver Care Award 2027
Designed to recognise outstanding achievements and leadership, these awards celebrate those driving innovation, strengthening the hepatology community, and helping advance liver health. We encourage eligible candidates to put themselves forward and invite colleagues to nominate individuals whose contributions deserve recognition.
Make your achievements count. Submit your application or nomination by 24 November.
Read more: easl.eu/awards-2027/ -
EASLnews
@EASLnews
In the next #talklivertome, experts revisit the fundamentals of hepatocellular carcinoma surveillance, with a practical look at patient selection, timing and the modalities available for early detection.
Tune in this Wednesday on your Spotify, Apple Podcasts or EASL Campus to listen to this interactive discussion.
More information: easl.eu/event/hepatocellular-carcinoma-who-to-screen-when… -
EASLnews
@EASLnews
📢 Calling all EASL Young Investigators with valid membership! Help us improve the EASL CPG Tool by testing it and sharing your experience.
Your feedback will help us enhance its usability, functionality, and clinical relevance!
How can you contribute?
- Explore and test the EASL CPG Tool
- Share your experience and suggestions through our feedback survey
📅 Deadline: 8 November 2026
🔗 Access the tool: easl.eu/llm-prototype-testing/
Your insights matter! Take this opportunity to contribute to the development of a tool designed to make EASL Clinical Practice Guidelines more accessible and easier to use in daily practice.
Thank you for helping us improve EASL's digital resources!
#livertwitter #liverx -
EASLnews
@EASLnews
🚨 Last days to apply! Don’t miss your chance to host an EASL School in 2028. Submit your proposal, showcase your institution’s expertise, and contribute to the future of liver education. Apply by next Monday, 26 October!
Read more: easl.eu/events/easl-courses-schools-masterclasses/ -
EASLnews
@EASLnews
🏆 Nominations are open for the 2027 EASL Community Award!
Do you know someone who is making an outstanding contribution to hepatology through teaching, advocacy, innovation or community engagement? Help us recognise their impact!
Nominees must have 10+ years of EASL membership. Self-nominations are not accepted.
🔗 Read more and submit your application by 24 November: easl.eu/awards-2027/ -
EASLnews
@EASLnews
🩺 One complex case. Key clinical questions. Expert insights.
Explore the case of a 44-year-old woman with HCC arising without cirrhosis or underlying liver disease. From surgical resection and recurrence management to liver transplantation, discover the clinical challenges and treatment considerations discussed by our experts.
🔬 Join our upcoming Molecular Tumour Board, next Wednesday!
Register now: easl-eu.zoom.us/webinar/register/7517912027060/WN_nRVLJgk… -
EASLnews
@EASLnews
Join our next EASL DeepDive to explore AI-driven trial design, patient selection, digital twins, and the use of real-world data to strengthen clinical evidence.
Discover the opportunities, scientific challenges, and limitations of AI in clinical research.
📅 Wedneday, 4 November, 18:00 CET
Register here: easl-eu.zoom.us/webinar/register/8617907590629/WN_2VrH88s… -
EASLnews
@EASLnews
How well do you know your Guidelines? Test yourself today as we examine the case of a 63-year-old man presented with painless jaundice, pruritus and a 3 kg weight loss over the previous 4 weeks, ECOG PS 1.
Take the quiz now: easlcampus.eu/quiz/question/q151 -
EASLnews
@EASLnews
Help us celebrate excellence in hepatology! Applications and nominations are now open for:
🏆EASL Community Award 2027
🏆EASL Emerging Leader Award 2027
🏆EASL Excellence in Liver Care Award 2027
Recognise those making a difference in liver health and the EASL community.
Submit your application or nomination by 24 November.
Learn more about eligibility and how to apply: easl.eu/awards-2027/ -
EASLnews
@EASLnews
Liver cancer is one of the few major cancers where deaths are still rising, even though most cases could be prevented.
Last week, the International Agency for Research on Cancer (IARC/WHO) hosted a webinar on Research Priorities for Liver Cancer Prevention. It brought together international experts to set out where the evidence gaps are and where research can make the biggest difference.
EASL Secretary General Prof. Debbie Shawcross spoke for the hepatology community. She made the case that liver cancer linked to MASLD (metabolic dysfunction-associated steatotic liver disease) is preventable. To reduce the global burden, we must generate robust evidence to identify those at risk, intervene earlier, and implement effective population-level strategies.
The scale of the challenge is clear. IARC projects that new liver cancer cases and deaths could rise by more than half by 2040 unless prevention improves substantially. The main risk factors are well known: hepatitis B and C, alcohol, tobacco, and the metabolic risks behind MASLD, including overweight and obesity.
Thank you to IARC for convening this discussion. EASL looks forward to continuing to work with WHO and partners to turn research priorities into prevention in practice.
🎥 Watch the full webinar: www.youtube.com/watch?v=KByNuHjj570
#easl #iarc #livercancer #cancerprevention #publichealth #liverhealth
@DebbieShawcros1 -
EASLnews
@EASLnews
💚 Barcelona, it's time to Love Your Liver!
We're at #uegweek2026, bringing liver health awareness and prevention directly to the public!
As part of our #loveyourliver initiative, EASL, in collaboration with United European Gastroenterology (UEG), is offering free, quick and non-invasive liver health testing outside Fira Barcelona Gran Via.
🩺 Free liver health testing, no appointment needed
👥 Open to everyone
📍 Location: North Entrance, Fira Barcelona Gran Via
📅 19 October: 09:00–18:00
📅 20 October: 09:00–12:00
Liver diseases can develop silently, making awareness and early detection essential. Taking a few minutes to check your liver health can be an important first step towards prevention.
💚 If you're in Barcelona, come and visit us! Let's put liver health in the spotlight, together.
👉Watch the video: x.com/lhdigitalh/status/2111779884251189632
👉en.ara.cat/society/free-tests-to-detect-liver-diseases-in…
👉beteve.cat/societat/prova-cinc-minuts-gratuita-prevencio-…
🔗 Find out more: ueg.eu/week/in-person-networking
#loveyourliver #uegweek #liverhealth #liverdiseaseawareness #easl #firabarcelona
LHdigital
@lhdigitalh
#salutlh | Centenars de persones es fan proves gratuïtes de fetge a la Fira
🩺Les elastografies s’emmarquen en el context del Congrés Europeu de Gastroenterologia
lhdigital.cat/noticies/centenars-de-persones-es-fan-prove… -
EASLnews
@EASLnews
Your next opportunity to connect with the liver cancer community is approaching!
Join us at the EASL Liver Cancer Summit 2027 to explore emerging evidence, exchange perspectives across disciplines and discuss advances in liver cancer management.
⏰ Early registration fees are available until tomorrow, 20 October.
📍 Valencia, 14-16 January 2027
Secure your place: easl.eu/event/easl-liver-cancer-summit-2027/
Learn more: easl.eu/event/easl-liver-cancer-summit-2027/
#livercancersummit -
EASLnews
@EASLnews
⏳ The countdown is on! There’s still time to apply to host an EASL School in 2028. Showcase your institution’s expertise and help shape the future of liver education. Apply by 26 October!
Read more: easl.eu/events/easl-courses-schools-masterclasses/ -
EASLnews
@EASLnews
🔬 HCC without underlying liver disease: What are the challenges?
Join our upcoming Molecular Tumour Board to explore the molecular characteristics of hepatocellular carcinoma, strategies for managing high-risk recurrence, and the potential role of liver transplantation in selected patients.
📅 Don’t miss this case-based expert discussion! Live on Wednesday, 28 October 2026.
Register now: easl-eu.zoom.us/webinar/register/7517912027060/WN_nRVLJgk… -
EASLnews
@EASLnews
🔬 What's next in the multidisciplinary treatment of primary liver cancers?
From radiotherapy and perioperative strategies to innovative combinations of locoregional and systemic treatments, discover the advances shaping care for hepatocellular carcinoma (HCC) and biliary tract cancers (BTC).
Join leading experts to explore the latest evidence and opportunities to improve patient outcomes.
👉 Discover the programme at EASL #livercancersummit 2027 and join the discussion! easl.eu/event/easl-liver-cancer-summit-2027/ -
EASLnews
@EASLnews
New episode out! Tune in #talklivertome for a discussion on psychohepatology, the gut–liver–brain axis, addiction biology, trauma, PTSD, and integrated approaches to care.
Listen now on EASL Campus: easlcampus.eu/tltm/episode-19
Also on Spotify and Apple Podcasts!
Host an EASL School in 2028: easl.eu/what-we-do/education/schools/This media couldn't be displayed. See it on the original post. -
EASLnews
@EASLnews
EASL in Action in Central Africa! ❤️
Liver health awareness starts with education, and young people have a vital role to play!
We are delighted to spotlight Lesly Kengne Djidjou, a medical student and passionate liver health advocate, who recently led an EASL #loveyourliver educational campaign at St. Paul’s College in Cameroon.
Together with 15 medical student volunteers, Lesly brought liver health education directly to young people, delivering engaging awareness sessions focused on liver health literacy, viral hepatitis prevention and the importance of tackling stigma.
🗣️“I go to medical school to get my degree, but I go into the community to find my purpose. Taking care of your personal health is vital, but advocating for the health of your community is an absolute act of justice, you do not need to be a doctor to do that. It simply takes the courage to get the facts right, break the silence, and protect the lives in our communities "
👏A huge thank you to Lesly and all the volunteers for their dedication to improving liver health awareness in Cameroon!
🌍 Together, we can build a future where everyone has the knowledge to protect their liver health.
👉More about EASL Love Your Liver: easl.eu/what-we-do/policy-public-health-and-advocacy/love…
@Solda_Society @WorldLiverDay -
EASLnews
@EASLnews
Nominations and applications are now open for three prestigious EASL awards:
▪️EASL Community Award 2027
▪️EASL Emerging Leader Award 2027
▪️EASL Excellence in Liver Care Award 2027
These awards recognise excellence, leadership, and contributions to advancing liver health.
Apply or nominate a colleague by 24 November.
Learn more about eligibility and how to apply: easl.eu/awards-2027/ -
EASLnews
@EASLnews
One global community. Four days of science. Countless opportunities to connect.
Join 8,500+ liver health professionals at EASL Congress 2027 in London!
Discover new research, exchange knowledge across specialties and connect with colleagues working to advance liver health worldwide.
📍 London, United Kingdom
📅 16-19 June 2027
Submit your abstract by 19 January
Register with early fees by 25 January
Discover EASL Congress 2027: www.easlcongress.eu
#easlcongress -
EASLnews
@EASLnews
🚨 LAST CHANCE! Today, 13 October, is your final opportunity to submit your abstract for the EASL #livercancersummit 2027!
From tumour biology and early detection to precision oncology and next-generation therapies, the EASL Liver Cancer Summit 2027 will bring together a multidisciplinary community to explore the latest research, exchange knowledge and translate progress into clinical practice.
📍 Valencia, Spain
📅 14–16 January 2027
💡 Your research could help drive the next breakthrough in liver cancer. Don't miss the opportunity to share your findings, contribute to scientific discussions and connect with experts from across the field.
👉Submit now: easl.eu/event/easl-liver-cancer-summit-2027/ -
EASLnews
@EASLnews
💙 Advancing research to prevent liver cancer
October marks Liver Cancer Awareness Month, an opportunity to highlight the importance of research, innovation and collaboration in reducing the global burden of liver cancer.
Join the International Agency for Research on Cancer (IARC/WHO) for an upcoming webinar exploring key research priorities for liver cancer prevention and how evidence can help inform policy and practice.
📅 14 October 2026
🕒 15:00 to 16:00 CET
💻 Online via Microsoft Teams
At EASL, we recognise the importance of advancing prevention strategies and translating scientific evidence into meaningful improvements in liver health.
🔗 Register now and be part of the conversation: events.teams.microsoft.com/event/242bb359-d9fd-4365-bc2e-… -
EASLnews
@EASLnews
⏰ Last chance to submit your research!
Abstract submissions for the EASL Liver Cancer Summit 2027 close tomorrow, 13 October.
Bring your latest findings to Valencia and contribute to the multidisciplinary discussions advancing liver cancer research and care.
📍 Valencia, Spain
📅 14-16 January 2027
Submit your abstract today: easl.eu/event/easl-liver-cancer-summit-2027/
Learn more: easl.eu/event/easl-liver-cancer-summit-2027/ -
EASLnews
@EASLnews
Are we overlooking mental health in liver disease care?
In this episode of #talklivertome we explore psychohepatology, from the gut–liver–brain axis to the links between liver disease, addiction, trauma, depression, and anxiety.
easl.eu/event/psychohepatology-are-we-overlooking-mental-…
Host an EASL School in 2028: easl.eu/what-we-do/education/schools/This media couldn't be displayed. See it on the original post. -
EASLnews
@EASLnews
Module 2 of the EASL MASLD Guidelines Academy took place on 8-9 October in Antwerp, Belgium, taking participants on a deeper dive into MASLD.
Expert-led sessions explored MASLD pathophysiology and its links with cardiovascular disease. Clinical cases and interactive workshops also examined the role of liver biopsy and non-invasive tests in clinical practice.
#livertwitter #liverx -
EASLnews
@EASLnews
Applications are open to host an EASL School in 2028! We are looking for innovative Clinical and Experimental & Translational Science School proposals from leading European institutions. Apply by 26 October!
Read more: easl.eu/events/easl-courses-schools-masterclasses/ -
EASLnews
@EASLnews
🔬 What's next for the management of PBC and PSC?
The scientific discussions continue at #slm2026 in Riyadh!
Today, EASL Vice-Secretary Ana Lleo de Nalda takes the stage to explore “Primary Biliary Cholangitis (PBC) and Primary Sclerosing Cholangitis (PSC): Risk Stratification or New Treatments”.
An important opportunity to discuss evolving approaches to risk assessment and the therapeutic landscape for patients living with these chronic liver diseases.
@sasltksa @analleo -
EASLnews
@EASLnews
🔬 Advancing the management of hepatitis B and Delta at #slm2026!
The SASLT / EASL Joint Symposium continues in Riyadh, with EASL Sabela Lens discussing “Hepatitis B and Delta: Diagnosis/Management and New Therapies”.
With the evolving therapeutic landscape for viral hepatitis, scientific exchange and continued education are key to improving diagnosis, treatment and patient outcomes.
@SaSi_Lens @sasltksa -
EASLnews
@EASLnews
💭 When is liver transplantation the right option for patients with ACLF?
An important clinical question being explored today at #slm2026 in Riyadh!
During the SASLT / EASL Joint Symposium, EASL Secretary General Debbie Shawcross addresses “Acute Chronic Liver Failure (ACLF): When to Transplant and When Not?”
A valuable discussion on one of the most complex decisions in hepatology, highlighting the importance of careful patient assessment and clinical decision-making.
@sasltksa @DebbieShawcros1 @analleo @SaSi_Lens @fprusso73 -
EASLnews
@EASLnews
💡 MASLD and liver transplantation: an important conversation at #slm2026!
Today in Riyadh, EASL Francesco Paolo Russo contributes to the SASLT / EASL / UCHID School of Hepatology with a session dedicated to MASLD and liver transplantation.
As MASLD becomes an increasingly important consideration in liver transplantation, sharing clinical expertise and discussing approaches to patient management is essential.
@sasltksa @DebbieShawcros1 @analleo @SaSi_Lens @fprusso73 -
EASLnews
@EASLnews
🔬 Three organisations, one shared commitment to advancing hepatology!
The SASLT / EASL / UCHID School of Hepatology is taking place today at #slm2026 in Riyadh!
This afternoon's programme brings together international experts for practical discussions on metabolic dysfunction-associated steatotic liver disease (MASLD), covering diagnosis, non-invasive testing, therapeutic approaches, portal hypertension and liver transplantation.
👏 We are proud to collaborate with SASLT and UCHID on this educational initiative, fostering scientific exchange and supporting better liver care through shared expertise.
@sasltksa @UCHID_eg @DebbieShawcros1 @analleo @SaSi_Lens @fprusso73 -
EASLnews
@EASLnews
📍 EASL is in Riyadh for #slm2026! 🇸🇦
The Saudi Liver Meeting 2026 kicks off today, bringing together the hepatology community to exchange knowledge, share expertise and advance liver care.
We are delighted to be part of this important meeting, organised by the Saudi Society for the Study of Liver Diseases and Transplantation (@sasltksa), and to contribute to a programme of scientific discussions and international collaboration.
👏 Thank you to SASLT for bringing the liver community together. We look forward to two inspiring days in Riyadh!
Stay tuned for updates from #slm2026!
@DebbieShawcros1 @analleo @SaSi_Lens @fprusso73 -
EASLnews
@EASLnews
You can still register for today's DeepDive webinar on the latest updates in the EASL CPGs on the management of hepatocellular carcinoma! The discussion will include diagnostic strategies, selection of candidates for surgery and locoregional therapies, and treatment adaptation according to response to systemic therapy.
📅TODAY, 7 October, 18:00 CEST
🔗 easl-eu.zoom.us/webinar/register/4517885096246/WN_wP9f-_T… -
EASLnews
@EASLnews
We are excited to announce the launch of the call for nominations and applications for three prestigious awards:
- EASL Community Award 2027
- EASL Emerging Leader Award 2027
- EASL Excellence in Liver Care Award 2027
These awards recognise outstanding contributions and leadership in the field of hepatology. We encourage individuals who have demonstrated excellence, innovation, and a commitment to advancing liver health to apply.
Apply by 24 November to showcase your achievements and gain recognition within the EASL community.
🔗 easl.eu/awards-2027/ -
EASLnews
@EASLnews
Alcohol can harm children long before they ever take a drink.
As a founding member of the European Health Alliance on Alcohol (EHAA), EASL is committed to protecting children from alcohol-related harm. On 11 October, our EHAA partners will meet at the World Health Summit in Berlin for a child-centred discussion that takes the issue from children's rights to public policy.
Alcohol affects children through three pathways that are too often discussed separately:
🔹 Before birth: prenatal alcohol exposure
🔹 At home: parental alcohol use and the family environment
🔹 During adolescence: alcohol and the still-developing brain
This session brings them together, from children's rights to public policy.
For hepatologists, this matters too. Protecting children from alcohol today is part of preventing alcohol-related liver disease tomorrow.
📍 Protecting Children from Alcohol-Related Harm: From Children's Rights to Public Policy
🗓 11 October 2026, 14:00–15:30 CEST
📌 World Health Summit side meeting, Berlin
Before birth. At home. During adolescence.
#ehaa #whs2026 #alcoholpolicy #childhealth #liverhealth #publichealth -
EASLnews
@EASLnews
The EASL Experimental & Translational Science School: The Spatial Biology of Liver Disease just ended after two great days of learning and networking in Utrecht, the Netherlands! 🔥
Participants came together for hands-on training, expert insights, and collaborative problem-solving around cutting-edge spatial omics technologies in liver research.
From Hyperion, CosMx/GeoMx and MALDI imaging to the Spatial Liver Biology Hackathon, this EASL School offered an inspiring two days of learning, exchange, and innovation.
#livertwitter #liverx -
EASLnews
@EASLnews
Apply now for the EASL Schools 2027! Here are the various opportunities:
• Infections in advanced chronic liver diseases, 4-5 June 2027, Zagreb (Croatia)
• Challenges in the treatment of hepatocellular carcinoma, 25-26 June 2027, Madrid (Spain)
• EASL Bootcamp: bridging the gap between science & medicine in hepatology, 16-18 September 2027 Rotterdam (the Netherlands)
• Portal Hypertension, 23-24 September 2027, Vienna (Austria)
Choose wisely and submit your application by Monday 5 October!
🔗 easl.eu/what-we-do/education/schools -
EASLnews
@EASLnews
The liver cancer community is coming together at the EASL #livercancersummit 2027!
📅 14–16 January 2027
📍 Valencia, Spain
Join experts from across the field to explore the latest advances in basic, translational and clinical liver cancer research, and their potential to transform patient care.
📣 Two important deadlines are approaching:
🔬 Submit your abstract by 13 October
🎟️ Register with early fees by 20 October
Share your research, exchange knowledge and be part of the conversations shaping the future of liver cancer care.
👉 Learn more, submit your abstract and register: easl.eu/event/easl-liver-cancer-summit-2027/
@DebbieShawcros1 @analleo @PinterMatthias @CrocettiLaura @SaborowskiAnna -
EASLnews
@EASLnews
Join the EASL education mission. Submit your proposal for an EASL School 2028 and help deliver world-class training in liver disease and liver research. Apply by 26 October!
Read more: easl.eu/events/easl-courses-schools-masterclasses/ -
EASLnews
@EASLnews
What if the future of hepatology is not just about treating liver disease, but preventing it before it starts?
Liver health is shaped by far more than what happens in the clinic. Alcohol, nutrition, metabolic health, socioeconomic inequalities, stigma, commercial influences and public policy all play a role in who develops liver disease, and who gets diagnosed in time.
That's why preventive hepatology matters. But the question many clinicians ask us is: what can I actually do about that from my clinic?
🎯 The new EASL Preventive Hepatology Course sets out to answer exactly that. Built on the roadmap of the EASL–Lancet Commission 2.0, it gives hepatologists and allied health professionals:
→ The latest evidence on social and commercial determinants as drivers of liver disease
→ A clear view of which policies genuinely work, and which don't
→ Practical tools to bring prevention and early detection into everyday practice
→ A way into advocacy, for those who want to go further and get involved
Clinicians are among the most trusted voices in health policy. This free course is about helping that voice carry further.
👉 Module 1 is open now: easlcampus.eu/course/preventive-hepatology-course
Prevention starts with knowledge. Let's put it at the heart of liver health.
#hepatology #preventivehepatology #liverhealth #publichealth #easl -
EASLnews
@EASLnews
Register now for next week's EASL DeepDive! Experts Josep Maria Argemi, Vincenzo Mazzaferro, Maria Reig and Maxime Ronot will discuss recent developments in the EASL Clinical Practice Guidelines, with a focus on diagnostic strategies, identifying appropriate candidates for surgery and locoregional therapies, and adapting treatment plans based on outcomes of systemic therapy.
📅7 October, 18:00 CEST
🔗 easl-eu.zoom.us/webinar/register/4517885096246/WN_wP9f-_T… -
EASLnews
@EASLnews
🔎EASL invites the hepatology community to participate in the European Endohepatology Practice Survey (EU-ENDOHEP Survey), supported by the ESGE Special Interest Group on HPB and disseminated with the support of EASL which aims to map current practice across Europe and identify key barriers, training needs and future priorities.
Whether your centre performs, refers for, is considering, or does not currently use endohepatology techniques, your perspective matters. Your input will help inform future European training, research, registries and guidance in this emerging field.
👉Complete the survey by 31 October 2026. It takes approximately 10 minutes for non-operators and 25 minutes for operators.
www.surveymonkey.com/r/RD5RMGR -
EASLnews
@EASLnews
The deadline for the EASL Schools 2027 has been extended! Time to fine tune your applications and submit them on 5 October!
🔗 easl.eu/what-we-do/education/schools -
EASLnews
@EASLnews
In this new episode of #talklivertome, experts discuss the practical use of resmetirom and semaglutide, based on the 2026 EASL–EASD–EASO Guidance.
Who should be treated, when should therapy start, and how should response be monitored?
Listen on EASL Campus: easlcampus.eu/tltm/episode-18
Also on Spotify: open.spotify.com/episode/4WtOIuEiHPKr0WSeC03geg
and Apple Podcasts: podcasts.apple.com/ch/podcast/resmetirom-and-semaglutide-… -
EASLnews
@EASLnews
🎆Registration and abstract submission are now open for EASL Congress 2027! 🎆
Join the global hepatology community in London, United Kingdom, from 16 to 19 June 2027, for four inspiring days of cutting-edge science, meaningful exchange and new opportunities to connect, collaborate and shape the future of hepatology.
Be a part of this unmissable event.
🔎easlcongress.eu
👉Register with early fees by 19 January: www.easlcongress.eu/registration/
👉Submit your abstract by 25 January: www.easlcongress.eu/abstracts/
📽️youtu.be/v64-u-qcsug -
EASLnews
@EASLnews
Resmetirom and semaglutide are changing the treatment landscape for MASH, but how should they be used in practice?🤔
Tune in to #talklivertome this Wednesday for a practical discussion on treatment initiation, monitoring, and efficacy assessment, based on the 2026 EASL–EASD–EASO Guidance.
Read more: easl.eu/event/resmetirom-and-semaglutide-in-mash-who-when…This media couldn't be displayed. See it on the original post. -
EASLnews
@EASLnews
Health effects associated with alcohol consumption: A burden of proof study
New evidence from the Institute for Health Metrics and Evaluation (IHME), published in Nature Health, offers one of the most comprehensive and conservative assessments to date of how alcohol affects health.
Drawing on 843 cohort and case-control studies across 20 health outcomes, the analysis finds that current alcohol consumption is associated with increased risk of ten cancers, including breast, colorectal, oesophageal, liver and stomach cancer, as well as pancreatitis, chronic liver disease, tuberculosis, lower respiratory infections and atrial fibrillation. At higher levels of consumption, risk increases across every outcome examined.
For some cardiometabolic conditions the observational evidence remains mixed at low levels. But the overall picture is clear: alcohol is a significant and preventable driver of disease across the population, and cancer risk rises even at low levels of consumption.
Drinking guidelines across Europe still vary widely, and many do not reflect this evidence. EASL calls on EU institutions and Member States to act on the science, through clear health information on labels and effective, evidence-based measures on price, availability and marketing.
🎥 Watch IHME's summary of the study: youtu.be/CLGBUQ0vScs
🔗 Read the study: www.healthdata.org/research-analysis/library/health-effec…
Institute for Health Metrics and Evaluation (IHME)
#easl #publichealth #alcohol #alcoholpolicy #cancerprevention #ncds -
EASLnews reposted
United European Gastroenterology
@my_ueg
Free liver health testing at UEG Week: Love Your Liver is a @EASLnews public health awareness initiative right in the heart of UEG Week – open to delegates, venue staff, and the local community.
🔗 Learn more: ueg.eu/week/in-person-networking
Kindly supported by Boehringer Ingelheim. -
EASLnews
@EASLnews
Host an EASL School and showcase your institution’s expertise to an international audience. Applications for 2028 are now open. Apply by 26 October! One month left!
Read more: easl.eu/events/easl-courses-schools-masterclasses/ -
EASLnews
@EASLnews
Last week, Module 5 of the EASL MASLD Guidelines Academy took place in Pamplona, Spain. The event brought together 21 nurses, allied health professionals and hepatologists for two days of learning, collaboration and discussion on the implementation of the MASLD Guidelines.
#livertwitter #liverxThis media couldn't be displayed. See it on the original post. -
EASLnews
@EASLnews
Join our next EASL DeepDive to examine key updates from the EASL Clinical Practice Guidelines, including diagnostic strategies, selection of candidates for surgery and locoregional therapies, and treatment adaptation according to response to systemic therapy.
📅7 October, 18:00 CEST
🔗 easl-eu.zoom.us/webinar/register/8317895719849/WN_wP9f-_T… -
EASLnews
@EASLnews
Less than a week left to apply to one of the 2027 EASL Schools! Next year, we're excited to be hosting the following opportunities:
• Infections in advanced chronic liver diseases, 4-5 June 2027, Zagreb (Croatia)
• Challenges in the treatment of hepatocellular carcinoma, 25-26 June 2027, Madrid (Spain)
• EASL Bootcamp: bridging the gap between science & medicine in hepatology, 16-18 September 2027 Rotterdam (the Netherlands)
• Portal Hypertension, 23-24 September 2027, Vienna (Austria)
Choose wisely and submit your application by Monday 28 September, 23:59 CEST!
🔗 easl.eu/events/easl-courses-schools-masterclasses/ -
EASLnews
@EASLnews
🤔What if we could see not only which cells make up a liver tumour, but where they are, how they interact, and how those interactions influence disease and treatment?
At the upcoming #livercancersummit on 14-16 January in Valencia, discover how spatial transcriptomics is bringing the tumour microenvironment into sharper focus, revealing the intricate crosstalk between malignant, immune, and stromal cells.
This session will explore how spatially resolved insights can advance biomarker discovery, refine patient stratification, and uncover actionable cellular niches, opening new possibilities for more precisely targeted therapies in liver malignancies.
👉Submit your abstract by 13 October easl.eu/event/easl-liver-cancer-summit-2027/
👉Secure your spot with early fees by 20 October easl.eu/event/easl-liver-cancer-summit-2027/ -
EASLnews
@EASLnews
🌍 EASL was proud to take part in the 9th Conference on Liver Disease in Africa (COLDA), held on 17-19 September 2026 in Addis Ababa, Ethiopia.
EASL Secretary General Prof. Debbie Shawcross, Prof. Francesco Paolo Russo and Prof. Sabela Lens joined colleagues from across Africa and the international hepatology community for three days of scientific exchange and collaboration.
#colda2026 provided an important platform for clinicians, researchers, policymakers and healthcare professionals to share knowledge and discuss the latest developments in the prevention, diagnosis and treatment of liver disease, with a particular focus on the African context.
A warm thank you to SOLDA, the COLDA organisers, speakers, participants and the wider community for an inspiring meeting and for continuing to strengthen collaboration and liver health across Africa.
**
🎙️ We continue the discussions at COLDA with the latest episode of EASL’s Talk Liver To Me podcast, dedicated to the burden of liver disease across Africa.
Hosted by Debbie Shawcross, with guests Wendy Spearman (University of Cape Town), Kwame Asomoah (University of Ghana Business School), the episode explores the evolving epidemiology of liver disease across the continent, including viral hepatitis, MASLD and HCC, as well as priorities for prevention, early detection and equitable access to care.
🎧 Listen to Episode 17, “Africa’s Liver Crisis: Why Is No One Talking About It?”: easlcampus.eu/tltm/episode-17
@DebbieShawcros1 @SaSi_Lens @fprusso73 @wendy_spearman @EASLedu -
EASLnews
@EASLnews
Module 5 of the EASL MASLD Guidelines Academy took place on 17–18 September in Pamplona, Spain, bringing together 21 nurses, allied health professionals and hepatologists.
Through clinical cases, role-play and hands-on training, participants explored multidisciplinary, patient-centred MASLD care, from behavioural change and nutrition to patient phenotyping, non-invasive assessment and evidence-based treatment.
Thank you to all participants for their engagement and contributions to advancing multidisciplinary care in liver health!
#livertwitter #liverx -
EASLnews
@EASLnews
Clinical or Experimental & Translational Science? We’re looking for engaging, hands-on EASL School programmes that inspire and educate future leaders in hepatology for 2028. Apply by 26 October!
Read more: easl.eu/events/easl-courses-schools-masterclasses/ -
EASLnews
@EASLnews
Discover our podcast series, Talk Liver to Me! Tune in to listen to interviews, debates, expert perspectives, and thematic episodes in a short, engaging, and easy-to-digest format. Available now on EASL Campus, Spotify and Apple Podcasts!
Learn more: easl.eu/what-we-do/education/tltm/ -
EASLnews
@EASLnews
Africa carries a major burden of liver disease but the crisis remains too often under-recognised.
That is why, in this episode, we address the drivers of liver disease across the continent, from viral hepatitis and MASLD to hepatocellular carcinoma, and ask what is needed to improve prevention, diagnosis, and care.
Listen on EASL Campus: easlcampus.eu/tltm/episode-17
Also on Spotify: open.spotify.com/episode/4u6tG5C8Srvag2U3qio5cD
and Apple Podcasts: podcasts.apple.com/ch/podcast/talk-liver-to-me-africas-li… -
EASLnews
@EASLnews
Make education your priority with the EASL Schools 2027!
Choose from three clinical schools and one basic science school — and apply today!
Deadline: 28 September
🔗 easl.eu/events/easl-courses-schools-masterclasses/ -
EASLnews
@EASLnews
Why is no one talking about Africa’s liver disease burden?
Tune in to #talklivertome this Wednesday for a discussion on the evolving epidemiology of liver disease across Africa, including viral hepatitis, MASLD, HCC, gaps in surveillance, and barriers to equitable care.
Read more: easl.eu/event/africas-liver-crisis-why-is-no-one-talking-…This media couldn't be displayed. See it on the original post. -
EASLnews
@EASLnews
EASL is seeking applications from leading European institutions to host EASL Schools in 2028. Regional collaborations are encouraged! 🤝Apply by 26 October!
Read more: easl.eu/events/easl-courses-schools-masterclasses/ -
EASLnews
@EASLnews
Test your guidelines knowledge as we explore today the case of a 32-year-old man who was referred for evaluation of elevated liver enzymes, hyperferritinaemia, and hepatic steatosis identified on ultrasound.
This EASL Quiz was developed in collaboration with ESPGHAN.
Play here: -
EASLnews
@EASLnews
On 27–28 August, the first module of the EASL MASLD Guidelines Academy 2026 brought together 26 participants from 20 countries in Angers, France. This programme is dedicated to supporting the implementation of MASLD guidelines in clinical practice and strengthening expertise across Europe and beyond.
#livertwitter #liverxThis media couldn't be displayed. See it on the original post. -
EASLnews
@EASLnews
There's still time for your to register for tonight's EASL DeepDive webinar on the role of genetic testing in the diagnosis of Progressive Familial Intrahepatic Cholestasis!
📅 TODAY, Wednesday 9 September 2026 at 18:00 CEST
🔗 easl-eu.zoom.us/webinar/register/1817872116967/WN_lEsqVOR… -
EASLnews
@EASLnews
Do you want hands-on experience with the latest techniques? Are you ready to connect with leading experts and peers across Europe? If so, the EASL Schools are for you!
Discover next year's four EASL Schools:
• Infections in advanced chronic liver diseases, 4-5 June 2027, Zagreb (Croatia)
• Challenges in the treatment of hepatocellular carcinoma, 25-26 June 2027, Madrid (Spain)
• EASL Bootcamp: bridging the gap between science & medicine in hepatology, 16-18 September 2027 Rotterdam (the Netherlands)
• Portal Hypertension, 23-24 September 2027, Vienna (Austria)
Which one interests you the most? You have until 28 September to decide and apply!
🔗 easl.eu/events/easl-courses-schools-masterclasses/ -
EASLnews
@EASLnews
Do you have an idea for an innovative Clinical or Experimental & Translational Science EASL School? Successful proposals receive dedicated EASL funding and organisational support. Apply by 26 October!
Read more: easl.eu/events/easl-courses-schools-masterclasses/ -
EASLnews
@EASLnews
Genetic testing is transforming the diagnostic approach to rare liver diseases.
In next week's webinar, discover how modern genomic technologies can support the diagnosis of #pfic, how to navigate challenging genetic findings, and what emerging advances could mean for the future of hepatology. 🧬
📅 Wednesday 9 September 2026 at 18:00 CEST
🔗 easl-eu.zoom.us/webinar/register/1817872116967/WN_lEsqVOR… -
EASLnews
@EASLnews
What should clinicians prioritise in the critical early stages of acute liver failure, and what should be avoided?
Tune in to #talklivertome for a practical discussion on the dos and don’ts of ALF management, including recognition, initial work-up, escalation, and referral to specialist centres.
Now on EASL Campus: easlcampus.eu/tltm/episode-16
Spotify: open.spotify.com/episode/7I4fXDU4kf41eIFWILdrky
Apple Podcasts: podcasts.apple.com/us/podcast/talk-liver-to-me-what-are-t… -
EASLnews
@EASLnews
The EASL Schools 2027 applications are open! Four unique learning opportunities await you, including this School on Portal Hypertension (23-24 September 2027, Vienna, Austria).
The aim of this School is to foster a new generation of physicians and physician-scientists working in the field of ACLD/PSVD who are highly skilled in portal hypertension.
Organisers Lorenz Balcar, Annalisa Berzigotti, Virginia Hernández-Gea, Mattias Mandorfer and Thomas Reiberger are looking forward to meeting and exchanging with you!
Read more and submit your application by 28 September: easl.eu/event/portal-hypertension-2027/ -
EASLnews
@EASLnews
In May 2026, the 79th World Health Assembly adopted WHA79 — the first global resolution dedicated to steatotic liver disease. It was led by Egypt and co-sponsored by 19 Member States. Writing now in the Journal of Hepatology, the resolution's architects reflect on what it means and what must follow.
Professor Khaled Abdel-Ghaffar, Egypt's Minister of Health and Population, alongside Dr. El Amira Rashwan and Prof. Mohamed Hassany, set out the case plainly. SLD affects around 1.7 billion people. It is among the fastest-growing chronic liver diseases. And until this year, it sat largely outside the global NCD architecture.
Egypt's leadership here is worth pausing on. A country that has already shown the world what is possible in liver health — through one of the most ambitious viral hepatitis elimination programmes ever undertaken — has now used that experience and standing to put steatotic liver disease on the global agenda. Placing SLD before the World Health Assembly and building a coalition of co-sponsors around it took sustained diplomatic effort. It is a reminder that global health priorities do not shift on evidence alone; they shift when a Member State decides to carry them.
WHA79 changes the landscape. By situating SLD within the noncommunicable disease agenda — alongside obesity, type 2 diabetes, cardiovascular disease and chronic kidney disease, with which it shares its principal drivers — the resolution enables prevention strategies that address several conditions at once rather than in isolation.
The authors are equally clear about the work ahead. Member States are asked to integrate SLD into national NCD plans with monitoring frameworks, build surveillance into existing NCD systems, bring prevention and screening into essential service packages, train the health workforce, and mobilise financing. Primary care is identified as the critical entry point.
Their closing argument deserves attention: a resolution is not an outcome. Implementation will depend on sustained political commitment, adequate resourcing, and a hepatology community willing to serve as both advocate and technical adviser to governments now writing this into national policy.
EASL shares that view — and, through our partnership in the WHO Collaborating Centre on Steatotic Liver Diseases, is working to support Member States across the European Region in doing exactly that.
📖 Read the full letter in the Journal of Hepatology: www.journal-of-hepatology.eu/article/S0168-8278(26)02752-…
#steatoticliverdisease #masld #globalhealth #wha79 #ncds #hepatology -
EASLnews
@EASLnews
This episode of #talklivertome explores the practical dos and don’ts of acute liver failure care, using case-based discussion to highlight what matters most in the critical early stages.
Out this Wednesday!
Read more: easl.eu/event/what-are-the-dos-and-donts-in-acute-liver-f… -
EASLnews reposted
EASL Education
@EASLedu
✨The EASL MASLD Guidelines Academy 2026 starts today!
26 participants from 20 countries have come together in Angers for Module 1: The basics of MASLD, kicking off a five-module learning journey.
Over the next two days, they’ll explore everything from pathophysiology and epidemiology to screening, non-invasive tests and hands-on liver elastography.
The first step in a programme designed to turn the latest #masld guidance into practical clinical knowledge and skills.
Welcome to all our participants and faculty! 👏
ℹ️easl.eu/easl-masld-guidelines-academy/
#liverx -
EASLnews
@EASLnews
The first module of the EASL MASLD Guidelines Academy 2026 took place on 27–28 August in Angers, France, bringing together 26 participants from 20 countries.
Over two days, participants explored the fundamentals of MASLD, from pathophysiology and epidemiology to screening, non-invasive testing and risk stratification, complemented by practical workshops on liver elastography and the implementation of screening pathways.
Module 1 marks the first step in a five-module programme designed to translate MASLD guidelines into clinical practice.
#livertwitter #liverx @EASLedu -
EASLnews
@EASLnews
Ready to shape the future of liver education? Host an EASL School in 2028 and bring together the next generation of hepatology experts. Apply now by 26 October!
More information: easl.eu/events/easl-courses-schools-masterclasses/ -
EASLnews
@EASLnews
Liver health starts before disease reaches its most advanced stages.
The EASL Preventive Hepatology Course draws on the latest findings from the EASL–Lancet Commission 2.0 to explore how we can shift liver care towards prevention, early detection and health equity.
From commercial and social determinants of health to stigma, unhealthy diets, alcohol-related harm and socioeconomic inequalities, the course examines the factors shaping liver disease and what healthcare professionals can do about them.
🎓 Gain the evidence, tools and practical strategies to bring preventive hepatology into everyday practice.
easlcampus.eu/courses/course/view.php?id=106 -
EASLnews
@EASLnews
From suspicion to genetic diagnosis 🔬
In the next EASL DeepDive, explore how genetic testing can support the diagnosis of #pfic, including:
🧬 Key genetic drivers
🔎 Modern testing approaches
🩺 Positioning testing in the diagnostic pathway
🧩 Interpreting findings in the clinical context
📅 Wednesday 9 September 2026 at 18:00 CEST
🔗 easl-eu.zoom.us/webinar/register/1817872116967/WN_lEsqVOR… -
EASLnews
@EASLnews
The EASL Schools 2027 applications are open! Four unique learning opportunities await you, including the EASL Bootcamp: bridging the gap between science & medicine in hepatology (16-18 September 2027, Rotterdam, the Netherlands).
This new format is designed to help scientists become familiar with clinical terminology, while also enabling clinicians to understand the principles of basic research, including experimental design, commonly used techniques (such as molecular biology, spatial biology and experimental models), and how to interpret scientific results. You will step beyond your comfort zone: scientists will learn how patients are diagnosed and treated, while clinicians will gain hands-on insight into the experimental tools driving discovery.
Organisers André Boonstra, Shilpa Chokshi, Robert de Knegt and Krista Rombouts are looking forward to meeting and exchanging with you!
Read more and submit your application by 28 September: easl.eu/event/easl-bootcamp-2027/ -
EASLnews
@EASLnews
⭐️The EASL #livercancersummit 2027 in Valencia, Spain brings together the liver cancer community to explore the latest advances in basic, translational, and clinical research, and their potential to transform patient care.
Spanning the full continuum of primary liver cancers, the programme takes you from prevention and early detection to innovative treatment strategies and long-term patient management.
Join experts and peers from across the field to exchange knowledge, foster collaboration, and accelerate progress towards better outcomes for patients with liver cancer.
🗣️“It is an opportunity for all of us to increase our knowledge in the management of these diseases - you cannot miss it.”
👉Early registration fee until 20 October: easl.eu/event/liver-cancer-summit-2027/registration/
👉Abstract submission until 13 October: easl.eu/event/liver-cancer-summit-2027/abstracts/
👉Scientific Programme: easl.eu/event/liver-cancer-summit-2027/scientific-programme/
@PinterMatthias @SaborowskiAnna @DebbieShawcros1 @analleoThis media couldn't be displayed. See it on the original post. -
EASLnews
@EASLnews
🧬 When should genetic testing be used in suspected #pfic and how should the results be interpreted?
Join this #easldeepdive webinar for a practical look at the genetic drivers of PFIC, modern diagnostic testing, common interpretation challenges and emerging trends in genomic diagnostics.
📅 Wednesday 9 September 2026 at 18:00 CEST
🔗 easl-eu.zoom.us/webinar/register/1817872116967/WN_lEsqVOR… -
EASLnews
@EASLnews
📢 Applications are now open to host an EASL School in 2028! If you're an EASL member at a European centre of excellence, submit your proposal by 26 October!
More information: easl.eu/events/easl-courses-schools-masterclasses/ -
EASLnews
@EASLnews
⏳ The countdown is on!
Applications for the EASL Mobility & Research Fellowship Programme close on 1 September 2026.
Whether you're looking to gain experience at a leading European institution through a Mobility Fellowship or pursue an innovative liver disease research project through a Research Fellowship, don't miss this opportunity to advance your career.
Apply now: easl.eu/fellowship/mobility-research-fellowship-programme/ -
EASLnews
@EASLnews
Endohepatology promises a more integrated approach to liver disease assessment.
But does combining EUS-guided biopsy, portal pressure measurement, and variceal evaluation in one session represent meaningful progress or premature adoption?
Listen to the latest #talklivertome to find out!
Now on EASL Campus: easlcampus.eu/tltm/episode-15
Spotify: open.spotify.com/episode/1xzfAPKcs9W8nzHSiATjjn
Apple Podcasts: podcasts.apple.com/us/podcast/talk-liver-to-me-endohepato… -
EASLnews
@EASLnews
The EASL Schools 2027 applications are open! Four unique learning opportunities await you, including this School on Challenges in the treatment of hepatocellular carcinoma (25-26 June 2027, Madrid, Spain).
This EASL School focusses on the management of real-life complex situations of liver cancer that sometimes are not fully captured by existing guidelines. You will be up to date on the most-recent advances in the multidisciplinary approach for the treatment of primary liver cancer. You will learn more about the management of challenging cases from experts in the treatment of liver cancer.
Organisers Delia D’Avola, Paloma Sangro and Manuel de la Torre are looking forward to meeting and exchanging with you!
Read more and submit your application by 28 September: easl.eu/event/challenges-in-the-treatment-of-hepatocelula… -
EASLnews
@EASLnews
Showcase your research at the EASL #livercancersummit 2027.
🗓️Submit your abstract by 13 October 2026 for the opportunity to present your work, gain visibility among international experts, and access exclusive trainee and postdoc bursaries!
👉easl.eu/event/liver-cancer-summit-2027/abstracts/
Benefit from early registation fees until 20 October, and attend an event that will explore the latest advances in primary liver cancers, spanning basic, translational, and clinical research.
⭐️We look forward to seeing you in Valencia on 14-16 January 2027!
@PinterMatthias @SaborowskiAnna @CrocettiLaura -
EASLnews
@EASLnews
Endohepatology could bring biopsy, portal pressure measurement, and variceal evaluation together in a single session but where does it fit in an era of non-invasive testing?
Tune in this Wednesday to #talklivertome for a discussion on evidence, clinical utility, and real-world feasibility.
Read more: easl.eu/event/endohepatology-added-value-or-added-complex…This media couldn't be displayed. See it on the original post. -
EASLnews
@EASLnews
Registration and abstract submission are now open for the EASL Steatotic Liver Disease Summit 2027!
📍Berlin, Germany
📅 10 to 13 February 2027
Join the global community for a comprehensive exploration of steatotic liver disease across the full metabolic–alcohol spectrum, from public health and patient care to disease mechanisms, diagnostics and emerging therapies.
Across the Summit, leading experts will connect science and clinical practice, tackling key questions in MASLD, MetALD and ALD, while sharing the latest evidence and developments shaping the future of the field.
Submit your research, exchange ideas with international experts and peers, and contribute to the conversations advancing SLD research and care.
📃 17 November 2026: Abstract submission deadline
📅 18 November 2026: Early registration fee deadline
👉 Learn more, register, and submit your research: easl.eu/event/easl-sld-summit-2027/
#sldsummit @horstef @DebbieShawcros1 -
EASLnews
@EASLnews
🚨 Applications are open for the EASL Mobility & Research Fellowship Programme!
Are you an early- or mid-career professional looking to take the next step in hepatology? Whether you want to expand your research experience or build new collaborations across Europe, EASL's fellowship programme is here to support your journey.
Apply by 1 September and invest in your future in liver research.
More information: easl.eu/fellowship/mobility-research-fellowship-programme/ -
EASLnews
@EASLnews
England is on track to become one of the first countries to eliminate hepatitis C — a landmark on the road to the WHO's 2030 target.
The figures are striking: over 100,000 people diagnosed and treated since 2015, the 80% treatment target already met, and hepatitis C-related deaths down 36% in a decade. With cure rates above 95%, this is a rare example of a viral hepatitis elimination target moving from aspiration to reality.
Progress like this doesn't happen by chance. It depends on sustained investment in screening, diagnosis pathways, and health system integration — precisely the barriers EASL’s Viral HOPE Programme (Hepatitis Outcomes & Pathways to Elimination) was designed to address across Europe.
Through research grants, policy roundtables, and a dedicated conference, our Viral HOPE programme connects evidence generation to policy action to real-world implementation — supporting the coordinated, multi-stakeholder effort needed to bring England's trajectory to the rest of Europe.
Learn more about the programme: easl.eu/easl-hope/
Read the article on BBC: www.bbc.com/news/articles/c75gk620r22o -
EASLnews
@EASLnews
The EASL Schools 2027 applications are open! Four unique learning opportunities await you, including this School on Infections in advanced chronic liver diseases (4-5 June 2027, Zagreb, Croatia).
This clinical school is designed to advance practical expertise in the prevention, diagnosis, and management of infections and sepsis in patients with advanced chronic liver disease. You will improve your antimicrobial decision-making, from empiric therapy to targeted treatment and de-escalation, guided by antimicrobial-stewardship practices. You will also gain insight into complex clinical decisions, including ACLF management and transplant assessment in patients with active infection.
Organisers Marina Berenguer, Iva Košuta, Anna Mrzljak and Neven Papić are looking forward to meeting and exchanging with you!
Read more and submit your application by 28 September: easl.eu/event/infections-in-advanced-chronic-liver-diseases/ -
EASLnews
@EASLnews
Explore the future of liver cancer research and care at the EASL #livercancersummit 2027!
📍 Valencia, Spain
📅 14 to 16 January 2027
Registration and abstract submission are now open.
Join a multidisciplinary community to discover the latest advances in primary liver cancer, from prevention and early detection to precision oncology, innovative treatments, and long term patient management.
Submit your research, connect with leading experts, and help shape the future of liver cancer care.
📅 7 August – 13 October, 2026: Abstract submission period
📅 7 August – 20 October, 2026: Early registration fees
👉 Learn more: easl.eu/event/liver-cancer-summit-2027/ -
EASLnews
@EASLnews
🚨 Applications are open for the EASL Mobility & Research Fellowship Programme!
Looking to advance your career in hepatology? EASL is supporting early- and mid-career professionals with two exciting 6-month fellowship opportunities:
🌍 Mobility Fellowships – Gain specialised skills and experience at another European institution while building international collaborations.
🔬 Research Fellowships – Conduct an impactful liver disease research project at your home institution.
If you're ready to expand your expertise and contribute to the future of hepatology, now is the time to apply.
Deadline: 1 September
More information: easl.eu/fellowship/mobility-research-fellowship-programme/ -
EASLnews
@EASLnews
You’re trained to do research, but who teaches you how to run a research group? 🤔
This episode of #talklivertome looks at the practical realities of early research independence, from managing people and funding pressures to building a sustainable academic career.
Listen now on EASL Campus: easlcampus.eu/tltm/episode-14
Available on Spotify: open.spotify.com/episode/1P07QQAcB7gdEUlRBFoQRf
and Apple Podcasts: podcasts.apple.com/fr/podcast/talk-liver-to-me-what-nobod… -
EASLnews
@EASLnews
⭐️Egypt's #worldhepatitisday 2026 celebration "Defeating the virus, shielding the liver" on 28 July highlighted the country's remarkable journey from eliminating viral hepatitis to building a sustainable, integrated liver health model. The event also marked three years since Egypt achieved WHO Golden Tier recognition for hepatitis elimination and showcased its growing role as a global reference for comprehensive liver disease management.
EASL was proud to be represented by Prof. @FrancqueSven , EASL Educational Councillor, who joined the panel discussion, "From Virus Elimination to Cancer Management. The Journey Continues.", to discuss the future of integrated liver health and international collaboration.
Congratulations to the Egyptian Ministry of Health and Population and all partners involved in delivering such an important event.
@mohpegypt -
EASLnews
@EASLnews
Looking to advance your clinical or research expertise? Ready to learn alongside leading experts and connect with peers from across Europe? Then the EASL Schools are your perfect opportunity!
Discover next year's four EASL Schools:
• Infections in advanced chronic liver diseases, 4-5 June 2027, Zagreb (Croatia)
• Challenges in the treatment of hepatocellular carcinoma, 25-26 June 2027, Madrid (Spain)
• EASL Bootcamp: bridging the gap between science & medicine in hepatology, 16-18 September 2027 Rotterdam (the Netherlands)
• Portal Hypertension, 23-24 September 2027, Vienna (Austria)
Which one interests you the most? You have until 28 September to decide and apply!
🔗 easl.eu/events/easl-courses-schools-masterclasses/ -
EASLnews
@EASLnews
⏳ There's still time to apply for an EASL leadership role, but not much!
Applications close 10 August for:
🔹 One Educational Committee member
🔹 Two AI Task Force members
Help shape EASL's educational programmes or contribute to the responsible development and implementation of AI in hepatology alongside experts from across the world.
Don't miss your opportunity to make an impact.
Apply now on easl.eu/news/call-governance-jul2026/ -
EASLnews
@EASLnews
For early-career researchers and clinician-scientists, the move to independence brings new challenges: leadership, funding, team management, and long-term career planning.
Tune in to #talklivertome this Wednesday for an honest discussion on what nobody tells you about early academic leadership.
Read more: easl.eu/event/what-nobody-tells-you-about-starting-a-rese… -
EASLnews
@EASLnews
💡 Every breakthrough starts with an opportunity.
The EASL Mobility & Research Fellowship Programme supports promising professionals committed to advancing liver disease research and improving patient care.
If you're ready to take your career to the next level, don't miss the chance to apply.
Deadline: 1 September
More information: easl.eu/fellowship/mobility-research-fellowship-programme/ -
EASLnews
@EASLnews
Do you want hands-on experience with the latest techniques? Are you ready to connect with leading experts and peers across Europe? If so, the EASL Schools are for you!
Discover next year’s four EASL Schools:
• Infections in advanced chronic liver diseases, 4-5 June 2027, Zagreb (Croatia)
• Challenges in the treatment of hepatocellular carcinoma, 25-26 June 2027, Madrid (Spain)
• EASL Bootcamp: bridging the gap between science & medicine in hepatology, 16-18 September 2027 Rotterdam (the Netherlands)
• Portal Hypertension, 23-24 September 2027, Vienna (Austria)
Which one interests you the most? You have until 28 September to decide and apply!
🔗 easl.eu/events/easl-courses-schools-masterclasses/ -
EASLnews
@EASLnews
💛Today is #worldhepatitisday.
With the WHO's 2030 viral hepatitis elimination target fast approaching, now is the time to turn ambition into action.
Despite remarkable scientific progress, viral hepatitis remains a major public health challenge. Too many people are still undiagnosed, barriers to prevention and care persist, and gaps in data continue to limit effective action.
Elimination will only be possible through collaboration across healthcare professionals, researchers, policymakers, patient organisations, public health experts, and communities.
Through the EASL Viral HOPE Programme, EASL is bringing together research, policy, and education to accelerate progress. By supporting multicentre research grants, convening policy roundtables in Brussels, and delivering a dedicated conference, the programme aims to transform evidence into action and drive meaningful progress towards hepatitis elimination.
Together, we can build a future where viral hepatitis is no longer a public health threat. 💛
👉Learn more: easl.eu/easl-hope/
#worldhepatitisday @Hep_Alliance @WHO_Europe @DebbieShawcros1 -
EASLnews
@EASLnews
🚨 EASL leadership opportunities now open.
We are inviting applications for the following positions:
🔹 1 Educational Committee member
🔹 2 AI Task Force members
These roles offer the chance to contribute to EASL’s strategic priorities, working alongside international experts to support education, innovation, and the advancement of hepatology.
🗓️ Application deadline: 10 August
More information: easl.eu/news/call-governance-jul2026/ -
EASLnews
@EASLnews
🌍 Great research thrives on collaboration.
The EASL Mobility & Research Fellowship Programme is designed to help early- and mid-career professionals develop new skills, strengthen research capacity and build meaningful collaborations across Europe.
Whether you're looking to broaden your expertise or advance an innovative research project, this is your opportunity to grow.
Deadline: 1 September
Apply now: easl.eu/fellowship/mobility-research-fellowship-programme/ -
EASLnews
@EASLnews
Who should be tested for hepatitis E? When should treatment be considered? And how should chronic infection be managed in immunosuppressed patients?
In the latest #talklivertome, experts bring perspectives from Europe and Asia to discuss practical approaches to acute and chronic hepatitis E.
Listen on EASL Campus: easlcampus.eu/tltm/episode-13
Apple Podcasts: podcasts.apple.com/us/podcast/talk-liver-to-me-global-upd…
Spotify: open.spotify.com/episode/67JXr3Emf32QYaapSykRUy -
EASLnews
@EASLnews
🚨 Step into an EASL leadership role.
Applications are now open for:
🔹 One Educational Committee member
🔹 Two AI Task Force members
This is your opportunity to help shape the future of hepatology by contributing to EASL's educational strategy or advancing the responsible use of AI in liver disease.
As a committee or task force member, you'll collaborate with leading experts, influence key initiatives, and contribute to projects that benefit the global liver community.
🗓️ Application deadline: 10 August
More information: easl.eu/news/call-governance-jul2026/ -
EASLnews
@EASLnews
Hepatitis E is not the same everywhere.
In this week's episode of #talklivertome, experts from Europe and Asia share practical perspectives on who to test, when to treat, and how to manage acute and chronic hepatitis E.
Out this Wednesday on EASL Campus, Spotify and Apple Podcasts!
More info: easl.eu/event/global-updates-on-hepatitis-e/This media couldn't be displayed. See it on the original post. -
EASLnews
@EASLnews
🚨 Applications are open for the EASL Mobility & Research Fellowship Programme!
Are you an early- or mid-career professional looking to take the next step in hepatology? Whether you want to expand your research experience or build new collaborations across Europe, EASL's fellowship programme is here to support your journey.
Apply by 1 September and invest in your future in liver research.
More information: easl.eu/fellowship/mobility-research-fellowship-programme/ -
EASLnews
@EASLnews
How well do you know your EASL Guidelines on Wilson’s disease?
Test your knowledge now with this new quiz, as we examine the case of a 29-year-old man who is referred because of persistently abnormal liver tests found during evaluation for fatigue.
Play here: easlcampus.eu/quiz/question/q147
@ERN_RARE_LIVER -
EASLnews
@EASLnews
✨ Happening soon on 16 and 17 July 2026!
Join us for Module II of the FOCUS, Middle East School of Steatotic Liver Disease (SLD), an educational initiative advancing knowledge and clinical practice in MASLD across the Middle East.
This module will explore MASLD risk assessment and therapeutic interventions, bringing together regional and international experts to discuss the latest evidence, practical management strategies, and emerging treatments.
Look forward to two days of scientific exchange, case based learning, and collaboration!
👉 Register here: us06web.zoom.us/meeting/register/XpERsc0fToq8KS2ygoeBcA
@FrancqueSven -
EASLnews
@EASLnews
🚨 EASL is recruiting new leadership members.
We are now accepting applications for:
🔹 1 Educational Committee member
🔹 2 AI Task Force members
These roles offer the opportunity to contribute to EASL’s mission by shaping education, advancing innovation, and supporting the hepatology community at a global level.
Join us in shaping the future of liver health.
🗓️ Application deadline: 10 August
More information: easl.eu/news/call-governance-jul2026/ -
EASLnews
@EASLnews
Liver health starts long before the clinic.
At #easlcongress 2026 in Barcelona, WHO/Europe and EASL highlighted how preventing liver disease requires action across public health, clinical practice and policy.
Through the Love Your Liver initiative:
• More than 500 people received free liver health checks and over 60 hepatitis C tests
• Around 150 health professionals received training in alcohol screening and brief interventions
• Visitors explored the links between liver health, alcohol, nutrition, physical activity and viral hepatitis through an interactive prevention village
The Congress also reinforced the importance of evidence based alcohol policies, stronger prevention strategies and cross sector collaboration, including the work of the European Health Alliance on Alcohol.
The message was clear: preventing liver disease requires informed communities, skilled health professionals and policies that make healthier choices easier.
👉Read the full article: www.who.int/europe/news-room/events/item/2026/05/27/defau…
youtu.be/qL-ZNxYld-MThis media couldn't be displayed. See it on the original post. -
EASLnews
@EASLnews
💡 Every breakthrough starts with an opportunity.
The EASL Mobility & Research Fellowship Programme supports promising professionals committed to advancing liver disease research and improving patient care.
If you're ready to take your career to the next level, don't miss the chance to apply.
Deadline: 1 September
More information: easl.eu/fellowship/mobility-research-fellowship-programme/ -
EASLnews
@EASLnews
What happens when the liver and heart are part of the same cardiometabolic story? This episode of Talk Liver to Me explores the link between MASLD and HFpEF, from diagnosis and risk stratification to liver–heart crosstalk and integrated care.
Available on EASL Campus: -
EASLnews
@EASLnews
🚨 Step into an EASL leadership role.
Applications are now open for:
🔹 One Educational Committee member
🔹 Two AI Task Force members
This is your opportunity to help shape the future of hepatology by contributing to EASL's educational strategy or advancing the responsible use of AI in liver disease.
As a committee or task force member, you'll collaborate with leading experts, influence key initiatives, and contribute to projects that benefit the global liver community.
🗓️ Application deadline: 10 August
More information: easl.eu/news/call-governance-jul2026/ -
EASLnews
@EASLnews
MASLD is not just a liver disease and HFpEF is not just a cardiology challenge. In this week's episode of Talk Liver to Me, experts explore how these conditions overlap, why HFpEF can be missed in MASLD, and whether cardio-hepatology collaboration could improve patient care.
Out this Wednesday on your favorite podcast platform!
Read more: easl.eu/event/masld-and-hfpef-do-we-need-a-shared-treatme…This media couldn't be displayed. See it on the original post. -
EASLnews
@EASLnews
🚨 Applications are open for the EASL Mobility & Research Fellowship Programme!
Looking to advance your career in hepatology? EASL is supporting early- and mid-career professionals with two exciting 6-month fellowship opportunities:
🌍 Mobility Fellowships – Gain specialised skills and experience at another European institution while building international collaborations.
🔬 Research Fellowships – Conduct an impactful liver disease research project at your home institution.
If you're ready to expand your expertise and contribute to the future of hepatology, now is the time to apply.
Deadline: 1 September
More information: easl.eu/fellowship/mobility-research-fellowship-programme/ -
EASLnews
@EASLnews
📢 The call for abstracts is now open for HepHIV2026!
Attend the HepHIV2026 Conference in Dublin, Ireland, on 2 to 3 November 2026 bringing together researchers, healthcare professionals, policymakers, public health institutions and civil society to advance testing and earlier linkage to care for hepatitis, HIV, STIs and TB.
🗓️ Abstract submission is open from 26 May to 26 July 2026.
Don't miss the opportunity to share your work and contribute to the scientific programme.
👉Learn more: www.eurotest.org/conferences/hephiv-2026-dublin-conference/
👉Submit your abstract: www.eurotest.org/conferences/hephiv-2026-dublin-conferenc… -
EASLnews
@EASLnews
Every two minutes, someone in the WHO European Region dies from liver disease.
Not from a lack of evidence. Not from a lack of clinical expertise. From a lack of action.
Now, that changes. WHO, Imperial College London and EASL have inaugurated the world's first WHO Collaborating Centre dedicated to liver disease yesterday, 24 June— turning May's landmark World Health Assembly resolution into the institutional machinery to deliver national health plans across 53 Member States.
EASL is proud to be the Centre's clinical and scientific partner. This is what advocacy looks like when it works.
👉 Read the press release here: easl.eu/news/who_imperial_easl_collaborating_centre/
#liverhealth #steatoticliverdisease #whocollaboratingcentre #easl #ncds #publichealth
@DebbieShawcros1 @hans_kluge @WHO_Europe @imperialcollege -
EASLnews
@EASLnews
⭐️Listen to the latest Talk Liver To Me episode!
Does the perfect preclinical model exist? In this episode, we explore the new EASL position paper on preclinical models of steatotic liver disease with Rui Castro, Mathias Heikenwälder and Suchira Gallage. Together, they discuss the challenges of modelling MASLD, MetALD, and ALD, and what researchers and clinicians should know when interpreting preclinical data.
👉Available on EASL Campus: easl.eu/event/chasing-the-perfect-sld-preclinical-model/
🎙️Spotify: open.spotify.com/episode/524b5QZ7qpF5ssvjDU6vu0
🎙️Apple Podcast: podcasts.apple.com/us/podcast/talk-liver-to-me-chasing-th…
@RuiCastroHD @CancerInflam @GallageSuchira @EASLedu -
EASLnews
@EASLnews
New Talk Liver to Me podcast coming up this Wednesday!
🐭 Can a mouse truly model human steatotic liver disease? And does the perfect preclinical model even exist?
In the upcoming episode, we will explore the new EASL position paper on preclinical SLD models with Rui Castro, Mathias Heikenwälder and Suchira Gallage. Together, they will discuss the challenges of modelling MASLD, MetALD, and ALD, and what researchers and clinicians should know when interpreting preclinical data.
👉 Read more easl.eu/event/chasing-the-perfect-sld-preclinical-model/
📰 Access the position paper that will be discussed! pubmed.ncbi.nlm.nih.gov/42191458/
@GallageSuchira @CancerInflam @RuiCastroHD -
EASLnews
@EASLnews
You can still register for today's joint EASL-ERN RARE-LIVER DeepDive on Wilson's disease!
Join leading experts for a 2026 update covering:
🧪 Lab & imaging interpretation
🧬 Genetic insights
💊 Treatment strategies & monitoring
📅 TODAY 18:00 CEST
Register now: easl-eu.zoom.us/webinar/register/6317751229290/WN_j466DiU…
@zoe_marino @Thomas_Sandahl
@ERN_RARE_LIVER #livertwitter #liverx -
EASLnews
@EASLnews
🎬 EASL announces new partnership with Content With Purpose @cwp_tw
We are proud to partner with Content With Purpose (CWP) to create The Future of Liver Health, a new digital film series exploring how science, prevention, and innovation are transforming liver health across Europe and beyond.
As liver disease continues to place a growing burden on individuals, healthcare systems, and societies, this ambitious project will shine a spotlight on the people, research, technologies, and collaborations driving progress in hepatology.
We look forward to showcasing the innovations and partnerships shaping a healthier future for liver health.
Read more: easl.eu/news/future-of-liver-health-announcement/ -
EASLnews
@EASLnews
A new era of collaboration between WHO/Europe and EASL has begun!
On 10 June, EASL joined fellow medical specialty associations and the WHO Regional Office for Europe, led by Regional Director Dr Hans Kluge, at UN City in Copenhagen for a high-level strategic dialogue — and signed a joint statement marking a shift towards structured, sustained and strategic partnership.
Aligned with the Second European Programme of Work 2026–2030 (EPW2), the signatories commit to three pillars of action:
🔹 Translating policy into clinical practice — bringing clinical expertise into WHO guidance, care pathways and medical curricula
🔹 Driving joint action on shared priorities — from the growing burden of NCDs and mental health to workforce challenges, climate and the responsible use of AI
🔹 Strengthening health systems and reducing inequalities — leveraging clinical networks to improve access to high-quality care across the Region
For EASL, this builds naturally on our existing collaboration with WHO: the WHO–Imperial College London–EASL Collaborating Centre on Steatotic Liver Disease, follow-up to the WHA79 resolution on SLD, and our work through the European Health Alliance on Alcohol (EHAA) to advance evidence-based alcohol policy. Liver health belongs at the heart of Europe's NCD response — and partnerships like this are how policy becomes practice.
We look forward to the next steps: dedicated mechanisms for joint initiatives, continuous clinician engagement, and a broader regional meeting of medical specialty associations.
Thank you to Dr Kluge and the WHO/Europe team for convening this important dialogue.
#easl #liverhealth #publichealth #whoeurope #epw2 #ncds @DebbieShawcros1 @hans_kluge -
EASLnews
@EASLnews
Don’t miss next week's joint EASL-ERN RARE LIVER DeepDive into Wilson’s disease 🔍
Enhance your understanding of:
• Diagnostic challenges
• Clinical & lab integration
• Treatment decision-making
📅 17 June 2026 | 18:00 CEST
Register now: easl-eu.zoom.us/webinar/register/6317751229290/WN_j466DiU…
@zoe_marino @Thomas_Sandahl
@ERN_RARE_LIVER #livertwitter #liverx -
EASLnews
@EASLnews
New Talk Liver to Me podcast out now! Haemochromatosis in 2026: Who Needs Testing and Who Needs Treatment? Tune in on EASL Campus or your favorite podcast platform and listen to this interactive discussion with experts John Ryan and Heinz Zoller, hosted by Tom Marjot.
Out now on Spotify and Apple Podcast!
podcasts.apple.com/us/podcast/talk-liver-to-me-haemochrom…
open.spotify.com/episode/13aAqbE5Y9stYPu3l19sYxThis media couldn't be displayed. See it on the original post. -
EASLnews
@EASLnews
Less than a week left to apply for the AASLD-EASL Masterclass 2026!
The programme has been designed with future leaders in mind, and includes academic lectures, interactive break-out sessions, individual meetings with tutors, abstract presentations, a poster session, and social events which will give early-stage investigators (MD, PhD, or MD/PhD, or equivalent) the opportunity to network with renowned leaders in hepatology and like-minded colleagues in the field.
Read more and apply by 15 June: easl.eu/event/aasld-easl-masterclass-2026
#livertwitter #liverx @AASLDtweets -
EASLnews
@EASLnews
New Talk Liver to Me podcast coming up this Wednesday!
What are the current challenges in diagnosis and management regarding haemochromatosis? Who should be tested? How can we interpret the results? Which patients benefit from intervention in modern hepatology practice? Our host Tom Marjot will ask all these questions and more to experts John Ryan and Heinz Zoller!
Read more: easl.eu/event/haemochromatosis-in-2026-who-needs-testing-… -
EASLnews
@EASLnews
Ready to deepen your expertise in Wilson’s disease? Join our EASL-ERN RARE-LIVER DeepDive for a 2026 update.
🧠 Diagnostics, interpretation challenges & treatment strategies
📅 17 June 2026 | 18:00 CEST
Register now: easl-eu.zoom.us/webinar/register/6317751229290/WN_j466DiU…
@zoe_marino @Thomas_Sandahl
@ERN_RARE_LIVER #livertwitter #liverx -
EASLnews
@EASLnews
🔬 New educational video series from @Decision4Liver
EASL is proud to support DECISION and the publication of its complete video series showcasing key research findings in advanced liver disease.
The series brings together leading researchers from across Europe to explain recent discoveries in decompensated cirrhosis and acute-on-chronic liver failure, covering topics such as immune dysfunction, epigenetic regulation, novel biomarkers, patient stratification tools, and innovative preclinical models for liver disease.
Designed for clinicians, researchers, healthcare professionals, and the wider community, these short videos translate complex science into accessible insights with the potential to improve patient care and outcomes.
🎥 Explore the full series and learn more about the latest advances from the DECISION consortium: easl.eu/news/decision-video-series/ -
EASLnews
@EASLnews
After strengthening the global community in Hong Kong SAR last year, this event comes back to Europe for another edition of the ILCA Annual Conference! Save the date for 3-5 September 2026 and join in Brussels, Belgium where a passionate community of liver cancer specialists and allied professionals comes together.
👉 ilcalive.org/annual-conference-2026/ -
EASLnews
@EASLnews
How well do you know your Guidelines on genetic cholestatic liver diseases? Test yourself now:
A patient with recurrent pruritus and cholestatic liver enzyme elevations is diagnosed with PFIC type 2. What do you know about the confirmed mutation?
Take the new EASL Quiz now: -
EASLnews
@EASLnews
From research to leadership, this AASLD-EASL Masterclass 2026 is your next step!
Get expert guidance, feedback, and connections across continents. Hear from former participant Ann Ma on how this experience benefited her and her career!
Read more and apply by 15 June: easl.eu/event/aasld-easl-masterclass-2026/
#livertwitter #liverx
@AASLDtweets -
EASLnews
@EASLnews
🎉 That's a wrap on #easlcongress 2026!
What an incredible few days of learning, collaboration, and connection. Together, we welcomed more than 8,500 attendees from 109 countries, shared 2,278 abstracts, and engaged in inspiring discussions that will help shape the future of liver health worldwide.
📹 Missed a session or want to revisit your favourite moments? On-demand content remains available via the Congress platform and app until 8 June. Content will also be available on EASL Campus from the week of 8 June.
While this year's Congress may be coming to a close, our shared mission continues. We are delighted to announce that #easlcongress 2027 will take place in London, United Kingdom, from 16-19 June 2027. Save the date!
🙏 Thank you to all delegates, faculty, abstract presenters, partners, and supporters for your energy, expertise, and commitment. You made EASL Congress 2026 an unforgettable event.
📊 Discover the best of slide decks! easlcampus.eu/Documents/best-easl-congress-2026-slide-decks
📷 See the photos here: easl.smugmug.com/EASL-Congress-2026
❓ Take the SCOPE survey to help us improve your experience in 2027! www.surveymonkey.com/r/RRPMWRJ
See you in London! -
EASLnews reposted
Marc Pañero-Moreno
@MPaneroMoreno
Continuous glucose monitoring in liver transplant recipients in the ICU: a randomized clinical trial cohort
Another poster presented at the @EASLnews Congress in Barcelona.
Thanks to all collaborators.
📄 Poster:
www.postersessiononline.eu/pr/aula_poster.asp?congreso=84…
@EASLnews @PSO_medical @hospitalclinic -
EASLnews reposted
Thomas Reiberger
@ReibergerThomas
Vienna @MedUni_Wien team
@EASLnews congress in #barclona #easl2026 -
EASLnews reposted
Palak Trivedi
@CholestasisDoc
Massive congrats to one of the best to ever do it. A superb supervisor, mentor, academic and clinician.
Very well deserved 👏🏾
@UoBinfectionsch @uhbtrust @unibirm_CMH
EASLnews
@EASLnews
🏆EASL recognises dedicated scientists who have made meaningful advances in research, clinical care, and education within their area of expertise.
We extend our heartfelt congratulations to Paolo Angeli, University Hospital of Padova, Italy, and David Adams, University of Birmingham, United Kingdom, for their prestigious EASL Recognition Award accolades! Their research and unwavering commitment continue to drive remarkable progress in liver health.🌟
@EASLedu @DebbieShawcros1 @analleo #easlcongress -
EASLnews reposted
Thomas Reiberger
@ReibergerThomas
Final Day @EASLnews 2026
🤝Networking
🚨LateBreakers
🛫 Safe Travels
🇬🇧 See you in #london27 -
EASLnews reposted
The Baveno Cooperation: an EASL Consortium
@BavenoCoop
🧫 Infection & HE in cirrhosis
🗣️ T. Thévenot | #easlcongress
🔬 Rifaximin & cotrimoxazole (ASEPTIC trial) for 1 PF SBP prophylaxis → no benefit — Baveno VIII agrees
⚠️ Antibiotic prophylaxis in GI bleeding also questioned in Child-Pugh A pts
💡 Future: albumin, probiotics & FMT -
EASLnews reposted
The Baveno Cooperation: an EASL Consortium
@BavenoCoop
🧫 TIPS in PSVD
🗣️ @marcosenzolo | #easlcongress
🔬 Bleeding control 92.4% | Ascites control 71.2%
🔎 Underdilated TIPS (<8mm) → same control & survival but ↓ oHE (10.5% vs 26.3%)
⚠️ Different predictors by indication
💡 Underdilation strategy preferred in PSVD -
EASLnews reposted
The Baveno Cooperation: an EASL Consortium
@BavenoCoop
🧫 Post-TIPS heart failure (EuroTIPS)
🗣️ @anna_baiges | #easlcongress
🔬 HF in 11% — Toulouse algorithm ❌ fails in real-world
🆕 EuroTIPS HF score (NT-proBNP, MetSyn, Na⁺, sex) → high risk 45% vs 3% (validated n=824)
⚠️ Check cardiac biomarkers BEFORE TIPS! -
EASLnews reposted
Terry Cheuk-Fung Yip
@TerryYip12
Great to present our work on #hcc risk in patient subgroups after #hbsag loss, performance of PAGE-B, and implications on #surveillance at #easlcongress. Enjoyed the fruitful discussions. #easl2026 @EASLnews @CUHKMedicine @CUHKGI
-
EASLnews reposted
loeymak
@loeymak
Thank you @EASLnews @EASLedu for inviting me to speak on Perinatal management and Global perspectives on HBV in the young at EASL 2026! It was a great session @thatliverguy #prof_harry_janssen #prof_jacob_george
#easl2026 -
EASLnews
@EASLnews
💚Last day of #easlcongress and the perfect opportunity to visit the Love Your Liver Village in front of Fira Barcelona until 15:00pm!
Get a free, non-invasive liver test, and meet public health professionals ready to talk about all things liver health!
😍What participants say:
- "I’ve been living in front of the Congress centre for seven years and this is the very first time a conference has done something to give back to the community."
- "I just did a Fibroscan with Francesca and she was just amazing. Speaking in Spanish and English, I felt right at home and like it wasn’t a typical patient-provider interaction. It felt comfortable and just really great." -
EASLnews
@EASLnews
🌟Awarding excellence at #easlcongress
We extend our heartfelt congratulations to Florence Wong, professor of gastroenterology at the University of Toronto and a physician in the Division of Gastroenterology and Hepatology at the University Health Network for the prestigious EASL International Recognition Award accolade. Her research and unwavering commitment continues to drive remarkable progress in liver health.
We wish to congratulate Cynthia Levy, Professor of Medicine in the Division of Digestive Health and Liver Diseases and is the Associate Director of the Schiff Center for Liver Diseases at the University of Miami for her EASL Community Award, recognising an outstanding medical and scientific contribution to improving liver health outcomes, promoting liver health awareness, education, and prevention.
@DebbieShawcros1 @analleo -
EASLnews
@EASLnews
🤩Day 3 of #easlcongress is underway in Barcelona, and the momentum continues to build!
Over the past days, we've welcomed thousands of delegates from around the world for inspiring discussions, remarkable science, hands-on learning, and meaningful collaboration.
We've celebrated excellence across the hepatology community, explored innovation, and connected through countless discussions, networking, and poster sessions.
Today promises even more highlights, including General Session II, State-of-the-Art lectures, CPGs, regenerative hepatology, liver cancer management, sustainable liver health, and much more.
Whether you're joining us in Barcelona or online, thank you for being part of this vibrant global community!🙏
@EASLedu -
EASLnews
@EASLnews
🏆EASL recognises dedicated scientists who have made meaningful advances in research, clinical care, and education within their area of expertise.
We extend our heartfelt congratulations to Paolo Angeli, University Hospital of Padova, Italy, and David Adams, University of Birmingham, United Kingdom, for their prestigious EASL Recognition Award accolades! Their research and unwavering commitment continue to drive remarkable progress in liver health.🌟
@EASLedu @DebbieShawcros1 @analleo #easlcongress -
EASLnews
@EASLnews
At #easlcongress we recognised five outstanding individuals whose dedication and contributions to liver research and patient care have been exemplary.
The Emerging Leader Award, designed to spotlight young fellows in the field, has been given to Laura J Pallett from London, United Kingdom, Panu Luukonen from Helsinki, Finland, and Elisa Pose, from Barcelona, Spain in honor of their remarkable liver research achievements.
The Excellence in Liver Care Award celebrates the commitment to improving the well-being of individuals with liver disease, with this year's recipient being Marie Skaarup Christiansen, from Copenhagen, Denmark.
The Daniel Alagille Award, recognising promising young scientists in the exploration of paediatric or adult genetic cholestatic diseases, has been given to Juan Bañares from Barcelona, Spain.
@DebbieShawcros1 @analleo @EASLedu -
EASLnews
@EASLnews
From diagnosis to treatment, get the full picture of Wilson’s disease with this upcoming joint EASL-ERN RARE-LIVER DeepDive!
Join leading experts for a 2026 update covering:
🧪 Lab & imaging interpretation
🧬 Genetic insights
💊 Treatment strategies & monitoring
📅 17 June 2026 | 18:00 CEST
Register now: easl-eu.zoom.us/webinar/register/6317751229290/WN_j466DiU…
@zoe_marino @Thomas_Sandahl
@ERN_RARE_LIVER #livertwitter #liverx -
EASLnews
@EASLnews
⚡️We hope you are having an exceptional start to #easlcongress in Barcelona and online!
🌍An extensive scientific programme covering all hepatology tracks is progressing, drawing over 2,200 abstracts from around the world and 8,500 international delegates.
💬💡Conversations are flowing, and the atmosphere is buzzing! We look forward to the next days filled with science and discussions.
👉easlcongress.eu
@DebbieShawcros1 @analleo -
EASLnews reposted
EASL Education
@EASLedu
Join Mihaela van der Schaar at the #easlcongress Postgraduate Course State-of-the-Art lecture as she explores how AI agents, multi-omics integration, and digital twins could transform personalised care, prognosis, and therapeutic decision-making.
⌛️Wednesday, 27 May | 17:00 - 17:45 CEST
📍Tiribelli - Hall 8.1
ℹ️pag.virtual-meeting.org/easl/easl2026/en-GB/pag/session/1…
@MihaelaVDS @maximeronot @DinaTiniakos -
EASLnews
@EASLnews
Discover the AASLD-EASL Masterclass 2026, taking place in Alexandria, Virginia (USA) on 11-13 December!
Hear from former participant @KGananandan on how to take your career to the next level!
Read more and apply by 15 June: easl.eu/event/aasld-easl-masterclass-2026/
#livertwitter #liverxThis media couldn't be displayed. See it on the original post. -
EASLnews
@EASLnews
🧬 Two cases. Unexpected phenotypes. New questions for genetic liver disease.
Join the Genetic Grand Round at EASL Congress to explore cases involving PKD1, PKD2, and BSEP variants, and discover how heterozygous individuals may challenge classical Mendelian disease models.
📍 Track Hub 4 | 28 May
Register for EASL Congress: www.easlcongress.eu -
EASLnews
@EASLnews
How can heterozygous genetic variants challenge what we know about Mendelian disease models?
At the Genetic Grand Round at #easlcongress, explore two compelling cases: portal hypertension with polycystic liver disease involving PKD1/PKD2, and DILI in a patient heterozygous for BSEP.
📍 Track Hub 4 | 28 May
Register for EASL Congress: www.easlcongress.eu -
EASLnews
@EASLnews
🏛️ A historic moment for liver health.
Yesterday at the 79th World Health Assembly, Member States adopted the resolution "Steatotic liver disease: a missing piece in the global noncommunicable disease response" — the first time liver disease has ever been formally recognised within the global NCD agenda.
This is not a symbolic gesture. It is a mandate.
For too long, steatotic liver disease — affecting an estimated 1.5 billion people worldwide — has been absent from national health plans, NCD financing frameworks, and government accountability mechanisms. That changes now.
With this resolution, WHO Member States are called upon to: ✅ Integrate liver health into national NCD strategies ✅ Include liver health indicators in NCD monitoring frameworks ✅ Align health financing with integrated, prevention-centred care
As Professor Debbie Shawcross, EASL Secretary General, said at our WHA79 side event yesterday: "The NCD community has fought for decades to put prevention at the centre of health systems. Liver disease has been a missing piece. With this resolution, we have a mandate. Now we need governments to make it count."
The evidence is overwhelming. The EASL–Lancet Commission 2.0 estimates 780 preventable deaths per day and €55 billion in annual economic costs from liver disease in Europe alone.
The vote has been cast. Now the real work begins — and EASL will be there every step of the way.
👉 Read our full press release: easl.eu/news/wha-side-event/
@DebbieShawcros1 -
EASLnews
@EASLnews
Discover the AASLD-EASL Masterclass 2026, taking place in Alexandria, Virginia (USA) on 11-13 December!
Hear from former participant @AniKardashianMD on how this was a unique opportunity to meet leading experts in the field!
Read more and apply by 15 June: easl.eu/event/aasld-easl-masterclass-2026/
#livertwitter #liverxThis media couldn't be displayed. See it on the original post. -
EASLnews
@EASLnews
🔴 Live from Geneva | Our side event at the 79th World Health Assembly is underway.
From Vision to Action: A Holistic Approach to Metabolic Health and NCD Prevention and Care brings together health ministers, policymakers, and global health leaders to place metabolic health at the centre of the NCD agenda.
Today, @WHO Member States vote on a landmark resolution on steatotic liver disease — a condition affecting an estimated 1.5 billion adults worldwide and sitting at the intersection of metabolic, cardiovascular, and broader NCD pathways. Today, we ask: what comes next?
Our panel is mapping the path from global commitment to national action. Thank you Dr Hans Kluge, WHO Regional Director for Europe, for your leadership and commitment to advancing this work. 🙏
Because science only creates impact when it shapes policy. 💪
#wha79 #liverhealth #steatoticliverdisease #metabolichealth #ncds #easl #sld #who
@DebbieShawcros1 @DrTedros -
EASLnews
@EASLnews
Wilson’s disease: are you confident in diagnosis and management?
This EASL-ERN RARE-LIVER DeepDive webinar will help you:
✔ Navigate copper metabolism testing pitfalls
✔ Build a robust diagnostic approach
✔ Understand treatment pathways & outcomes
📅 17 June 2026 | 18:00 CEST
Register now: easl-eu.zoom.us/webinar/register/6317751229290/WN_j466DiU…
@zoe_marino @Thomas_Sandahl
@ERN_RARE_LIVER #livertwitter #liverx -
EASLnews
@EASLnews
A powerful message from Dr Tedros Adhanom Ghebreyesus, WHO Director-General, for today's EASL side event at the World Health Assembly.
Take a listen 🎧
Thank you, Dr Tedros, for your leadership and support. 🙏
#wha79 #who #easl #sld #liverhealth #ncdsThis media couldn't be displayed. See it on the original post. -
EASLnews
@EASLnews
Apply now for the AASLD-EASL Masterclass 2026! Get the skills to lead, publish, and secure funding.
All within an exclusive, small-group Masterclass experience.
Not convinced yet? Hear directly from former participant @tom_marjot!
Read more and apply by 15 June: easl.eu/event/aasld-easl-masterclass-2026/
#livertwitter #liverx @AASLDtweetsThis media couldn't be displayed. See it on the original post. -
EASLnews
@EASLnews
Join the MICROB-PREDICT Consensus Conference "Microbiome-based mechanisms and biomarkers for improved patient stratification & therapeutic response prediction in decompensated cirrhosis and ACLF" taking place during #easlcongress!
Discover the agenda: microb-predict.eu/wp-content/uploads/2026/03/MICROB-PREDI… -
EASLnews
@EASLnews
We're thrilled to partner with @EMJReviews!
EMJ Hepatology is the go-to open-access resource for trusted medical education. Their content empowers Hepatology professionals to enhance clinical decisions, transform patient care, and optimise their valuable time.
Subscribe to EMJ Hepatology today: go.emjreviews.com/emj-subscribe-to-hepatology -
EASLnews
@EASLnews
On 21 May, EASL will host its WHA2026 high-level side event: “From Vision to Action.”
As the World Health Assembly prepares to vote on the resolution on steatotic liver disease (#sld), this is a pivotal moment to rethink how liver health is addressed within the broader NCD agenda.
We are honoured to confirm that Dr Tedros Adhanom Ghebreyesus, WHO Director-General, will deliver a video address, while Dr Hans Kluge, WHO Regional Director for Europe, will give the keynote address during this important discussion on the future of NCDs and metabolic health.
Video address
· Dr Tedros Adhanom Ghebreyesus, WHO Director-General
Keynote address
· Dr Hans Kluge, WHO Regional Director for Europe
Speakers
· Prof Debbie Shawcross, EASL Secretary General
· Prof Khaled Abdel-Ghaffar, Minister of Health, Egypt
· Dr Pedro Gullón Tosio, General Director of Public Health and Equity, Ministry of Health, Spain
· Dr Kerri Elgar, Senior Global Health Advisor, OECD
· Prof Faisal Abaalkhail, President, Saudi Society for the Study of Liver Disease & Transplantation
· Ms Katie Dain, CEO, NCD Alliance
Moderated by Nicola Bedlington.
📅 Thursday, 21 May 2026 | 09:00–10:20 CEST
📍 Ballroom AED, InterContinental Hotel, Geneva
👉 Register and view the full programme: easl.eu/event/easl-wha-side-event-from-vision-to-action/ -
EASLnews
@EASLnews
Meet @ValdigGroup at #easlcongress 2026!
📅 Saturday, 30 May 09:45-10:15
📍Track Hub 6
Register to EASL Congress: www.easlcongress.eu/2026-registration/
#livertwitter #liverx -
EASLnews
@EASLnews
Meet @CcaEns at #easlcongress 2026! Representatives Luke Boulter and Pedro Miguel Rodrigues will be discussing the project and answer all your questions!
📅 Saturday, 30 May 09:45-10:15
📍Track Hub 3
Register to EASL Congress: www.easlcongress.eu/2026-registration/
#livertwitter #liverx -
EASLnews
@EASLnews
Meet @LiverAim at #easlcongress 2026! Representatives Adria Juanola and Marta Tonon will be discussing how to conduct an ambitious pragmatic screening study across Europe and answer all your questions!
📅 Friday, 29 May 10:00-10:30
📍Track Hub 7
Register to EASL Congress: www.easlcongress.eu/2026-registration/
#livertwitter #liverx -
EASLnews
@EASLnews
Ready to deepen your expertise in Wilson’s disease? Join our EASL-ERN RARE-LIVER DeepDive for a 2026 update.
🧠 Diagnostics, interpretation challenges & treatment strategies
📅 17 June 2026 | 18:00 CEST
Register now: easl-eu.zoom.us/webinar/register/6317751229290/WN_j466DiU…
@zoe_marino @Thomas_Sandahl
@ERN_RARE_LIVER #livertwitter #liverx -
EASLnews
@EASLnews
The 2026 Summer Liver Academy Meeting (SLAM) will be hosted by the American Society for Investigative Pathobiology (ASIP) from 14-18 June in Cape Coral, Florida, USA! This meeting was formerly the biennial FASEB Liver Biology Conference, which ASIP hosted for the first time in 2024.
Registration includes access to all sessions, 12 conference meals, social events, and more!
The organisers, including Drs. Kari Nejak-Bowen (University of Pittsburgh), Georg Halder (KU Leuven), and Robert Schwartz (Weill Cornell Medical College), have put together a fantastic programme with two keynotes, internationally-renowned invited speakers, and opportunities for trainees.
Last-chance abstract submission, registration, and housing deadlines are Monday, 18 May.
👉 slam26.asip.org -
EASLnews reposted
MICROB-PREDICT
@MicrobPredict
🚨Survey closes on 17 May⌛️
👉Take this 15 min survey to shape the future of #hepatology:
survey.alchemer.eu/s3/91085482/MICROB-PREDICT-Delphi-onli…
🦠#microbiome-based mechanisms & biomarkers for improved patient stratification + prediction of therapeutic response in decompensated #cirrhosis / #aclf #liverx -
EASLnews
@EASLnews
New Talk Liver to Me episode out now!
From xenotransplantation to machine perfusion, liver transplantation is being redefined. What’s the hype? What’s the evidence? What’s ready for practice?
Out now on Spotify, Amazon Podcast, and EASL Campus!
easlcampus.eu/tltm/episode-09
podcasts.apple.com/us/podcast/talk-liver-to-me-liver-tran…
open.spotify.com/episode/1odvWUBocQMlN5RDSUBjFz
@Drfattyliver #livertwitter #liverx -
EASLnews
@EASLnews
The abstract book for #easl Congress 2026 is now available to consult. Read the abstracts waiting for you in Barcelona and online on 27-30 May.
*The content will continue to be updated in accordance with our embargo policy.
👉Download the abstract book: www.easlcongress.eu/wp-content/uploads/2026/05/EASL_2026-…
👉Secure your spot: www.easlcongress.eu/2026-registration/
@DebbieShawcros1 @analleo -
EASLnews
@EASLnews
Meet A-TANGO at #easlcongress 2026! Representatives Cornelius Engelmann and @RajivJalan1 will be discussing the A-TANGO Score: A Novel Tool for Risk Stratification and Clinical Endpoints in ACLF, and answer all your questions!
📅 Friday, 29 May 10:00-10:30
📍Track Hub 6
Register to EASL Congress: www.easlcongress.eu/2026-registration/
#livertwitter #liverx -
EASLnews
@EASLnews
Only 1 week to go until EASL’s WHA2026 high-level side event: “From Vision to Action”
As the World Health Assembly prepares to vote on the resolution on steatotic liver disease (#sld), this is a critical moment to rethink how we address liver health within the broader NCD agenda.
We are honoured to confirm that Dr Hans Kluge, WHO Regional Director for Europe, will deliver the keynote address at this important discussion on the future of NCDs and metabolic health.
Joining the discussion:
Prof Debbie Shawcross, EASL Secretary General
Prof Khaled Abdel-Ghaffar, Minister of Health, Egypt
Dr Pedro Gullón Tosio, General Director of Public Health and Equity, Ministry of Health, Spain
Dr Kerri Elgar, Senior Global Health Advisor, OECD
Prof Faisal Abaalkhail, President, Saudi Society for the Study of Liver Disease and Transplantation
Ms Katie Dain, CEO, NCD Alliance
Moderated by Nicola Bedlington.
📅 Thursday, 21 May 2026 | 09:00–10:20 CEST
📍 Ballroom AED, InterContinental Hotel, Geneva
👉 Register and view the full programme: easl.eu/event/easl-wha-side-event-from-vision-to-action/
#wha2026 #ncds #metabolichealth #liverhealth #sld #globalhealth #publichealth @DebbieShawcros1 @hans_kluge -
EASLnews
@EASLnews
Applications for the AASLD-EASL Masterclass 2026 are open!
Listen to former participant Adam Buckholz on how you will get more than just training!
Apply now to gain mentorship, sharpen your vision, and build an international network that lasts.
Read more and apply by 15 June: easl.eu/event/aasld-easl-masterclass-2026/
#livertwitter #liverx -
EASLnews
@EASLnews
Meet @GENIAL_project at #easlcongress 2026! Representatives Stephan Buch, Clelia Galvanin and Pierre Nahon will be discussing the project and answer all your questions!
📅 Friday, 29 May 10:00-10:30
📍Track Hub 3
Register to EASL Congress: www.easlcongress.eu/2026-registration/
#livertwitter #liverx -
EASLnews
@EASLnews
Liver transplantation is entering a new era.
In this week's Talk Liver to Me episode, we explore xenotransplantation breakthroughs and the rapid rise of machine perfusion.
Tune on Wednesday to find out what’s real, what’s promising, and what’s next!
Read more: easl.eu/event/liver-transplantation-rise-of-the-machines/
@Drfattyliver #livertwitter #liverxThis media couldn't be displayed. See it on the original post. -
EASLnews
@EASLnews
Watch the new THRIVE Project video!
The video introduces the overall objectives of THRIVE and presents the project partners. It has been prepared in collaboration with Exelixis Research Management & Communication & the EU-funded MULTIR project, reflecting our partnership within the U-THI Cluster projects.
We encourage you to share it with your networks and help spread the word about the great work happening through THRIVE.
thrive-liver-cancer.eu -
EASLnews
@EASLnews
We're thrilled to partner with @EMJReviews!
EMJ Hepatology is the go-to open-access resource for trusted medical education. Their content empowers Hepatology professionals to enhance clinical decisions, transform patient care, and optimise their valuable time.
Subscribe to EMJ Hepatology today: go.emjreviews.com/emj-subscribe-to-hepatology -
EASLnews
@EASLnews
Meet @THRIVE_LiverCan at #easlcongress 2026! Representatives Josep M. Llovet and Roser Pinyol will be discussing the project and answer all your questions!
📅 Thursday, 28 May 16:15-16:45
📍Track Hub 3
Register to EASL Congress: www.easlcongress.eu/2026-registration/
#livertwitter #liverx -
EASLnews
@EASLnews
Meet @ef_clif at #easlcongress 2026! Representatives Paolo Angeli, Anna Bosch, Joan Claria, Javier Fernandez, Richard Moreau and @JonelTrebicka will be discussing the consortium and answer all your questions!
📅 Thursday, 28 May 10:00-10:30
📍Track Hub 6
Register to EASL Congress: www.easlcongress.eu/2026-registration/
#livertwitter #liverx -
EASLnews
@EASLnews
Meet @BavenoCoop at #easlcongress 2026! Representatives @acv69cardenas, @EltonDajti, Jose Fortea & @Laura_Turco83 will be discussing the consortium and answer all your questions!
📅 Wednesday, 27 May 16:15-16:45
📍Track Hub 6
Register to EASL Congress: www.easlcongress.eu/2026-registration/
#livertwitter #liverx -
EASLnews
@EASLnews
🚨Happening today at 1:00pm! We are pleased to invite you to participate in the Middle East School of Steatotic Liver Disease, a dedicated educational initiative focused on MASLD.
This scientific programme is designed to support hepatogastroenterologists across the Middle East, with the aim of addressing the increasing burden of liver diseases. In 2026, the curriculum will feature a comprehensive SLD module that integrates the latest global research, evolving disease nomenclature, and current best practices in diagnosis, management, and prevention.
👉More information: easl.eu/event/focus_uchid/
👉Register here: us06web.zoom.us/meeting/register/YFX2NsNLTICSIMXrBxBKqw -
EASLnews
@EASLnews
With less than a month to go, #easlcongress is fast approaching!
We look forward to bringing together the global liver community for a dynamic and engaging scientific experience, accredited with 27 CME credits.
🌟Marking its 60th edition, an inspiring atmosphere awaits, with a comprehensive and forward-looking programme covering the latest advances in hepatology, alongside countless opportunities to connect, exchange ideas, and build meaningful collaborations with peers from around the world.
👉You can still secure your spot for 27 - 30 May in person, in Barcelona, or online! www.easlcongress.eu/2026-registration/
@DebbieShawcros1 @analleo -
EASLnews
@EASLnews
Meet @MicrobPredict at #easlcongress 2026! Representatives Minneke Coenraad and @JonelTrebicka will be discussing the highlights from the MICROB-PREDICT Consensus Conference and answer all your questions!
📅 Saturday,30 May 11:45-12:15
📍Track Hub 6
Register to EASL Congress: www.easlcongress.eu/2026-registration/
#livertwitter #liverx -
EASLnews
@EASLnews
Milestones and horizons in Hepatology - tribute to Michael Manns
25-26 June, Hannover Medical School
We warmly invite you to the symposium “Milestones and Horizons in Hepatology – A Tribute to Michael Manns” this June in Hannover. Honouring his remarkable impact on hepatology in Germany and worldwide, the event will bring together an outstanding international faculty to reflect on his legacy while exploring current advances and future directions in liver disease research.
🔗 Access the programme: www.mhh.de/ghie/veranstaltungen/milestones-horizons-in-he…
🔗 Participation is free of charge – registration is mandatory: register.falkfoundation.org/registration?eventID=NIEE-DSJJCG -
EASLnews
@EASLnews
How well do you know your EASL CPGs on the management of hepatitis B virus infection?
Test your guidelines knowledge with this new EASL Quiz, as we explore the case of a 36-year old man who was found to be HBsAg positive 10 years ago.
Play here: easlcampus.eu/quiz/question/q142 -
EASLnews
@EASLnews
Meet the EASL Consortium for Regenerative Hepatology at #easlcongress 2026! Representative Pedro Baptista will be discussing the consortium and answer all your questions!
📅 Thursday, 28 May 10:00-10:30
📍Track Hub 5
Register to EASL Congress: www.easlcongress.eu/2026-registration/
#livertwitter #liverx -
EASLnews
@EASLnews
Ready to level up your career?
Apply now to the AASLD-EASL Masterclass 2026 and get tailored training, 1:1 mentorship, and direct feedback on your research. All in one experience!
Hear from former participant Marten Latingua on how beneficial this unique experience was for him!
Read more and apply by 15 June: easl.eu/event/aasld-easl-masterclass-2026/
#livertwitter #liverx @AASLDtweets -
EASLnews
@EASLnews
Meet @Decision4Liver at #easlcongress 2026! Representatives Estefania Huergo, @RautouE and Frank Erhard Uschner will be discussing the project and answer all your questions!
📅 Wednesday, 27 May 13:45-14:15
📍Track Hub 6
Register to EASL Congress: www.easlcongress.eu/2026-registration/
#livertwitter #liverx -
EASLnews
@EASLnews
Share your research at #colda2026
The 9th Conference on Liver Disease in Africa is calling for abstracts on HBV, HCV, diagnostics, co-infections & more.
Abstract deadline: 19 June 26
See the program and submit your abstract here: academicmedicaleducation.com/programs/9th-conference-on-l… -
EASLnews
@EASLnews
We're thrilled to announce our partnership with @EMJReviews!
EMJ Hepatology is the go-to open-access resource for trusted medical education. Their content empowers Hepatology professionals to enhance clinical decisions, transform patient care, and optimise their valuable time.
Subscribe to EMJ Hepatology today: go.emjreviews.com/emj-subscribe-to-hepatology -
EASLnews
@EASLnews
Meet @SALVE_liver at #easlcongress 2026! Representatives Alexandre Louvet, @MorenoChristop8, Richard Parker and @horstef will be discussing the consortium and answer all your questions!
📅 Wednesday, 27 May 13:45-14:15
📍Track Hub 2
Register to EASL Congress: www.easlcongress.eu/2026-registration/
#livertwitter #liverx -
EASLnews
@EASLnews
⭐ Baveno Webinar, 5 May 2026, 17:00 CET, Online
Join the webinar next week to explore the Baveno VIII award winning abstracts presented by leading researchers.
👉 Join at this link: cemm-at.zoom.us/j/84141998647?pwd=UiyBbI0cRR7ax3hHm43guh6… -
EASLnews
@EASLnews
🎯The new EASL–Lancet Commission outlines 3 key priorities to advance liver health in Europe:
📌Make Liver Disease a Top Health Priority
Include liver disease in national and European health plans. Recognise steatotic liver disease as a preventable #ncd within the core NCD framework. Develop standardised liver health indicators for transparent monitoring of outcomes.
📌Detect & Treat Earlier
Build joined-up care pathways for people who often have multiple health conditions. Integrate primary care, endocrinology, psychiatry, and addiction services. Leverage AI-driven risk stratification and non-invasive fibrosis assessment.
📌Tackle the Root Causes
Address alcohol, unhealthy food, and other factors shaped by industry and the wider environment. Implement health warning labels on alcohol. Enforce bans on digital marketing of alcohol and unhealthy foods to under-18s.
We thank all attendees for having participated to the EASL-Lancet Commission 2.0 Launch event in Brussels and online today.
🔗 Read the full report: www.thelancet.com/commissions-do/europe-liver-health
🔗 Read an article on the Guardian: www.theguardian.com/society/2026/apr/29/alcohol-junk-food…
📸 See photos from the event: easl.smugmug.com/Launch-of-the-EASL-Lancet-Commission-20/… -
EASLnews
@EASLnews
“Liver disease is no longer a silent condition — it is a growing public health failure that we have the tools to prevent.
What is missing is not evidence, but action. Europe now has a clear opportunity to turn the tide, but this will require political courage to address the root causes of disease and put health ahead of harmful commercial interests.”
Prof. @DebbieShawcros1 , EASL Secretary General, King’s College London
🔗 www.thelancet.com/commissions-do/europe-liver-health
📍 Launch of the EASL–Lancet Commission, today in Brussels and online -
EASLnews
@EASLnews
“For patients living with liver disease, this report is long overdue. Too many people across Europe are still being diagnosed too late, when treatment options are limited and outcomes are poor.
The Commission’s recommendations, on earlier detection, integrated care, and tackling the root causes of disease, reflect what patients and their families have been asking for.
We now urge policymakers to move from words to action, because for the people we represent, time is not a luxury.”
@Marko_Korenjak , President, European Liver Patients Association (ELPA)
🔗 www.thelancet.com/commissions-do/europe-liver-health
📍 Launch of the EASL–Lancet Commission, today in Brussels and online -
EASLnews
@EASLnews
“Europe has the knowledge and tools to prevent much of the liver disease burden. The real challenge now is implementation and harmonisation across Europe.
There is a window of opportunity to align European health policies against the negative trends we describe in the Commission report.”
Prof. Tom H. Karlsen, Commission Co-Chair, Oslo University Hospital
🔗 www.thelancet.com/commissions-do/europe-liver-health
📍 Launch of the EASL–Lancet Commission, today in Brussels and online -
EASLnews
@EASLnews
“Current data should be a wake-up call. In the WHO European Region, cirrhosis and liver cancer cause nearly 780 deaths every day — around 3% of all deaths.
Tackling the shared risk factors that drive liver disease, including alcohol, unhealthy diets, and viral hepatitis, needs to be an integral part of the broader response to noncommunicable diseases.”
Dr Hans Kluge, WHO Regional Director for Europe
🔗 www.thelancet.com/commissions-do/europe-liver-health
📍 Launch of the EASL–Lancet Commission, today in Brussels and online -
EASLnews reposted
Tom Hemming Karlsen
@tomhemmingk
@TheLancet @EASLnews second Liver Commission report is online. What a tremendous team effort. A roadmap for health, far beyond that pertaining to liver disease. www.thelancet.com/journals/lancet/article/PIIS0140-6736(2…
-
EASLnews
@EASLnews
🚨 NEW: Nearly 780 people die every day in Europe from liver disease — a largely preventable crisis.
The new EASL–Lancet Commission calls for urgent policy action on alcohol, diet, viral hepatitis & more.
👉Full report: www.thelancet.com/commissions-do/europe-liver-health -
EASLnews
@EASLnews
Spontaneous bacterial peritonitis management is evolving. Resistance patterns are shifting. Prophylaxis strategies are debated. Are we ready to rethink the rules? 🤔
Find out now with the new Talk Liver to Me podcast episode!
Out now on Spotify, Amazon Podcast, and EASL Campus!
@Tom_Marjot @bogdanprocopet @o_alastair
easlcampus.eu/tltm/episode-08
#livertwitter #liverx -
EASLnews
@EASLnews
Connect & collaborate at #easlcongress 🚀
Looking for your next step in hepatology, or the right person to join your team? Join our live networking and opportunity pitch session, designed for the hepatology research community.
🎤 Selected participants get 5 minutes on stage at the Science & Solution Stage to:
• Present an open position
• Introduce their research profile
• Pitch a collaboration idea
• Highlight a technique, model, or dataset they need
Apply with your contact details, a pitch title, and a short description (max 250 words).
Spots are limited, apply now 👇
events.easl.eu/Login.aspx?event=easl2026
@DebbieShawcros1 @analleo -
EASLnews
@EASLnews
Applications for the AASLD-EASL Masterclass 2026 are open!
Shape your future in hepatology and join this exciting 3-day intensive Masterclass with expert mentorship, global networking, and hands-on training.
Hear from former participant @VirginiaHdezGea and submit your application by 15 June!
🔗 easl.eu/event/aasld-easl-masterclass-2026/
#livertwitter #liverxThis media couldn't be displayed. See it on the original post. -
EASLnews
@EASLnews
#easlcongress will take place in Barcelona, Spain, from 27 to 30 May 2026, welcoming the international liver health community for four days of scientific exchange and collaboration.
The Congress has now been accredited by the European Accreditation Council for Continuing Medical Education EACCME, awarding 27.0 European CME credits (ECMEC®s).
⭐️We look forward to you joining us there! www.easlcongress.eu/2026-registration/
@DebbieShawcros1 @analleo -
EASLnews
@EASLnews
Spontaneous bacterial peritonitis remains a turning point in the course of advanced cirrhosis.
In this week's Talk Liver to Me episode, we examine how evolving resistance patterns and new data are influencing decisions around prophylaxis, albumin, and treatment strategies.
Out this Wednesday!
@Tom_Marjot @bogdanprocopet @o_alastair
Read more: easl.eu/event/spontaneous-bacterial-peritonitis/
#livertwitter #liverx -
EASLnews
@EASLnews
Global partnerships matter 🌍
Our Secretary General @DebbieShawcros1 represented EASL at @APASL2026 today, strengthening ties in liver health. -
EASLnews
@EASLnews
The @AASLDtweets - EASL Masterclass 2026 is taking place 11 – 13 December in Alexandria, Virginia 🇺🇸.
Join an exclusive cohort for tailored training, one-on-one mentorship, and global networking! Take this opportunity to present your work, gain expert feedback, and connect with future collaborators 😎
Apply by 15 June!
Read more: easl.eu/event/aasld-easl-masterclass-2026/
#livertwitter #liverx -
EASLnews
@EASLnews
Test your Guidelines knowledge and take this new EASL Quiz!
This time we explore the case of a male patient of Caucasian descent, 62 years old, diagnosed with type 2 diabetes at the age of 48, current BMI 29 kg/m2, treated with metformin and empagliflozin, HbA1c 6.3% (45 mmol/mol), who has chronically but only slightly elevated transaminases.
Play here: easlcampus.eu/quiz/question/q141 -
EASLnews
@EASLnews
We are proud to announce the launch of the European Health Alliance on Alcohol (EHAA) — and our new website: alliance-ehaa.org
The story of EHAA begins with a shared recognition. WHO Europe and the European Association for the Study of the Liver (EASL) saw something that the evidence made impossible to ignore: alcohol is one of Europe's greatest, yet most preventable, public health challenges — causing illness, injury, and death on a vast scale, and imposing an enormous burden on individuals, families, and healthcare systems across the continent.
But they also saw something else: that the medical and health professional community was speaking in too many separate voices. That needed to change.
Together, they co-founded EHAA with a clear purpose — to bring Europe's leading medical organisations together under one roof, to speak with one coordinated voice grounded in evidence, and to advocate for the bold, proven public health policies needed to reduce alcohol-related harm.
Today, EHAA unites 28 organisations, representing over 2 million medical and health professional organisations, spanning a wide range of specialties. Together, we are committed to:
✅ Raising awareness of the evidence-based health consequences of alcohol use
✅ Challenging misinformation that undermines public health
✅ Protecting children and young people — among the most vulnerable — from alcohol harm
✅ Advocating for effective, evidence-based policies that save lives
Because when the medical community stands together, policymakers listen.
This is only the beginning. Explore our work, our members, and our mission at 👉 alliance-ehaa.org
#publichealth #alcoholharm #ehaa #evidencebasedpolicy #healthadvocacy #europehealth #whoeurope #easl #noncommunicablediseases
@DrCarina_FB Catherine Paradis @DebbieShawcros1 -
EASLnews
@EASLnews
You can still register for today's EASL DeepDive on the Key Updates in the EASL Clinical Practice Guidelines on extrahepatic Cholangiocarcinoma (eCCA)!
Join us tonight 18:00 CEST for an interactive discussion.
🔗 easl-eu.zoom.us/webinar/register/5217709017720/WN_Oh2OWEj…
#livertwitter #liverx -
EASLnews
@EASLnews
🚨 Hepatology experts– Take this 15 min survey (survey.alchemer.eu/s3/91085482/MICROB-PREDICT-Delphi-onli…) to shape the future of liver research & clinical care for cirrhosis patients!
We invite you to complete this short Consensus Survey, ahead of the upcoming MICROB-PREDICT Consensus Conference at #easlcongress 2026 in Barcelona.
🦠 Focus: Microbiome-based mechanisms & biomarkers
🩺 Scope: Decompensated cirrhosis & ACLF
👉 Goal: Better patient stratification & Improved prediction of therapeutic response
⏱️ Time required: 15–20 minutes
Your input will directly support a Delphi-based, evidence-informed consensus on the following themes and topics:
1️⃣ Theme 1: Progression of decompensated cirrhosis & ACLF
Topic 1: Mechanisms of progression
Topic 2: Biomarkers of progression
Topic 3: Biomarkers of failure within the gut-liver-axis
2️⃣ Theme 2: Mechanisms and biomarkers of therapeutic response
Topic 4: Albumin
Topic 5: Rifaximin
Topic 6: Terlipressin
💡 Your voice will help identify key areas of agreement, highlight uncertainties, and guide future research and clinical decision-making in this rapidly evolving field. Responses are fully anonymised and will be analysed in aggregate only.
🔗 Survey Link: survey.alchemer.eu/s3/91085482/MICROB-PREDICT-Delphi-onli…
⏳ The survey closes on Sunday, 17 May 2026.
We look forward to advancing this important field together - and to see you in Barcelona at the upcoming MICROB-PREDICT Consensus Conference on Wednesday, 27 May 2026, from 15:30 – 18:30 CEST, at #easlcongress! -
EASLnews
@EASLnews
🤩 World Liver Day is a moment to start conversations, but liver health action must continue beyond a single date.
Thank you to everyone, partners, healthcare professionals, patient advocates, and communities around the world, who contributed to raising awareness and promoting liver health! Your efforts help drive meaningful change, reduce stigma, and bring us closer to better prevention, earlier detection, and improved care for all.
worldliverday.org
#worldliverday #loveyourliver #liverhealth #prevention #solidhabitsstrongliver
@AASLDtweets @alehlatam @Solda_Society @APASLnews @WorldLiverDay -
EASLnews reposted
World Liver Day
@WorldLiverDay
Living healthily is not always simple, and it is not just about willpower.
What we eat, how active we are, whether we drink alcohol, and how often we access healthcare are all shaped by the world around us, from marketing and pricing to how our cities are designed.
Policies and environments matter. Clear food labelling, healthier school meals, safe spaces to walk and cycle, and access to affordable health checks can all make healthy choices easier.
But there is also something within your control.
Understanding how your daily habits affect your liver is a powerful first step.
worldliverday.org
#worldliverday #solidhabitsstrongliver
@EASLnews @alehlatam @AASLDtweets @APASLnews @Solda_Society -
EASLnews
@EASLnews
🥼 Many liver conditions develop silently, which is why regular check-ups matter. Early detection opens the door to earlier action, and in many cases, prevention of more serious disease.
EASL’s Love Your Liver impact work focuses on awareness, early detection, and better access to care in local communities. 🧡 easl.eu/impact-projects/
#worldliverday #earlydetection #loveyourliver
worldliverday.org
@AASLDtweets @alehlatam @Solda_Society @APASLnews @WorldLiverDay -
EASLnews
@EASLnews
Lifestyle change does not happen in a vacuum.
💸 ⏱️ 🧠 Cost, time, mental health, caregiving responsibilities, and the wider environment, societies and policies all shape what is possible.
That is why liver health also needs public health action.
#worldliverday
worldliverday.org
@AASLDtweets @APASLnews @alehlatam @Solda_Society @WorldLiverDay -
EASLnews
@EASLnews
⛲ Talking about alcohol should be supportive, practical, and free from judgement.
For liver health, zero alcohol is the safest level, and reducing intake can be a critical step in prevention and care.
👉 The European Health Alliance on Alcohol launched in 2025 brings together health organisations to reduce alcohol-related harm through evidence-based advocacy. alliance-ehaa.org
#worldliverday #alcoholharm
worldliverday.org
@AASLDtweets @alehlatam @Solda_Society @APASLnews @WorldLiverDay -
EASLnews reposted
NCD Alliance
@ncdalliance
📢Today is #worldliverday.
Did you know that small changes at every meal can prevent liver disease?
💪Let's advocate for policies promoting healthy nutrition together!
💪Join European Association for the Study of the Liver (EASL)'s campaign here 👉 worldliverday.org/wld-2026-get-involved/
#solidhabitsstrongliver #actonncds -
EASLnews reposted
World Liver Day
@WorldLiverDay
🚴 🚶 🏊 🕺 Physical activity helps your body use energy more efficiently and reduces fat build up in the liver.
Even without weight loss, regular movement can improve liver function and reduce the risk of disease.
It does not have to be intense. Walking, cycling, swimming, dancing, whatever you enjoy counts. The key is to keep moving.
👉 worldliverday.org/wld-2026-physical-activity/
#worldliverday #solidhabitsstrongliver
@EASLnews @alehlatam @AASLDtweets @APASLnews @Solda_Society -
EASLnews
@EASLnews
🤾 🏊 For liver health, the worst option is doing nothing.
Movement matters, from early disease through to more advanced stages, when tailored and supported safely.
We highlight the value of realistic, personalised goals that patients can build on step by step. 👉 worldliverday.org/wld-2026-physical-activity/
worldliverday.org
#worldliverday #solidhabitsstrongliver
@AASLDtweets @alehlatam @Solda_Society @APASLnews @WorldLiverDay -
EASLnews
@EASLnews
🥗 Healthy lifestyle is not an optional extra, it is part of liver care. For many people, improving diet does not mean perfection, it means practical shifts towards healthier everyday habits that can be sustained over time.
👉 Listen to a conversation with Prof. Shira Zelber-Sagi, a leading expert in nutrition and liver health. As a clinical dietitian, epidemiologist, and researcher, she brings extensive experience in the connection between diet and liver disease. youtu.be/bRgjC5ml_KA
👉 Consult the World Liver Day recipe book! heyzine.com/flip-book/26f1a56510.html
#worldliverday #masld #nutrition #solidhabitsstrongliver
@AASLDtweets @alehlatam @Solda_Society @APASLnews @WorldLiverDay -
EASLnews reposted
LiverAim
@LiverAim
🌍 World Liver Day 2026: Solid habits, strong liver!
#chronicliverdiseases are often silent, but largely preventable!
💪#liveraim is working for early diagnosis and timely interventions.
#liverhealth
@IHIEurope @EASLnews @WorldLiverDay @EuropeLiver -
EASLnews
@EASLnews
🧡 Liver health is not just about biology, it is also about how people are treated. Stigma and discrimination can delay diagnosis, reduce access to care, and worsen health outcomes. It is time to move away from blame and towards dignity, respect, and equitable care for all.
👉 Explore EASL’s policy statement calling for action to end stigma in liver disease. easl.eu/publication/policy-statement-ending-stigma-and-di…
worldliverday.org
#worldliverday #liverhealth #endstigma #healthequity
@AASLDtweets @alehlatam @Solda_Society @APASLnews @WorldLiverDay -
EASLnews
@EASLnews
🤸 Successful lifestyle change starts with the person, not just the diagnosis. What matters most to them? What barriers do they face?
Personalised goals, peer support, and celebrating small wins can help turn advice into action.
Listen to EASL’s #talklivertome podcast on how to make lifestyle change possible.
👉 easlcampus.eu/tltm/episode-07
#worldliverday #patientcentredcare #masld
worldliverday.org
@WorldLiverDay @AASLDtweets @alehlatam @Solda_Society @APASLnews -
EASLnews
@EASLnews
🚨 MASLD affects around one third of adults globally, and steatotic liver disease is rising worldwide. Early action matters. A balanced diet, physical activity, alcohol reduction, and regular monitoring can help protect liver health before complications develop.
👉 Explore the latest EASL, EASD, EASO Clinical Practice Guidelines on MASLD. easl.eu/publication/easl-easd-easo-clinical-practice-guid…
👉 worldliverday.org
@Solda_Society @AASLDtweets @alehlatam @APASLnews @WorldLiverDay #worldliverday -
EASLnews reposted
World Liver Day
@WorldLiverDay
🎉 Happy #worldliverday 2026!
Your liver is one of the hardest working organs in your body. It filters your blood, processes nutrients, stores energy, and helps keep everything in balance, every single day.
This World Liver Day, we are focusing on one simple idea, small, consistent habits can make a big difference. You do not need to change everything overnight. Start with one step and build from there.
💚 xn--worldliverday-of77l.org
#solidhabitsstrongliver
@EASLnews @AASLDtweets @alehlatam @Solda_Society @APASLnews -
EASLnews
@EASLnews
🧱 Happy #worldliverday 2026!
Today we remember that liver health is also shaped by everyday choices.
Small, consistent steps, healthier food, more movement, less alcohol, regular check-ups, can make a meaningful difference. 🥕 🏋️ 🫗 🥼
Listen to EASL’s World Liver Day podcast on making lifestyle change possible.
🎙️ easlcampus.eu/tltm/episode-07
#worldliverday #solidhabitsstrongliver #liverhealth #masld
@AASLDtweets @WorldLiverDay @alehlatam @Solda_Society @APASLnews -
EASLnews
@EASLnews
Free liver screening in action at Meyrin Centre on 17 and 18 April📍
Taking place in Geneva, where EASL is based, this initiative brings global liver health expertise directly to the local community ahead of #worldliverday on 19 April.
🧱 This year’s theme, “Solid habits, strong liver”, highlights the importance of prevention, including one key pillar: regular check-ups.
The need is clear:
• Liver disease causes around 2 million deaths every year worldwide
• An estimated 1.5 billion people live with chronic liver conditions
• Many diseases remain silent until advanced stages
📌 In Geneva, risk factors such as high blood pressure, type 2 diabetes, obesity, smoking and alcohol consumption are present across the population. Financial barriers can also delay access to care, increasing the risk of late diagnosis and complications.
In the Lake Geneva region, hospitalisation rates for cirrhosis are among the highest in Switzerland, reinforcing the importance of early detection.
Through free, quick and non-invasive FibroScan tests, this event encourages people to take a simple but meaningful step, because regular screening, alongside healthy habits such as a balanced diet, reducing alcohol intake, and physical activity, can help protect liver health and save lives!
📸 See all photos from the event! easl.smugmug.com/World-Liver-Day-Love-Your-Liver-2026/Wor…
Photo Credit: Aigal Studio
👉 Learn more about World Liver Day: worldliverday.org
@WorldLiverDay @DebbieShawcros1 @AASLDtweets @alehlatam @Solda_Society @APASLnews
#worldliverday #solidhabitsstrongliver -
EASLnews
@EASLnews
🔎A fantastic first day of free liver check-ups is ongoing at Meyrin Centre ahead of #worldliverday 2026!
🧡We thank everyone who came by already to learn more about their liver health!
We’re back again tomorrow, visit us at Av. de Feuillasse 24 from 10:00 to 16:00 and take a simple step towards better health.
First come, first served. See you there!
👉Learn more about World Liver Day: worldliverday.org
#solidhabitsstrongliver @AASLDtweets @alehlatam @APASLnews @Solda_Society @DebbieShawcros1 @WorldLiverDay
©️Photo credit: Lea Selosse -
EASLnews reposted
Society for Liver Disease in Africa (SOLDA)
@Solda_Society
2M lives are lost to liver disease each year, many preventable.
This #worldliverday, join our webinar on “Solid Habits, Strong Liver” and learn how small actions can protect liver health.
🗓 22 April
⏰ 15:00 SAST
🔗 virology.eventsair.com/solda/wldsoldawebinar/Site/Register -
EASLnews
@EASLnews
🇨🇭HAPPENING TOMORROW: Are you based in Switzerland or visiting the Geneva area?
Ahead of #worldliverday, something important, and completely free, is happening right on your doorstep!
📅From 10:00 to 16:00 on 17 and 18 April, head to Meyrin Centre Av. de Feuillasse 24, 1217 Meyrin, and take a moment for your health.
A local campaign organised by EASL is offering free liver checks, making it easier than ever to stay one step ahead of potential issues!
In just a few minutes, you can have a FibroScan, a fast, painless and non-invasive test that measures liver stiffness and detects liver fat levels. You will get your results immediately, explained clearly by healthcare professionals on site.
🤫Liver disease often develops quietly, without obvious symptoms. That is why early testing matters, it can help detect problems before they become serious.
If you are in the area, drop by, it is quick, informative, and could make a real difference to your health!
👉 Read more here: worldliverday.org/wp-content/uploads/2026/04/meyrin_283_w…
👉Prepare for World Liver Day 2026: worldliverday.org
@WorldLiverDay @AASLDtweets @alehlatam @Solda_Society @APASLnews @DebbieShawcros1 -
EASLnews
@EASLnews
Register for the next EASL DeepDive to explore key updates in the EASL Guidelines on extrahepatic cholangiocarcinoma (eCCA). Experts will discuss the role of systemic therapy in the management of eCCA across all disease stages (including neoadjuvant, adjuvant, and palliative settings).
Wednesday, 22 April, 18:00 CEST
🔗 easl-eu.zoom.us/webinar/register/5217709017720/WN_Oh2OWEj…
#livertwitter #liverx -
EASLnews reposted
World Liver Day
@WorldLiverDay
🎧 New episode just dropped for #worldliverday!
@EASLnews latest Talk Liver to Me podcast dives into the real impact of lifestyle changes in MASLD/MASH and alcohol-related liver disease.
From prevention to advanced stages, we explore:
✨ What actually works
✨ Why small changes matter
✨ How healthy living supports, not replaces, treatment
Listen to the full episode now on EASL Campus 👇
easlcampus.eu/tltm/episode-07
Also available on Apple Podcasts & Spotify!
Featuring: @HallsworthKate @mromerogomez
#solidhabitsstrongliver #talklivertome @AASLDtweets @alehlatam @APASLnews @Solda_Society @EASLeduThis media couldn't be displayed. See it on the original post. -
EASLnews
@EASLnews
⏰ Reminder: Don’t miss this important conversation on the future of liver health in Europe
Liver disease continues to rise across Europe, but strong evidence can lead to meaningful action.
Join the launch of the EASL–Lancet Commission 2.0
“From Evidence to Impact: Implementing Sustainable Liver Health in Europe”
📅 30 April 2026
🕒 11:00–13:00
📍 Brussels + online
Bringing together policymakers, clinicians, researchers, economists and civil society, this event will focus on:
🔹 Strengthening prevention
🔹 Improving early detection
🔹 Advancing liver care across Europe
Hear from global health leaders, Commission experts, and take part in a key discussion on turning recommendations into real-world impact.
👉 View the programme: easl.eu/event/liver-commision-from-evidence-to-impact/
👉 Register here: www.surveymonkey.com/r/LJ9NB6F
@DebbieShawcros1 @analleo -
EASLnews
@EASLnews
New Talk Liver to Me podcast episode out now!
Released for World Liver Day, this conversation unpacks the evidence behind lifestyle modification in MASLD/MASH and alcohol-related liver disease. From prevention to advanced disease, we explore what truly makes a difference, why small changes count, and how healthy living works with pharmacology not against it.
Available now on EASL Campus: easlcampus.eu/tltm/episode-07
Also on your Apple Podcasts and Spotify!
@HallsworthKate @mromerogomez
#livertwitter #liverx -
EASLnews
@EASLnews
On World Liver Day, this new Talk Liver to Me podcast episode explores one of today’s most pressing questions: If new drugs can treat steatotic liver disease, do diet and exercise still matter?
Full episode out this Wednesday, on EASL Campus, Apple Podcasts and Spotify!
More info: easl.eu/event/world-liver-day-making-lifestyle-change-pos…
@HallsworthKate @mromerogomez
#livertwitter #liverxThis media couldn't be displayed. See it on the original post. -
EASLnews
@EASLnews
Have you secured your place at #easlcongress next month?
Join us at Europe’s largest and most influential event dedicated to liver health, bringing together a global community of doctors, scientists, allied health professionals, patients, and industry partners.
Discover a rich scientific programme covering the full spectrum of hepatology, with a wide range of session formats tailored to different interests and professional needs, and numerous opportunities for networking and collaboration.
Register now!
👉www.easlcongress.eu/2026-registration/
@DebbieShawcros1 @analleo -
EASLnews
@EASLnews
We’re pleased to spread the word about ILTS for the 2026 ILTS Congress: Pushing Boundaries, Elevating Standards in Liver Transplantation, taking place in Geneva, Switzerland, May 6–9.
This landmark 30th annual congress will bring together the global liver transplantation community for world-class education, collaborative science, and meaningful in-person exchange. We encourage our members to attend and take advantage of this exceptional opportunity.
Explore the programme: ilts.org/2026-congress
#iltscongress2026 #livertransplantation #hepatology #transplantmedicine #medicalconference -
EASLnews
@EASLnews
Register for the next EASL DeepDive to explore key updates in the EASL Guidelines on extrahepatic cholangiocarcinoma (eCCA). Learn how to define the optimal candidates for resection and liver transplantation, and discuss challenges in the surgical management of eCCA.
Wednesday, 22 April, 18:00 CEST
🔗 easl-eu.zoom.us/webinar/register/5217709017720/WN_Oh2OWEj…
#livertwitter #liverx -
EASLnews
@EASLnews
New EASL Quiz! This time we explore the case of a 52-year old male with compensated advanced liver disease due to primary sclerosing cholangitis, who is in need of partial nephrectomy because of renal cell carcinoma.
Play now: easlcampus.eu/quiz/question/q140
#livertwitter #liverx -
EASLnews reposted
World Liver Day
@WorldLiverDay
🤔What if a few simple habits could protect your liver and your long term health?
No extreme diets. No complicated routines. Just small, everyday choices.
🙌We are getting ready for #worldliverday 2026 on 19 April. Prepare your campaign and join us!
worldliverday.org -
EASLnews
@EASLnews
Are you attending #easlcongress 2026 in Barcelona?
Get expert insight into some of the most pressing challenges and opportunities in hepatitis C at this interactive Meet-the-Experts session. Discussions will focus on key topics such as point-of-care diagnosis, the management of acute infection, reinfection, and considerations during pregnancy. Join leading specialists to explore current clinical questions, share experiences, and gain practical perspectives on advancing care and improving outcomes in Hepatitis C.
👉pag.virtual-meeting.org/easl/easl2026/en-GB/pag/session/1…
👉Register now: www.easlcongress.eu/2026-registration/ -
EASLnews
@EASLnews
Join us in Brussels or online on 30 April for a key moment in advancing liver health across Europe.
We are proud to launch the EASL–Lancet Commission 2.0, presenting updated evidence and actionable policy recommendations to reduce the burden of liver disease and strengthen prevention, early detection, and care.
Under the theme “From Evidence to Impact: Implementing Sustainable Liver Health in Europe”, this event will bring together policymakers, researchers, health experts and stakeholders to turn science into meaningful action.
📅 30 April 2026
🕒 10:30 registration and coffee
11:00–13:00 programme
13:00 onwards lunch
📍 Brussels and online
Be part of the conversation shaping the future of liver health in Europe.
👉 Register now www.surveymonkey.com/r/LJ9NB6F
👉 Discover the programme
easl.eu/event/liver-commision-from-evidence-to-impact/
@DebbieShawcros1 @analleo -
EASLnews
@EASLnews
Register for the next EASL DeepDive to explore key updates in the EASL Guidelines on extrahepatic cholangiocarcinoma (eCCA). Learn how to identify at-risk patients, optimise diagnosis and staging, navigate surgical and transplant decisions, and understand the role of systemic therapies across disease stages.
Wednesday, 22 April, 18:00 CEST
🔗 easl-eu.zoom.us/webinar/register/5217709017720/WN_Oh2OWEj…
#livertwitter #liverx -
EASLnews
@EASLnews
New Talk Liver to Me podcast episode out now!
Experts @tom_marjot, @MattiasMandorf1 & Cristina Ripoll share their immediate impressions from the the Baveno VIII meeting and break down the key highlights shaping the management of portal hypertension and advanced liver disease.
Watch or listen on EASL Campus: easlcampus.eu/tltm/episode-06
Listen on Spotify: open.spotify.com/episode/4TfvNEHGXSSC8ljSqUPMo6
Listen on Apple Podcasts: podcasts.apple.com/us/podcast/talk-liver-to-me-baveno-vii…
#livertwitter #liverxThis media couldn't be displayed. See it on the original post. -
EASLnews
@EASLnews
This Wednesday, a new Talk Liver to Me podcast episode awaits you!
This time, experts @tom_marjot, @MattiasMandorf1 & Cristina Ripoll break down the key takeaways from the Baveno VIII meeting. What’s changed in portal hypertension management, what reached consensus, and what’s still debated?
Read more: easl.eu/event/baveno-viii-takeaways/
#livertwitter #liverx -
EASLnews
@EASLnews
🤩We are organising a free liver health check in Geneva to celebrate the upcoming @WorldLiverDay!
📍Meyrin Centre, Geneva, Switzerland
🗓️17 and 18 April, 10:00 - 16:00
If you are in the Geneva area drop by, bring a friend and start building a stronger, healthier life!
#solidhabitsstrongliver @DebbieShawcros1 @analleo
World Liver Day
@WorldLiverDay
Join us for @WorldLiverDay in Geneva!
📍Meyrin Centre, 17 &18 April, 10:00 -16:00!
Get a free, quick, and painless liver health check with results on the spot. Discover simple daily habits that protect your liver and boost your wellbeing. Drop by! -
EASLnews
@EASLnews
Test your guidelines knowledge! How well do you know your CPGs on the management of autoimmune hepatitis? Take this new EASL Quiz to find out, as we explore the case of a 24-year old female who presents fatigue and malaise.
🎮 easlcampus.eu/quiz/question/q139
#livertwitter #liverx -
EASLnews
@EASLnews
New EASL-ESP Course Inflammatory and non-tumoural liver diseases now available!
Explore the evolving role of liver biopsy through expert-led modules covering MASLD, autoimmune hepatitis, hereditary and biliary liver diseases, and more. Learn when biopsy adds value alongside non-invasive techniques and review key grading and staging systems used in clinical practice.
🔗 easlcampus.eu/course/easl-esp
#livertwitter #liverx -
EASLnews
@EASLnews
You can still register for today's EASL DeepDive on key changes in the latest EASL HBV CPGs!
Join @maud_lemoine, @CornbergMarkus, @SaSi_Lens & Jerzy Jaroszewicz for an important discussion, tonight 18:00 CET
Register now: easl-eu.zoom.us/webinar/register/8117726210951/WN_IEA1UGT…
#livertwitter #liverx -
EASLnews
@EASLnews
There is just one week left to submit your late-breaking abstract for #easlcongress 2026. If you have important new findings that were not available during the regular submission period, this is your opportunity to share them with the global hepatology community in Barcelona from 27 to 30 May.
Be part of one of the leading international meetings in liver disease! www.easlcongress.eu/2026-abstracts/
Secure your spot: www.easlcongress.eu/2026-registration/ -
EASLnews
@EASLnews
One month to go until World Liver Day on 19 April 💚
Whether you are organising an event, sharing content or raising awareness in your community, every action helps put liver health on the agenda.
This year’s theme, Solid Habits, Strong Liver, is a powerful reminder that prevention starts with simple, everyday choices.
Help us spread the message:
✔️ Promote a balanced diet
✔️ Encourage regular physical activity
✔️ Raise awareness about reducing alcohol intake
✔️ Highlight the importance of regular checks
Start preparing your campaign today, and join us on 19 April. #worldliverday #solidhabitsstrongliver 💚
👉worldliverday.org
World Liver Day
@WorldLiverDay
1 month to go until #worldliverday on 19 April 💚
Whether you are organising an event, sharing content or raising awareness in your community, every action helps put liver health on the agenda.
🌽🏋️♀️🥤🩺Solid Habits, Strong Liver
worldliverday.org -
EASLnews
@EASLnews
Today’s #readoftheweek📚highlights how #masld is rapidly increasing among women of childbearing age, with marked regional and socioeconomic disparities.
Read here this @JHEP_Reports article: www.jhep-reports.eu/article/S2589-5559(25)00328-3/fulltext
#livertwitter #liverx -
EASLnews
@EASLnews
Join next week's EASL DeepDive to navigate the new EASL guidelines for chronic hepatitis B. Learn when to initiate or discontinue antiviral therapy, how to monitor patients, and what’s next in HBV treatment.
🗓️ Wednesday, 25 March, 18:00 CET
With @maud_lemoine, @CornbergMarkus, @SaSi_Lens & Jerzy Jaroszewicz!
Register now: easl-eu.zoom.us/webinar/register/8117726210951/WN_IEA1UGT…
#livertwitter #liverx -
EASLnews
@EASLnews
New Talk Liver to Me podcast episode is out now! Experts @MattiasMandorf1, @MarcoSanduzzi and @LorenzaRimassa discuss the strengths and limitations of the BCLC model in an era of rapidly evolving systemic therapies and personalised care, sharing real-world examples of when the algorithm helps and when clinical practice diverges.
Listen on Apple Podcasts: podcasts.apple.com/us/podcast/talk-liver-to-me-updated-bc…
Listen on Spotify: open.spotify.com/episode/3yFFMERMXWeQqa3B6Tyz0s
Watch on EASL Campus: easlcampus.eu/tltm/episode-05
#livertwitter #liverx -
EASLnews
@EASLnews
The next Talk Liver to Me podcast drops tomorrow!! Here's a sneak-peek from this interactive discussion between @MattiasMandorf1, @MarcoSanduzzi and @LorenzaRimassa!
Read more: easl.eu/event/updated-bclc-guidelines-for-hcc-protocolise…
#livertwitter #liverx -
EASLnews
@EASLnews
📰🚨Late-breaking abstract submission is now open for #easlcongress 2026, taking place in Barcelona from 27-30 May. This is your opportunity to present the most recent and impactful findings in liver research to a global audience of clinicians, researchers and experts in hepatology.
Late-breaking abstracts are designed to highlight important new data that were not available during the regular submission period. Submitting your latest results allows you to share cutting edge research, contribute to timely scientific discussions, and gain visibility within the international liver community!
👉Submit your late-breaking abstract now: events.easl.eu/Home/Index/Event/easl2026/en-GB
@DebbieShawcros1 @analleo -
EASLnews
@EASLnews
Only a couple of days left to apply for the EASL MASLD Guidelines Academy!
Discover the five-module, in-person training programme designed to help healthcare professionals confidently apply MASLD guidelines in everyday clinical practice.
Apply by 15 March, 23:59 CET: easl.eu/easl-masld-guidelines-academy/
@FrancqueSven
#livertwitter #liverx -
EASLnews
@EASLnews
Liver disease is a growing public health challenge across Europe, but evidence can drive real change.
Join us for the launch of the EASL–Lancet Commission 2.0
“From Evidence to Impact: Implementing Sustainable Liver Health in Europe.”
This event will bring together policymakers, clinicians, researchers, economists and civil society to discuss how the latest evidence and policy recommendations can strengthen prevention, improve early detection and advance liver care across Europe.
📅 30 April 2026
🕒 11:00–13:00
📍 TownHall Europe, Brussels
💻 Online participation available
The programme will feature keynote insights from global health leaders and presentations from Commission experts, followed by a panel discussion on translating recommendations into action at EU and national levels.
👉 See the full programme here: easl.eu/event/liver-commision-from-evidence-to-impact/
👉 Register now: www.surveymonkey.com/survey-closed/?sm=WH7v_2FMrpiQGrxeja… -
EASLnews
@EASLnews
The authors in today’s #readoftheweek📚 assess the differences in overall survival and recurrence-free survival in patients with macrovascular invasion and HCC undergoing liver transplantation.
Read here this @JHEP_Reports article: www.jhep-reports.eu/article/S2589-5559(25)00248-4/fulltext
🙏 @Anudarizorigt, @ArndtVogel et al.
#livertwitter #liverx -
EASLnews
@EASLnews
Register for the next EASL DeepDive and discover the latest EASL guidance on antiviral therapy decisions, patient monitoring, and emerging therapies shaping the future of HBV management.
🗓️ Wednesday, 25 March, 18:00 CET
With @maud_lemoine, @CornbergMarkus, @SaSi_Lens & Jerzy Jaroszewicz!
🔗 easl-eu.zoom.us/webinar/register/8117726210951/WN_IEA1UGT…
#livertwitter #liverx -
EASLnews
@EASLnews
EASL is deeply saddened by the loss of Dr Ahmed Elsharkawy, consultant transplant hepatologist, researcher, educator and valued member of the EASL Governing Board.
Ahmed served EASL with honesty, courage and a deep commitment to the community he cared so much about. He was never afraid to speak up when it mattered, always guided by a strong sense of fairness and integrity. His leadership helped shape important initiatives that will continue to benefit the liver community for years to come.
Beyond his professional achievements, Ahmed will be remembered for his warmth, humour and generosity as a colleague and friend.
Our thoughts are with his wife Sarah, his children, his family and all those who knew and worked with him.
@DebbieShawcros1 @analleo -
EASLnews
@EASLnews
Today’s #readoftheweek highlights how TIPS dilation diameter represents an independent key determinant of post-TIPS overt hepatic encephalopathy.
Read here this @JHEP_Reports article: www.jhep-reports.eu/article/S2589-5559(25)00359-3/fulltext
🙏 @MontagneseSara @filippo_schepis et al.
#livertwitter #liverx -
EASLnews
@EASLnews
What’s next in chronic hepatitis B management?
The next EASL DeepDive will explore updated treatment recommendations, real-world monitoring strategies, and future advances outlined in the new EASL guidelines.
🗓️ Wednesday, 25 March, 18:00 CET
With @maud_lemoine, @CornbergMarkus, @SaSi_Lens & Jerzy Jaroszewicz!
Register now: easl-eu.zoom.us/webinar/register/8117726210951/WN_IEA1UGT…
#livertwitter #liverx -
EASLnews
@EASLnews
🗞️New research offers hopeful news for patients with advanced alcohol related liver disease.
An international multicentre study led by @MedUni_Wien and published in @JHepatology shows that consistent alcohol abstinence can lead to a remarkable recovery, even in patients with previously decompensated alcohol related cirrhosis.
The study analysed 633 patients from 17 specialised centres across Europe and Asia. Within five years, up to one third achieved “recompensation”, meaning complete regression of liver related complications together with recovery of liver function.
Key findings
• Even advanced cirrhosis is not always irreversible
• Early and sustained alcohol abstinence more than doubles the chance of recovery
• Patients who recompensated and maintained abstinence had no liver related deaths in the study
• Risks of liver cancer and overall mortality were significantly reduced
These findings highlight the powerful impact of early intervention and long term support for alcohol abstinence. Strengthening addiction support programmes is therefore not only a public health priority, but also essential for improving outcomes in patients with alcohol related liver disease.
👉Read the full study:
www.journal-of-hepatology.eu/article/S0168-8278(26)00018-… -
EASLnews
@EASLnews
If cure isn’t possible, what does good care look like?
🎧 This new Talk Liver to Me podcast episode explores practical guidance from the new EASL Position Paper and how we can better support this vulnerable group.
Available now on EASL Campus: easlcampus.eu/tltm/episode-04
Spotify: open.spotify.com/episode/7utKyUcWysheP1CqYiJMSC
Apple Podcasts: podcasts.apple.com/us/podcast/talk-liver-to-me-when-cure-…
@DebbieShawcros1 @KuePatrizia #livertwitter #liverx -
EASLnews
@EASLnews
🌍 How is hepatology practised around the world? Help us find out.
EASL has launched the Global Hepatology Survey in collaboration with @AASLDtweets , @alehlatam , @APASLnews & @Solda_Society — and we need your input!
The survey takes just a few minutes and is available in 🇬🇧🇫🇷 🇪🇸 🇨🇳
📅 Closes 31 March 2026 🔗 www.surveymonkey.com/r/BNLB9BM -
EASLnews
@EASLnews
🗞️News from A-TANGO!
We celebrate a new consortium publication by Cornelius Engelmann et al. (2026) that introduces the A-TANGO organ failure (OF) score, a refined tool for diagnosing acute-on-chronic liver failure (ACLF) in patients with cirrhosis and acute decompensation.
Developed using data from 3,896 patients in Europe and Latin America and validated in large cohorts from India and China, the score updates thresholds for organ dysfunction and adds a new ACLF grade 4 to better capture severely ill patients. Compared with the widely used CLIF-C OF score, A-TANGO improves detection of ACLF (24% to 36%) while maintaining strong prediction of 28- and 90-day mortality. The study also introduces two related prognostic models.
Together, these tools provide a more accurate framework for risk stratification, treatment evaluation, and the design of clinical trials in ACLF.
👉Read the publication here: www.sciencedirect.com/science/article/abs/pii/S0168827826… -
EASLnews
@EASLnews
Apply for the EASL MASLD Guidelines Academy, our new hands-on training programme supporting the real-world implementation of the latest MASLD Clinical Practice Guidelines!
Read more and apply here: easl.eu/easl-masld-guidelines-academy/
#livertwitter #liverx -
EASLnews reposted
EASD
@EASDnews
🎥This week, our @EASDacademy is hosting a #webinar with Prof. @gastaldelli_amy, co-author of the @EASLnews Guidance on the full steatotic #liver disease (SLD) trajectory on #masld: current treatments & what's next.
📅5 March |🕛16:30 CET
👉Register now: us06web.zoom.us/webinar/register/WN_qdnafDFxR8yCUxBo3muB2A -
EASLnews
@EASLnews
Patients with advanced liver disease face complex physical, emotional, and spiritual challenges yet few are referred to palliative care in time.
🎙️ This Talk Liver To Me episode explores the new EASL Position Paper and the key areas that can truly improve quality of life.
Available this Wednesday!
Read more: easl.eu/event/palliative-care-in-advanced-liver-disease/
@DebbieShawcros1 @KuePatrizia #livertwitter #liverxThis media couldn't be displayed. See it on the original post. -
EASLnews
@EASLnews
Immunotherapy is redefining hepatocellular carcinoma care, and this #easlcongress 2026 Symposium in Barcelona explores what comes next.
Discover how ICI based combinations are moving into earlier stage HCC, from perioperative strategies to integration with loco regional and transplant approaches. Hear the latest on next generation therapies and the real world challenges of putting them into practice.
Register now and discover this and more in a rich scientific programme!
👉www.easlcongress.eu/2026-registration/
👉www.easlcongress.eu/2026-scientific-programme/ -
EASLnews
@EASLnews
⭐️As we close the EASL #sldsummit 2026, thank you to all 440 delegates from 47 countries, our 42 faculty members, our valued industry partners, and our patient organisation attendees.
Over the past days, we explored the latest advances in MASLD, MetALD and ALD, debated the impact of public policy on the SLD environment, and examined emerging therapeutic strategies in an evolving landscape. Most importantly, we strengthened collaboration across disciplines and career stages, with rich discussion at the heart of every session. 🤝
CME credits will be awarded to all attendees.
Registered delegates can access all sessions on demand via the platform and later on EASL Campus.
🙏Thank you for your energy, insight and commitment to improving care in steatotic liver disease. See you at the SLD Summit 2027 in Berlin, on 11-13 February!
👉Access the Best of Slide Deck: easlcampus.eu/documents/best-easl-sld-summit-2026-slide-deck
📸View all photos from the event: easl-sld.virtual-meeting.org
@rabataller @WillAlazawi @AnnaAlisi -
EASLnews
@EASLnews
We closed #sldsummit 2026 with a forward looking Plenary session dedicated to scanning the horizon of SLD research and care.
The discussion explored whether genetics can meaningfully guide future treatment strategies, questioning the feasibility and desirability of pan SLD drug development, and reflecting on the core skills required for the next generation of SLD specialists.
@SagiZelber @marurinella @NoureddinMD @tom_marjot -
EASLnews
@EASLnews
The State of the Art lecture at #sldsummit turned the spotlight on MetALD and the emerging therapeutic targets identified through preclinical models.
The session explored how metabolic and alcohol related liver disease converge, examining the distinct pathophysiology that shapes prognosis, diagnosis and treatment strategies.
By framing MetALD as a critical category within the broader SLD spectrum, the discussion highlighted how experimental insights can inform future therapeutic development and refine clinical approaches. #sldsummit
@GSzaboMD -
EASLnews
@EASLnews
A key Plenary session is now providing an important update on the joint @AASLDtweets and EASL consensus on clinical trial design and endpoints in MetALD and ALD.
The discussion is outlining general considerations for trial design, before moving into phase 2 and 3 endpoints in pre cirrhotic disease, and specific considerations for compensated and decompensated advanced chronic liver disease.
Challenges around harmonising endpoints across overlapping phenotypes, the role of biomarkers and imaging, and regulatory expectations are all under careful examination. Patient centred outcomes and emerging surrogate markers are central to shaping the next generation of trials. #sldsummit
@AleksanderKrag @DebbieShawcros1 @NoureddinMD @hlcortezpinto -
EASLnews
@EASLnews
🗞️A major new guidance document on steatotic liver disease has just been published online, providing a global, multidisciplinary framework for screening and patient management across the entire disease spectrum.
With SLD affecting more than 1 in 3 adults worldwide, the document uses the patient trajectory as its anchor, providing practical recommendations on case finding, risk stratification, referral pathways and stage specific care, from early disease to advanced fibrosis and cirrhosis.
All recommendations are categorised as must have or nice to have, enabling adaptation across different healthcare systems and resource settings.
👉Read it now: www.jhep-reports.eu/action/showPdf?pii=S2589-5559(26)00069-8
@FrancqueSven -
EASLnews
@EASLnews
The first Plenary of the final day is focusing on one of the foundations of effective SLD care, accurate and timely diagnosis.
The session is examining whether blood tests truly outperform clinical history in detecting alcohol use, how referral pathways can be structured to ensure meaningful treatment, and how prognostic tools can better identify individuals at risk of alcohol related liver disease.
Long term continuity of care is also under discussion, highlighting the crucial role of practitioners in supporting both liver health and addiction management. Integration across services is a central theme in this practical and patient centred exchange. #sldsummit -
EASLnews
@EASLnews
🏆Congratulations to Mario Romeo and Mirko Zoncapè on receiving Poster Awards at the EASL #sldsummit 2026! 🌟
Their outstanding work and scientific excellence stood out among a highly competitive field, reflecting the innovation and translational strength driving research in steatotic liver disease.
@rabataller @WillAlazawi @AnnaAlisi @mirkozoncape @tom_marjot @PMRodrigues19 -
EASLnews
@EASLnews
The closing Plenary of Day 2 at #sldsummit 2026 is focused on the next wave of therapeutic development in SLD.
Metabolic directed and liver directed treatment strategies are being examined in depth, reflecting the rapidly expanding pipeline of potential interventions. Fresh data on metabolic modulation in MASLD and type 2 diabetes are contributing to the evolving evidence base.
The discussion is also tackling a key question in cirrhosis care, whether treatment goals should prioritise fibrosis regression or tangible clinical outcomes. A forward thinking exchange is setting the tone as we head into the final day of the Summit.
@schattenbergJ -
EASLnews
@EASLnews
This State of the Art lecture at #sldsummit is focusing on one of the most urgent and often overlooked drivers of liver disease, alcohol use disorder.
The session is outlining evidence based strategies to improve screening and diagnosis of AUD, alongside practical approaches to management within liver clinics. Integrated care pathways are being highlighted as essential to ensure patients receive timely and effective support.
A clear and practice oriented overview is helping translate evidence into action for everyday clinical care.
@rabataller @WillAlazawi @AnnaAlisi -
EASLnews
@EASLnews
The afternoon Plenary examined immunity and inter organ cross talk in SLD, reinforcing its role as a multisystem condition.
New insights into metabolomic modelling shed light on multiorgan interactions, while emerging data on immunological circuits in MASLD are refining our understanding of inflammatory pathways. Genetic influences beyond the liver and the impact of the gut barrier and brain input in ALD were also part of this wide ranging discussion.
Together, these perspectives are highlighting the systemic complexity of SLD and opening the door to novel intervention strategies. #sldsummit -
EASLnews
@EASLnews
📃Poster Tour II is now bringing another wave of cutting edge research into focus at #sldsummit.
Innovative machine learning approaches for risk stratification in MASLD are being presented alongside data on the impact of new therapeutic indications on treatment eligibility. Experimental studies are also exploring acute dietary effects on hepatic fat, environmental drivers of immune reprogramming, mitochondrial interactions in MASLD and the role of pro inflammatory CD8+ T cells in early fibrosis.
The tour is sparking lively discussion as attendees engage directly with investigators and examine the translational potential of these findings!
@PMRodrigues19 @tom_marjot @EASLedu -
EASLnews
@EASLnews
The Plenary session on #omics and new experimental tools is unfolding with a deep dive into the technologies reshaping SLD research.
Single cell and spatial omics are revealing new layers of biological complexity, while human genetics is helping to identify susceptibility factors and molecular drivers of disease. Innovative liver on chip systems and organoid bioengineering approaches are also being explored to model fibrosis and multiorgan interactions with greater precision.
The discussion is highlighting how the integration of multi omics platforms with advanced bioengineering can accelerate discovery and refine disease modelling in SLD. #sldsummit
@HanleyPiper @etrepo -
EASLnews
@EASLnews
The first Plenary of Day 2 at #sldsummit is addressing pressing clinical questions in SLD across the disease spectrum.
The session is exploring evolving trends in transplantation for MASLD and ALD, questioning whether HCC behaves differently in the context of SLD, and presenting new data on incidence and risk stratification during long term follow up.
Attention is also turning to adolescent care, with discussion on when and how teenagers with SLD should transition into adult services.
@ma5RN @PatriziaBurra @claudiamandato @GSzaboMD -
EASLnews reposted
Debbie Shawcross
@DebbieShawcros1
📣The @EASLedu abstract selection for the #easlcongress2026 in Barcelona is completed! A record breaking year of high quality abstracts has been submitted. For me….some of the best basic & translational abstracts I’ve ever seen. 👏 Have you registered?
-
EASLnews
@EASLnews
Day 1 of the EASL #sldsummit 2026 in Budapest and online brought together a global community to explore the latest advances in steatotic liver disease.
A full day of science and discussion is closing now with a networking event from 17:45 to 18:45! See you there!
@rabataller @WillAlazawi @AnnaAlisi -
EASLnews
@EASLnews
The first State of the Art lecture at #sldsummit is examining adipose tissue as a central driver in SLD progression.
The focus is on how dysfunctional adipose tissue contributes to inflammation, fibrosis and broader metabolic disruption, reshaping the way we understand disease mechanisms.
By positioning adipose tissue as both a therapeutic and diagnostic target, this session is offering a sharper lens on future strategies for intervention and prevention.
@VidalPuig @gastaldelli_amy -
EASLnews
@EASLnews
The Plenary session is diving into the rapidly evolving world of artificial intelligence in SLD.
Big data analytics, deep learning and AI driven imaging are being explored as powerful tools to refine diagnosis and deepen our understanding of disease mechanisms. Novel machine learning approaches for monitoring progression are also in focus, highlighting how digital innovation is opening new possibilities.
The discussion is now addressing how these technologies can be embedded into clinical workflows, the regulatory hurdles ahead and what AI truly means for day to day hepatology practice.
A forward looking debate on how innovation can translate into better patient care. #sldsummit
@nicolapugliese_ @C_V_Schneider @Bernd_Schnabl -
EASLnews
@EASLnews
📃Poster Tour I is now underway at #sldsummit, bringing a wealth of research into an interactive setting!
New data are being presented on frailty and muscle density in cirrhosis, metabolic consequences following treatment withdrawal in experimental models, and fibrosis risk scores in paediatric MASLD.
Dietary interventions, platelet function across the SLD spectrum, and biomarkers linked to major liver outcomes are also part of the discussion, highlighting the breadth of translational and clinical research shaping the field.
Attend it now in Bartok 1!
@tom_marjot @PMRodrigues19 @EASLedu -
EASLnews
@EASLnews
Be sure to visit the @FattyLiverA booth at #sldsummit to connect with one of our valued EASL Patient Synergies partners! Their team is on site to share insights on patient advocacy and collaboration, and we encourage you to stop by and learn more about their important work in the liver community.
@betelm @rabataller @WillAlazawi @AnnaAlisi @EASLedu -
EASLnews reposted
Ramon Bataller
@rabataller
A study in the US showed that 70% of calories in children come from ULTRAPROCESSED food.
We need to care more about our little ones.
@SagiZelber at the #sldsummit -
EASLnews
@EASLnews
The Plenary session at #sldsummit has tackled a crucial question in SLD care, whose job is it?
Effective management demands a truly multidisciplinary approach. The discussion explored who should assess liver fibrosis, who takes responsibility for cardiovascular risk, and how screening for advanced chronic liver disease can be refined in the general population.
Addiction therapy was also in focus, with practical insights into who should deliver it and how care pathways can be better coordinated.
This is a powerful exchange on clarifying roles, closing gaps and strengthening collaboration across specialties to improve outcomes in SLD.
@phil_newsome7 @TomLuscher @betelm @escardio @EASLedu -
EASLnews reposted
Tom Marjot
@tom_marjot
Great to touch down in #budapest for @EASLnews #sldsummit 2026
📜Join me & @PMRodrigues19 for POSTER TOUR #1
Come to Bartok 1 at 15:30 for some fantastic basic + translational + clinical science
Biomarkers, platelets, paediatrics, mitochondiral function, myosteatosis & more -
EASLnews reposted
Ramon Bataller
@rabataller
Starting in Budapest the #sldsummit
Dr. Frank Murray, from the European Health Alliance on Alcohol, revealing this fact:
Europe is the world region with highest alcohol consumption ! -
EASLnews
@EASLnews
The ePoster area is buzzing with discussion as delegates explore the latest research in SLD.
From clinical outcomes and novel biomarkers to metabolic pathways and therapeutic strategies, the digital posters offer a deeper dive into innovative data and fresh perspectives from across the field.
Take the opportunity to browse the ePosters onsite or online, connect with investigators, and discover research that is shaping the future of SLD care!
#sldsummit @EASLedu -
EASLnews
@EASLnews
The first plenary session is exploring the scale of the SLD challenge and what is driving its rapid rise worldwide.
From shifting epidemiology to the impact of #alcohol policy and the growing influence of ultra processed foods (#upf), this session is unpacking the societal and environmental forces shaping today’s SLD landscape.
The discussion is focusing on how public health strategies and policy decisions can alter the trajectory of SLD and reduce its burden globally. A dynamic panel exchange is bringing these perspectives together. #sldsummit
@SagiZelber @WillAlazawi -
EASLnews
@EASLnews
We are opening #sldsummit 2026 with a warm welcome from the organisers @rabataller @AnnaAlisi @WillAlazawi and Cyrielle Caussy to our delegates here in Budapest and online.
The scene is set for three days of in depth discussion, bringing together experts and colleagues committed to advancing care in SLD! -
EASLnews
@EASLnews
The doors are opening in Budapest and online for the EASL #sldsummit 2026!
We are getting ready to kick off the first day of inspiring lectures, fresh insights into #sld, and meaningful conversations with colleagues from across the globe.
An exciting programme awaits, along with plenty of opportunities to connect, exchange ideas and strengthen our community!
@rabataller @WillAlazawi @AnnaAlisi -
EASLnews
@EASLnews
Test your guidelines knowledge with this new EASL Quiz on rare liver diseases!
Play here: easlcampus.eu/quiz/question/q137
#livertwitter #liverx -
EASLnews
@EASLnews
You can still register to tonight's EASL DeepDive on autoimmune hepatitis! Our faculty break down the 2025 EASL Clinical Practice Guidelines, covering induction and maintenance therapy, flare management, and personalised approaches to care.
📅 TODAY, 18:00 CET
🔗 easl-eu.zoom.us/webinar/register/WN_QqYCHa5rQnintuWLIgBFig
#livertwitter #liverx -
EASLnews
@EASLnews
Discover the EASL MASLD Guidelines Academy! This in-person training programme focuses on practical application of the latest clinical guidelines, covering disease understanding, patient management, diagnostic tools, and prevention strategies. There are 4 in-person modules for clinicians and 1 dedicated module for nurses and allied health professionals, delivered at leading European liver centres.
Hear from module 4 organiser, Sona Frankova, on what you can expect to learn from this programme.
Apply by 15 March on easl.eu/easl-masld-guidelines-academy
#livertwitter #liverxThis media couldn't be displayed. See it on the original post. -
EASLnews
@EASLnews
Join the next EASL DeepDive on autoimmune hepatitis! Explore the latest advances in the 2025 EASL Clinical Practice Guidelines on autoimmune hepatitis and learn how to optimise treatment, manage flares, and tailor care for specific patient groups.
📅 Wednesday, 25 February, 18:00 CET
🔗 easl-eu.zoom.us/webinar/register/WN_QqYCHa5rQnintuWLIgBFig
#livertwitter #liverx -
EASLnews
@EASLnews
The authors of today’s #readoftheweek📚 investigate the acute effects of binge drinking on the liver and its reversibility in healthy individuals.
Read here this @JHEP_Reports article: www.jhep-reports.eu/article/S2589-5559(25)00305-2/fulltext
🙏 @kristoffer_kj, @DaugaardAC et al.
#livertwitter #liverx -
EASLnews
@EASLnews
Liver cancer is the sixth leading cause of cancer-related deaths in Europe, with most cases caused by viral hepatitis. While the tools to eliminate hepatitis exist, less than 4 in 10 people living with hepatitis in the EU/EEA have been diagnosed.
We must act now if we are to turn the tide and prevent hepatitis cases advancing to liver cancer across Europe.
To accelerate action, the World Hepatitis Alliance (WHA), in partnership with the European Association for the Study of the Liver (EASL), the European Cancer Organisation (ECO), and the European Liver Patients’ Association (ELPA), are organising a hybrid event at the European Parliament on Tuesday 24 March at 13:30 - 15:00 CET to bring together different stakeholders to discuss how to finance and embed comprehensive hepatitis programmes into national cancer plans by building on Europe’s Beating Cancer Plan.
Register to attend here www.worldhepatitisalliance.org/news/european-parliament/
@Hep_Alliance @EuropeanCancer @EuropeLiver -
EASLnews
@EASLnews
Is MetALD a useful clinical concept or an unnecessary complication? In this Talk Liver To Me episode, experts @tom_marjot, @marurinella & @AleksanderKrag debate definitions, overlap, and real-world impact on patient care.
Listen to the podcast: easlcampus.eu/tltm/episode-03
#livertwitter #liverx -
EASLnews
@EASLnews
EASL strongly welcomes and supports the WHO Draft Resolution “Steatotic Liver Disease – A Missing Piece in the Global Noncommunicable Disease Response” [EB158/CONF./7], a historic opportunity to integrate liver health into global NCD prevention, care, and policy frameworks.
By embedding liver disease into national and global NCD strategies, countries can enable earlier detection, strengthen prevention, improve care, and reduce avoidable morbidity and mortality.
EASL calls on all WHO Member States to support and adopt this landmark resolution at the upcoming World Health Assembly.
👉 Read EASL’s full position statement: easl.eu/wp-content/uploads/2026/02/EASL-Position-Statemen…
👉 Read the Press Release: easl.eu/news/support-for-who-resolution/
Without liver health, the global NCD response remains incomplete.
@DebbieShawcros1 @analleo -
EASLnews
@EASLnews
Applications for the EASL MASLD Guidelines Academy are open!
There are four modules tailored for clinicians (must be attended in full, and in person) and one dedicated module for nurses and Allied Health Professionals.
Hear from Henning Grønbæk, organiser of module 3, what you can expect to get out of this exclusive course!
Apply by 15 March on easl.eu/easl-masld-guidelines-academy/
#livertwitter #liverx -
EASLnews
@EASLnews
Metabolic dysfunction, alcohol use, and blurred boundaries: does MetALD clarify steatotic liver disease or complicate it? Find out in the next Talk Liver to Me Podcast, dropping this Wednesday!
With @tom_marjot, @marurinella & @AleksanderKrag!
Read more: easl.eu/event/metald-in-practice-does-it-change-how-we-tr…
#livertwitter #liverxThis media couldn't be displayed. See it on the original post. -
EASLnews
@EASLnews
ALD and MetALD are driving a growing global burden of chronic liver disease, and the way we approach care is changing fast.
At #easlcongress 2026, this forward thinking session will offer a powerful preview of what the next generation of care could look like.
From biomarker led risk stratification and multi omic profiling, to targeted pharmacological, nutritional and behavioural strategies, discover how precision medicine is reshaping the full disease continuum. The session will also highlight the rise of digital hepatology and mobile health tools, showing how scalable technologies can improve adherence, widen access and help reduce disparities.
If you are working in hepatology, metabolic health or digital innovation, this is one to add to your agenda!
👉Register now and secure your place. www.easlcongress.eu/2026-registration/
@DebbieShawcros1 @analleo -
EASLnews
@EASLnews
One month left to apply for the EASL MASLD Guidelines Academy, our new hands-on training programme supporting the real-world implementation of the latest MASLD Clinical Practice Guidelines!
Read more and apply here: easl.eu/easl-masld-guidelines-academy/
#livertwitter #liverx -
EASLnews
@EASLnews
Register for this month's DeepDive on "EASL Clinical Practice Guidelines on the management of autoimmune hepatitis"! The session will focus on treatment optimisation, management of flares and intolerance, and tailored approaches for specific patient groups.
📅 Wednesday, 25 February, 18:00 CET
🔗 easl-eu.zoom.us/webinar/register/WN_QqYCHa5rQnintuWLIgBFig
#livertwitter #liverx -
EASLnews
@EASLnews
The Abstract Book for EASL #sldsummit2026 is now available! Discover the research submitted that will shape the discussions ahead.
Consult it here, and get ready to join us in Budapest or online on 26-28 February! easl.eu/wp-content/uploads/2026/02/EASL-SLD-Summit-2026_A…
Haven't registered yet? Secure your spot in person or online! easl.eu/event/easl-sld-summit-2026/
@rabataller @WillAlazawi @AnnaAlisi @DebbieShawcros1 @analleo -
EASLnews
@EASLnews
How well do you know your EASL Guidelines on vascular liver diseases of the liver?
Test yourself now, as we explore the case of a 47-year-old woman with no history of liver disease who presents with progressive abdominal pain, new-onset ascites, and elevated D-dimer.
Take the EASL Quiz: easlcampus.eu/quiz/question/q136
#livertwitter #liverx -
EASLnews
@EASLnews
Discover the EASL MASLD Guidelines Academy, a new hands-on training programme designed to support healthcare professionals in applying the latest official clinical guidelines in real-world practice.
There are four modules tailored for clinicians (must be attended in full, and in person) and one dedicated module for nurses and Allied Health Professionals.
Hear from Jérôme Boursier, organiser of module 1, what you can expect to get out of this exclusive course!
Apply by 15 March on easl.eu/easl-masld-guidelines-academy/
#livertwitter #liverx -
EASLnews
@EASLnews
Did you know that you can follow EASL on Spotify?
Stay up to date with upcoming Talk Liver to Me podcast episodes and catch up on EASL Studio, DeepDives and more! -
EASLnews
@EASLnews
🧩We at EASL – The European Association for the Study of the Liver are delighted to see the WHO Executive Board’s draft resolution on Steatotic Liver Disease as a missing piece in the global non-communicable disease (NCD) response being considered for recommendation to the World Health Assembly. This proposal addresses a crucial gap in global health policy by formally recognising the significant burden of steatotic liver disease within the broader NCD agenda and calling for its systematic integration into prevention, early detection, management and national strategies.
This development reflects the impact of sustained EASL advocacy and policy engagement in highlighting the growing global challenge of liver disease, its shared risk factors with other major NCDs, and the need for coordinated public health action. We are therefore particularly delighted by the broad support this resolution has received from Member States, underscoring strong political recognition of liver health as a priority within the global NCD response.
🌎We call on additional Member States to join in supporting this resolution. Its adoption would mark a significant step towards ensuring that liver health is no longer overlooked, and that people affected by liver disease benefit from comprehensive, equitable and evidence-based care worldwide.
👉apps.who.int/gb/ebwha/pdf_files/EB158/B158_CONF7-en.pdf
@DebbieShawcros1 @analleo -
EASLnews
@EASLnews
Why should early detection of chronic liver disease be a priority in primary care?
In this on-demand @LiverAim webinar, leading experts from across Europe share real-world perspectives on how primary care can strengthen risk stratification, integrate digital and AI supported tools, and prepare for emerging treatments in liver disease.
The discussion explores practical challenges and solutions around case finding, referrals, and long-term management of people with liver fibrosis, asking a critical question, is primary care ready to scale up?
👉 Watch the webinar on demand and explore how early detection can transform liver care pathways: www.youtube.com/watch?v=NWnMEjbgWrU
👉Learn more about LIVERAIM: www.liveraim.eu
@schattenbergJ -
EASLnews
@EASLnews
Today's #readoftheweek📚 highlights the complex role of adaptive immunity in MASH progression and provide potential targets for future immunomodulatory therapies.
Read here this @JHEP_Reports article: www.jhep-reports.eu/article/S2589-5559(25)00301-5/fulltext
🙏 @ElmarJaeckel @HardtkeWolenski et al.
#livertwitter #liverx -
EASLnews
@EASLnews
Register now for the upcoming EASL DeepDive which will explore key updates from the 2025 EASL Clinical Practice Guidelines on autoimmune hepatitis!
📅 Wednesday, 25 February, 18:00 CET
🔗 easl-eu.zoom.us/webinar/register/WN_QqYCHa5rQnintuWLIgBFig
#livertwitter #liverx -
EASLnews
@EASLnews
Join us at the EASL #sldsummit from 26-28 February 2026 in Budapest, and earn 18 European CME credits (ECMEC®s).
The summit has now been officially accredited by the European Accreditation Council for Continuing Medical Education (EACCME®).
⭐️ Learn from leading experts, engage in cutting edge discussions, and help shape the future of steatotic liver disease research and care.
👉easl.eu/event/easl-sld-summit-2026/registration/
@rabataller @AnnaAlisi @WillAlazawi @DebbieShawcros1 @analleo -
EASLnews
@EASLnews
New Talk Liver To Me Podcast available now! Listen to a candid conversation on the challenges, opportunities, and power of mentorship for women in hepatology.
🔉 easlcampus.eu/tltm/episode-02
@analleo @DebbieShawcros1
#livertwitter #liverx -
EASLnews
@EASLnews
Registrations for the MASLD Guidelines Academy are now open! Discover the five-module, in-person training programme designed to help healthcare professionals confidently apply MASLD guidelines in everyday clinical practice.
Apply by 15 March on easl.eu/masld-academy
#livertwitter #liverx -
EASLnews
@EASLnews
Steatotic Liver Disease is now the leading cause of liver disease worldwide. On 26–28 February 2026, be part of the global conversation shaping the future of MASLD, MetALD and ALD care at EASL #sldsummit.
🔬 Cutting edge science
🤝 Multidisciplinary exchange
💬 Highly interactive discussions
🌍 Global experts, real impact
👉 Have you already secured your spot? Join us in Budapest or online and be at the forefront of SLD research and patient care!
easl.eu/event/easl-sld-summit-2026/registration/
@DebbieShawcros1 @analleo @rabataller @AnnaAlisi @WillAlazawi -
EASLnews
@EASLnews
Chronic liver disease disrupts the balance between vascular integrity and parenchymal regeneration, limiting the liver’s ability to restore functional tissue. Despite its global burden, effective regenerative therapies remain scarce.
🧠A key unmet need is understanding how changes in the sinusoidal microenvironment and extracellular matrix constrain liver regeneration, locking progenitor cells into a biliary fate.
🎓A new #easlfellowship project by Rita Manco, INSERM and Institut Pasteur Lille, investigates how capillarised liver sinusoidal endothelial cells and laminin rich niches shape regenerative outcomes. Using multiplex imaging, proteomics, and three dimensional culture systems, the project will define mechanisms driving endothelial remodelling and test whether reversing these changes can promote hepatocyte differentiation.
🔍By decoding these regenerative niches, this work aims to lay the groundwork for new therapeutic strategies to restore functional liver architecture and enhance regeneration in chronic liver disease. -
EASLnews
@EASLnews
New Talk Liver to Me podcast episode coming out this Wednesday, hosted by Maja Thiele!
To mark International Women and Girls in Science Day, @DebbieShawcros1 and @analleo
reflect on leadership, mentorship, and the realities of building a career in hepatology.
Read more: easl.eu/event/from-imposter-syndrome-to-influence-women-s…
#livertwitter #liverx -
EASLnews
@EASLnews
🚨 Do not miss this State-of-the-Art lecture at #easlcongress 2026 🚨
Viral hepatitis care is moving fast, and this session will help you stay ahead of what is coming next.
Jean-Pierre Benhamou Clinical State-of-the-Art
Advances in diagnosis and treatment in viral hepatitis
🗓 Friday 29 May 2026
🕑 14:00–14:45 CEST
📍 Tiribelli Room
Delivered by Professor @HeinerWedemeyer, this lecture will focus on what truly matters for clinical practice and public health impact.
🔬 From hepatitis C elimination strategies and micro-elimination in real life
🧬 To novel biomarkers and finite therapy concepts in hepatitis B
💊 To the rapidly evolving therapeutic landscape for hepatitis D
Expect a forward-looking, clinically grounded overview of how innovation in antivirals, diagnostics and care models is reshaping decision-making today, and what this means for achieving meaningful, sustainable impact tomorrow.
If viral hepatitis is part of your practice, research or policy work, this is a session you will want in your calendar.👉pag.virtual-meeting.org/easl/easl2026/en-GB/pag/session/1…
Register to EASL Congress 2026 today: www.easlcongress.eu/2026-registration/ -
EASLnews
@EASLnews
⚠️Last chance to apply for the EASL Daniel Alagille Award!
If you are a young scientist exploring the frontiers of paediatric or adult genetic cholestatic diseases... showcase your potential and propel your career to new heights 🚀
Apply by tonight, 2 February, 23:59 CET on easl.eu/fellowship/easl_daniel_alagille_award/
#livertwitter #liverx -
EASLnews
@EASLnews
Today’s #readoftheweek📚 explores the first systematic evaluation of large language models for drug-induced liver injury-focused patient education.
Read here this @JHEP_Reports article: www.jhep-reports.eu/article/S2589-5559(25)00261-7/fulltext
#livertwitter #liverx -
EASLnews
@EASLnews
How well do you know your HCC Guidelines?
Test your treatment decision-making with a case-based quiz which focuses on a 69-year-old woman with compensated HBV- and MASLD-related cirrhosis, who was a former smoker, with compensated diabetes as comorbidity together with a BMI of 29 kg/m2.
Play here: easlcampus.eu/quiz/question/q135
#livertwitter #liverx -
EASLnews
@EASLnews
You can still register for tonight's DeepDive on HCC management strategies! From early detection to treatment selection and systemic therapy optimisation, faculty @allaire_manon, @A_DAlessioMD, Fabio Piscaglia and @SaborowskiAnna are looking forward to discussing this important topic!
Register now and see you tonight 18:00 CET: easl-eu.zoom.us/webinar/register/6717649443317/WN_Bw-j-fs…
This webinar is accredited up to 1 CME credit, available for live attendance only💡
#livertwitter #liverx -
EASLnews
@EASLnews
EASL proudly supports a stronger EU commitment to organ donation and transplantation
The European Association for the Study of the Liver (EASL) proudly supports the joint initiative led by the European Kidney Health Alliance (EKHA), the European Society for Organ Transplantation (ESOT), and more than 40 European organisations calling on the European Commission to strengthen organ donation and transplantation across the EU.
With more than 50,000 people in Europe currently waiting for a life-saving transplant — and unacceptable disparities in access, outcomes, and donation rates between Member States — the need for coordinated, equitable, and sustainable transplantation systems has never been more urgent.
We strongly support the call for a second EU Action Plan on Organ Donation and Transplantation, building on the 2024 Council Conclusions and recent World Health Assembly resolutions. The proposed priorities — from capacity building and data harmonisation, to equity, ethical frameworks, awareness, and research — are essential to saving lives, improving quality of care, and strengthening Europe’s leadership in transplantation.
EASL stands ready to work alongside EU institutions, Member States, and partner organisations to advance innovation, prevention of organ failure, and fair access to transplantation for all patients.
👉 easl.eu/wp-content/uploads/2026/01/Transplantation-letter… -
EASLnews
@EASLnews
Unexplained genetic cholestatic liver diseases remain a significant diagnostic challenge. While whole exome sequencing has transformed genetic investigation, many patients are left without a clear diagnosis due to variants of uncertain significance, limiting the ability to guide clinical management.
🧬A major unmet need in this field is functional validation of genetic findings. Without models that accurately reflect a patient’s liver biology, linking genotype to phenotype remains difficult and delays precise diagnosis and treatment selection.
🎓A new #easlfellowship project by Marta Alonso Pena, IDIVAL and University of Cantabria, addresses this gap by developing patient specific hepatobiliary organoid “avatars” derived from induced pluripotent stem cells. By recreating each patient’s genetic and cellular liver environment in a three dimensional model, the project aims to bridge the gap between genetic variants and their functional consequences.
🔬Patient and control hiPSCs will be differentiated into hepatobiliary organoids that recapitulate liver architecture and key functions. These models will undergo detailed morphological, molecular, and functional characterisation using advanced imaging, cytometry, transcriptomics, and metabolomics, alongside assays of bile secretion, metabolism, and drug detoxification.
🔍By enabling functional validation of genetic variants, personalised disease modelling, and preclinical drug testing, this project represents an important step towards precision hepatology. Ultimately, it seeks to improve diagnostic accuracy, support tailored treatment decisions, and reduce reliance on animal experimentation. -
EASLnews
@EASLnews
Only 1 week left to apply for the EASL Daniel Alagille Award!
Are you a young scientist on a dynamic career path in hepatology? Do you have novel, forward-looking research ideas that you are eager to implement?
Apply now on easl.eu/fellowship/easl_daniel_alagille_award/ -
EASLnews
@EASLnews
✨The full scientific programme for #easlcongress 2026 is now live!
From late breaking science and state of the art lectures to interactive workshops, skills learning and multidisciplinary discussions, the programme captures the full scope and momentum of modern hepatology.
With more than 8,000 delegates set to gather in Barcelona on 26-30 May, now is the time to explore the sessions, discover speakers and start shaping your personal Congress experience.
Explore the full programme and start planning today!
🔗 easl.us1.list-manage.com/track/click?u=07d7246bcae2c9bb6e…
@DebbieShawcros1 @analleo -
EASLnews reposted
European Liver Patients' Association
@EuropeLiver
Putting patients at the heart of #livercancer care 💙
At the #easl #livercancersummit, Julio Burman, Vice President of ELPA, powerfully reminded us that integrating the patient perspective into #hcc and #cca management is not optional—it’s essential.
When patients are heard, care becomes more human.
When their experiences guide decisions, outcomes improve.
When science and lived experience meet, real progress happens.
This is how we build a future where #hcc - #cca management is not only clinically excellent, but compassionate, inclusive, and truly patient-centred.
👏 Thank you for championing the patient voice and inspiring action across the liver cancer community.
#patientperspective #hcc #livercancer #easl #elpa #patientcentredcare #strongertogether #voicesthatmatter
#elpa 🤝 #easl together we are stronger 💪
EASL the home of Hepatology #hepatitis B,C and D , Alcohol-related liver disease, #masld #mash #rareliverdisease #livercancer #eucancerplan #earlydetection #patientempowerment #noninvasivetests #bridgingthegaps #euresearch #futureofliverhealth #cardiovascularprevention EASL - The Home of Hepatology -
EASLnews reposted
Lorenza Rimassa
@LorenzaRimassa
#lindabartalini presenting her work on prognostic role of adverse events in patients with #btc #cca treated with #cisgem #durvalumab at @EASLnews #livercancersummit in Edinburgh.
A big thank you to @AIOMtweet for the mentorship program! @casadei_gardini -
EASLnews
@EASLnews
⭐️As the EASL #livercancersummit comes to an end, a sincere thank you to all organisers, faculty, industry partners, and our 598 participants for three outstanding days of science, collaboration and shared commitment to improving outcomes for people with liver cancer, that unfolded in Edinburgh.
An inspiring meeting, and a strong platform for what comes next! We look forward to seeing you again in Valencia on 14-16 January 2027!
👉Registered delegates can access content from the Summit on demand: easl-lcs.virtual-meeting.org
@josepmllovet @IreneBargellini @DJPinato @PinterMatthias @EASLedu -
EASLnews
@EASLnews
EASL #livercancersummit 2026's last plenary: a forward looking symposia on where liver cancer care is heading next. Biomarker driven therapies, emerging treatments and the patient perspective are front and centre, alongside a strong call to address inequities in access to diagnosis and care across Europe. A fitting end, focused on precision medicine, inclusion and improved outcomes.
@PinterMatthias @ReigMarina @DJPinato -
EASLnews
@EASLnews
Starting the final day of EASL #livercancersummit with a session unpacking key challenges in systemic therapy for HCC.
Discussion is centred on choosing first line immunotherapy, navigating sequential treatment strategies, and the real world complexity of treating patients with Child Pugh B liver function.
Methodological issues are also in focus, particularly how non proportional hazards can influence interpretation of advanced HCC trial outcomes.
@PinterMatthias @SaborowskiAnna @LorenzaRimassa -
EASLnews
@EASLnews
A symposia at EASL #livercancersummit is now tackling the full spectrum of loco regional therapies in liver cancer, from ablation to TACE and TARE.
The focus is firmly on real world decision making, with lively debate around combining TACE with immunotherapy and the role of TARE in patients with portal vein invasion. Patient selection, risk benefit balance and emerging evidence are front and centre.
@BargelliniIrene @josepmllovet -
EASLnews reposted
Maria Varela
@Maria_Var_Cal
@HUCA_Asturias multidisciplinary liver cancer team contribution to European Liver Cancer Summit @EASLnews
#biomarkers
#tare_y90 -
EASLnews
@EASLnews
📃The ongoing abstract session at EASL #livercancersummit is showcasing a fast paced snapshot of where liver cancer research is heading.
From long term survival data in biliary tract cancer to immune modulation, imaging uptake, and real world predictors of HCC outcomes, the presentations underline the diversity and clinical relevance of current research, with strong discussion around how these findings could inform future practice. #livercancersummit
@DJPinato -
EASLnews
@EASLnews
🌟The second State of the Art at our EASL #livercancersummit, delivered by @josepmllovet is taking a deep dive into recent and ongoing pivotal phase III RCTs in HCC.
Key trial designs and emerging strategies, including immunotherapy, targeted agents and combination approaches, are under the spotlight, with a clear focus on how upcoming data may redefine future standards of care.
@DJPinato -
EASLnews
@EASLnews
Presenting the final results of the PRIME HCC study, Antonio D’Alessio delivered the first European prospective evidence on neoadjuvant immunotherapy in resectable hepatocellular carcinoma, with deep immune profiling before and after surgery.
💬 “Neoadjuvant trials are a unique window to link immune biology with clinical outcome.” -
EASLnews
@EASLnews
Stefan Schneeberger addressed one of the most persistent challenges in liver cancer care, how to increase access to liver #transplantation.
▶️Organ shortage is not only a technical issue, but one of culture, beliefs, personal choices and resource allocation
▶️Despite stable or improving transplant numbers, mortality on waiting lists remains largely unchanged
▶️Living donor liver transplantation is well established and effective in increasing organ availability
▶️Liver normothermic machine perfusion extends preservation time, improves organ assessment and reduces discard rates
▶️Better utilisation of existing organs may be as important as finding new donors
Meaningful progress requires commitment, coordination and willingness to change practice.
💬 “The lack of organs is not just a medical problem, it is a matter of human behaviour and collective responsibility.”
@EASLedu @SherrieBhoori @BasGrootKoerkam -
EASLnews
@EASLnews
Bruno Sangro at #livercancersummit reviewed the current evidence, unmet needs and future directions for neoadjuvant and adjuvant therapies in hepatocellular carcinoma.
▶️Neoadjuvant and adjuvant strategies in HCC differ fundamentally from other solid tumours due to underlying chronic liver disease and limited resection margins
▶️Biology matters, early stage HCC differs markedly from advanced disease, so benefit cannot be assumed
▶️Key unmet needs include validated pathological response cut offs, predictive biomarkers and phase 3 trials comparing perioperative strategies
💬 “Biology should come before breadth, we need a short window to learn from the tumour, not to treat forever. The liver is the patient and agents must respect hepatic function. Treat the residual risk, not the calendar - MPR/MRD drive adjuvant intensity.”
@SherrieBhoori @BasGrootKoerkam -
EASLnews
@EASLnews
🤩Day 2 is underway at the EASL #livercancersummit 2026!
In a focused and practical presentation, Eric Vibert reviewed how minimally invasive, laparoscopic and robotic approaches are reshaping hepatobiliary cancer resection.
▶️Laparoscopy is an efficient approach in intrahepatic cholangiocarcinoma
▶️Surgery remains indicated for selected HCC, including single tumours larger than 3 cm or up to three nodules smaller than 3 cm
▶️Laparoscopic and robotic techniques facilitate ICG guided surgery and intraoperative precision
▶️Digital twin concepts may help identify complex patients and guide personalised surgical strategies
▶️Robotic surgery is expanding in HPB surgery, but it is still too early to draw firm conclusions
@A_DAlessioMD @BasGrootKoerkam @SherrieBhoori @EASLedu -
EASLnews
@EASLnews
A joint symposia with @curecc Cholangiocarcinoma Foundation and @CharityAMMF at #livercancersummit provides an in depth update on cholangiocarcinoma and rare liver tumours, spanning molecular mechanisms, tumour microenvironment and real world clinical management. Surgical, transplant and systemic strategies are being discussed alongside emerging targeted therapies and immunotherapy.
-
EASLnews
@EASLnews
In a state-of-the-art at #livercancersummit 2026 Matthias Heikenwälder @CancerInflam outlined how chronic inflammation, metabolism and immune contexture converge to drive hepatocellular carcinoma, and how this biology can be therapeutically exploited.
▶️MASLD and MetALD are emerging as dominant future causes, adding to tumour heterogeneity
▶️Distinct molecular and immune subclasses of HCC shape prognosis and therapy response
▶️Drug repurposing, such as metformin combined with immunotherapy, shows promise in both experimental and patient data
▶️The future of HCC treatment lies in integrated molecular, pathological and clinical stratification
Liver cancer is caused by chronic inflammation, but it is the specific inflammatory and metabolic context that determines therapy response. -
EASLnews
@EASLnews
Spatial single cell biology sheds light on immunotherapy response.
Presenting new data Guillem Cano-Segarra used single cell spatial transcriptomics to dissect mechanisms of response and resistance to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma.
▶️Spatial transcriptomics reveals distinct immune architectures linked to treatment response
▶️Resistance to atezolizumab plus bevacizumab is associated with immunosuppressive niches
▶️TREM2 positive macrophage dominated clusters characterise resistant inflamed tumours
▶️Responding tumours show enrichment of CD8 positive T effector cells and CXCL10 positive macrophages
▶️Spatial proximity of immune effector cells to malignant cells appears critical for response
These findings highlight the importance of tumour immune organisation, not just cell presence
#livercancersummit -
EASLnews
@EASLnews
In a forward looking presentation at #livercancersummit, Katherine Hewitt outlined how rapid advances in AI are reshaping liver cancer research and care, from pathology to radiology and beyond.
▶️AI has evolved from task specific models to generalist and agent based systems capable of complex problem solving
▶️Multiple AI applications are already approved in Europe, including in liver histopathology and imaging
▶️AI can act as a surrogate for complex biomarkers, predicting treatment response and molecular features from routine data
▶️Pathology and radiology are shifting from detection to prediction, including outcomes, recurrence and therapy response
▶️Real world implementation requires robust validation, regulatory frameworks and cultural acceptance
▶️New European guidelines now classify AI biomarkers by level of evidence and clinical readiness
▶️Prospective AI trials, particularly in radiology, are critical to demonstrate true clinical value
💬 “The challenge is no longer whether AI works, but how we validate, regulate and implement it safely in clinical practice.”
@jnkath -
EASLnews
@EASLnews
Georg Zeller shared results from the largest microbiome analysis of liver cancer tissues to date
▶️Robust bacterial signatures can be detected in liver cancer tissues
▶️Findings remain consistent across heterogeneous sequencing datasets
▶️Careful negative controls and computational decontamination are essential
▶️Replication in independent trial cohorts and functional validation are now underway
💬 “We see first evidence that intrahepatic bacteria may play a role in therapy response.”
#livercancersummit 2026 -
EASLnews
@EASLnews
Jeroen Deckervel showed how current knowledge of single-cell sequencing and spatial transcriptomics in liver cancer can turn individual patients into powerful sources of biological and clinical insight in hepatocellular carcinoma.
▶️Single cell RNA sequencing, spatial transcriptomics and TCR sequencing provide unprecedented insight into tumour biology and immune response
▶️Single cell discoveries can be translated into predictive biomarkers and novel therapeutic strategies
▶️Personalised mRNA cancer vaccines based on patient specific tumour antigens are now entering early phase clinical testing
#livercancersummit -
EASLnews reposted
Maria Varela
@Maria_Var_Cal
Terrific talk by @maximeronot
@EASLnews
#livercancersummit -
EASLnews
@EASLnews
🧑🎓👩🎓The Young Investigator ePoster tour is underway, putting early career researchers in the spotlight. Impressive science, fresh perspectives and engaging discussion from the next generation of liver cancer researchers at #livercancersummit 2026!
@josepmllovet @DJPinato @IreneBargellini -
EASLnews
@EASLnews
The ePoster area is now open, showcasing a wide range of translational and clinical research across liver cancer.
👋A great opportunity to explore new data, exchange ideas and connect with colleagues throughout the day!
#livercancersummit @josepmllovet @IreneBargellini @DJPinato -
EASLnews
@EASLnews
Amit Singal made a clear case for moving beyond ultrasound ± AFP in early detection of hepatocellular carcinoma at #livercancersummit.
▶️Ultrasound with or without AFP has suboptimal sensitivity for early stage HCC and poor real world adherence
▶️Biomarker based surveillance has the potential to improve both sensitivity and uptake
▶️Protein based biomarker panels show promising performance for early stage HCC and may be competitive with ultrasound
▶️Liquid biopsy approaches demonstrate superior sensitivity in early studies
▶️Cost effectiveness, feasibility and risk stratification will be critical for adoption
The future lies in personalised, precision screening rather than a one size fits all approach. -
EASLnews
@EASLnews
Larisa Sandulescu reviewed the evolving landscape of clinical trials aimed at improving early detection of hepatocellular carcinoma.
▶️Surveillance is effective in cirrhosis, but remains underused in real world practice
▶️Current ultrasound based strategies face detection, quality and implementation gaps
▶️Risk based and multimodal surveillance strategies are moving the field forward
▶️Biomarkers and imaging tools such as contrast enhanced ultrasound and abbreviated MRI may overcome ultrasound limitations
▶️System level interventions, including patient reminders and navigation, are critical to improve uptake
Harms and costs must be evaluated alongside effectiveness in all new strategies.
💬 “Surveillance is effective in cirrhosis, but remains underused.”
#livercancersummit -
EASLnews
@EASLnews
In his opening presentation, @FrankTacke highlighted how metabolic dysfunction associated steatotic liver disease (MASLD) is rapidly emerging as a leading driver of HCC worldwide.
▶️MASLD is a fast growing aetiology of HCC and will soon be the leading cause
▶️Liver fibrosis is the main determinant of liver related outcomes, including HCC
▶️Risk stratification is already feasible in primary care using non invasive tools
▶️Lifestyle modification remains the cornerstone of therapy, supported by optimal management of metabolic comorbidities
▶️Regular ultrasound surveillance is established in cirrhosis, with limitations in earlier disease stages -
EASLnews
@EASLnews
🌠Everything is ready to welcome you in Edinburgh as we open the EASL #livercancersummit 2026!
Three days of science, debate and clinical insight ahead, bringing together the global liver cancer community.
Follow the discussion by using the hashtag #livercancersummit, and tell us about your impressions and favourite sessions! 🤩
👉Download the "EASL Liver Cancer Summit 2026" App for a smoother navigation of the scientific programme while you are onsite!
@IreneBargellini @josepmllovet #livercancer #hcc #cca @DebbieShawcros1 -
EASLnews
@EASLnews
What are strategies to optimise surveillance and early diagnosis of hepatocellular carcinoma? What are the optimal candidates for surgery (including liver transplantation) and locoregional therapies (alone or combined with immunotherapy)? These and more questions will be discussed in the upcoming DeepDive with faculty @allaire_manon, @A_DAlessioMD, Fabio Piscaglia and @SaborowskiAnna!
📅 Wednesday, 28 January, 18:00 CET
Register now: easl-eu.zoom.us/webinar/register/6717649443317/WN_Bw-j-fs…
#livertwitter #liverx -
EASLnews
@EASLnews
EASL's new Talk Liver to Me podcast is now out! From admission patterns to alcohol use, infections, DILI, nutrition, and access to transplant, this episode, in collaboration with @INASL_Liver, highlights key differences and opportunities for shared learning across regions.
With @tom_marjot @ebtapper & @MaiwallRakhi!
Listen to the full discussion here: easlcampus.eu/tltm/episode-01
#livertwitter #liverx -
EASLnews
@EASLnews
#livertwitter, this is your last chance to join the EASL Governing Board or Task Forces!
Discover all 17 available positions and apply today on easl.eu/news/call-governance-dec2025/
⏰You have until tonight, 20 January 23:59 CET -
EASLnews
@EASLnews
EASL is now calling for applications for three members to join the Young Investigators Task Force. The EASL Young Investigators Task Force is established to enhance the visibility, engagement, and development of early and mid-career professionals in hepatology within EASL’s framework.
Apply by tonight, 20 January, 23:59 CET on: easl.eu/news/call-governance-dec2025/
@DraMartaAlonsoP @IsraelsenMads @tom_marjot @PMRodrigues19 @C_V_Schneider
#livertwitter #liverx -
EASLnews
@EASLnews
Registrations for the MASLD Guidelines Academy are now open🔥
Discover the five-module, in-person training programme designed to help healthcare professionals confidently apply MASLD guidelines in everyday clinical practice.
Module 1: The basics of MASLD
Angers, France, 27-28 August 2026
Organiser: @JeromeBoursier
Module 2: A deeper dive into MASLD
Antwerp, Belgium, 8-9 October 2026
Organisers: @FrancqueSven, Luisa Vonghia & Wilhelmus Kwanten
Module 3: Multidisciplinary management of the patient with MASLD
Aarhus, Denmark, 12-13 November 2026
Organisers: Henning Grønbæk, @konskaza & Karen Louise Thomsen
Module 4: The specifics of advanced disease in MASLD
Prague, Czechia, 2-3 December 2026
Organisers: Sona Frankova & Jan Sperl
Module 5: Multidisciplinary management and the role of AHCP
Pamplona, Spain, 17-18 September 2026
Organisers: Gema Frühbeck, Javier Escalada & Carolina Perdomo
Deadline to apply: 15 March
Read more: easl.eu/easl-masld-guidelines-academy/
#livertwitter #liverx -
EASLnews
@EASLnews
🧩A major unmet need in autoimmune liver disease is a deeper understanding of the tissue microenvironment that drives distinct disease phenotypes. Without robust tissue based biomarkers, clinicians lack reliable tools to predict treatment response and personalise therapy for patients with variant syndromes.
🎓A new #easlfellowship project by Maria Buzias, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj Napoca, addresses this challenge by applying an integrative spatial biology approach to autoimmune hepatitis, primary biliary cholangitis, and AIH–PBC variant syndrome. Using immunofluorescence, immunohistochemistry, and spatial transcriptomics, the project will map immune and epithelial cell populations across portal tracts, interface regions, lobules, and fibrotic septa to identify spatial signatures that distinguish the variant syndrome from AIH or PBC alone.
🔬Key immune and cholangiocyte features, including regulatory to effector T cell ratios, helper T cell clustering, macrophage and B cell localisation, and distinct cholangiocyte phenotypes, will be linked to biochemical, serologic, and histologic parameters. These findings will be further stratified by fibrosis stage and treatment response.
🔍By uncovering duct centric signalling pathways and cellular interaction networks, this project aims to identify predictive tissue biomarkers and mechanistic drivers of disease. Ultimately, it seeks to support a more precise, personalised approach to the management of autoimmune liver diseases, improving therapeutic decision making and patient outcomes. -
EASLnews
@EASLnews
If you are a young scientist exploring the frontiers of paediatric or adult genetic cholestatic diseases... showcase your potential and propel your career to new heights 🚀
Apply by 2 February on easl.eu/fellowship/easl_daniel_alagille_award/ -
EASLnews
@EASLnews
We're excited to launch the first episode of our podcast Talk Liver To Me this Wednesday!🔥
In this week's episode, in collaboration with @INASL_Liver, faculty @tom_marjot @ebtapper & @MaiwallRakhi will discuss how regional context shapes acute liver care.
Read more: easl.eu/event/hepatology-ward-rounds-east-meets-west/
🎙️Talk Liver To Me is EASL’s new podcast bringing sharp, accessible conversations straight to busy hepatology professionals. New episodes drop every other Wednesday on EASL Campus, Spotify, Apple Podcasts and Amazon Music.
#livertwitter #liverx -
EASLnews
@EASLnews
👩⚕️Nurses and allied health professionals are at the heart of high quality liver care across Europe.
In this new Q&A, the EASL Nurses and Allied Health Professionals Task Force shares how collaboration, education and evidence based practice are helping to strengthen hepatology care across diverse healthcare settings.
From tackling variation in roles and resources to building shared learning and professional networks, the Task Force outlines its mission and priorities, and why supporting nurses and AHPs is essential for better patient outcomes.
Read the full article to learn how coordinated, multidisciplinary action is shaping the future of liver care across Europe: touchimmunology.com/insight/easl-nurses-allied-health-pro…
Applications to join the Task Force are open until 20 January: easl.eu/news/call-governance-dec2025/
@MaleneOConnell -
EASLnews
@EASLnews
Happy Friday! 🎉 End your week informed and inspired with a new episode of the EASL Policy Dialogues now available to watch on EASL Campus.
This episode dives into one of Europe’s most pressing health challenges, the growing burden of #ncds, #obesity, and #liverdisease. Together with Prof. Cyrielle Caussy, the discussion unpacks key insights from EASL’s recent Brussels event, explores effective strategies to tackle obesity and other major risk factors, and looks at how health can stay front and centre across food, digital, and social policies.
If you are interested in EU health policy, prevention, and liver health, this is one not to miss.
▶️ Watch now on EASL Campus: easlcampus.eu/videos/easl-policy-dialogues-s4-e6
EASL Policy Dialogues Season 4 is supported by Novo Nordisk. EASL has received no input from Novo Nordisk with regards to the content of the EASL Policy Dialogues Season 4.
@EASLedu @DebbieShawcros1 @analleo @SagiZelber -
EASLnews
@EASLnews
Today’s #readoftheweek📚 highlights the importance of treatment sequencing to optimise outcomes in advanced HCC.
Read here this @JHEP_Reports article: www.jhep-reports.eu/article/S2589-5559(25)00277-0/fulltext
🙏@CiroCelsa @FulgenziClaudia @A_DAlessioMD @BeStef33 @niraj_doshi @PinterMatthias @M_Schoenlein @KudoM_Kindai @LorenzaRimassa @cabibbo78 @hongjaechon @DJPinato et al.
#livertwitter #liverx -
EASLnews
@EASLnews
Bacterial infections remain a major driver of morbidity and mortality in patients with cirrhosis. Current diagnostic tools often detect infection only after clinical symptoms appear, when valuable opportunities for early intervention may already be lost.
🦠A key unmet need in cirrhosis care is the ability to identify early increases in bacterial DNA in the bloodstream, before infection becomes clinically evident and outcomes worsen. Earlier risk stratification could allow more timely and targeted preventive strategies.
🎓A new #easlfellowship project by Lukas Hartl, Medical University of Vienna, explores the potential of nanomechanical sensor technology to meet this challenge. This innovative approach enables the detection of bacterial DNA at levels far below the sensitivity of conventional PCR. The project will assess whether a nanosensor targeting 16S ribosomal bacterial DNA can distinguish patients with and without active infection, and identify those at high risk of developing infection, ACLF, or death within six months.
🔬The prognostic performance of this technology will be compared with established clinical scores, including CTP, MELD 3.0 and GEMA Na, to evaluate its added value in clinical decision making.
🔍By developing a rapid, sensitive and minimally invasive blood test, this project aims to lay the groundwork for a practice changing diagnostic tool. Ultimately, it seeks to support more precise and proactive management of patients with cirrhosis, improving outcomes through earlier and better informed interventions. -
EASLnews
@EASLnews
Don't miss our next upcoming DeepDive Webinar! You will be guided through the latest advances in hepatocellular carcinoma management, from the rising impact of immunotherapy combinations to evolving approaches in intermediate-stage disease.
Faculty @allaire_manon, @A_DAlessioMD, Fabio Piscaglia and @SaborowskiAnna will also outline the continued importance of liver transplantation and the criteria shaping patient selection today.
📅 Wednesday, 28 January, 18:00 CET
Register now: easl-eu.zoom.us/webinar/register/6717649443317/WN_Bw-j-fs…
#livertwitter #liverx -
EASLnews
@EASLnews
🚨Stay safe and avoid phishing and scams!
We remind you that the only official EASL Congress website is www.easlcongress.eu. For all EASL Congress related transactions please only refer to this URL and/or official EASL communications.
For housing and registration purposes, Congrex is our official partner.
#easlcongress -
EASLnews
@EASLnews
EASL Quiz is back! This Dry January, test your knowledge with a new Public Health quiz based on the EASL Policy Statement: Reducing alcohol harms (2023), featuring a real-world case on alcohol-related liver disease.
Play now: easlcampus.eu/quiz/question/q134
#livertwitter #liverx -
EASLnews
@EASLnews
Only 1 week left to apply!
Are you committed to advancing hepatology and ready to play a role in EASL’s governance?
We’re still recruiting for:
1 Educational Councillor-elect
3 Scientific Committee Members
2 Basic Science Task Force Members
7 Pharmacy Task Force Members
3 Young Investigators Task Force Members
1 Nurses & AHPs Task Force Member
Submit your application by 20 January: easl.eu/news/call-governance-dec2025/
#livertwitter #liverx -
EASLnews
@EASLnews
⏰ Last call for early registration!
Tomorrow, 13 January, is your final chance to benefit from early registration fees for #easlcongress 2026 in Barcelona. Secure your place at Europe’s leading event in hepatology and liver research at a discounted rate.
Join global experts, researchers and healthcare professionals to explore the latest scientific advances, exchange ideas and connect with peers.
👉 Register now and do not miss out. www.easlcongress.eu/2026-registration/
@DebbieShawcros1 @analleo -
EASLnews
@EASLnews
Join us at the EASL #livercancersummit from 22 to 24 January 2026 in Edinburgh, and earn 17.5 European CME credits (ECMEC®s).
The summit has now been officially accredited by the European Accreditation Council for Continuing Medical Education (EACCME®). ⭐️
Learn from leading experts, engage in cutting edge discussions, and help shape the future of liver cancer research and care.
👉easl.eu/event/liver-cancer-summit-2026/registration/
@DebbieShawcros1 @analleo @IreneBargellini @fruhbecklab @josepmllovet -
EASLnews
@EASLnews
The Abstract Book for EASL #livercancersummit is now available!
Discover the research submitted that will shape the discussions ahead.
Consult it here, and get ready to join us in Edinburgh on 22-24 January! 📑easl.eu/wp-content/uploads/2026/01/EASL_LCS_2026_abstract…
Haven't registered yet? Secure your spot in person or online!👉easl.eu/event/liver-cancer-summit-2026/registration/
@josepmllovet @IreneBargellini @fruhbecklab @DJPinato @DebbieShawcros1 -
EASLnews
@EASLnews
Register now for the upcoming EASL DeepDive on HCC management strategies! Faculty @allaire_manon, @A_DAlessioMD, Fabio Piscaglia and @SaborowskiAnna will discuss surveillance, candidates selection for surgery or transplantation, and the latest systemic therapy options and treatment sequencing.
📅 Wednesday, 28 January, 18:00 CET
Register now: easl-eu.zoom.us/webinar/register/6717649443317/WN_Bw-j-fs…
#livertwitter #liverx -
EASLnews
@EASLnews
Calling dedicated hepatology professionals! Join EASL’s governance and help drive our scientific and educational mission.
We’re seeking:
• Educational Councillor-elect
• 3 Scientific Committee Members
• 2 Basic Science Task Force Members
• 7 Pharmacy Task Force Members
• 3 Young Investigators Task Force Members
• 1 Nurses & AHPs Task Force Member
Deadline 20 January, only 2 weeks left!
Apply here: easl.eu/news/call-governance-dec2025/
#livertwitter #liverx -
EASLnews
@EASLnews
Are you a young scientist on a dynamic career path in hepatology? Do you have novel, forward-looking research ideas that you are eager to implement?
Then apply today for the EASL Daniel Alagille Award!
Apply by 2 February on easl.eu/fellowship/easl_daniel_alagille_award/ -
EASLnews
@EASLnews
⏰ Last chance to submit your abstract to #easlcongress 2026!
The abstract submission deadline is tomorrow, 6 January. Do not miss the opportunity to showcase your research, share your insights with the global liver community and engage with leading experts in the field.
Join the thousands of researchers who help shape the conversation at EASL Congress each year!
👉 Submit your abstract: www.easlcongress.eu/2026-abstracts/
@DebbieShawcros1 @analleo -
EASLnews reposted
AASLD
@AASLDtweets
That’s a wrap! The 2025 EASL-AASLD Masterclass brought early-career investigators together for three immersive days of learning, collaboration, and career-shaping conversations at the beautiful Château de Bellinglise in France. @EASLnews #livertwitter
-
EASLnews
@EASLnews
Are you developing exciting research in genetic cholestatic diseases? Then you might be interested in applying for the Daniel Alagille Award!
Apply by 2 February on easl.eu/fellowship/easl_daniel_alagille_award/ -
EASLnews
@EASLnews
⏰ Abstract submission deadline approaching
A little over two weeks left to submit your abstract for #easlcongress 2026.
🗓 Deadline: 6 January 2026
Do not miss the opportunity to showcase your research to the international hepatology community.
*A special reduced registration fee is available for nurses and allied health professionals, making it even easier to take part.
Take advantage of the holiday period to finalise your work and submit in time.
👉 Submit your abstract now and be part of EASL Congress 2026.
www.easlcongress.eu/2026-abstracts/ -
EASLnews
@EASLnews
This week's EASL Studio on #pbc is now available on demand!
Catch up here: easlcampus.eu/videos/easl-studio-s9-e12
@analleo @MCarbone80 @PBCFoundation
#livertwitter #liverx -
EASLnews
@EASLnews
The winter break is the perfect moment to plan ahead ☃️
Take time to secure your place at #easlcongress 2026 in Barcelona on 27-30 May.
Finalise your work and submit your abstract by 6 January, then lock in your attendance with early registration by 18 January.
Start the new year with exciting science, global networking and Barcelona on the horizon.
❄️Register now: www.easlcongress.eu/2026-registration/
❄️Submit your abstract: www.easlcongress.eu/2026-abstracts/
@DebbieShawcros1 @analleo @FrancqueSven @RuiCastroHD -
EASLnews
@EASLnews
U.N. General Assembly adopts historic health declaration
This week (15 December 2025), the United Nations General Assembly adopted a new Political Declaration on non-communicable diseases (#ncds) and mental health, marking the first time the UN has brought these issues together within a single global political framework.
The declaration, titled “Equity and integration: transforming lives and livelihoods through leadership and action on non-communicable diseases and the promotion of mental health and well-being,” sets out global targets for 2030 and calls on countries to strengthen national policies and health systems to achieve them.
In a notable expansion of scope, the declaration explicitly includes liver health among its priority areas. It commits to preventing liver cancer and other liver diseases by scaling up hepatitis B and C prevention, diagnosis and treatment, including universal hepatitis B vaccination, and by strengthening the screening and management of non-alcoholic fatty liver disease (NAFLD), referenced explicitly, as part of comprehensive NCD action.
The adoption of the declaration represents a significant global policy shift towards recognising chronic diseases and mental health as interlinked priorities for sustainable development and public health.
@DebbieShawcros1 @analleo @SagiZelber -
EASLnews
@EASLnews
Want to contribute your expertise to EASL’s governance and the future of liver research?
Open positions include:
1 Educational Councillor-elect
3 Scientific Committee Members
2 Basic Science Task Force Members
7 Pharmacy Task Force Members
3 Young Investigators Task Force Members
1 Nurses & AHPs Task Force Member
Learn more & apply by 20 January: easl.eu/news/call-governance-dec2025/
#livertwitter #liverx -
EASLnews
@EASLnews
SAVE THE DATE
WHA Side Event | 21 May 2026
From Vision to Action: A Holistic Approach to Metabolic Health and NCD Prevention and Care
Join us during the 2026 World Health Assembly for a high-level side event examining why the global response to non-communicable diseases (NCDs) must evolve to meet today’s realities.
As metabolic dysfunction continues to rise worldwide—affecting an estimated 1.5 billion adults—health systems are under increasing strain. This growing burden highlights the urgent need to move beyond siloed approaches to NCD prevention and care. Conditions such as steatotic liver disease (SLD) sit at the intersection of metabolic, cardiovascular, and broader NCD pathways—yet remain largely overlooked in global and national health strategies. Policymakers and health leaders can no longer afford to address NCDs without placing metabolic health at the centre of the response.
This event will mobilise policymakers, clinicians, researchers, and civil society leaders to set the course for integrating metabolic health into global NCD strategies. Together, we will define a roadmap for embedding metabolic health into global NCD strategies—breaking down silos, strengthening prevention, improving outcomes, and building health systems capable of responding effectively to changing patterns of disease and wellbeing.
The panel will be led by EASL’s Secretary General, @DebbieShawcros1.
🔹 Date: 21 May 2026
🔹 Time: Side event 11:30–13:00 CET, followed by a networking lunch
🔹 Location: InterContinental Hotel, Chemin du Petit Saconnex 7–9, 1209 Geneva
👉 Register here to secure your place
easl.eu/event/easl-wha-side-event-from-vision-to-action/
A formal invitation and the full programme will follow. -
EASLnews
@EASLnews
Hepatocellular carcinoma is the most common primary liver cancer and remains a leading cause of cancer related mortality worldwide. Despite major advances in systemic therapy, including atezolizumab plus bevacizumab, only around 30% of patients derive meaningful benefit, and clinicians still lack reliable biomarkers to guide treatment decisions.
🧬A critical unmet need in HCC care is the ability to predict who will respond to immunotherapy and to monitor treatment effectiveness early. Without this, many patients are exposed to ineffective therapy and unnecessary toxicity, while losing valuable time to switch strategies.
🎓A new #easlfellowship project by Claudia Campani, Centre de Recherche des Cordeliers, Paris addresses this challenge by developing a serum based proteomic signature for patients with advanced HCC treated with atezolizumab and bevacizumab. Using high throughput Olink® technology, more than 5,000 circulating proteins were analysed in 88 patients, leading to the identification of 35 proteins strongly associated with both progression free and overall survival. These promising candidates will now be validated in an independent multicentre cohort of 120 patients using multiplex ELISA, a cost effective and clinically feasible approach.
🔍By integrating baseline and longitudinal biomarker analyses, this project aims to deliver a non invasive tool to improve prognostic stratification and early treatment monitoring. Ultimately, it seeks to support a more personalised, biomarker driven approach to #hcc management, maximising therapeutic benefit while sparing patients from ineffective treatments.
@DebbieShawcros1 @analleo -
EASLnews
@EASLnews
Join us today 18:00 CET for EASL Studio, as experts David Jones, @MCarbone80, Bettina Hansen and @analleo explore the use of surrogate endpoints, the challenges in current trial design and regulation, the value of real-world evidence, and how quality-of-life assessment can support future pathways.
Watch here: easl.eu/easl-studio-episode/s9e12/
@PBCFoundation
#livertwitter #liverx -
EASLnews
@EASLnews
Are you ready to push the boundaries of research in paediatric or adult genetic cholestatic diseases? The Daniel Alagille Award could be your next big step!
Who should apply?
- Promising young scientists with innovative research ideas
- PhD/MD holders in positions at European institutions
- EASL members (join today!)
What’s in it for you?
- EUR 25,000 funding for your research (over up to 2 years)
- A bursary to present your work at the #easlcongress
Learn more and apply by 2 February: easl.eu/fellowship/easl_daniel_alagille_award/
#livertwitter #liverx -
EASLnews
@EASLnews
This week's EASL Studio explores the collaboration across disciplines to find the best solution for people living with #pbc.
Live this Wednesday 18:00 CET on: easl.eu/easl-studio-episode/s9e12/
@analleo @MCarbone80 @PBCFoundation
#livertwitter #liverx -
EASLnews
@EASLnews
⏰ Last call for late breaking abstracts!
The deadline to submit late breaking abstracts for the EASL #sldsummit 2026 is tomorrow, 16 December.
Do not miss the opportunity to present your novel findings and emerging insights that are shaping the future of SLD.
Join leading experts, researchers and clinicians in Budapest, Hungary, for a forward focused discussion on the latest advances in research, diagnostics and patient care. The Summit will take an integrated view of SLD, exploring how lifestyle, environment, genetics and social factors influence disease patterns, progression and treatment decisions.
Submit your late breaking abstract before the deadline and be part of the conversation!
👉easl.eu/event/easl-sld-summit-2026/abstracts/
@rabataller @AnnaAlisi @WillAlazawi @DebbieShawcros1 @analleo -
EASLnews
@EASLnews
This week's EASL Studio on the burden of MASLD, MetALD, and ALD in Europe is now available on demand.
Catch up now: easlcampus.eu/videos/easl-studio-s9-e11
@SagiZelber @DrCarina_FB
#livertwitter #liverx -
EASLnews
@EASLnews
Are you deeply engaged in hepatology and science and ready to get involved in EASL’s governance?
We are looking for:
- One Educational Councillor-elect
- Three Scientific Committee Members
- Two Basic Science Task Force Members
- Seven Pharmacy Task Force Members
- Three Young Investigators Task Force Members
- One Nurses & Allied Health Professionals (AHPs) Task Force Member
Read more and apply by 20 January: easl.eu/news/call-governance-dec2025/
#livertwitter #liverx -
EASLnews
@EASLnews
Today's EASL Studio explores the burden of MASLD, MetALD, and ALD in Europe, the synergistic effects of alcohol and metabolic risk factors, and why the younger population is especially vulnerable.
Tune in today 18:00 CET on easl.eu/easl-studio-episode/s9e11/
@SagiZelber @DrCarina_FB #livertwitter #liverx -
EASLnews
@EASLnews
How well do you know your HBV Guidelines? Test yourself with this new EASL Quiz, as we examine the case of an asymptomatic 45-year-old man who comes to the clinic because he was found to be HBsAg positive.
Play here: easlcampus.eu/quiz/question/q133
#livertwitter #liverx -
EASLnews
@EASLnews
Exciting moments from our YI Task Force meeting in Geneva!🇨🇭
We shared ideas, planned new initiatives, and strengthened our vision for the future of hepatology 🔥
Proud to support the next generation of hepatologist and liver researchers at EASL!
Opportunities to join our our community of passionate young investigators coming soon😉#easlnextgen
#livertwitter #liverx -
EASLnews
@EASLnews
How can we protect young adults from steatotic liver disease? Join experts @SagiZelber, @DrCarina_FB and Zobair Younossi this Wednesday 18:00 CET for an important discussion!
Read more: easl.eu/easl-studio-episode/s9e11/
#livertwitter #liverx -
EASLnews
@EASLnews
This week's EASL Studio episode is now available on demand!
Catch up now: easlcampus.eu/videos/easl-studio-s9-e10
@DebbieShawcros1 @saulkarpen @allisonkwong @NoureddinMD
#livertwitter #liverx -
EASLnews
@EASLnews
The authors of today's #readoftheweek📚 developed a genetically tractable Hepatitis A virus model through rational mutagenesis.
Read here this @JHEP_Reports article: www.jhep-reports.eu/article/S2589-5559(25)00264-2/fulltext
#livertwitter #liverx -
EASLnews
@EASLnews
What were the key takeaways from this year’s AASLD The Liver Meeting? Tune in today as experts @DebbieShawcros1, @saulkarpen, @allisonkwong and @NoureddinMD unpack the most impactful studies, clinical insights, and emerging trends shaping the future of hepatology.
Read more: easl.eu/easl-studio-episode/s9e10/
#livertwitter #liverx -
EASLnews
@EASLnews
In acute decompensated cirrhosis and acute on chronic liver failure, vulnerability to infection is a major driver of multiorgan failure and early death.
This stems from a combination of heightened systemic and intrahepatic inflammation and a progressive weakening of antimicrobial defences. Together these changes form cirrhosis associated immune dysfunction (#caid), a state where both innate and adaptive immunity are impaired.
🧩A key piece of this puzzle may lie in neutrophils. In cirrhosis, immune cells are exposed to abnormal circulating signals that trigger inappropriate activation. Although neutrophil dysregulation is well described in other conditions, its full complexity in cirrhosis is only beginning to emerge. Early evidence shows that during decompensation, expanded neutrophil subpopulations become reprogrammed, displaying altered activation states and regulatory functions that differ from those seen in compensated disease. These shifts may fuel ongoing inflammation and increase susceptibility to infection, ultimately worsening clinical outcomes.
🎓A new #easlfellowship project in the Triantafyllou lab at Imperial by Ahmed El-Masry will delve deeper into this process. By characterising circulating neutrophil subgroups across #masld and alcohol related liver disease, the team will explore phenotypic, metabolic, transcriptomic and functional changes linked to their density and maturity. The goal is to uncover how these altered neutrophils contribute to immune failure in #cirrhosis and to pave the way for future therapeutic strategies.
@DebbieShawcros1 @analleo -
EASLnews
@EASLnews
Missed the AASLD Liver Meeting? Catch up with EASL Studio this Wednesday as experts @DebbieShawcros1, @saulkarpen, @allisonkwong and @NoureddinMD decode the key studies, breakthroughs, and trends shaping the future of hepatology.
Read more: easl.eu/easl-studio-episode/s9e10/
#livertwitter #liverx -
EASLnews
@EASLnews
Last chance to polish your application for the EASL Mentorships Programme!
Deadline tomorrow 23:59 CET!
Read more: easl.eu/research-funding/mentorships/
#livertwitter #liverx -
EASLnews
@EASLnews
This week's EASL Studio on Rifaximin for Hepatic Encephalopathy is now available on demand!
🔗 easlcampus.eu/videos/easl-studio-s9-e09
@DebbieShawcros1 @RajivJalan1 @DrVishalCPatel @JonelTrebicka
#livertwitter #liverx -
EASLnews
@EASLnews
The study in today’s #readoftheweek📚 shows that complete immunoglobulin G normalization in patients with persistently normal transaminases does not significantly impact disease progression in autoimmune hepatitis, highlighting the need to validate these results and potentially revise the definition of complete biochemical response.
Read here this @JHEP_Reports article: www.jhep-reports.eu/article/S2589-5559(25)00244-7/fulltext
🙏@adiazgonzalezMD @LorenaCarballoF @canavascues99 @MGRetortillo310 @mh_guerra
@Indhira0224 @Rod_Peralvarez @DrJavierCrespo @MagdalenaSalced @macarlotal et al.
#livertwitter #liverx -
EASLnews
@EASLnews
How well do you know your EASL-EASD-EASO Guidelines on MASLD?
Test yourself now with this second EASL Quiz featured in the EASL MASLD Guidelines Implementation Programme!
Play now: easlcampus.eu/quiz/question/q132
More information about the EASL MASLD Guidelines Implementation Programme: easlcampus.eu/easl-masld-guidelines-implementation-programme
#livertwitter #liverx -
EASLnews
@EASLnews
See you today 18:00 CET for an interactive EASL Studio on Rifaximin for Hepatic Encephalopathy, as we honour World Antimicrobial Awareness Week.
🔗 easl.eu/easl-studio-episode/s9e9/
@DebbieShawcros1 @RajivJalan1 @DrVishalCPatel @JonelTrebicka
#livertwitter #liverx -
EASLnews
@EASLnews
Do you want to learn from the experience of a senior expert and receive valuable guidance as you grow as a Young Investigator? Then the EASL Mentorships Programme is for you!
The EASL Mentorships Programme fosters scientific exchange through personal developmental relationships, with an experienced mentor guiding a Young Investigator through a crucial stage of their career. We welcome applications from all Health Care Professionals, Nurses, Allied Health Professionals and Patient Advocates.
👥 Two mentorship formats available
🔍 Discover this year’s mentors and apply by this Sunday, 30 November!
🔗 easl.eu/research-funding/mentorships/
#livertwitter #liverx -
EASLnews
@EASLnews
Tune in this Wednesday for EASL Studio, as our faculty will explore the balance between rifaximin’s benefits in hepatic encephalopathy and the global challenge of antimicrobial resistance.
easl.eu/easl-studio-episode/s9e9/
@DebbieShawcros1 @RajivJalan1 @vishalcpatel @JonelTrebicka #livertwitter #liverxThis media couldn't be displayed. See it on the original post. -
EASLnews
@EASLnews
📄Share your new findings and connect with the liver community by submitting an abstract to the #easlcongress 2026, taking place on 27-30 May in Barcelona!
With more than 2,000 submissions last year, it is a great place to showcase your work.
Take this chance to join an international event, add your ideas to the discussion and be considered for awards.
👉Send your abstract by 6 January 2026! www.easlcongress.eu/2026-abstracts/
@DebbieShawcros1 @analleo @aelsharkawy75 @RuiCastroHD @bogdanprocopet @fprusso73 @SaSi_Lens @PinterMatthias -
EASLnews reposted
EASL Education
@EASLedu
Should future HE guidelines revise rifaximin recommendations in light of potential AMR risks?
1 👉Yes – apply stronger caution/restriction
2 👉No – maintain current recommendations
3 👉Unsure – await further evidence -
EASLnews
@EASLnews
This week's EASL Studio is now available on demand! Learn about MASLD in practice, how to decide when to initiate, continue, or stop treatment, and how to recognise treatment futility.
Watch now: easlcampus.eu/videos/easl-studio-s9-e08
@marurinella @phil_newsome7 @NoureddinMD
#livertwitter #liverx -
EASLnews
@EASLnews
In today’s #readoftheweek📚, learn how legacy data, when re-analyzed with artificial intelligence-supported tools, can reveal clinically actionable insight. Large EVs – particularly derived from rare progenitor-like subpopulations – combined with classical serum markers, provide a promising non-invasive screening approach.
Read here this @JHEP_Reports article: www.jhep-reports.eu/article/S2589-5559(25)00219-8/fulltext
🙏 @JesusMBanales et al.
#livertwitter #liverx -
EASLnews
@EASLnews
In anticipation of next week's EASL Studio, faculty @DebbieShawcros1, @RajivJalan1, Vishal Patel and @JonelTrebicka have a question for you!
Tune in next Wednesday, 18:00 CET for this important discussion!
easl.eu/easl-studio-episode/s9e9/
#livertwitter #liverx
EASL Education
@EASLedu
How concerned are you about rifaximin driving antimicrobial resistance (AMR) in cirrhosis care?
1👉We should act now
2👉Evidence is not yet sufficient
3👉Benefits clearly outweigh risks -
EASLnews reposted
EASL Education
@EASLedu
How concerned are you about rifaximin driving antimicrobial resistance (AMR) in cirrhosis care?
1👉We should act now
2👉Evidence is not yet sufficient
3👉Benefits clearly outweigh risks -
EASLnews
@EASLnews
Tune in today's EASL Studio! Experts Cyrielle Caussy, @marurinella, @phil_newsome7 and @NoureddinMD will explore the real-world challenges of treating patients with MASLD.
Live today 18:00 CET: easl.eu/easl-studio-episode/s9e8/
#livertwitter #liverx -
EASLnews
@EASLnews
📢Announcement: Late-Breaker Abstract Submission coming up for EASL #sldsummit 2026
As the SLD research landscape continues to advance rapidly, we are delighted to announce submissions for the Late-Breaker Abstracts at the EASL #sldsummit 2026. This special session offers an outstanding platform to highlight cutting-edge discoveries and emerging trends that are transforming the field.
Stay tuned, and make sure to have your late-breaking abstract ready to submit between 8-16 December 2025!
👉More information: easl.eu/event/easl-sld-summit-2026/
@rabataller @WillAlazawi @AnnaAlisi @DebbieShawcros1 @analleo -
EASLnews
@EASLnews
Join us: “NCDs, obesity and liver health – Can the EU turn the tide?”, Brussels 4 December
Our understanding of metabolic disease is evolving — and so must our approach. At EASL we believe that tackling obesity, metabolic dysfunction and liver-health cannot be done in silos.
The event “NCDs, obesity and liver health – Can the EU turn the tide?” shines a spotlight on how liver conditions like steatotic liver disease (SLD) remain under-recognised within broader NCD strategies.
👉events.euractiv.com
It’s time to integrate liver health into metabolic-disease frameworks, so we can deliver better outcomes for patients across Europe.
🔹 Early detection and intervention.
🔹 Multi-disciplinary collaboration (hepatology, endocrinology, primary care).
🔹 Policy coherence across food, social, digital and healthcare sectors.
Join us at EASL in driving a holistic agenda—because strong liver health is fundamental to overall metabolic resilience.
Speakers include Prof Cyrielle Caussy (EASL & University and Hospices Civils de Lyon), MEP @TomislavSokol, Dr @KremlinKW (WHO Europe), and other leading experts.
In-person attendees in Brussels will also have the opportunity to receive a free Fibroscan — a quick, non-invasive liver test.
📅4 December – 12:30-13:45 - Brussels Network Office - International Press Centre
1 Bd Charlemagne // 2nd floor & Online Streaming -
EASLnews
@EASLnews
This week on EASL Studio: MASLD in Practice: Who to Treat, With What, and for How Long?
Faculty Cyrielle Caussy, @marurinella, @phil_newsome7 and @NoureddinMD will discuss these questions and more, this Wednesday 18:00 CET!
Read more: easl.eu/easl-studio-episode/s9e8/
#livertwitter #liverx -
EASLnews
@EASLnews
🚨Last chance to register for the EASL #sldsummit 2026 with the early fee.
👉The deadline is tomorrow, 18 November, so make sure you secure your place in time.
The Summit will gather leading experts, researchers and clinicians to share the latest insights on Steatotic Liver Disease, including #masld, #ald and MetALD. With its multidisciplinary focus on epidemiology, diagnostics, therapeutics and the factors that drive disease progression, this event is an ideal opportunity to learn and connect.
🤩Register now: easl.eu/event/easl-sld-summit-2026/registration/
@DebbieShawcros1 @analleo @AnnaAlisi @rabataller @WillAlazawi -
EASLnews
@EASLnews
This week's EASL Studio is now available on demand! The faculty had an interactive discussion around the JHEP Reports editorial journey.
Watch now: easlcampus.eu/videos/easl-studio-s9-e07
@MattiasMandorf1 #livertwitter #liverx -
EASLnews
@EASLnews
Today’s #readoftheweek📚 explores the accuracy of bedside ultrasound measurement of the rectus femoris cross-sectional area in assessing sarcopenia and its prognostic value in patients with #cirrhosis.
Read here this @JHEP_Reports article: www.jhep-reports.eu/article/S2589-5559(25)00246-0/fulltext
🙏@salvatore_piano et al.
@UniPadova #livertwitter #liverx -
EASLnews
@EASLnews
How well do you know your EASL Guidelines on TIPS? Test yourself now with this new EASL Quiz and examine the case of a 58-year-old man with alcohol-related cirrhosis (Child-Pugh B, MELD 13) who is admitted with acute hematemesis.
Play now: easlcampus.eu/quiz/question/q131
#livertwitter #liverx -
EASLnews
@EASLnews
In today's EASL Studio, learn what happens to your manuscript after submission, as the JHEP Reports editorial team takes you behind the scenes!
Watch live today 18:00 CET on easl.eu/easl-studio-episode/s9e7/
@MattiasMandorf1 #livertwitter #liverx -
EASLnews
@EASLnews
Only one week left to send your nomination for the EASL Awards!
🏆Community Award – Recognising significant contributions in hepatology, including teaching, advocacy, and innovation.
🏆Emerging Leader Award – Celebrating young researchers with outstanding liver research achievements.
🏆Excellence in Liver Care Award – Honoring emerging talents in liver care and service excellence.
Read more and apply by 18 November on easl.eu/news/call-for-easl-awards-2026/
#livertwitter #liverx -
EASLnews
@EASLnews
How can you maximize your chances of publication in @JHEP_Reports? Discover the behind-the-scenes with this week's EASL Studio!
📅 Wednesday 12 November, 18:00 CET
Read more: easl.eu/easl-studio-episode/s9e7/
@MattiasMandorf1 #livertwitter #liverx -
EASLnews
@EASLnews
After 150+ years of unanswered questions, PSC may finally be turning a corner. New trials are showing promise and new hope for patients.
Catch up now on this week's EASL Studio to learn more: easlcampus.eu/videos/easl-studio-s9-e06
#livertwitter #liverx -
EASLnews
@EASLnews
The authors in today’s #readoftheweek📚 discusses the prognostic significance of mitochondrial biomarkers in genetically-predisposed patients with #masld.
Read here this @JHEP_Reports article: www.jhep-reports.eu/article/S2589-5559(25)00218-6/fulltext
🙏@Erikapaolini1 @marica_meroni @FranceGentMD @AnnaAlisi @lmiele74 et al.
#livertwitter #liverx -
EASLnews reposted
EASL Education
@EASLedu
It's not just norUDCA the phase 2 ELMWOOD trial of elafibranor also showed progress in #psc 👇
📈 50% ALP reduction
🧪 Fibrosis & biomarker stabilisation
✨ Improved itch, even in severe cases
Ongoing: open-label extension
@DebbieShawcros1 @DrCynthiaLevy @joostphdrenth @PSCPartnersCa @F8MArtine @PSCSupportUK
#easlstudio #liverx #psc -
EASLnews
@EASLnews
📣 In a UK Parliamentary debate, MP Beccy Cooper called obesity and fatty liver disease a “public health emergency.”
She urged the Government to treat liver health as part of the wider metabolic crisis and called for a national liver strategy.
🧠 Liver disease deaths have risen 400% in 20 years.
#liverhealth #masld #publichealth
Watch the full session here: www.youtube.com/watch?v=FME5vCFVj4c
@DebbieShawcros1 @analleo @EASLedu @SagiZelber @aelsharkawy75 @BeccyCooper4Lab -
EASLnews
@EASLnews
Tune in today 18:00 CET for an exclusive EASL Studio episode on effective treatment for PSC, led by @DebbieShawcros1, @DrCynthiaLevy, Stephen Rossi, and Michael Trauner.
Watch here: easl.eu/easl-studio-episode/s9e6/
#livertwitter #liverx -
EASLnews
@EASLnews
The EASL Studio is back! Join experts @DebbieShawcros1, @DrCynthiaLevy, Stephen Rossi, and Michael Trauner this Wednesday 18:00 CET to learn more about endpoints, safety, and where they might fit in the care pathway for PSC patients.
Read more: easl.eu/easl-studio-episode/s9e6/
#livertwitter #liverxThis media couldn't be displayed. See it on the original post. -
EASLnews
@EASLnews
🚨 Final call for abstracts! 🚨
The EASL #sldsummit Abstract submission closes tomorrow, 4 November!
👉Present your work to an international audience of experts, gain visibility within the liver community, and inspire new collaborations!
📜Don't miss your chance - submit now: easl.eu/event/easl-sld-summit-2026/abstracts/
@DebbieShawcros1 @analleo @rabataller @AnnaAlisi @WillAlazawi -
EASLnews
@EASLnews
What’s the difference between acute decompensation and ACLF?
In this short video, Prof. Paolo Angeli explains how understanding these two conditions can transform patient care.
🎥 Watch the full #easlstudio episode on demand to hear the expert discussion:
easlcampus.eu/videos/easl-studio-s9-e05
@EASLedu @ProfPaoloAngeli @tom_marjotThis media couldn't be displayed. See it on the original post. -
EASLnews
@EASLnews
Today’s #readoftheweek📚 highlights the need for more inclusive research and calls attention to potential sex-specific prognostic factors in liver transplantation for colorectal liver metastases.
Read here this @JHEP_Reports article: www.jhep-reports.eu/article/S2589-5559(25)00183-1/fulltext
🙏 @Vaital73, @prof_cillo, @AlessandroRov19, @mserenari85, @FAucejo, @CarloSposito, @HagnessMorten, @pdline at al.
@unipadova @Oslounivsykehus
#livertwitter #liverx -
EASLnews reposted
EASL Education
@EASLedu
🌹ACLF or acute decompensation, what’s in a name?
More than words: understanding the distinction could change how we treat and save lives.
📽️Find out more in this #easlstudio episode on demand
easlcampus.eu/videos/easl-studio-s9-e05
@tom_marjot @ProfPaoloAngeli @BavenoCoop @VirginiaHdezGea @RautouE -
EASLnews
@EASLnews
#steatoticliverdisease is increasingly recognised as a multisystem disease.
This session will highlight new findings on immunological networks in #masld, metabolomic models of organ cross-talk, and the gut–brain–liver axis in #ald.
Together, these perspectives underline the systemic nature of SLD and point to unveil novel intervention outputs.
🤔Curious to find out more? Attend the EASL #sldsummit on 26-28 February in Budapest!
👉Early fees available until 18 November: easl.eu/event/easl-sld-summit-2026/registration/
@rabataller @WillAlazawi @AnnaAlisi @DebbieShawcros1 @analleo -
EASLnews
@EASLnews
📰Only a few days left for you to finalise and submit your abstract to EASL #sldsummit, taking place in Budapest on 26-28 February 2026!
⏰Deadline: 4 November
💡This is your opportunity to showcase your latest findings, gain international visibility, and contribute to advancing understanding and management of steatotic liver disease.
👉Submit now: easl.eu/event/easl-sld-summit-2026/abstracts/
@AnnaAlisi @rabataller @WillAlazawi @DebbieShawcros1 @analleo -
EASLnews reposted
EASL Education
@EASLedu
🩺 Clinical cases preview - tonight’s #easlggr!
👉 Case 1: 28-year-old female; cholecystectomy at 12y for symptomatic gallstones; DILI to ibuprofen in 2019 and ICP in 2021; referred to university hospital due to persistently elevated transaminases.
👉Case 2: 41-year-old female; referred from local hospital to specialist centre for HPB cancer multidisciplinary meeting; presented to hospital as emergency a month earlier with anaemia, weight loss, abdominal distension and pruritus.
🚨 Register and join the experts' discussion in 30 minutes!
easl-eu.zoom.us/webinar/register/WN_0KWZtxPLTKOcZWa0X-n31w
@EASLnews @KeitelVerena @DorienPint
#easlggr #liverx -
EASLnews
@EASLnews
You can still register for tonight's EASL Genetic Grand Round on the many faces of MDR3!
🗓️ Wednesday, 29 October, 18:00 CET
🔗 easl-eu.zoom.us/webinar/register/WN_0KWZtxPLTKOcZWa0X-n31w
@DorienPint @KeitelVerena #livertwitter #liverx -
EASLnews
@EASLnews
⏰Have you secured your spot at the EASL #livercancersummit?
TODAY, 28 October is the last day to do so with advantageous early fees.
Discover a scientific programme tailored to your interests, numerous possibilities for networking, and the most current updates in liver tumour research and care.
👉Join us in Edinburgh on 22-24 January! easl.eu/event/liver-cancer-summit-2026/registration/
@DebbieShawcros1 @analleo @PinterMatthias @IreneBargellini @josepmllovet @DavidPinato -
EASLnews
@EASLnews
3 weeks left to send your application or nomination for the EASL Awards 2026!
🏆Community Award – Recognising significant contributions in hepatology, including teaching, advocacy, and innovation.
🏆Emerging Leader Award – Celebrating young researchers with outstanding liver research achievements.
🏆Excellence in Liver Care Award – Honoring emerging talents in liver care and service excellence.
Read more and apply by 18 November: easl.eu/news/call-for-easl-awards-2026/
#livertwitter #liverx -
EASLnews
@EASLnews
🍷 To mark the final week of Breast Cancer Awareness Month, over 20 health groups have come together with one clear message for policymakers: it’s time to take stronger action against alcohol.
In a joint statement, the European Health Alliance on Alcohol (EHAA) - a coalition of experts and organisations working to reduce the burden of alcohol-related harm across Europe – is calling on EU and national policymakers to introduce mandatory health warnings on alcoholic beverages.
Why? Because these warnings are essential to better inform people about the proven link between alcohol and cancer.
🗨️ “Alcohol increases breast cancer risk, even in small amounts. This Breast Cancer Awareness Month, we call on the European Commission and EU member states to follow the WHO’s recommendations, dispel the dangerous myth that only heavy drinkers are affected, and to introduce science-based policies that ensure people know what is hidden in their glass,” explains Alba Gil, Policy Officer at the Association of European Cancer Leagues (ECL).
➡️ Read the full press release: www.cancer.eu/over-20-health-ngos-call-for-stronger-eu-ac…
@myESMO @WHO_Europe @EuropeanCancer -
EASLnews
@EASLnews
🚨 Last chance for early registration!
Be part of the EASL #livercancersummit 2026, a leading event dedicated to advancing the science and care of liver cancer.
Join world-renowned experts, researchers, and clinicians to explore the latest breakthroughs, evolving standards of care, and key controversies in HCC and related malignancies.
🗓 Early fee deadline: TOMORROW, 28 October
🔗 Don’t miss out – register today and secure your spot at a reduced rate! easl.eu/event/liver-cancer-summit-2026/registration/
💙 EASL Members enjoy even greater discounts – become a member and benefit now.
@DebbieShawcros1 @analleo @IreneBargellini @josepmllovet @DJPinato @PinterMatthias -
EASLnews reposted
Tom Hemming Karlsen
@tomhemmingk
Position statement by @AleksanderKrag, Franco Negro and @DebbieShawcros1 in
perspective of the NCD declaration of the UN General Assembly @EASLnews @JHepatology - who decides if SLD is a NCD or not? www.journal-of-hepatology.eu/article/S0168-8278(25)02566-… -
EASLnews
@EASLnews
🚨A new publication calls for Liver Health to be fully recognised within the global NCD agenda
🧩Closing the Gap: Why Liver Health Must Be Central to the UN Political Declaration on NCDs
The 2025 UN Political Declaration mentions liver disease but fails to treat it as a priority NCD.
Authors call this a dangerous blind spot.
By Krag, Negro & Shawcross (2025)
👉Read the article here: easl.eu/news/closing-the-gap/
@AleksanderKrag, Francesco Negro @DebbieShawcros1
#sld #ncd #liverhealth #masld #publichealth -
EASLnews
@EASLnews
Host an EASL School in 2027 in your European Institution!
Polish your application and send it by this Sunday, 26 October, 23:59 CET!
Read more: easl.eu/events/easl-courses-schools-masterclasses/
#livertwitter #liverx -
EASLnews
@EASLnews
In today’s #readoftheweek📚, learn about an ultrasound-based deep learning model for HCC risk stratification and early-stage HCC detection in patients with compensated advanced chronic liver disease.
Read here this @JHEP_Reports article: www.jhep-reports.eu/article/S2589-5559(25)00188-0/fulltext
🙏 @maximeronot et al.
@IHUStrasbourg @univ_spn @mcgillu
@univ_paris_cite
#livertwitter #liverx -
EASLnews
@EASLnews
🌟 Are you a young hepatologist ready to take the next step in your career?
Do you want to learn from the experience of a senior expert and receive valuable guidance as you grow as a Young Investigator?
Then the EASL Mentorships Programme is for you!
This initiative fosters scientific exchange through meaningful, personal developmental relationships. A senior hepatologist will guide you through a key stage of your professional journey, helping you build confidence, skills, and connections for the future.
👥 Two mentorship formats available:
Classic (face-to-face): Meet your mentor during #easlcongress, and organise a visit to their institution during the year.
Virtual: Connect online through monthly meetings and ongoing discussions, with no geographical restrictions.
🔍 Discover this year’s mentors and apply by 30 November! easl.eu/mentorships
@DebbieShawcros1 @analleo @FrancqueSven @fprusso73 @aelsharkawy75 @EASLedu -
EASLnews
@EASLnews
🍎 Nutrition and lifestyle – what can I do?
In this United against Liver Cancer Podcast, @SagiZelber discusses how unhealthy eating habits can increase the risk of liver cancer.
She also shares what a healthy diet really looks like and what policymakers can do to help promote healthier choices for everyone.
🎗️ October is #livercancerawarenessmonth. EASL, together with partners such as @dice_europe, the International Liver Cancer Movement, and @EuropeLiver, is raising awareness of the growing burden of this disease.
🎧 Listen now on Spotify and learn how small changes in lifestyle can make a big difference for your liver health. open.spotify.com/episode/1pEI3ynwNh6i7kJdq7p57H?nd=1&dlsi… -
EASLnews
@EASLnews
🎗️October is #livercancerawarenessmonth, and EASL, along with other organisations such as @dice_europe, International Liver Cancer Movement, and @EuropeLiver have mounted an awareness campaign to shine a light on the growing burden of this disease.
The prevalence of liver cancer is growing across Europe and disproportionately affects men; key drivers of the disease include alcohol consumption, obesity, and viral hepatitis infection.
📽️Watch on as Manon Allaire, representative from ILCM, speaks on the campaign for 2025. easlcampus.eu/videos/easl-policy-dialogues-s4-e5
The EASL Policy Dialogues Season 4 is supported by Novo Nordisk. EASL has received no input from Novo Nordisk with regards to the content of the EASL Policy Dialogues Season 4.
@SagiZelber @josewillemse @DebbieShawcros1 @analleo -
EASLnews
@EASLnews
Register for next week's EASL Genetic Grand Round, as our faculty explore how MDR3 impacts diagnosis and management.
🗓️ Wednesday, 29 October, 18:00 CET
🔗 easl-eu.zoom.us/webinar/register/WN_0KWZtxPLTKOcZWa0X-n31w
@DorienPint @KeitelVerena #livertwitter #liverx -
EASLnews
@EASLnews
🚨 Last call for abstracts!
Tomorrow, 21 October, is the final deadline to submit your work for the EASL #livercancersummit 2026. Don’t miss the chance to share your latest research, connect with global experts, and shape the future of liver cancer care.
The Summit will bring together the international liver oncology community to explore the latest advances in research, clinical practice, and innovation.
Join us and be part of the conversation driving progress in liver oncology!
👉easl.eu/event/liver-cancer-summit-2026/abstracts/
@DebbieShawcros1 @analleo @josepmllovet @PinterMatthias @DJPinato @IreneBargellini -
EASLnews
@EASLnews
One month left to apply for the 2026 EASL awards!
🏆Community Award – Recognising significant contributions in hepatology, including teaching, advocacy, and innovation.
🏆Emerging Leader Award – Celebrating young researchers with outstanding liver research achievements.
🏆Excellence in Liver Care Award – Honoring emerging talents in liver care and service excellence.
Read more and apply by 18 November: easl.eu/news/call-for-easl-awards-2026/
#livertwitter #liverx -
EASLnews reposted
الجمعية السعودية لأمراض وزراعة الكبد (SASLT)
@sasltksa
Continuing our Best of EASL (HCC Focus)
Dr. Leonidas Chelis discusses
Systemic Therapy in Downstaging Hepatocellular Carcinoma — a key strategy shaping treatment decisions and patient outcomes.
With guidance from our moderators:
Dr. Ashraf Omar, Dr. Ahmad Aleid & Dr. Jawad Khamis
#slm2025 #bestofeasl #hcc #livercancer -
EASLnews
@EASLnews
Bring the next generation of hepatologists to your centre of excellence and host an EASL Schools in your institution in 2027!
Apply by 26 October on easl.eu/events/easl-courses-schools-masterclasses/
@FrancqueSven @DebbieShawcros1 #livertwitter #liverx -
EASLnews reposted
الجمعية السعودية لأمراض وزراعة الكبد (SASLT)
@sasltksa
Starting the “Best of EASL Congress 2025 – Liver Transplant” session with a deep dive into
Liver Transplantation & Acute-on-Chronic Liver Failure (ACLF)
by Prof. Francesco Paolo Russo.
Grateful to our moderators
Dr. Hadi Kariry, Dr. May Alzahrani & Dr. Mansour Alghanim
for guiding this vital discussion.
#slm2025 #livertransplant #hepatology -
EASLnews
@EASLnews
Today’s #readoftheweek📚 discusses how relative exchangeable copper is a highly specific and sensitive biomarker for Wilson disease diagnosis.
Read here this @JHEP_Reports article: www.jhep-reports.eu/article/S2589-5559(25)00216-2/fulltext
🙏 @CDesjardinsMD et al.
@FondARothschild @hopital_necker @HopLariboisiere
#livertwitter #liverx -
EASLnews
@EASLnews
There's still time to register for tonight's EASL Molecular Tumour Board on HCC-neuroendocrine transition!
Register now: easl-eu.zoom.us/webinar/register/WN_PSbTkyCZTZi-IaALumu6bw
@VChernyakMD @ma5RN @MarcoSanduzzi @siadaniela @Vaital73
#livertwitter #liverx -
EASLnews
@EASLnews
In honour of Liver Cancer Awareness Month, take the new EASL Quiz!
Test your knowledge on the EASL Policy Statements on liver cancer screening and surveillance: easlcampus.eu/quiz/question/q129
#livertwitter #liverx -
EASLnews
@EASLnews
🌍 Join the global liver oncology community at the EASL #livercancersummit 2026, in Edinburgh on 22-24 January!
Discover the latest breakthroughs in liver cancer research, clinical care, and innovation. This year’s programme covers the full spectrum of liver cancer, from molecular mechanisms and biomarker discovery to advanced imaging, surgery, and systemic therapies.
🧬 Explore cutting-edge advances in spatial transcriptomics, AI-driven diagnostics, and new therapeutic targets for HCC and cholangiocarcinoma.
💡 Hear from world-leading experts on combination treatments, evolving standards of care, and strategies to improve outcomes and healthcare equity.
⏰ 1 week left to submit your research!
Abstract submission closes 21 October 2025. easl.eu/event/liver-cancer-summit-2026/abstracts/
Share your latest findings, connect with peers, and shape the future of liver cancer research and care.
Join with early fees by 28 October!
easl.eu/event/liver-cancer-summit-2026/registration/
@DebbieShawcros1 @analleo @josepmllovet @IreneBargellini @DavidPinato -
EASLnews
@EASLnews
📢 NEW! EASL’s new Guidelines Dissemination Programme advances liver care by promoting awareness and uptake of Clinical Practice Guidelines. Its key initiative, the EASL Guidelines Implementation Programme, turns recommendations into practical tools for everyday use.
Discover the first edition focused on the EASL–EASD–EASO CPGs for #masld: EASL MASLD Guidelines Implementation Programme: easlcampus.eu/easl-guidelines-dissemination-implementatio…
#livertwitter #liverx @DebbieShawcros1 @analleo @FrancqueSven @MajaThiele -
EASLnews
@EASLnews
Catch up on this week's EASL Studio thought-provoking episode!
Experts debate the real-world utility of prognostic scores, the clarity (or confusion) created by multiple definitions, and whether the ACLF concept drives urgency, facilitates transplant access, or improves outcomes.
Watch here: easlcampus.eu/videos/easl-studio-s9-e05
@tom_marjot @ProfPaoloAngeli @BavenoCoop @VirginiaHdezGea @RautouE
#livertwitter #liverx -
EASLnews reposted
Decision4Liver
@Decision4Liver
Our final GA is a look back and forward - from major scientific milestones to future discoveries!
After a keynote by Prof. Rubén Francés, partners shared results on omics integration, biomarkers & systems medicine - and closed with a masterclass on data repositories. #cirrhosis -
EASLnews
@EASLnews
In today’s #readoftheweek📚, learn about the effectiveness and active ingredients of digital behaviour change interventions for the management of #masld.
Read here this @JHEP_Reports article: www.jhep-reports.eu/article/S2589-5559(25)00185-5/fulltext
🙏@stumcp @HallsworthKate @healthpsychleah et al.
#livertwitter #liverx -
EASLnews
@EASLnews
🚨 Landmark in hepatology
@JHepatology reports the world’s first pig-to-human liver xenotransplant in a living patient.
A genetically engineered pig liver supported vital metabolic and synthetic functions in a 71-year-old man for 171 days.
👉 Proof-of-concept: genetically modified pig livers can function in humans
👉Challenges remain: immune complications and coagulation dysregulation
👉Potential impact: bridging the global gap between organ demand and availability
“Xenotransplantation may open completely new paths for patients with acute liver failure, #aclf, and #hcc. A new era of transplant hepatology has started.” - Prof. Heiner Wedemeyer, Co-Editor, Journal of Hepatology
🔗Read the press release and access the article: easl.eu/news/pig-to-human-liver-65891710/.
@DebbieShawcros1 @analleo @VladRatziu
EASLnews
@EASLnews
In the press 🗞️:
edition.cnn.com/2025/10/09/health/pig-liver-transplant-china -
EASLnews
@EASLnews
Register now for next week's EASL Molecular Tumour Board on HCC-neuroendocrine transition!
When HCC takes on neuroendocrine features, it becomes rarer, more aggressive, and tougher to treat. Experts @VChernyakMD, @ma5RN, @MarcoSanduzzi, @siadaniela and @Vaital73 will unpack what this transition means for care and research.
🗓️Wednesday, 15 October, 18:00 CET
🔗easl-eu.zoom.us/webinar/register/WN_PSbTkyCZTZi-IaALumu6bw
#livertwitter #liverx -
EASLnews
@EASLnews
Today's EASL Studio questions whether assigning the label “ACLF” to a deteriorating patient truly alters clinical decisions, or if focusing on the specifics of organ failure and reversibility is more useful.
See you tonight at 18:00 CEST on easl.eu/easl-studio-episode/s9e5/
@tom_marjot @ProfPaoloAngeli @BavenoCoop @VirginiaHdezGea @RautouE
#livertwitter #liverx -
EASLnews
@EASLnews
Each year, EASL celebrates excellence within the hepatology community. We are now inviting nominations for the following awards:
🏆Community Award – Recognising significant contributions in hepatology, including teaching, advocacy, and innovation.
🏆Emerging Leader Award – Celebrating young researchers with outstanding liver research achievements.
🏆Excellence in Liver Care Award – Honoring emerging talents in liver care and service excellence.
Read more and apply by 18 November: easl.eu/news/call-for-easl-awards-2026/
@DebbieShawcros1 @analleo @tom_marjot @HallsworthKate @CatarinaLindq11
#livertwitter #liverx -
EASLnews
@EASLnews
Does it really matter whether we call it ACLF or acute decompensation? Find out this Wednesday in this new EASL Studio episode!
More information: easl.eu/easl-studio-episode/s9e5/
@tom_marjot @ProfPaoloAngeli @BavenoCoop @VirginiaHdezGea @RautouE
#livertwitter #liverx -
EASLnews
@EASLnews
Would you like to host an EASL School in 2027, in your European institution?
Please share your ideas by completing and returning the application by 26 October.
Read more: easl.eu/events/easl-courses-schools-masterclasses/
@FrancqueSven @DebbieShawcros1 #livertwitter #liverx -
EASLnews
@EASLnews
This week's EASL Studio on "The Clinical Blind Spot: Are We Neglecting Alcohol?" is now available on demand!
Catch up now on easlcampus.eu/videos/easl-studio-s9-e04
@MajaThiele @MzamoMbelle @PoseElisa
#livertwitter #liverx -
EASLnews
@EASLnews
The authors in today’s #readoftheweek📚 identify and validate nine genetic variants associated with an increased risk of HCC development.
Read here this @JHEP_Reports article: www.jhep-reports.eu/article/S2589-5559(25)00163-6/fulltext
🙏 @ColmJJORourke, @VilarinhoSilvia, @henrik_ullum, @TLaisk, @bjornsson_s, @patsule, @StefanStender, et al.
#livertwitter #liverx -
EASLnews
@EASLnews
HCC neuroendocrine transition refers to the rare process where HCC develops features of neuroendocrine tumors, leading to more aggressive disease and challenging treatment decisions.
Register now to join the upcoming EASL Molecular Tumour Board to explore what this means for clinical management and research: easl-eu.zoom.us/webinar/register/WN_PSbTkyCZTZi-IaALumu6bw
Faculty @VChernyakMD, @ma5RN, @MarcoSanduzzi, @siadaniela and @Vaital73 are looking forward to discussing these cases!
#livertwitter #liverx -
EASLnews
@EASLnews
Do current classification systems (heavily favoring metabolic causes) misrepresent the true burden of ALD and MetALD? What can clinicians do to better map the role of alcohol in liver patients?
Faculty @MajaThiele, Brian Lee, @MzamoMbelle and @PoseElisa will explore these questions in today's EASL Studio!
Tune in today 18:00 CEST: easl.eu/easl-studio-episode/s9e4/
#livertwitter #liverx -
EASLnews
@EASLnews
How well do you know your EASL Clinical Practice Guidelines on extrahepatic abdominal surgery in patients with cirrhosis and advanced chronic liver disease?
Test yourself now with this new EASL Quiz: easlcampus.eu/quiz/question/q128
#livertwitter #liverx -
EASLnews
@EASLnews
In this second online edition of the EASL Genetic Grand Round, experts @DorienPint, @KeitelVerena, Jeremy Nayagam and Richard Thompson will discuss cases of MDR3 deficiency.
🗓️ Wednesday 29 October, 18:00 CEST
Register now on: easl-eu.zoom.us/webinar/register/WN_0KWZtxPLTKOcZWa0X-n31w
#livertwitter #liverx -
EASLnews
@EASLnews
✨ Kick off your 2026 with new insights on Steatotic Liver Disease!
Join us at the EASL #sldsummit 2026 to explore the latest advances in SLD, from MASLD and MetALD to ALD.
The programme will highlight:
🔬 Cutting-edge research
💊 Novel therapies
🥗 The impact of modern diets and public policy
🤝 Integrated patient care
This is your chance to connect with global experts and peers in an interactive setting.
📢 Abstract deadline: 4 November 2025 easl.eu/event/easl-sld-summit-2026/abstracts/
💡 Early registration: 18 November 2025
easl.eu/event/easl-sld-summit-2026/registration/
👉 Register now and share your work with the international liver community!
#livertwitter #liverx -
EASLnews
@EASLnews
Good news! 🎉 We know you’ve been working hard on your applications, so we’re giving you a little extra time.
The deadline to apply for EASL Schools 2026 has been extended to next Monday, 6 October 2026!
Take this chance to polish your submission and send it in: easl.eu/events/easl-courses-schools-masterclasses/
#livertwitter #liverx -
EASLnews
@EASLnews
This week's EASL Studio explores the discrepancy between the huge burden of patients hospitalised with, and dying from, alcohol-related liver disease (ALD) or MetALD, versus the same disease’s near non-existence from population data.
Tune in this Wednesday, 18:00 CEST on easl.eu/easl-studio-episode/s9e4/
@MajaThiele @MzamoMbelle @PoseElisa
#livertwitter #liverx -
EASLnews
@EASLnews
🌟 We are thrilled to announce that registration and abstract submission are now officially open for #easlcongress 2026!
📍 Taking place in Barcelona, Spain, from 27–30 May 2026, this is the must-attend event for all who are passionate about advancing hepatology. Whether you are a clinician, researcher, policymaker, or trainee, EASL Congress offers something for everyone.
🔬 What makes EASL Congress 2026 unmissable?
- A scientific programme covering every track in hepatology: clinical practice, basic science, translational research, and public health.
- Diverse formats that allow you to engage with the content most relevant to your expertise.
📢 Abstract submission is open until 6 January 2026 www.easlcongress.eu/2026-abstracts/
💡 Early bird registration is open until 13 January 2026 www.easlcongress.eu/2026-registration/
🔗easlcongress.eu
#livertwitter #liverx -
EASLnews
@EASLnews
Register now for the Paris PSVD Meeting, taking place 4-5 December 2025:
app.evalandgo.com/f/325218/4qEYUdUmW66dSGr9ubQDXK
@ValdigGroup @filfoie @RautouE #livertwitter #liverx -
EASLnews
@EASLnews
⏳ Less than one month left to submit your abstract!
Be part of the EASL #livercancersummit 2026, the leading global meeting on liver tumours.
The programme will cover:
🔬 Basic, translational and clinical research
🌍 Cutting-edge insights from international experts
💡 Discussions shaping the future of liver cancer care
📢 Abstract deadline: 21 October 2025
easl.eu/event/liver-cancer-summit-2026/abstracts/
Don’t miss your chance to present your research and connect with the global liver cancer community.
💡 Register early: 28 October
easl.eu/event/liver-cancer-summit-2026/registration/
#livertwitter #liverx -
EASLnews
@EASLnews
This week's EASL Studio on the management of Hepatitis C in people who inject drugs and other high-risk groups is now available on demand!
Catch up here: easlcampus.eu/videos/easl-studio-s9-e03
@aelsharkawy75 @TatyanaKushner @SaSi_Lens
#livertwitter #liverx -
EASLnews
@EASLnews
In today's #readoftheweek📚, the authors discuss a PBC care bundle that they designed to improve adherence to management guidelines and promote standardised care.
Read here this @JHEP_Reports article: www.jhep-reports.eu/article/S2589-5559(25)00099-0/fulltext
🙏 @NadirAbbas_X @dougton @adyeoman @PBCRobert @stumcp @CholestasisDoc @Dr_AlRubaiy
#livertwitter #liverx -
EASLnews
@EASLnews
Save the date for the upcoming EASL Molecular Tumour Board, taking place Wednesday 15 October at 18:00 CEST!
Experts @VChernyakMD, @ma5RN, @MarcoSanduzzi, @siadaniela and @Vaital73 will discuss a case of HCC-neuroendocrine transition.
Register now: easl-eu.zoom.us/webinar/register/WN_PSbTkyCZTZi-IaALumu6bw
#livertwitter #liverx -
EASLnews
@EASLnews
Only a few days left to apply for the EASL Schools 2026! Which one interests you the most?🤔 Discover all four opportunities and apply by this Sunday, 23:59 CEST.
🔗easl.eu/events/easl-courses-schools-masterclasses/
#livertwitter #liverx -
EASLnews
@EASLnews
Tune in today at 18:00 CEST for a new EASL Studio episode, as our faculty discuss the challenges of managing Hepatitis C in people who inject drugs (PWID) and other high-risk groups.
📺 easl.eu/easl-studio-episode/s9e3/
@aelsharkawy75 @TatyanaKushner @SaSi_Lens
#livertwitter #liverx -
EASLnews reposted
Debbie Shawcross
@DebbieShawcros1
2 important messages that you must hear 👂
1. 1/3 of the globe has Steatotic Liver Disease #sld. A metabolic disease that is 100% preventable.
2. Every 2 mins someone unnecessarily dies of viral hepatitis
@EASLnews are at #unga80 in NYC championing liver disease
@SagiZelber -
EASLnews
@EASLnews
We are delighted to announce a new collaboration between EASL and @UCHID_eg (United Conference of Hepato–Gastroenterology & Infectious Diseases).
As part of UCHID 2025, taking place in Egypt this week, attendees will have the unique opportunity to experience the “Best of EASL Congress 2025” session - bringing the latest science, innovations, and highlights from EASL Congress directly to Cairo.
This special session will feature cutting-edge updates on:
▶️Immune-mediated & Cholestatic Disease
▶️Liver Tumours
▶️Viral Hepatitis
▶️Steatotic Liver Disease
🤝This partnership marks a significant step in strengthening international collaboration and advancing hepatology and gastroenterology in the region.
@DebbieShawcros1 @fprusso73 @analleo @FrancqueSven -
EASLnews
@EASLnews
Session highlight at the EASL #sldsummit 2026!
Artificial intelligence is transforming medicine, and SLD is no exception. This session will explore how big data, deep learning, and AI-powered imaging are enhancing our understanding and diagnosis of SLD.
Speakers will present emerging tools that are redefining pathology interpretation and diagnostic precision, while a panel will reflect on challenges in integration into clinical workflows, regulatory approval of AI tools, and real-world clinical applicability.
👉Send your abstract by 4 November! easl.eu/event/easl-sld-summit-2026/abstracts/
👉Register with early fees by 18 November! easl.eu/event/easl-sld-summit-2026/registration/
@DebbieShawcros1 @rabataller @AnnaAlisi @WillAlazawi -
EASLnews
@EASLnews
Session highlight at the EASL #livercancersummit 2026!
Gain an in-depth update on cholangiocarcinoma and rare liver tumours, from molecular pathogenesis and tumour microenvironment to clinical management.
Experts will explore surgical and transplant options, review current and emerging systemic therapies, and address challenges in treating rare primary liver tumours.
👉Submit your abstract by 21 October! easl.eu/event/liver-cancer-summit-2026/abstracts/
👉Join with early fees by 28 October! easl.eu/event/liver-cancer-summit-2026/registration/
@DebbieShawcros1 @llovet_m @PinterMatthias @DJPinato @IreneBargellini @CharityAMMF @curecc -
EASLnews
@EASLnews
What do we call it when someone with high-risk practices becomes viraemic again after treatment? Tune in this Wednesday 18:00 CEST for a new EASL Studio episode!
Read more: easl.eu/easl-studio-episode/s9e3/
@aelsharkawy75 @TatyanaKushner @SaSi_Lens
#livertwitter #liverx -
EASLnews
@EASLnews
This week's EASL Studio which focused on communication and patient-centred care is now available on demand! Catch up here: easlcampus.eu/videos/easl-studio-s9-e02
@RautouE
@josewillemse
#livertwitter #liverx -
EASLnews
@EASLnews
The authors in today’s #readoftheweek📚 ran a survey on HDV infection in Africa and found that awareness of HDV prevalence and access to diagnostic tests is limited and suboptimal, though there is substantial regional variability.
Read here this @JHEP_Reports article: www.jhep-reports.eu/article/S2589-5559(25)00173-9/fulltext
🙏@Mariabutif et al.
#liverx #livertwitter -
EASLnews
@EASLnews
Don't miss today's EASL Studio! Our faculty will highlight how listening carefully can improve adherence, enhance quality of life, and ultimately lead to better outcomes.
Watch live at 18:00 CEST on easl.eu/easl-studio-episode/s9e2/
@RautouE @josewillemse #livertwitter #liverx -
EASLnews
@EASLnews
Test your guidelines knowledge with this new EASL Quiz! We're exploring the case of a 19-year-old female patient with a history of a large extrahepatic congenital portosystemic shunt and severe portopulmonary hypertension.
Play now: easlcampus.eu/quiz/question/q127
#livertwitter #liverx -
EASLnews reposted
الجمعية السعودية لأمراض وزراعة الكبد (SASLT)
@sasltksa
Join Dr. Mohammed Mawardi as he explores the mysteries of IgG4-related disease — separating evidence from assumption in autoimmune hepatology.
Don’t miss this highlight from the Best of EASL Congress 2025!
📅 Friday, Oct 17, 2025
🕔 05:20 – 05:35 PM
📍 Voco Hotel – Riyadh Hall
🎓 14 CME Hours Accredited
✨ The Best of EASL – Cholestatic & Autoimmune Hepatitis
🔗 Register now: saslt.vax.solutions
#slm2025 #autoimmunehepatitis #aih #saslt #easl #livercare -
EASLnews
@EASLnews
This week's EASL Studio explores the crucial questions hepatologists should ask to truly understand their patients’ needs, values, and priorities.
Watch live this Wednesday 18:00 CEST on: easl.eu/easl-studio-episode/s9e2/
@RautouE @josewillemse
#livertwitter #liverx -
EASLnews
@EASLnews
🌍✨ See you at the Saudi Liver Meeting 2025 for a full-day EASL session on the Best of #easlcongress 2025.
From cutting-edge research to the latest clinical guidelines, the programme will cover:
✅ Liver transplantation & oncology
✅ Advances in HCC management
✅ Updates on viral hepatitis & HBV cure pipeline
✅ MASLD – non-invasive tests, pharmacological therapy & obesity management
✅ Autoimmune & cholestatic liver diseases
📅 Friday 17 October 2025
📍 Voco Hotel, Riyadh Hall
🎓 CME Accredited
This is a unique opportunity to hear international experts share the highlights of EASL Congress 2025, directly with the liver community in the region.
Register now: saslt.vax.solutions
@sasltksa @fprusso73 -
EASLnews
@EASLnews
🍷The EU is set to allow wines with up to 6% alcohol to be labelled as “low-alcohol” : a dangerously misleading term.
Alcohol is a Group 1 carcinogen with no safe level of consumption. Calling 6% ABV wine “low-alcohol” gives a false sense of safety, weakens cancer prevention efforts, and threatens decades of progress in reducing harm.
The European Health Alliance on Alcohol (EHAA), representing 1.7 million medical professionals, urges the European Parliament to act:
✅ Ban “low-alcohol” labelling above 1.2% ABV, use “reduced alcohol” instead
✅ Require clear on-package health warnings and nutritional info, not hidden QR codes
✅ Align with Europe’s Beating Cancer Plan and WHO guidance
Every consumer deserves transparency and protection. Public health must come first.
📄 Read the press release and statement: easl.eu/news/6-percent-alcohol-is-not-low-alcohol/
@DebbieShawcros1 @analleo @WHO_Europe @SagiZelber @myESMO @WoncaEurope @escardio -
EASLnews
@EASLnews
🟢Share your research at the EASL #sldsummit 2026!
📅 26–28 February 📍 Budapest, Hungary
This year’s Summit will go beyond isolated organ perspectives to explore SLD through lifestyle, environment, genetics, and social determinants of health, and how these drivers shape progression and treatment.
📝 Submit your abstract by 4 November 2025:
easl.eu/event/easl-sld-summit-2026/abstracts/
👉Register with early fees by 18 November: easl.eu/event/easl-sld-summit-2026/registration/
@rabataller @AnnaAlisi @WillAlazawi @DebbieShawcros1 @analleo -
EASLnews
@EASLnews
🎗️Join us at the EASL #livercancersummit 2026
📅 22–24 January 📍 Edinburgh, UK
Each day promises new highlights in the field of liver tumours. Browse the full programme to create an agenda tailored to your interests!
👉easl.eu/event/liver-cancer-summit-2026/scientific-programme/
Day 1: #masld and #hcc links, novel surveillance and biomarkers, AI, and emerging molecular therapies.
Day 2: Advances in surgery, transplant, locoregional therapies, pivotal trials, and debates in liver cancer care.
Day 3: Systemic therapies, treatment sequencing, immunotherapy, and the future of biomarker-driven, equitable, patient-centred care.
👉 Submit your abstract by 21 October easl.eu/event/liver-cancer-summit-2026/abstracts/
👉 Register with early fees by 28 October easl.eu/event/liver-cancer-summit-2026/registration/
@DebbieShawcros1 @analleo @DJPinato @IreneBargellini @DJPinato @PinterMatthias -
EASLnews
@EASLnews
This week's EASL Studio is now available on demand! Learn from our faculty as they discuss biochemical and imaging-based endpoints in primary biliary cholangitis.
Watch here: easlcampus.eu/videos/easl-studio-s9-e1
@MCarbone_80
#livertwitter #liverx -
EASLnews
@EASLnews
In today’s #readoftheweek📚, learn about the role of senescence in the pathogenesis of alcohol-associated hepatitis (AH), as well as into the potential use of senescence and SASP-related molecules as biomarkers for AH.
Read here this @JHEP_Reports article: www.jhep-reports.eu/article/S2589-5559(25)00156-9/fulltext
🙏@Dmarti_aguado, @laura_zanatto, @AzucenaSalas17, @RautouE, @rabataller et al.
#livertwitter #liverx -
EASLnews
@EASLnews
Today's EASL Studio episode shifts the focus from symptoms and quality of life to biochemical and imaging-based endpoints in primary biliary cholangitis.
Watch live today 18:00 CEST on easl.eu/easl-studio-episode/s9e1/
@MCarbone_80
#livertwitter #liverx -
EASLnews
@EASLnews
The EASL Studio is back! Tune in this Wednesday 18:00 CEST as the faculty explore the relevance of alkaline phosphatase response, non-invasive fibrosis assessment, and composite scores like GLOBE and UK-PBC.
Read more: easl.eu/easl-studio-episode/s9e1/
@MCarbone_80 @FrancqueSven
#livertwitter #liverx -
EASLnews
@EASLnews
Are you interested in Steatotic Liver Disease? Attend the EASL #sldsummit 2026!
📅 26–28 February
📍 Budapest, Hungary
Join leading experts and early-career researchers for a dynamic exchange shaping the future of steatotic liver disease research and care.
✔️ Submit your abstract by 4 November easl.eu/event/easl-sld-summit-2026/abstracts/
✔️ Register with early fees by 18 November easl.eu/event/easl-sld-summit-2026/registration/
✔️ Explore the scientific programme easl.eu/event/easl-sld-summit-2026/scientific-programme/
Don’t miss this chance to connect, share, and discover the latest in SLD science and clinical care. -
EASLnews
@EASLnews
✨ The state-of-the-art sessions at the EASL #livercancersummit bring you authoritative updates on the latest science, challenges, and future directions in the field of liver tumours.
This lecture will take you from the mechanisms driving HCC to new therapeutic targets and the future of personalised treatment.
🎯 Learning objectives:
✔️ Describe the molecular and cellular mechanisms shaping HCC pathogenesis
✔️ Discuss current challenges and knowledge gaps
✔️ Explore future opportunities for prevention, diagnosis, and therapy
Join us in Edinburgh!
📢 Showcase your latest research: submit your abstract by 21 October.
🔗 easl.eu/event/liver-cancer-summit-2026/abstracts/
💡 Register by 28 October to benefit from early fees.
🔗 easl.eu/event/liver-cancer-summit-2026/registration/ -
EASLnews
@EASLnews
In today’s #readoftheweek📚, we spotlight a study on stereotactic body radiotherapy. The authors examined its safety and outcomes in patients with hepatocellular carcinoma awaiting liver transplantation.
Read here this @JHEP_Reports article: www.jhep-reports.eu/article/S2589-5559(25)00129-6/fulltext
🙏 @claasen_m, @lucksheee, @magyar_ch, @NaziaSelzner, @MarkusSelzner, @shwaartz, @ArndtVogel, @Dr_AliHosni, @j_lukovic, @aislingbarryro et al.
#livertwitter #liverx -
EASLnews
@EASLnews
How familiar are you with the newest EASL Guidelines on autoimmune hepatitis? Time to test yourself with this EASL Quiz!
🕹️ easlcampus.eu/quiz/question/q126
#liverx #livertwitter -
EASLnews
@EASLnews
🎗️ EASL Liver Cancer Summit 2026
📅 22–24 January
📍 Edinburgh, UK
✨ Session highlight: explore the latest technologies transforming our understanding of hepatocellular carcinoma, including single-cell sequencing, spatial transcriptomics, the gut–liver microbiome axis, and the integration of artificial intelligence into diagnostics. These cutting-edge advances are paving the way for precision medicine in liver oncology.
Register today to gain access to a dynamic scientific programme featuring inspiring keynote lectures, interactive sessions, and valuable networking opportunities with peers and leaders from around the world.
👉Submit your abstracts by 21 October: easl.eu/event/liver-cancer-summit-2026/abstracts/
👉Secure your place early and benefit from early fees until 28 October. easl.eu/event/liver-cancer-summit-2026/registration/ -
EASLnews
@EASLnews
In today’s #readoftheweek📚, learn how transformer neural networks on liver MRI data can be used to enhance cardiovascular risk prediction.
Read here this @JHEP_Reports article: www.jhep-reports.eu/article/S2589-5559(25)00104-1/fulltext
🙏@JClusmann, @tom_luedde, @DanielTruhn, @jnkath et al.
#liverx #livertwitter -
EASLnews
@EASLnews
Are you looking to grow your skills and connect with peers across Europe? Do you want to advance your research in liver disease? 🔍
Discover our two fellowship types and apply by this Monday, 1 September 2025!
🔗 easl.eu/fellowship/mobility-research-fellowship-programme/
#livertwitter #liverx -
EASLnews
@EASLnews
🍷 ➡️🥦🏃♀️
A large new study in the @JHepatology has found that a healthy #diet and regular #physicalactivity lower the risk of liver-related death across all drinking patterns, including heavy and binge drinking.
🏋️♀️🥗The findings highlight the importance of considering lifestyle factors when evaluating the health risks of #alcohol consumption.
👩🦰Women, while at higher risk from alcohol-related liver disease, also gain greater protection from diet and exercise.
👉Read more: easl.eu/news/diet-and-exercise-on-alcohol-related-liver-h…
@DebbieShawcros1 @analleo -
EASLnews reposted
الجمعية السعودية لأمراض وزراعة الكبد (SASLT)
@sasltksa
✨ A historic collaboration in Riyadh! ✨
SASLT 🤝 EASL present “The Best of EASL Congress 2025” at #slm2025 🌍
📅 Friday, Oct 17, 2025
📍 Voco Hotel, Riyadh
Top global hepatology insights, all in ONE day.
🔗 Secure your spot now: saslt.vax.solutions
#saslt #easl #slm2025 #liverhealth #hepatology #riyadh -
EASLnews
@EASLnews
🚀 Two exciting opportunities to join the EASL Governing Board are open!
We’re recruiting:
▫️One Internal Affairs Councillor – driving EASL’s internal strategy by strengthening member engagement, governance, and long-term sustainability.
▫️One External Affairs Councillor – representing EASL externally, building partnerships, boosting outreach, and increasing our visibility in the global medical and scientific community.
Do you see yourself in one of these roles—or know someone who would thrive here? 🔎
👉 Learn more and apply by 14 September: easl.eu/news/call-for-applications-easl-internal-affairs-…
@aelsharkawy75 @fprusso73
#livertwitter #liverx -
EASLnews
@EASLnews
🌍 At EASL, we are committed to building an inclusive community across our four pillars: Education, Advocacy, Science, and Leadership.
Our new Equity, Diversion, and Inclusion policy sets out:
✔️ Practical steps to remove barriers and promote fair representation
✔️ Procedures to address discrimination
✔️ Short- and long-term goals for lasting progress
We believe that diversity strengthens innovation, drives collaboration, and ensures liver health for all.
📢 We invite all stakeholders to review the policy and share feedback during the consultation phase, by 15 September.
easl.eu/news/easl-edi-policy-statement/
@DebbieShawcros1 @analleo @aelsharkawy75 @fprusso73 @SaSi_Lens @SagiZelber @PinterMatthias @RuiCastro @MajaThiele @bogdanprocopet @EmmaCulver6 @FrancqueSven -
EASLnews
@EASLnews
🧩The EASL #sldsummit 2026 (26–28 February, Budapest) will bring together experts and early-career researchers to explore the latest in steatotic liver disease, from prevention and diagnostics to innovative therapies and patient care.
🔎 Don’t miss the opening session:
The scale of SLD
📅 Thursday, 26 February, 🕦 11:30–12:30 CET
This session will examine the global burden of #sld, fuelled by dietary shifts, the rise of ultra-processed foods, and broader societal and policy challenges.
💡 Key takeaways:
- Understand the social and environmental drivers of SLD
- Assess the role of global dietary trends in disease burden
- Explore policy-level strategies to counter the “pro-SLD environment”
👉Submit your abstract by 4 November: easl.eu/event/easl-sld-summit-2026/abstracts/
👉Register with early fees by 18 November: easl.eu/event/easl-sld-summit-2026/registration/
👉Check the Scientific Programme: easl.eu/event/easl-sld-summit-2026/scientific-programme/
@WillAlazawi @rabataller @AnnaAlisi @DebbieShawcros1 @analleo @EASLedu -
EASLnews
@EASLnews
🎗️The EASL #livercancersummit 2026, happening on 22-24 January in Edinburgh will cover the full spectrum of liver cancer research and care, from molecular pathogenesis and novel diagnostics to cutting-edge therapies and patient-centred approaches.
Over 3 days, experts will share the latest advances in the liver tumour field.
🔎 Don’t miss the opening session:
Epidemiology, risk factors, and surveillance for HCC
📅 Thursday, 22 January | 🕚 11:15–12:35 CET
This session will highlight the rising impact of #masld, its strong link to #hcc, and updates on surveillance strategies (ultrasound, abbreviated MRI, blood-based biomarkers), plus novel approaches for risk reduction and treatment.
👉Submit your abstract by 21 October: easl.eu/event/liver-cancer-summit-2026/abstracts/
👉Register with early fees by 28 October: easl.eu/event/liver-cancer-summit-2026/registration/
👉Check the Scientific Programme: easl.eu/event/liver-cancer-summit-2026/scientific-programme/
@IreneBargellini @DJPinato @DebbieShawcros1 @analleo @EASLedu -
EASLnews
@EASLnews
Would you like to host an EASL School in 2027, in your European institution?🤩
Please share your ideas by completing and returning the application by 26 October.
🔗easl.eu/events/easl-courses-schools-masterclasses/
#livertwitter #liverx -
EASLnews
@EASLnews
In today’s #readoftheweek📚, the authors explore how TIPS could limit the risk of portal hypertensive complications in patients with ascites.
Read here this @JHEP_Reports article: www.jhep-reports.eu/article/S2589-5559(25)00147-8/fulltext
🙏@balcar_lorenz, @hartl_md, @MattiasMandorf1, @ProfPaoloAngeli, @ReibergerThomas, @salvatore_piano, et al.
#liverx #livertwitter -
EASLnews
@EASLnews
Which of the upcoming EASL Schools would you attend?🤔
Apply by 28 September: easl.eu/events/easl-courses-schools-masterclasses/
#liverx #livertwitter -
EASLnews
@EASLnews
🎗️Register and submit your abstract to the EASL Liver Cancer Summit 2026, 22-24 January, Edinburgh, UK.
The leading global event for liver cancer research and clinical practice is back.
🔬 Rapid advances in #hcc and #cca are transforming treatment strategies, from immunotherapy and novel systemic therapies to AI-driven diagnostics.
✨ Why attend?
✔️ Learn the latest on primary liver cancer science and care
✔️ Connect with global experts in a dynamic, collaborative setting
✔️ Gain fresh insights into trials, guidelines, and personalised treatment
Join the global liver cancer community and shape the future of patient care.
👉21 October: Abstract submission
👉28 October: Early Fee Registration
easl.eu/event/liver-cancer-summit-2026/
@IreneBargellini @DJPinato @PinterMatthias @EASLedu @DebbieShawcros1 @analleoThis media couldn't be displayed. See it on the original post. -
EASLnews
@EASLnews
EASL is deeply saddened to share the news of the passing of Professor Michael P. Manns (1951–2025).
A visionary leader in hepatology, Professor Manns shaped the field through his pioneering research in viral hepatitis, autoimmune liver diseases, transplantation and regenerative medicine. He served as Director of the Department of Gastroenterology, Hepatology and Endocrinology at Hannover Medical School for nearly three decades, and held leading roles in Hep-Net, the German Liver Foundation, UEG, and EASL.
His scientific excellence, dedication and mentorship inspired colleagues around the world. Professor Manns received numerous awards, including the EASL Recognition Award (2007) and the UEG Lifetime Achievement Award (2022).
EASL extends heartfelt condolences to his family, friends and colleagues. His legacy will continue to inspire generations of hepatologists. -
EASLnews
@EASLnews
Today’s #readoftheweek📚highlights the importance of the biomarkers phosphatidylethanol and ethyl glucuronide, and their ability in detecting any alcohol use and rule out increased alcohol use in patients with alcohol-related #cirrhosis.
Read here this @JHEP_Reports article: www.jhep-reports.eu/article/S2589-5559(25)00110-7/fulltext
🙏 @Tom__gevers et al.
#livertwitter #liverx -
EASLnews
@EASLnews
There are currently two open positions to join the EASL Governing Board! We're looking for:
One EASL Internal Affairs Councillor who will support the strategic direction and operational excellence of the Association internally through member engagement, governance, and sustainability.
One EASL External Affairs Councillor who will advance EASL’s external strategic objectives through partnerships, outreach, and visibility in the broader medical and scientific communities.
Is this you? Or do you know someone who would be a great fit? 🔍
Read more and apply by 14 September on easl.eu/news/call-for-applications-easl-internal-affairs-…
#livertwitter #liverx -
EASLnews
@EASLnews
🌟 Registration and abstract submission now open for the EASL SLD Summit 2026!
📅 26–28 February
📍 Budapest, Hungary
Explore the latest science and clinical advances in Steatotic Liver Disease (MASLD, MetALD, ALD). The EASL SLD Summit will cover the latest in AI-powered diagnostics, omics technologies, organoid research, and innovative therapies, alongside vital public health discussions. Join the conversation shaping the future of SLD care.
Key Deadlines:
📌Abstract submission: 11 August – 4 November 2025
📌Early registration: 11 August – 18 November 2025
👉Secure your spot & send in your research: easl.eu/event/easl-sld-summit-2026/
@rabataller @WillAlazawi @AnnaAlisi @DebbieShawcros1 @analleo -
EASLnews
@EASLnews
🌟 Registration and abstract submission now open for the EASL Liver Cancer Summit 2026! 🌟
🗓️ 22–24 January 2026
📍 Edinburgh, UK
Join the global liver cancer community for three transformative days of science, innovation, and collaboration. The EASL Liver Cancer Summit is the meeting for everyone involved in the care, research, and advocacy of liver cancer.
Key Deadlines:
📌 Abstract submission: 11 August – 21 October 2025
📌 Early registration: 11 August – 28 October 2025
👉Secure your spot & send in your research: easl.eu/event/liver-cancer-summit-2026/
@DebbieShawcros1 @analleo @DJPinato @BargelliniIrene @PinterMatthias -
EASLnews
@EASLnews
This study from the @EdinburghUni in today’s #readoftheweek📚 shows that neutrophil functions contribute to both hepatic damage in early stages and repair in late stage of APAP-ALI, clarifying previous studies.
👉Read here this JHEP Reports article: www.jhep-reports.eu/article/S2589-5559(25)00094-1/fulltext
@LaraCampana1, @LiverStark205, @CalumTRobb, @A_G_Rossi et al.
#liverx #livertwitter -
EASLnews
@EASLnews
Make education your priority with the EASL Schools 2026!
Choose from three clinical schools and one basic science school — and apply today!
🗓️Deadline: 28 September
🔗 easl.eu/events/easl-courses-schools-masterclasses/
#liverx #livertwitter -
EASLnews
@EASLnews
In today’s #readoftheweek📚, learn about the utility of patient-derived tumour organoids established from minimal growth factor-reduced media in many facets of precision oncology advancements.
Read here this @JHEP_Reports article: www.jhep-reports.eu/article/S2589-5559(25)00103-X/fulltext
#livertwitter #liverx -
EASLnews
@EASLnews
We are currently looking for two new members to join the EASL Governing Board:
One EASL Internal Affairs Councillor who will support the strategic direction and operational excellence of the Association internally through member engagement, governance, and sustainability.
One EASL External Affairs Councillor who will advance EASL’s external strategic objectives through partnerships, outreach, and visibility in the broader medical and scientific communities.
Read more and apply by 14 September on easl.eu/news/call-for-applications-easl-internal-affairs-…
@aelsharkawy75 @fprusso73
#livertwitter #liverx -
EASLnews reposted
Ahmed Elsharkawy
@aelsharkawy75
#worldhepatitisday is a good reminder to us all of the work that still needs to be done to achieve viral elimination and prevent people from dying of preventable disease. Together we are stronger 💪🏽💪🏽 @HepBFoundation @Hep_Alliance @EASLnews
Liver UK
@LiverUK_charity
🌍 Today is #worldhepatitisday — a global call to eliminate viral hepatitis. In the UK, urgent action is needed to find & support those with hepatitis B.
🔗 Learn more: britishlivertrust.org.uk/hepatitis-b-breaking-the-silence/
On all types of viral hepatitis:
👉 liveruk.org/about-liver-disease/conditions/?dfg_page=1&df… -
EASLnews reposted
EHC_Haemophilia
@EHC_Haemophilia
📣 Together, we can eliminate viral hepatitis by 2030—but policy changes are essential.
On #worldhepatitisday, EHC supports @EASLnews urging policymakers to expand access to testing, care & vaccination.
👉 worldhepatitisday.org
#policyaction #hepatitiselimination -
EASLnews
@EASLnews
📢Today EASL celebrates #worldhepatitisday 2025 and the @hep_alliance campaign “Let’s break it down”!
Listen to an EASL Policy Dialogue where two expert voices came together to unpack the urgent challenge of hepatitis and the bold initiatives driving its elimination.
In this powerful discussion, they explore:
- The stigma and discrimination faced by people living with hepatitis
- How these issues shape advocacy efforts across the EU
- What the future holds for national hepatitis elimination strategies
👉 Stay informed:
easlcampus.eu/videos/easl-policy-dialogues-s3-e4-inspirin…
👉 Visit the campaign website and get involved: www.worldhepatitisday.org/take-action/
@Hep_Alliance @EHC_Haemophilia @EASLedu @EuropeLiver @DebbieShawcros1 @SagiZelber -
EASLnews
@EASLnews
🌍 More than 1 million lives are lost each year to viral hepatitis — and the number is still rising. But with early testing, diagnosis and care, we can change the trajectory.
🦠 Over 250 million people live with chronic hepatitis B. It’s a leading cause of cirrhosis and liver cancer — yet many remain undiagnosed.
📘 The updated EASL Clinical Practice Guidelines on HBV offer essential, evidence-based tools for improving care across all settings. From simplified algorithms and vaccination to antiviral therapy and risk stratification, these guidelines support the global goal of HBV elimination.
📢 This #worldhepatitisday, join us in raising awareness, promoting early testing and empowering healthcare providers with the latest in management.
👉 Read the guidelines here: www.journal-of-hepatology.eu/article/S0168-8278(25)00174-…
👉 Visit the campaign website: www.worldhepatitisday.org/take-action/
@hep_alliance @EASLEdu @EHC_Haemophilia @EuropeLiver @DebbieShawcros1 @SagiZelber -
EASLnews reposted
Decision4Liver
@Decision4Liver
Today is #worldhepatitisday! We spotlight two DECISION partners deeply committed to #liverhealth:
🔬 @EASLnews – advancing #hepatology research
🧡 @EuropeLiver – amplifying the voice of liver patients
Together, we work toward a healthier future beyond ACLF.
#cirrhosis -
EASLnews reposted
EHC_Haemophilia
@EHC_Haemophilia
🌍 1M+ lives lost yearly to viral hepatitis, but early testing can change this trajectory.
🩸 EHC marks #worldhepatitisday recognising liver health for #bleedingdisorders.
📘 Read the @EASLnews Clinical Practice Guidelines on #hbv👉 www.journal-of-hepatology.eu/article/S0168-8278(25)00174-… -
EASLnews
@EASLnews
EASL Members, applications for the 2026 EASL Schools are now open!
Discover the four schools, choose the one you're most interested in, and apply by 28 September!
easl.eu/events/easl-courses-schools-masterclasses/
#livertwitter #liverx -
EASLnews
@EASLnews
Today is #worldhepatitisday 2025!
EASL stands alongside WHO, the World Hepatitis Alliance, and European hepatology societies in marking this important day with the campaign “Let’s break it down”.
🌍 Join us in amplifying a single global message: Take action. Get tested. End hepatitis stigma.
👉 Visit the campaign website and get involved: www.worldhepatitisday.org/take-action/
@hep_alliance @EASLEdu @EHC_Haemophilia @EuropeLiver @SagiZelber @DebbieShawcros1 -
EASLnews
@EASLnews
🚨 Alcohol is still hiding in plain sight as one of Europe's biggest public health threats.
🍺 1 in 4 deaths among young Europeans is caused by alcohol.
🚫 Yet we have proven tools to prevent this.
At #easlcongress 2025, @WHO_Europe and EASL launched the European Health Alliance on Alcohol: a coalition to put public health before profit.
Read the full article in the latest @CPME_EU Magazine and join the movement to shift from cure to prevention. 👉www.cpme.eu/api/documents/adopted/2025/07/cpme_magazine_s…
@DebbieShawcros1 @SagiZelber @josewillemse @mathisheydtmann @EASLedu -
EASLnews
@EASLnews
The authors of today’s #readoftheweek📚 discuss the use of invasive coronary angiography in #livertransplant candidates.
Read here this @JHEP_Reports article: www.jhep-reports.eu/article/S2589-5559(25)00105-3/fulltext
🙏@Giulia76907046, @sbrugaletta, @AnderRegueiro, @ColmeneroJordi, @goncrespo1 et al.
#liverx #livertwitter -
EASLnews reposted
World Hepatitis Alliance
@Hep_Alliance
What's it like living with hepatitis? 🤔
Like many others, you may have hepatitis but not know it.
This #worldhepatitisday, let’s break the stigma and debunk the myths around hepatitis.
Get the facts. Get tested for hepatitis. It could save your life.
Download and share our campaign film: www.worldhepatitisday.org/wp-content/uploads/2025/07/WHA-… -
EASLnews
@EASLnews
The 2025 EASL #sldsummit content is now available on demand is now accessible on demand for all users with a MyEASL account.
Re-discover the sessions and ePosters on EASL Campus!
🔗 easlcampus.eu/list-search-taxonomy-sub/515
#liverx #livertwitter -
EASLnews reposted
Elsevier News
@ElsevierNews
Study in @jhepatology reports unprecedented 5-year survival in unresectable hepatocellular carcinoma, a milestone poised to reshape clinical practice and future treatment decisions. www.elsevier.com/about/press-releases/clinical-breakthrou…
#livercancer #oncology #hepatology
@LorenzaRimassa
@GABOUALFA
@EASLnews -
EASLnews
@EASLnews
🍷🚫The European Health Alliance on Alcohol (EHAA), representing 1.2 million health professionals across Europe, has submitted a formal letter of support for Ireland’s alcohol labelling regulations, set to take effect in May 2026.
This evidence-based policy is critical for reducing alcohol-related harm, ensuring consumer health literacy, and safeguarding public trust.
We call on the Irish Government to resist commercial pressure and implement this measure without delay.
👉Read the full letter: easl.eu/wp-content/uploads/2025/07/EHAA-Letter-to-Ministe…
👉 Learn more about the EHAA: www.who.int/europe/news/item/08-05-2025-european-health-a…
#publichealth #alcoholawareness #cancerprevention #ehaa #righttoknow
@DebbieShawcros1 @ShiraZelbe31142 @WHO_Europe @ESPGHANSociety @my_ueg @EuropeanCancer @escardio @EASLedu -
EASLnews
@EASLnews
What are the latest and concrete recommendations for the clinical application of AI in hepatology?🤖
Read now this position paper from the EASL AI Task Force from @JHepatology: easl.eu/news/new-publication-from-the-easl-ai-task-force/
#liverx #livertwitter
@JClusmann @C_V_Schneider @tpseraphin @tom_luedde @tom_marjot @AshleySpannMD @DebbieShawcros1 @SaSi_Lens @etrepo @jnkath -
EASLnews reposted
Frontline Gastro
@FrontGastro_BMJ
🗣️ Stigma in liver disease isn’t just harmful—it’s a barrier to care.
It fuels shame, delays diagnosis, limits engagement, and reinforces damaging stereotypes.
Sharrock et al. call for a fundamental shift in how we talk about liver disease—placing empathy, equity, and evidence at the centre.
📖 doi.org/10.1136/flgastro-2025-103223
#livertwitter #hepatology #gastroenterology #healthequity #stigma #fgadvocacy #patientvoice #medtwitter #publichealth #nafld #alcoholharm
@PhilSmithIsBack @OTavabie @dr_aditi_kumar @TrevorTabone @eathar_s @IrenePerezMD @KGananandan @zare_benjamin @medicalreg @dtleiberman @BASLedu @BSGtrainees @WorldGastroOrg @ulstergastro @SEEDendoscopia @EASLedu @AmCollegeGastro @Aegastro @SAGES_updates @UHSEndoscopy @WAGE_media @EASLnews @my_ueg @livernursing -
EASLnews
@EASLnews
EASL joins the global hepatology community in mourning the passing of Prof. Jaime Bosch, a visionary clinician-scientist, educator, and leader whose legacy has shaped our field over the past five decades.
From pioneering research in portal hypertension to mentoring generations of hepatologists, Prof. Bosch's contributions have advanced liver care worldwide.
We extend our deepest condolences to his family, friends, and colleagues.
easl.eu/news/tribute-jaime-bosch/
@DebbieShawcros1 -
EASLnews
@EASLnews
🆕We are excited to announce the launch of the new Fellowship Programme!
Are you looking to grow your skills and connect with peers across Europe? Do you want to advance your research in liver disease?
Discover our two fellowship types and apply by 1 September 2025!
🔗 easl.eu/fellowship/mobility-research-fellowship-programme/
#livertwitter #liverx -
EASLnews
@EASLnews
Last chance to apply for the EASL-@AASLDtweets Masterclass!
This is a key opportunity to sharpen your leadership, communication & career skills! From mentorship to publishing, negotiation to networking — prepare to thrive in academic & clinical life.
❗Application deadline: this Sunday, 13 July 23:59 CEST
Discover the programme and apply on easl.eu/event/easl-aasld-masterclass-2025/
#liverx #livertwitter -
EASLnews reposted
massimo iavarone
@massimoiava
It's been a while since I last posted on X, but I think this is a great opportunity: the @EASLedu and @AASLDtweets Masterclass is a chance to learn about the latest developments in the field of #liverx disease. Only a few days left to register! @EASLnews
EASLnews
@EASLnews
You asked for more time to complete your application for the EASL–AASLD Masterclass 2025 — and we’re giving it to you.
🗓️ The new deadline is 13 July 2025!
Take this extra time to perfect your application and get ready for an unforgettable learning experience!
🔗 easl.eu/event/easl-aasld-masterclass-2025/
#livertwitter #liverx -
EASLnews reposted
Ahmed Elsharkawy
@aelsharkawy75
This is a fantastic opportunity to connect with colleagues from across the pond and spend a few days thinking about how to develop your career with mentoring from experienced international experts. I am yet to meet an attendee who does not rave about it. Please consider applying!
EASLnews
@EASLnews
You asked for more time to complete your application for the EASL–AASLD Masterclass 2025 — and we’re giving it to you.
🗓️ The new deadline is 13 July 2025!
Take this extra time to perfect your application and get ready for an unforgettable learning experience!
🔗 easl.eu/event/easl-aasld-masterclass-2025/
#livertwitter #liverx -
EASLnews
@EASLnews
🎙️Our media partners at @touchIMMUNOLOGY have published an insightful interview with EASL Secretary General, Professor @DebbieShawcros1 .
In this piece, Professor Shawcross discusses the pressing challenges facing hepatology in Europe, from early diagnosis and equitable access to care to managing complex liver diseases. She also shares how EASL is driving change through education, research and advocacy, ensuring innovation translates into better patient outcomes.
👉 Read the full article and discover how EASL is working to improve liver health across Europe: touchimmunology.com/insight/easls-approach-to-liver-disea… -
EASLnews
@EASLnews
In today’s #readoftheweek📚 from @karolinskainst, learn how paediatric obesity enhances the risk in individuals who had alcohol use disorders during adolescence or young adulthood.
Read here this @JHEP_Reports article: www.jhep-reports.eu/article/S2589-5559(25)00102-8/fulltext
#liverx #livertwitter -
EASLnews
@EASLnews
🚨 Applications now open! 🚨
Do you have lived experience with steatotic liver disease or advocate for those who do? Are you passionate about changing the future of liver health?
Apply now for the Dr. Stephen A. Harrison Patient Advocacy Fellowship, a programme supporting and training patient advocates across the UK, North America, and the EU.
🧬 Whether you're living with MASLD, MASH, ALD, or MetALD , or advocating on behalf of those who are, this Fellowship is for you.
👥 Who should apply?
✅ Individuals with lived experience
✅ Patient advocates (new or experienced)
✅ Caregivers, care partners & community leaders
💡 What fellows receive:
Expert training, mentorship, and support to engage in scientific meetings, clinical panels, and public policy work.
🗓️ Deadline: July 14, 2025
🔗 Learn more & apply at www.harrisonfellows.org
👉Read more: easl.eu/wp-content/uploads/2025/07/Harrison-Fellowship-Pr…
@SagiZelber @josewillemse @DebbieShawcros1 -
EASLnews
@EASLnews
How well do you know your EASL Clinical Practice Guidelines on the management of extrahepatic cholangiocarcinoma?
Test yourself now with this new #easlquiz!
🎮 easlcampus.eu/quiz/question/q125
#liverx #livertwitter -
EASLnews
@EASLnews
In today’s #readoftheweek📚, learn how METS-IR and SPISE are effective, non-invasive markers for predicting pediatric #masld, which offer valuable tools for early detection and improved clinical management.
Read here this @JHEP_Reports article: www.jhep-reports.eu/article/S2589-5559(25)00096-5/fulltext
@yonsei_u @Yonsei_TGIL
#liverx #livertwitter -
EASLnews
@EASLnews
🧠New EASL Policy Dialogue! Mind & Liver: Bridging the Gap Between Mental and Liver Health
Mental and liver health are deeply connected, yet they are often treated separately.
In this newly released episode, Dr. Victoria Kronsten, Kings College tells us about the hidden mental health challenges people with liver disease face, the overlap in symptoms, and the urgent need for integrated care.
🫂 How can we better support mental health in people living with liver disease? Find out by watching now. easlcampus.eu/videos/easl-policy-dialogues-s4-e4
The EASL Policy Dialogues Season 4 is supported by Novo Nordisk. EASL has received no input from Novo Nordisk with regards to the content of the EASL Policy Dialogues Season 4.
@EASLedu @vtkronsten @SagiZelber -
EASLnews reposted
EASL Education
@EASLedu
🚨 New #readoftheweek on the prognostic value of residual ascites post-TIPS
👉Cohort: 292 patients with cirrhosis, stratified by #ascites grade at 3 months (36% none; 28% minimal; 36% mod/sev)
👉 Minimal ascites independently predicted:
🔎further decompensation (aSHR 1.76; p=0.026)
🔎transplant-free mortality (aSHR 1.73; p=0.030)
👉Moderate/severe ascites conferred the worst transplant-free survival
📖 More info below 👇
@Jhepatology @RautouE @Apichatka @Yujun__Wong
#tips #liverx
EASLnews
@EASLnews
The authors in today’s #readoftheweek📚 evaluated the prognostic relevance of residual ascites grades in patients with advanced chronic liver disease after #tips placement.
Read here this @JHEP_Reports article: www.jhep-reports.eu/article/S2589-5559(25)00011-4/fulltext
🙏 @hartl_md, @mathiasjachs, @tiede_anja, @ninadominik, @HeinerWedemeyer, @MattiasMandorf1, @b_maasoumy, @ReibergerThomas, et al.
#livertwitter #liverx -
EASLnews
@EASLnews
This week's EASL DeepDive is now available on demand! The faculty examined how to apply non-invasive tests for screening and risk assessment, and explore strategies for #hcc surveillance in patients with #masld.
Watch here: easlcampus.eu/deepdive/diagnosis-non-invasive-screening-a…
#livertwitter -
EASLnews reposted
Debbie Shawcross
@DebbieShawcros1
My 1st @EASLnews Governing Board as Secretary General! We started off day 1 with a Retreat facilitated by the amazing #64millionartists
I am so proud to be working with such an incredible team who are the best of the best and to call EASL my home for the next 2 yrs #livertwitter -
EASLnews
@EASLnews
The authors in today’s #readoftheweek📚 evaluated the prognostic relevance of residual ascites grades in patients with advanced chronic liver disease after #tips placement.
Read here this @JHEP_Reports article: www.jhep-reports.eu/article/S2589-5559(25)00011-4/fulltext
🙏 @hartl_md, @mathiasjachs, @tiede_anja, @ninadominik, @HeinerWedemeyer, @MattiasMandorf1, @b_maasoumy, @ReibergerThomas, et al.
#livertwitter #liverx -
EASLnews
@EASLnews
New #easlquiz is out!
Test your guidelines knowledge on Wilson’s Disease with this new Quiz, as we examine the case of a 32-year-old lean women who has long standing vague symptoms of fatigue and right upper quadrant discomfort.
Play now: easlcampus.eu/quiz/question/q124
#livertwitter #liverx -
EASLnews reposted
JHEP Reports
@JHEP_Reports
🎉Our new Impact Factor is 7.5!
We are firmly among the top journals in hepatology👏
Thank you to our authors, reviewers & readers!🙏
#livertwitter
@EASLedu
@EASLnews -
EASLnews
@EASLnews
⭐️Help shape #easlcongress 2026!
We’re calling on clinicians, researchers, nurses, AHPs, public health experts, and patient representatives to share your insights in a short survey.
❓What are the most pressing issues in liver health? Where are the key knowledge gaps? What emerging topics deserve greater attention?
Your insights will help us build a congress that is relevant, inclusive, and impactful for all.
📢 Take the SCOPE survey now: www.surveymonkey.com/r/6F9BRBD
🏆If you share your email, you’ll be entered to win a free registration to #easlcongress 2026! -
EASLnews
@EASLnews
Register now for the EASL DeepDive on #masld, taking place this Wednesday 18:00 CEST!
Our faculty will discuss the concept/definition of MASLD within the framework of the new SLD nomenclature, including its contribution to disease progression in other diseases.
🔗 easl-eu.zoom.us/webinar/register/WN_VAL3KOPYSUGw7hlukWCGdQ
#livertwitter #liverx -
EASLnews
@EASLnews
You asked for more time to complete your application for the EASL–AASLD Masterclass 2025 — and we’re giving it to you.
🗓️ The new deadline is 13 July 2025!
Take this extra time to perfect your application and get ready for an unforgettable learning experience!
🔗 easl.eu/event/easl-aasld-masterclass-2025/
#livertwitter #liverx -
EASLnews reposted
EASL Education
@EASLedu
That’s a wrap! 🎬
2 days of learning and networking at the #easlschools dedicated to liver disease in pregnancy at @imperialcollege 🤰 and liver critical care at @RoyalFreeNHS 🏥.
Huge thanks to the amazing faculty, organisers, and students 🙌
@EASLnews #liverx @DebbieShawcros1 @FrancqueSven -
EASLnews reposted
EASL Education
@EASLedu
➡️ State-of-the-art lecture by Prof @RajivJalan1 on understanding the syndrome of #aclf.
Followed by an insightful Q&A session at the #easlschool! 🇬🇧
@EASLnews #liverx @RoyalFreeNHS @DebbieShawcros1 @FrancqueSven -
EASLnews reposted
EASL Education
@EASLedu
Time to put learning into practice! 🧠💡
Students are now working on clinical cases, guided by a fantastic team of experts at the #easlschool on the management of liver disease in pregnancy 🤰@imperialcollege 🇬🇧
#liverx @EASLnews @DebbieShawcros1 @FrancqueSven -
EASLnews reposted
EASL Education
@EASLedu
Prof. Julia Wendon delivers a state-of-the-art lecture on extracorporeal liver support in the liver ICU ➡️ on Day 2 of #easlschool.
Cutting-edge insights from one of the leading experts in the field! 🙌
@EASLnews @DebbieShawcros1 @FrancqueSven @RoyalFreeNHS -
EASLnews
@EASLnews
📃We are proud to announce the 2024 Impact Factors for our journals:
🔵 Journal of Hepatology reaches a record 33.0, confirming its place as the leading journal in hepatology.
🟣 JHEP Reports achieves an impact factor of 7.5, firmly establishing itself among top publications in the field.
👏 A huge thank you to our editorial boards, peer reviewers and the global research community for their trust, dedication and contributions!
📚 Together, we continue advancing liver research and scientific excellence worldwide.
Read the article here: easl.eu/news/impact-factors-2024/
@JHepatology @JHEP_Reports @DebbieShawcros1 @analleo -
EASLnews
@EASLnews
Catch up on this week's #easlstudio and find out what's new in the recently published CPGs on vascular liver diseases!
🔗 easlcampus.eu/videos/easl-studio-s8-e15
@RautouE #livertwitter #liverx -
EASLnews reposted
EASL Education
@EASLedu
🚨 New #readoftheweek 🚨
Targeting DHCR7 could offer a new strategy to halt progression of #metald and prevent #hcc.
✅ Inhibition reduced steatosis, inflammation, fibrosis & tumour growth in vivo
✅ Validated in 3D human liver spheroids (incl. HCC)
💡 A translational target for alcohol & metabolic liver cancer therapy.
🔗Find out more in the post below, #liverx👇
@JesusMBanales @RuiCastroHD @Apichatka
EASLnews
@EASLnews
In today’s #readoftheweek📚 discover how targeting DHCR7 can become a strategy for the treatment of #metald and #hcc.
Read this @JHEP_Reports article: www.jhep-reports.eu/article/S2589-5559(25)00092-8/fulltext
@UCSanDiego #livertwitter #liverx -
EASLnews
@EASLnews
In today’s #readoftheweek📚 discover how targeting DHCR7 can become a strategy for the treatment of #metald and #hcc.
Read this @JHEP_Reports article: www.jhep-reports.eu/article/S2589-5559(25)00092-8/fulltext
@UCSanDiego #livertwitter #liverx -
EASLnews reposted
LiverAim
@LiverAim
🚀Launching the #liverriskscore app!
📱A simple digital tool to spot liver disease risk early using routine clinical data! Easy to use, built for everyday care.
🔗iOS: apps.apple.com/us/app/liverrisk-score/id6742401340
🔗Android play.google.com/store/apps/details?id=com.liverriskscore.…
@IHIEurope @EASLnews -
EASLnews reposted
EASL Education
@EASLedu
Portal Vein Thrombosis (PVT) in cirrhosis, what do we know?
👉#masld is a leading cause of #pvt
👉#cirrhosis increases PVT risk, regardless of aetiology
👉Risk persists despite treatment in some cases (e.g. HCV)
@Jhepatology @EASLNews @RautouE @jcgarciapagan @BavenoCoop @DebbieShawcros1
#easlstudio #liverx -
EASLnews reposted
EASL Education
@EASLedu
Should we treat all cirrhosis patients with anticoagulants to prevent PVT?
Not yet, evidence is limited.
➡️ Some studies (Rivaroxaban, Enoxaparin) suggest benefit
➡️ Potential to reduce complications & decompensation
But more data is needed before a general recommendation.
@Jhepatology @EASLNews @RautouE @jcgarciapagan @BavenoCoop @DebbieShawcros1
#easlstudio #liverx -
EASLnews reposted
EASL Education
@EASLedu
Should we screen for thrombosis risk factors in cirrhosis?
NO.
🔹Studies show no added PVT risk from inherited thrombophilia
🔹PVT in cirrhosis is more linked to low portal inflow & local wall stress
➡️ Thrombophilia screening not routinely recommended.
@Jhepatology @EASLNews @RautouE @jcgarciapagan @BavenoCoop @DebbieShawcros1
#easlstudio #liverx -
EASLnews reposted
EASL Education
@EASLedu
Who should receive anticoagulation in cirrhosis with PVT?
Liver transplant candidates: Treat progressive PVT
Non-candidates:Treat if >50% lumen occlusion
<50%: Consider surveillance or treatment on a case-by-case basis
⚖️ Decision based on extent, progression, and transplant candidacy.
@Jhepatology @EASLNews @RautouE @jcgarciapagan @BavenoCoop @DebbieShawcros1
#easlstudio #liverx -
EASLnews
@EASLnews
Tune in tonight 18:00 CEST for the #easlstudio episode on the vascular liver disease CPGs!
Learn all about the key challenges in vascular complications of liver disease, including the management of portal vein thrombosis (PVT) in patients with and without cirrhosis.
🔗 easl.eu/easl-studio-episode/s8e15/
#livertwitter #liverx -
EASLnews reposted
Tom Hemming Karlsen
@tomhemmingk
Impact factors as of 2025 have been released. Proud to be part of the editors team of @EASLnews @JHepatology - standing on the shoulders of efforts by @ProfPaoloAngeli over the past 5 years.
-
EASLnews reposted
Journal of Hepatology
@JHepatology
📢Our new Impact Factor is 33.0🎉
🥇Ranking number 1 in the Hepatology field once again!
👏Thanks to the Editorial Team, untiring peer reviewers & very innovative authors❕
@EASLnews
@EASLedu
#livertwitter -
EASLnews reposted
EASL Education
@EASLedu
#liverx, are you ready for the #easlstudio season 8 finale tomorrow?
We’ll be exploring the upcoming EASL Clinical Practice Guidelines on vascular liver diseases.
▶️ PVT in cirrhosis & non-cirrhosis
▶️ DOACs, TIPS & CIRROXABAN insights
▶️ Splanchnic artery aneurysms
@Jhepatology @EASLNews @RautouE @jcgarciapagan @BavenoCoop @DebbieShawcros1 -
EASLnews
@EASLnews
Register now for next week's #easldeepdive on #masld!
Learn about the role of non-invasive tests for risk stratification in MASLD, their pro- and cons, and how and in whom to use them for screening/case finding 🔍
🗓️ Wednesday 25 June, 18:00 CEST
🔗 easl-eu.zoom.us/webinar/register/WN_VAL3KOPYSUGw7hlukWCGdQ
#livertwitter #liverx @lucavalenti75 @lmiele74 -
EASLnews
@EASLnews
This Wednesday, don't miss the final episode of #easlstudio season 8!
Faculty @RautouE, Sarwa Darwish Murad, Juan-Carlos Garcia-Pagan and Valérie Vilgrain are looking forward to an interesting discussion around the recently published EASL CPGs on vascular liver diseases.
🔗 easl.eu/easl-studio-episode/s8e15/
#livertwitter #liverx -
EASLnews
@EASLnews
📢 New in The Lancet Gastroenterology & Hepatology: a timely and urgent opinion piece calls on European policymakers to confront the continent’s unsustainable burden of alcohol-related harms.
🔍 The article features the European Health Alliance on Alcohol, launched during #easlcongress, a new coalition advocating for stronger policies to reduce alcohol-related liver disease, cancer, injuries and social harm. It highlights the worrying disconnect between public perception and clinical evidence, especially around the alcohol–cancer link.
🗣️ Frank Murray, member of the EASL PPHA Committee, says:
“We need to move beyond awareness and into action. The evidence is clear, and the time for political courage is now.”
🚨With 80 lives lost to alcohol every hour in Europe, the need for action is urgent.
👉Read it here: www.thelancet.com/action/showPdf?pii=S2468-1253(25)00165-7
@DebbieShawcros1 @LancetGastroHep @SagiZelber @josewillemse -
EASLnews
@EASLnews
Final call to join the EASL Scientific Committee!
We are looking for a candidate with a strong scientific track record in Immune-mediated and Cholestatic Diseases. Is this you? Or, do you know someone? 🔍
Read more any apply by tomorrow, 15 June, 23:59 CEST on: easl.eu/news/scientific-committee-2025/
#livertwitter #liverx -
EASLnews
@EASLnews
The week's #easlstudio episode on steatotic liver disease is now available on demand on #easlcampus!
Catch up here: easlcampus.eu/videos/easl-studio-s8-e14
#livertwitter #liverx -
EASLnews
@EASLnews
This week's #easldeepdive on the pathophysiology and clinical progression of #masld is now available on demand!
Watch here: easlcampus.eu/deepdive/addressing-unmet-needs-and-definin…
#livertwitter #liverx @gbaffy @FrancqueSven @ReibergerThomas -
EASLnews
@EASLnews
The authors of today’s #readoftheweek📚 investigate p53 activity throughout #mash development, with implications for disease prevention.
Read here this @JHEP_Reports article: www.jhep-reports.eu/article/S2589-5559(25)00074-6/fulltext
#livertwitter #liverx -
EASLnews
@EASLnews
Today's EASL Studio episode will focus on integrating cardiometabolic risk profiling and dynamic alcohol consumption assessment.
🗓️ Today, Wednesday 11 June, 18:00 CEST
🔗 easl.eu/easl-studio-episode/s8e14/
@AleksanderKrag @ArunJSanyalVCU #livertwitter #liverx -
EASLnews reposted
EASLDHILIconsortium
@easldhili
🆕Seminar! 😊#nanotechnology
🗓️Wednesday, 18th June 2025
🕟 4:30 pm (CEST) with 𝐃𝐫. 𝐈𝐬𝐚𝐛𝐞𝐥 𝐆𝐚𝐫𝐜í𝐚 𝐌𝐚𝐫𝐭í𝐧
♾ Register here: us06web.zoom.us/meeting/register/3zUSYDT5RXCPXUl6WsthLQ
@lilydaramd @EASLnews @_ibima @DigestivoHuvv -
EASLnews
@EASLnews
A new #easlquiz in collaboration with @ESPGHANSociety is out! Test your knowledge on congenital portosystemic shunt with this interesting case of a 23 year old male patient.
🎮: easlcampus.eu/quiz/question/q123
#livertwitter #liverx -
EASLnews reposted
EASL Education
@EASLedu
🔴LIVE tonight! 🔴
Experts examine integration of cardiometabolic profiling and dynamic alcohol consumption assessment into diagnostic algorithms for steatotic liver disease.
Don't miss it:
🗓️Wednesday, June 11 at 18:00 CEST
🔗easl.eu/easl-studio-episode/s8e14/
@DebbieShawcros1
#easlstudio #liverx #sld
EASLnews
@EASLnews
This week's EASL Studio episode will explore state-of-the-art practices in diagnosing steatotic liver disease and stratifying patients effectively for targeted treatment in 2025.
🗓️ Wednesday 11 June, 18:00 CEST
🔗 easl.eu/easl-studio-episode/s8e14/
@AleksanderKrag @ArunJSanyalVCU #livertwitter #liverx -
EASLnews
@EASLnews
In tonight's #easldeepdive, learn all about the pathophysiology and clinical progression of #masld.
Key topics include:
🔑Unmet Clinical Needs
🔑Valuable clinical endpoints
🔑Emerging therapies to improve patient care
You can still register! easl-eu.zoom.us/webinar/register/WN_IPMF4um6Q7ubuoSr2GgurA
@gbaffy @FrancqueSven @ReibergerThomas #livertwitter #liverx -
EASLnews
@EASLnews
🏆Barbora Smolkova, PhD, is a doctoral researcher at the Department of Paediatric Research at Oslo University Hospital, where she focuses on the cellular mechanisms of genetic liver diseases. Her work, which combines stem cell technologies and liver organoid models, recently earned her the prestigious Daniel Alagille Award 2025 at #easlcongress. In this interview, Barbora shares insights into her academic background, the inspiration behind her work in hepatology, and her ongoing efforts to better understand and ultimately treat rare cholestatic disorders like Aagenaes syndrome.
👉Read the article here: easl.eu/news/2025-easl-daniel-alagille-awardee/
@BorkaSmolka @DebbieShawcros1 -
EASLnews
@EASLnews
This week's EASL Studio episode will explore state-of-the-art practices in diagnosing steatotic liver disease and stratifying patients effectively for targeted treatment in 2025.
🗓️ Wednesday 11 June, 18:00 CEST
🔗 easl.eu/easl-studio-episode/s8e14/
@AleksanderKrag @ArunJSanyalVCU #livertwitter #liverx -
EASLnews
@EASLnews
This week's #easlstudio episode on artificial intelligence is now available on demand.
Catch up now on easl.eu/easl-studio-episode/s8e13/
@aelsharkawy75 @jnkath @SaSi_Lens @AshleySpannMD #livertwitter #liverx -
EASLnews
@EASLnews
🚨 New EASL Policy Dialogue:
Breaking Barriers: Improving Access to Harm Reduction & Treatment for Young People
How can we ensure youth across Europe get the alcohol harm reduction support they need? Experts Arianna Rogialli & Joana Moura unpack the challenges—and solutions.
🎥 Watch now: easlcampus.eu/videos/easl-policy-dialogues-s4-e3
#easlpolicydialogue #harmreduction #youthhealth #publichealth #eupolicy #liverx #livertwitter -
EASLnews
@EASLnews
In today’s #readoftheweek📚, learn why odevixibat is effective and safe in reducing sBA levels and improving pruritus in a real-life scenario in both patients with classic PFIC types and in those with other rarer subtypes.
Read here this JHEP Reports article: www.jhep-reports.eu/article/S2589-5559(24)00313-6/fulltext
🙏 @analleo @manunicastro et al.
#livertwitter #liverx -
EASLnews
@EASLnews
Register now for the EASL-AASLD Masterclass, 4-6 December in France!
2 days of intensive training with renowned leaders in hepatology & like-minded peers in the field 🔥
Read more and apply by 10 June: easl.eu/event/easl-aasld-masterclass-2025/
#livertwitter #liverx -
EASLnews reposted
European Liver Patients' Association
@EuropeLiver
🚨 A DEFINING MOMENT FOR LIVER HEALTH IN EUROPE!🚨
🎯 Fatty Liver & NCDs: A European Policy Action”
🏛 Hosted by MEPs Michalis Hadjipantela (EPP, 🇨🇾 Cyprus) & Irena Joveva (Renew, 🇸🇮 Slovenia)
🎤 Opened with a powerful welcome by ELPA President Marko Korenjak
💬 “From silence to visibility. From fragmentation to integration.”
With these words, Marko Korenjak ignited a unified call for change—welcoming patients, policymakers, public health leaders, and experts to the biggest liver policy event ever held in Brussels.
🧬 Fatty Liver Disease affects 1 in 4 adults in Europe and is tightly linked to obesity, diabetes, and cardiovascular disease. Yet it’s still missing from most national and EU-level NCD strategies.
But today, that changes.
🤝 With bold leadership from MEPs, unwavering commitment from ELPA, and strong partnerships with IDF, ECPO, Global Heart Hub, EPHA, and EASL, we are shaping the future of public health policy in Europe.
🔵 This is not just an event—it’s a movement.
It’s time to move from rhetoric to reform.
💪 The liver patient community is here. We are loud. We are united. We are unstoppable.
#fattyliveraction #elpa #markokorenjak #mepsforliverhealth #liverhealthmatters #unitedforliver #fromsilencetoaction #policyforpatients #europeanparliament #ncds #brussels2025 -
EASLnews
@EASLnews
How is artificial intelligence transforming healthcare? 🤖💭
Tune in tonight's #easlstudio episode to find out with faculty @aelsharkawy75, @jnkath, @SaSi_Lens & @AshleySpannMD!
🔗 easl.eu/easl-studio-episode/s8e13/
#livertwitter #liverx -
EASLnews
@EASLnews
Are you interested in building the future of hepatology with us? Do you have a strong scientific track record in Immune-mediated and Cholestatic Diseases?
The EASL Scientific Committee is looking for one new member 🔍
Read more and apply by 15 June (23:59 CEST): easl.eu/news/scientific-committee-2025/
#livertwitter #liverx -
EASLnews
@EASLnews
Ready to rethink #masld care?🤔
Register for next week's #easldeepdive to explore:
🔹 Pathophysiology & progression
🔹 Unmet clinical needs
🔹 Emerging therapies & endpoints
🗓️ 10 June, 18:00 CEST
🔗 easl-eu.zoom.us/webinar/register/WN_IPMF4um6Q7ubuoSr2GgurA
@gbaffy @FrancqueSven @ReibergerThomas… -
EASLnews reposted
Debbie Shawcross
@DebbieShawcros1
Always my favourite @EASLedu meeting of the year ❤️
EASLnews
@EASLnews
Register now for the EASL-AASLD Masterclass, 4-6 December in France, and take your career to the next level 🚀
Read more and apply by 10 June: easl.eu/event/easl-aasld-masterclass-2025/
#livertwitter #liverx -
EASLnews
@EASLnews
📣 Abstract submissions are still open for COLDA 2025! Join us in shaping the agenda for the 8th edition of the Conference on Liver Disease in Africa (COLDA), taking place in Accra, Ghana.
🔬 Have impactful research or insights on liver disease? Submit your abstract and be part of a powerful scientific conversation that drives change across Africa and beyond.
🗓️ Deadline: Friday, 20 June 2025
🌍 Languages accepted: English & French
🔗 Submit now:
👉 English: virology.eventsair.com/colda-2025/abstracts
👉 Français : virology.eventsair.com/colda-2025/abstract-portal-francais
#colda2025 #liverhealth #globalhealth #medicalresearch #africahealth #hepatology #publichealth -
EASLnews
@EASLnews
Join this week's #easlstudio episode to explore how artificial intelligence is transforming healthcare 🤖
Our faculty @aelsharkawy75, @jnkath, @SaSi_Lens & @AshleySpannMD will discuss its potential to revolutionise medical practice, its limitations, and whether it poses a threat or an opportunity for the future of the medical profession.
🗓️ This Wednesday, 4 June 18:00 CEST
🔗 easl.eu/easl-studio-episode/s8e13/
#livertwitter #liverx -
EASLnews
@EASLnews
EASL has released new CPGs on abdominal extrahepatic surgery in patients with cirrhosis and advanced chronic liver disease at #easlcongress—a critical step in improving surgical outcomes for this high-risk population. 🏥🩺
🔍 Why it matters:
As non-hepatic abdominal surgeries become more common in cirrhotic patients, the need for structured, evidence-based perioperative care is urgent. These guidelines offer practical, multidisciplinary strategies to improve care before, during, and after surgery.
👨⚕️👩⚕️ For frontline providers, these CPGs help reduce uncertainty and improve outcomes by bridging surgical and hepatic expertise—promoting better coordination and consistency across diverse healthcare systems.
📲 Available on the EASL Guideline App: Get real-time access to protocols during surgical planning, MDTs, and consultations—wherever care happens.
easl.eu/news/easl-cpgs-extrahepatic-surgery/ -
EASLnews
@EASLnews
This week's #easlstudio episode on Hepatitis B is now available on demand!
Catch up now on easlcampus.eu/videos/easl-studio-s8-e12
@aelsharkawy75 @CornbergMarkus @sitalgoneviral #livertwitter #liverx -
EASLnews
@EASLnews
Register now for the EASL-AASLD Masterclass, 4-6 December in France, and take your career to the next level 🚀
Read more and apply by 10 June: easl.eu/event/easl-aasld-masterclass-2025/
#livertwitter #liverx -
EASLnews
@EASLnews
Tonight's #easlstudio episode will take us to a fascinating discussion around Hepatitis B following the release of the new HBV Guidelines.
Tune in tonight 18:00 CEST on easl.eu/easl-studio-episode/s8e12/
@aelsharkawy75 @CornbergMarkus @sitalgoneviral #livertwitter #liverx -
EASLnews
@EASLnews
How well do you know your EASL Clinical Practice Guidelines on hepatitis delta virus?
Test yourself now with this new #easlquiz, where we take a look at a male individual, 45 years old, who presents to a liver clinic because he was found to have positive HBsAg during blood donation.
🎮 easlcampus.eu/quiz/question/q122
#livertwitter #liverx -
EASLnews
@EASLnews
📢 Released at #easlcongress: The newly updated EASL Clinical Practice Guidelines on Autoimmune Hepatitis (AIH) are here—bringing major changes since the 2015 edition to help standardise and improve care worldwide. 🌍🩺
💡 With clear diagnostic criteria, updated treatment algorithms, and global applicability—even in low-resource settings—these guidelines aim to reduce variability and improve long-term outcomes in AIH.
📲 Now available via the EASL Guideline App 2.0 for easy access at the point of care.
easl.eu/news/easl-cpgs-autoimmune-hepatitis-2025/ -
EASLnews
@EASLnews
Join the EASL Scientific Committee 🔥
We are looking for a candidate with a strong scientific track record in Immune-mediated and Cholestatic Diseases. Is this you? Or, do you know someone? 🔍
Read more and apply by 15 June (23:59 CEST): easl.eu/news/scientific-committee-2025/
#livertwitter #liverx -
EASLnews
@EASLnews
Join the upcoming #easldeepdive to gain a deeper understanding of #masld’s pathophysiology and its progression to advanced liver disease and portal hypertension.
What you'll learn:
🔎 Unmet clinical needs and challenges in current practice
🔎 How to define and apply valuable clinical endpoints
🔎 The latest emerging therapies addressing gaps in patient care
🔗 easl-eu.zoom.us/webinar/register/WN_IPMF4um6Q7ubuoSr2GgurA
@gbaffy @FrancqueSven @ReibergerThomas #livertwitter #liverx -
EASLnews
@EASLnews
With the release of the new HBV guidelines, treatment eligibility broadens 💭
This EASL Studio explores how to communicate these changes, support shared decision-making, ensure adherence, and engage patients in ongoing care and clinical trials.
🗓️ This Wednesday, 28 May 18:00 CEST
🔗 easl.eu/easl-studio-episode/s8e12/
@aelsharkawy75 @CornbergMarkus @sitalgoneviral #livertwitter #liverx -
EASLnews reposted
EASL Education
@EASLedu
🎥 Missed it live? The latest #easlstudio episode is now available on demand!
Explore how to translate the guidelines into practice, with insights on behavioural change, care coordination, and the critical role of nurses.
📺Watch: admin.easlcampus.eu/videos/easl-studio-s8-e11
🎧Listen: easlcampus.eu/podcasts/easl-studio-podcast-s8-e11
@EASLNews @EASDnews @EASOobesity @FrancqueSven @shelley_keating @elenas_george
#liverx
EASL Education
@EASLedu
📢 Happening today on #easlstudio!
We’re focusing on the vital role of nurses and care teams in implementing the new #masld Guidelines.
📅Wednesday 21 May at 18:00 CEST
🔗easl.eu/easl-studio-episode/s8e11/
@EASLNews @EASDnews @EASOobesity @FrancqueSven @elenas_george @shelley_keating @DebbieShawcros1 @Livernursing
#liverx #masldThis media couldn't be displayed. See it on the original post. -
EASLnews
@EASLnews
EASL proudly stands with the European Week Against Cancer #ewac2025 to raise awareness, promote prevention, and fight for a healthier future for all.
Liver cancer is preventable — but two major risks remain under-addressed:
🥗 Overweight & obesity increase the risk of at least 13 cancers, including liver cancer. www.cancer.eu/cancer-prevention-the-european-code-against…
🍷 Alcohol causes at least 7 cancers, including liver cancer — and no amount is safe. www.who.int/europe/news/item/04-01-2023-no-level-of-alcoh…
✅ Choose a balanced diet
✅ Stay physically active
✅ Get screened early
✅ Rethink your relationship with alcohol
Visit the campaign page here and get involved: www.cancer.eu/ewac
@CancerLeagues @DebbieShawcros1 -
EASLnews reposted
EASL Education
@EASLedu
Join experts to explore pathophysiology, clinical gaps, endpoints & emerging therapies in #masld in cirrhosis. 📅 Live Tuesday, 10 May | 18:00 CEST
✒️Register here: easl-eu.zoom.us/webinar/register/WN_IPMF4um6Q7ubuoSr2GgurA
@EASLNews @gbaffy @FrancqueSven @ReibergerThomas
#easldeepdive #liverx -
EASLnews
@EASLnews
This week's #easlstudio episode on the new MASLD Guidelines is now available on demand!
Catch up now on easlcampus.eu/videos/easl-studio-s8-e11
#livertwitter #liverx @FrancqueSven @elenas_george @shelley_keating -
EASLnews
@EASLnews
At #easlcongress, EASL unveiled its latest CPGs for extrahepatic cholangiocarcinoma (eCCA)—offering a much-needed, evidence-based roadmap for this complex malignancy. 🎗️🩺
Highlights include:
✅ Clear anatomical classification
✅ Standardised diagnostics
✅ Precision oncology
✅ Updated treatment regimens
✅ Accessible via the EASL Guideline App 2.0—with interactive tools for real-time clinical use!
This comprehensive update marks a step forward in harmonising care, enhancing diagnostic accuracy, and personalising treatment—ultimately aiming to improve patient outcomes in eCCA.
👉Read the full article from the authors behind the guidelines now. easl.eu/news/easl-cpgs-extrahepatic-cholangiocarcinoma/
@JHepatology @EASLedu -
EASLnews reposted
Joost PH Drenth
@joostphdrenth
Some 850 people were tested for liver disease #easl2025
🆓@fibroscansw at @RAIamsterdam
🎤 Spearhead by @EASLnews own Bart Takkenberg
🇳🇱 You want a free liver test?
📌 www.masld-nl.nl/onderzoek/grip-on-nash/
nltimes.nl/2025/05/11/hundreds-get-free-liver-scans-amste… -
EASLnews
@EASLnews
The authors of today’s #readoftheweek📚 explore how TIPS leads to a sustained reduction of SI and bacterial translocation in patients with decompensated cirrhosis.
Read here this @JHEP_Reports article: www.jhep-reports.eu/article/S2589-5559(24)00312-4/fulltext
🙏@hartl_md @tiede_anja @ninadominik @MattiasMandorf1 @b_maasoumy @ReibergerThomas
#livertwitter #liverx -
EASLnews
@EASLnews
Catch up now on the #easlstudio sessions that took place in Amsterdam at #easlcongress!
11 interactive talks await you now on EASL Campus: easlcampus.eu/search/resources/congress/easl-congress-202…
#livertwitter #liverx -
EASLnews reposted
EASL Education
@EASLedu
What can be done to support #masld care?
✅Promote co-prescription of lifestyle care with pharmacotherapy.
✅Invest in research on practical implementation.
✅Provide clear protocols so practitioners can make care accessible and realistic for patients.
👉Solutions must be simple, time-efficient, and adapted to real-world socioeconomic contexts.
#liverx #easlstudio -
EASLnews
@EASLnews
🎧 NEW EASL Policy Dialogue out now!
Liver cancer is among the deadliest cancers in Europe- and early diagnosis is often missed in primary care.
In this episode Dr. Helen Jarvis discusses:
🔍 Why liver cancer is so hard to detect early
🛠️ How better tools and policy can support GPs
📊 What needs to change in medical training
📈 Why urgent action is needed as cases are projected to rise 22% by 2040.
This episode is essential for anyone invested in cancer prevention, primary care, or liver health.
🎙️ Watch here: easlcampus.eu/videos/easl-policy-dialogues-s4-e2
EASL Policy Dialogues Season 4 is supported by Novo Nordisk. Content is developed independently by EASL.
🚨 Next week is the European Week Against Cancer (#ewac2025): see how you can get involved at www.cancer.eu/ewac.
@CancerLeagues @EuropeanCancer @DebbieShawcros1 @SagiZelber @EASLedu -
EASLnews
@EASLnews
Last week's EASL DeepDive on TIPS is now available on demand!
Catch up now: easlcampus.eu/webinars/easl-deepdive-key-tips-success-ide… -
EASLnews
@EASLnews
Don't miss tonight's #easlstudio episode on the new #masld Guidelines, at 18:00 CEST!
Hear from experts on navigating the nomenclature change, implementing guidelines in clinical workflows, and fostering behavioral change to improve patient outcomes across the care team.
🔗 easl.eu/easl-studio-episode/s8e11/
#livertwitter #liverx @FrancqueSven @elenas_george @shelley_keating -
EASLnews reposted
EASL Education
@EASLedu
📢 Happening today on #easlstudio!
We’re focusing on the vital role of nurses and care teams in implementing the new #masld Guidelines.
📅Wednesday 21 May at 18:00 CEST
🔗easl.eu/easl-studio-episode/s8e11/
@EASLNews @EASDnews @EASOobesity @FrancqueSven @DebbieShawcros1 @Livernursing
#liverx -
EASLnews reposted
EASL Education
@EASLedu
This year, 11 #easlstudio episodes, covering a diverse range of topics, were broadcast live from #easlcongress in Amsterdam.
Missed an episode?
You can watch them here 👉easlcampus.eu/search/resources/congress/easl-congress-202…
@EASLnews
#liverx -
EASLnews
@EASLnews
Are you interested in building the future of hepatology with us? Do you have a strong scientific track record in Immune-mediated and Cholestatic Diseases?
The EASL Scientific Committee is looking for one new member!
Read more and apply by 15 June 23:59 CEST on: easl.eu/news/scientific-committee-2025/
#livertwitter #liverx -
EASLnews
@EASLnews
Register for this #easldeepdive to learn all about the pathophysiology and clinical progression of #masld.
Key topics include:
🔑Unmet Clinical Needs
🔑Valuable clinical endpoints
🔑Emerging therapies to improve patient care
🔗 easl-eu.zoom.us/webinar/register/WN_IPMF4um6Q7ubuoSr2GgurA
@gbaffy @FrancqueSven @ReibergerThomas #livertwitter #liverx -
EASLnews reposted
Decision4Liver
@Decision4Liver
It’s #clinicaltrialsday! At DECISION, we’re proud of our COMBAT & PROSPECT trials advancing care in decompensated cirrhosis.
💡COMBAT Q&A videos in multiple languages help engage patients ➡️ www.youtube.com/playlist?list=PLO8jG2hfQd30H6-qktb2qsQfhZ…
Thanks to all who make our trials possible! #liverresearch -
EASLnews
@EASLnews
This Wednesday, tune in for an exciting #easlstudio episode on the new #masld guidelines and their practical application.
Faculty @FrancqueSven, Marta Cervera, @elenas_george & @shelley_keating are looking forward to this important discussion!
🔗 easl.eu/easl-studio-episode/s8e11/
#livertwitter #liverx -
EASLnews reposted
EASL Education
@EASLedu
The latest #easldeepdive on #tips in #masld is now available on demand!
Learn how to identify suitable candidates, navigate cardiopulmonary risks, and address post-TIPS encephalopathy.
🔗easlcampus.eu/webinars/easl-deepdive-key-tips-success-ide…
@EASLNews
#liverx
EASL Education
@EASLedu
What defines a good TIPS candidate?
How do we assess risk and optimise outcomes?
🔴 Join experts in 1 hour to explore strategies in TIPS management!
🔗 Register here: easl-eu.zoom.us/webinar/register/WN_2bsK6RpMSbekLBmuKEaiJg
@EASLnews @VirginiaHdezGea @manhalizzy @FrancqueSven @BavenoCoop @Apichatka @ReibergerThomas
#liverx #easldeepdive -
EASLnews
@EASLnews
In today's #readoftheweek📚, learn how soluble TREM2 reflects liver fibrosis status and predicts postoperative liver dysfunction after liver surgery.
Read this @JHEP_Reports article here: www.jhep-reports.eu/article/S2589-5559(24)00230-1/fulltext
🙏@TELL_Santol @D_Rajcic @cohoebinger @TELLRumpf @tgruenberger @TELL_Starlinger @THendrikx1 et al.
#livertwitter #liverx -
EASLnews reposted
EASL Education
@EASLedu
Recommendations are found in the first-ever EASL Clinical Practice Guidelines on #tips!
🖹 Full text here: www.journal-of-hepatology.eu/article/S0168-8278(25)00066-…
📲 Available now in the EASL Guidelines App: easlcampus.eu/easl-guidelines-app
@EASLnews @VirginiaHdezGea @manhalizzy @FrancqueSven @BavenoCoop @Apichatka @ReibergerThomas @JHepatology
#liverx #easldeepdive -
EASLnews
@EASLnews
The EASL DeepDive on Key for TIPS Success: Identifying Suitable Candidates and Risk Control is taking place today at 18:00 CEST!
You can still register here: easl-eu.zoom.us/webinar/register/WN_2bsK6RpMSbekLBmuKEaiJg -
EASLnews
@EASLnews
How familiar are you with the EASL Clinical Practice Guidelines on the management of liver diseases in pregnancy?
🎮 Test yourself with this new #easlquiz!
🔗 easlcampus.eu/quiz/question/q121
#livertwitter #liverx -
EASLnews reposted
EASL Education
@EASLedu
Best of #easlcongress 2025 Slide Decks are here!🎊
👉Top abstracts in editable PPT format
👉Key data & abbreviations
👉Full texts in the notes.
🔗easlcampus.eu/Documents/best-easl-congress-2025-slide-decks
Free to adapt, use, share ... just credit @EASLNews!
@Jhepatology @ProfPaoloAngeli @JoostPHDrenth @DrElePalma @ThomasBerg24 @massimoiava
#liverx -
EASLnews
@EASLnews
Ready to rethink #masld care?🤔
Register for the next #easldeepdive to explore:
🔹 Pathophysiology & progression
🔹 Unmet clinical needs
🔹 Emerging therapies & endpoints
🗓️ 10 June, 18:00 CEST
🔗 easl-eu.zoom.us/webinar/register/WN_IPMF4um6Q7ubuoSr2GgurA
@gbaffy @FrancqueSven @ReibergerThomas #livertwitter #liverx -
EASLnews reposted
IDFEurope / Diabetes
@IDFEuropeBXL
🙌Attending #wha78 in Geneva? Don’t miss the event co-hosted by @Globalliver, @EASLnews and @AASLDtweets.
💡IDF Europe Regional Manager, @ElisabethDupo10, will join the discussion on tackling interconnected health crises together.
➡️Register here: docs.google.com/forms/d/e/1FAIpQLSddqrLOfd0nITfbCVwwBW19-… -
EASLnews reposted
FLASH - Liver Research
@FLASH_OUH
Four successful days at #easlcongress 2025 in Amsterdam! 💡🌷
Over 7,000 liver professionals joined — and FLASH contributed with 1 oral presentation, 3 poster tours, and 7 posters! 📢🎉
We’re returning home full of insights and inspiration.
@OUHhospital @EASLnews -
EASLnews reposted
Joaquín Primo
@joaprimo
🧮@EASLnews Clinical Practice Guidelines on the management of autoimmune hepatitis.
🔓@JHepatology www.journal-of-hepatology.eu/article/S0168-8278(25)00173-…
#aih #livertwitter #liverx #openaccess -
EASLnews
@EASLnews
RT @EASLedu: 🧑⚕️In honour of #internationalnursesday, join us next week for an interprofessional #easlstudio episode on putting the new E…
-
EASLnews reposted
Jesus Bañales
@JesusMBanales
So proud of @PMRodrigues19 !!💫😊
EASL Meeting, Amsterdam🇳🇱
🏆Best Oral Clinical presentation
🍀Plenary session
👉novel 3-in-1🩸metabolomic test for PSC and CCA early diagnosis & risk stratification
🙏@PSCPartnersCa @PSCSupportUK #rubiometabolomics -
EASLnews reposted
Sanchit
@Sanchit30497977
This trial is a reminder why in RCT design and methodology is as important as results are. This was one of its kind which could have surely answered the question if not for logistics. Well done Dhiraj and colleagues.
More 🙌 to carvedilol. #liverx @BavenoCoop @EASLnews
The Baveno Cooperation: an EASL Consortium
@BavenoCoop
🇬🇧 CALIBRE trial – D. Tripathi at #easl2025
RCT: carvedilol vs VBL for 1º prevention in cirrhosis
🟰 No difference in bleeding or survival at 12 months
💊 Carvedilol safe, simpler & cost-effective
📉 Follow-up limited (12 mo), but extension planned
⚠️ Underpowered due to COVID -
EASLnews reposted
Elliot Tapper
@ebtapper
Well done, Nadim
Make sure your mom puts this on the fridge. And every practicing hepatologist
Journal of Hepatology
@JHepatology
🆕CPG in press❕
EASL Clinical Practice Guidelines on extrahepatic abdominal surgery in patients with cirrhosis and advanced chronic liver disease
Find it here👉www.journal-of-hepatology.eu/article/S0168-8278(25)00235-…
@EASLnews
@EASLedu -
EASLnews reposted
Christian Molina Aguilar
@Christian_moli_
the mechanisms by which Time-Restricted Feeding generates its protective effect against liver damage and the development of pathologies as fibrosis, cirrhosis and HCC. Thank you so much, Daniela Robles and all collaborators. @EASLnews #easl2025 @EASLedu
-
EASLnews reposted
DR AJEET S BHADORIA
@ajeetsbhadoria
Congratulations @SagiZelber & team for the launch of Global Liver Advocacy Network at #easl2025 Grateful for opportunity to share success story of #preventivehepatology @aiimsrishi Public health to join hands to advance liver health globally @INASL_Liver @EASLnews @AASLDPresident
-
EASLnews reposted
Francesco Paolo Russo
@fprusso73
What a team! Thank you Grace, it was great working with you! @EASLnews @EASLedu
Grace Wong
@wonglaihung
Honoured to be part of the #easl #hbv #cpg! 😊😊😊
EASL Clinical Practice Guidelines on the management of hepatitis B virus infection
Free text here: authors.elsevier.com/a/1l3v2cOnAYPKI
#easlcongress -
EASLnews reposted
Grace Wong
@wonglaihung
A perfect end of my #easlcongress #easl2025 🏃♀️🏃♀️🏃♀️🇳🇱🇳🇱🇳🇱🌷🌷🌷
@EASLnews @EASLedu
#zuideramstelkanaal #amsterdam #jogging #masldprevention -
EASLnews reposted
Asociación Española para el Estudio del Hígado
@AEEHLiver
👏👏Miembros de la #aeeh, reconocidos en el #easl2025. Nuestra enhorabuena para @SilviaAffo, del @hospitalclinic, por su Premio como como Líder Emergente de la #easl.
Silvia Affò
@SilviaAffo
I'm truly honored to receive the Emerging Leader Award from EASL. Thank you to the EASL community for this recognition and for supporting science and scientists in liver research. Grateful to my mentors and team—this is a shared achievement!
-
EASLnews reposted
Romelia Barba MD
@RomeliaBarba
Can’t ask for a better role model. Thank you @BonderAlan for inspiring us and leading the way in rare liver diseases!
So glad to see your amazing work highlighted at #easl2025 — excited for #aasld in DC!
Alan Bonder
@BonderAlan
Had an amazing time at #easl2025 in Amsterdam! So inspired by the incredible research and loved reconnecting with colleagues from around the globe. Can’t wait to see everyone at #aasld in DC! 🌍✨ #liverresearch #medtwitter
-
EASLnews reposted
Asociación Española para el Estudio del Hígado
@AEEHLiver
Nuestros #hepatólogos en el #easl2025 👏👏
gloria s. antolin
@gsanchezantolin
The #castillayleón team have had Fanny time with the #yellowliver in #easlcongress
-
EASLnews reposted
Decision4Liver
@Decision4Liver
🧬Poster THU-159-YI
Can dimethylarginines (DAS) predict #aclf before it strikes?
At #easl2025, Kohilan Gananandan (@UCL) presents new data validating DAS as a biomarker for pre-ACLF and outcome prediction post-acute #decompensation in two large EU cohorts.
#biomarkers #cirrhosis -
EASLnews reposted
Karina Sato, MD.
@KarinaSato15
So happy to present my research at #easlcongress! Grateful for this amazing experience and for the chance to connect with so many liver disease experts. Huge thanks to my mentor @KirkWangensteen for the support and guidance! #liverdisease #easl2025 @MayoClinicGIM
-
EASLnews reposted
The Baveno Cooperation: an EASL Consortium
@BavenoCoop
Do’s & Don’ts: How do you manage depression and anxiety in patients with cirrhosis?
Ines Mega – #easl2025
💬 Mental health matters!
📋 Screen routinely
💊 Antidepressants can be used – monitor HE risk
🤝 Multidisciplinary approach is essential
👇 Slides from the session -
EASLnews reposted
sidbarritt4
@sidbarritt4
@AndrewMMoon of @UNCLiverCenter @UNCGastro presents on increasing cirrhosis related deaths among young people especially from alcohol. COVID may have exacerbated this trend but dangerous alcohol use persists!#easl2025
-
EASLnews reposted
The Baveno Cooperation: an EASL Consortium
@BavenoCoop
🇬🇧 CALIBRE trial – D. Tripathi at #easl2025
RCT: carvedilol vs VBL for 1º prevention in cirrhosis
🟰 No difference in bleeding or survival at 12 months
💊 Carvedilol safe, simpler & cost-effective
📉 Follow-up limited (12 mo), but extension planned
⚠️ Underpowered due to COVID -
EASLnews reposted
Ismail Elkhattib
@IKhattib
🚨 Big news from #easl2025!
The new EASL Liver Transplantation Guidelines just dropped — first major update since 2016.
Here’s what changed and why it matters. 🧵
@EASLnews @EASLedu
#livertwitter #liverbites #medtwitter -
EASLnews reposted
The Baveno Cooperation: an EASL Consortium
@BavenoCoop
📊 EuroTIPS registry – Anna Baiges (Barcelona) at #easl2025
Analysis of 1,334 cirrhotic patients with covered TIPS placement.
🧮 Common prognostic scores underperformed. New prognostic scores are needed
🌍 EuroTIPS is open to new centers — check the criteria to join!
👇 Slides -
EASLnews reposted
Jimmy Che-To Lai
@JimmyLaiCT
Another fruitful EASL! Glad to have met friends from all over the world! @VWSWong @wonglaihung @TerryYip12 @CUHKMedicine #easl2025
-
EASLnews reposted
-
EASLnews reposted
Dr Scott P Davies
@ScottPLand
Anybody attending #easl2025, be sure to talk to Sofia Pat who will be presenting some work she completed (as an undergrad!!) about CD8+ T cells invading Cholangiocytes - FRI-70-YI
-
EASLnews reposted
The Baveno Cooperation: an EASL Consortium
@BavenoCoop
ESGE and Baveno together – what a team! 🔥
Key messages:
🔹 Just because it’s technically feasible doesn’t mean it should be done
🔹 Evidence is still lacking -> studies are needed!!
🔹 Center experience is crucial
#easl2025
Few slides 👇👇 -
EASLnews reposted
Natalia Sainz
@NataliasNutri
Lipids&Liver at #easl2025 🧪
@aspichuetaLab
An unforgettable experience!💥
Really grateful for the opportunity to share my results for the first time with my colleges at the EASL Congress in Amsterdam!
➡️I hope to repeat next year in Barcelona! -
EASLnews reposted
Grainne O'Kane
@graokane
Fabulous talk @MarcoSanduzzi on drug sequencing in #hcc
➡️understanding patterns of progression & liver function 🔑
➡️ integrating evidence &RWD post ICIs
➡️ different drug availability across Europe
➡️ exciting trials to report #easl2025
@EASLnews @BCLC_group @ArndtVogel -
EASLnews reposted
Terry Cheuk-Fung Yip
@TerryYip12
Thank you @JHepatology for the recognition as a statistical reviewer! Always happy to review and support great research. #easl2025 @EASLnews @CUHKMedicine
-
EASLnews reposted
Parminder Kaur
@pinderbrar888
Honored to receive the Best Poster Presentation award in the 'Cirrhosis & Complications - Clinical' at #easl2025. Grateful for the support of my mentors at @HepatologyPGI and a special thanks to @drnipunverma for invaluable mentorship. @ajay_duseja @drsuniltaneja @doc_arka
-
EASLnews reposted
Alan Bonder
@BonderAlan
Had an amazing time at #easl2025 in Amsterdam! So inspired by the incredible research and loved reconnecting with colleagues from around the globe. Can’t wait to see everyone at #aasld in DC! 🌍✨ #liverresearch #medtwitter
-
EASLnews reposted
Pedram Pirghasemi
@Pedram_Pgh
Great to be back at the annual @EASLnews Congress this time in sunny Amsterdam 🇳🇱. A few excellent days of learning and engaging discussions.
#easl2025 -
EASLnews reposted
EASL Education
@EASLedu
In cirrhosis, decompensation is often driven by portal hypertension, but does systemic inflammation take over as the disease progresses?
❗No current biomarkers clearly distinguish between PH-dominant and inflammation-driven pathways.
@EASLNews
#easlstudio #easlcongress #liverx -
EASLnews reposted
EASL Education
@EASLedu
At #easlcongress 2025, there’s something for everyone. Whether you're into cutting-edge research, clinical practice, or learning new skills.
🤝 Don’t forget to network, catch up with colleagues (new and old), and most importantly and don’t be afraid to say hello!
@EASLNews
#easlstudio #liverx -
EASLnews reposted
Scott Isaacs
@scottisaacsmd
Hepatic and #cardiometabolic effects of #masld drugs in late stage trials. Elisabetta Bugianesi. @EASLnews #easlcongress
-
EASLnews reposted
ElisaPinto
@ElisaPinto93
Excited to present at the #easlcongress ✨ some of the work I did during six amazing months in Pamplona 🇪🇸, exploring how SIRT + immunotherapy impacts the immune system in HCC🧬. Grateful for the science, mentorship, and growth!
@EASLnews @EASLedu -
EASLnews reposted
EASL Education
@EASLedu
From FIB-4 to future-ready care:
@AshleySpannMD is sharing how #ai tools embedded in EHRs boosted clinical action from 30% to 46% 📈
💡LLMs, chatbots, & eCDSS are reshaping liver care leading to faster, smarter decisions.
@EASLnews
#easlcongress #liverx -
EASLnews reposted
Oana Sandulescu
@sandulescu_oana
Time to say goodbye to #easlcongress 2025 in beautiful Amsterdam.
It was a privilege to be part of this year's faculty, and to deepen the collaboration between @EASLnews and @ESCMID @esgvh_escmid.
Heading off to share this year's insight with colleagues back home. -
EASLnews reposted
EASL Education
@EASLedu
Focusing on Steatotic Liver Disease and Toxicity, Hannes Hagström shares his #easlcongress Highlights 2025.
👉🏽 Download the Best of EASL Congress Slide Decks here: easlcampus.eu/Documents/best-easl-congress-2025-slide-decks
@EASLnews @Rabataller @FrancqueSven
#liverx -
EASLnews reposted
Pierre Gholam
@pgholam
@AlkhouriNaim presents 52 wk data for OL #resmetirom trial at year 2 @EASLedu #easlcongress
Fraction of patients with CSPH decreased by 30+% depending on modality used (Baveno, MRE)
#livertwitter -
EASLnews reposted
Issy Phillips
@issypips
My first but definitely not last trip to EASL: an awesome few days at what I can only describe as Disneyland to the budding hepatologist #easlcongress
-
EASLnews reposted
Pierre Gholam
@pgholam
Prof. Lok @umichmedicine with the summary on where we stand with therapeutics and #hbv sAg loss @EASLedu #easlcongress
Early days but naked ASO may be most promising
#livertwitter -
EASLnews reposted
NEJM
@NEJM
Original Article: Efruxifermin in Compensated Liver Cirrhosis Caused by MASH (SYMMETRY trial) www.nejm.org/doi/full/10.1056/NEJMoa2502242
@EASLnews | #easlcongress -
EASLnews reposted
Joost PH Drenth
@joostphdrenth
🟠 Is the color of our national 🇳🇱 team
😎 represents my dedication to the field
✊ @EASLnews for allowing me to present #easlcongress
EASL Education
@EASLedu
@joostphdrenth covers the latest insights in Immune-Mediated & Cholestatic Diseases at #easlcongress 2025.
👉🏽 Download the Best of EASL Congress Slide Decks here: easlcampus.eu/Documents/best-easl-congress-2025-slide-decks
@EASLnews @AnaLleo @KeitelVerena @yujun__wong @Cholestasisdoc
#liverx -
EASLnews reposted
Sara Della Torre
@SDT_Coach
Thanks to #easlcongress! Great sessions and great talks! Honoured to be a small part of such a great community! #easl #liverresearch @EASLnews @EASLedu
-
EASLnews reposted
L. Marie Asad
@LmarieAsad
We missed you! @FriendsofPBC @PBCFoundation #pbcsummit2025 crew!
-
EASLnews reposted
Graciela Castro Narro
@GCastro_NarroMD
Young Hepatologist #easlcongress 2025 @issacvargas Sharig opportunities and challenges of hepatology training in México @alehlatam @incmnszmx Congratulations
-
EASLnews reposted
gloria s. antolin
@gsanchezantolin
Leaving Amsterdam today — until next time at #easl2026! It’s been an enriching congress, full of shared knowledge and great friends. #easlcongress #livercommunity See you in #barcelona2026
-
EASLnews reposted
Tom Hemming Karlsen
@tomhemmingk
A special day for PSC. One phase II (in @JHepatology below, elafibranor) and one phase III (nor-UDCA, presented at the #easlcongress) trial with potentially positive efficacy signals. Great inspiration. www.journal-of-hepatology.eu/article/S0168-8278(25)00252-…
-
EASLnews reposted
Manuel Mendizabal
@MMendizabalMD
🚨Liver Screen Study final results
⭐️+30.000 patients
Tremendous effort.
👏congratulations to all the investigators.
@igraupe @MajaThiele
#easl2025 -
EASLnews reposted
Jesus Bañales
@JesusMBanales
Wonderfull election!!! 👏👏👏 Bravo dear @analleo 🍀😄
Lorenza Rimassa
@LorenzaRimassa
Congrats to @analleo elected vice-secretary of @EASLnews 👏🏻👏🏻👏🏻
#easlcongress #easl2025 in Amsterdam @HUNIMED @HumanitasMilano @EASLedu -
EASLnews reposted
Alexandra Rosu
@AlexandraRosu9
MASH treatment represents a challenge A holistic approach is the best in clinical practice
Resmetiron treatment
*Improves liver fibrosis reverse mash
*Prevent decompensation of LD
*Improvement in metabolic factors
#easlcongress @EASLedu @EASLnews -
EASLnews reposted
EASL Education
@EASLedu
@ProfPaoloAngeli wraps up #easlcongress 2025 with key developments in Cirrhosis.
👉🏽 Download the Best of EASL Congress Slide Decks here: easlcampus.eu/Documents/best-easl-congress-2025-slide-decks
@EASLnews @BavenoCoop @ReibergerThomas @VirginiaHdezGea
#liverx -
EASLnews reposted
EASL Education
@EASLedu
@massimoiava presents important updates in the field of Liver Tumours at the #easlcongress Highlights session.
👉🏽 Download the Best of EASL Congress Slide Decks here: easlcampus.eu/Documents/best-easl-congress-2025-slide-decks
@EASLnews @NaultJc @ArndtVogel @LorenzaRimassa
#liverx -
EASLnews
@EASLnews
🌍 That’s a wrap on #easlcongress 2025!
After four incredible days in Amsterdam and online, we’re grateful for the 7,748 attendees from 119 countries who joined us, explored 1,886 abstracts, and helped shape the future of liver health.
From expert-led sessions to global networking, we’ve shared knowledge, celebrated excellence, and strengthened our community. 🙌
A huge thank you to all of our delegates, faculty, industry partners, patient representatives, providers, and public who made this event so fantastic.
📺 Missed a session? On-demand content is available on the online platform& app until the end of May, and will be on EASL Campus starting the week of 12 May.
⭐️Best of slide decks: easlcampus.eu/Documents/best-easl-congress-2025-slide-decks
📷Look back at the unforgettable moments: easl.smugmug.com/EASL-Congress-2025-
🙏Give us your feedback: www.surveymonkey.com/r/6F9BRBD
📍Next stop: #easlcongress2026 in Barcelona, on 27–30 May!
@easledu -
EASLnews reposted
Rui Castro
@RuiCastroHD
And the 2025 #easlcongress is drawing to a close
@DrElePalma highlights some of the best Basic Science studies presented in these last days here is Amsterdam🌷
Thanks @EASLnews team for an amazing meeting! 🙌🏼 Looking forward to #easlcongress 2026 in Barcelona! 💃🏽👋🏼 -
EASLnews reposted
EASL Education
@EASLedu
If you are curious about the latest discoveries in Basic Science - non-disease related, check out @DrElePalma presenting at #easlcongress Highlights 2025.
👉🏽 Download the Best of EASL Congress Slide Decks here: easlcampus.eu/Documents/best-easl-congress-2025-slide-decks
@EASLnews @RuiCastroHD
#liverx -
EASLnews reposted
EASL Education
@EASLedu
@joostphdrenth covers the latest insights in Immune-Mediated & Cholestatic Diseases at #easlcongress 2025.
👉🏽 Download the Best of EASL Congress Slide Decks here: easlcampus.eu/Documents/best-easl-congress-2025-slide-decks
@EASLnews @AnaLleo @KeitelVerena @yujun__wong @Cholestasisdoc
#liverx -
EASLnews reposted
ElePalma
@DrElePalma
Ready to highlight the best of #easl2025 #easlcongress in basic science!!!
@EASLnews @EASLedu -
EASLnews reposted
EASL Education
@EASLedu
What’s new in Viral hepatitis? @Thomasberg24 kicks off the #easlcongress Highlights 2025!
👉🏽 Download the Best of EASL Congress Slide Decks here: easlcampus.eu/Documents/best-easl-congress-2025-slide-decks
@EASLnews @HeinerWedemeyer @aelsharkawy75
#liverx -
EASLnews reposted
Grace Wong
@wonglaihung
Honoured to be part of the #easl #hbv #cpg! 😊😊😊
EASL Clinical Practice Guidelines on the management of hepatitis B virus infection
Free text here: authors.elsevier.com/a/1l3v2cOnAYPKI
#easlcongress -
EASLnews reposted
EASL Education
@EASLedu
As we bid farewell to @AleksanderKrag, @DebbieShawcros1 invites you to the #easlcongress in Barcelona next year for:
🔬 Science,
🌞Sun,
🤝and Synergy!
Tot ziens Amsterdam, hola Barcelona! 👋
@EASLnews
#liverx -
EASLnews reposted
Mazen Noureddin, MD, MHSc
@NoureddinMD
@AlkhouriNaim is giving his first and 2 of the LB abstracts at @EASLnews @NASH_and_coffee @DrLoomba @ebtapper #livertwitter
-
EASLnews reposted
Nadeem Tehami
@helpatologist
Small but mighty Team Soton @UHS_LiverTeam at #easl2025 in Amsterdam 🇳🇱 I’m sure the hepatology world 🌐 is in awe of your academic charisma and brilliance!
-
EASLnews reposted
Decision4Liver
@Decision4Liver
Clinical trajectories of patients with cirrhosis and ascites receiving long-term albumin
#poster SAT-145-YI by Enrico Pompili (UNIBO) proposes a personalized management approach for patients w. cirrhosis &ascites, based on real-world data from long-term albumin therapy. #easl2025 -
EASLnews reposted
gloria s. antolin
@gsanchezantolin
Day 4 at #easlcongress: new guidelines on autoimmune hepatitis and hilar cholangiocarcinoma just released. A must-read for clinical practice! Don’t miss them. #tips and new horizons, really interesting, yesterday with @luistevilla #liverx @EASLnews @AparatoDigesti1
-
EASLnews reposted
Decision4Liver
@Decision4Liver
❤️Cardiac performance is impaired in patients with proven alcohol-related hepatitis and predicts 3-month mortality in this patient population
#poster SAT-503-YI by Pierre-Emmanuel Rautou (@Inserm, APHP, EF CLIF)
📅 Presented at the #easlcongress | #easl2025
@EASLnews -
EASLnews reposted
@ESGVH
@esgvh_escmid
Exceptional presentation by #esgvh chair, Prof @sandulescu_oana at #easlcongress
#id perspective on #mdr infections in #liver #cirrhosis: diagnostics pipeline, precision treatment and how to evaluate each individual clinical case.
@EASLnews
@ESCMID
@esgvh_escmid -
EASLnews reposted
EASL Education
@EASLedu
@analleo, new EASL Vice Secretary General, highlights how cholestatic liver diseases took centre stage at #easlcongress 2025:
🟠With a pre-congress consensus event
🟠A dedicated postgraduate course
@EASLnews
#liverx -
EASLnews reposted
Jordi Bruix
@bruixj
@MarcoSanduzzi also efficiently moderated a liver cancer poster tour. Step by step growing in the field with @Alexfornergon paying intense attention.
-
EASLnews reposted
EASL Education
@EASLedu
The #easlcongress reminded us: hepatology is not just one field, it's multidisciplinary and fast evolving.
🆕AI Taskforce
👉Diversity across sessions and abstracts
👉Content for experts, patients & non-experts
👉Do's & don'ts
👉Meet-the-Expert sessions
... and much more!!
@EASLnews
#liverx -
EASLnews reposted
Joost PH Drenth
@joostphdrenth
Adriaan J. van der Meer &Alejandra Villamil chair the 2nd autoimmune liver disease session #easlcongress
🔝Mapping Science and key developments -
EASLnews reposted
Joost PH Drenth
@joostphdrenth
🔥Lotte Slooter on fire #easlcongress
🔮Predict the future of patients with #aih
🧮 New prediction model
👍easy available biomerkers
@EASLnews @ERN_RARE_LIVER @analleo -
EASLnews reposted
Thomas Reiberger
@ReibergerThomas
@EASLnews #easlcongress 2025
Acute-on-chronic Liver Failure #aclf session
@VladTaruMD presenting data of on the effects of #nsbb in #aclf
@MedUni_Wien @ViennaLiverNews -
EASLnews
@EASLnews
🏃♂️Attend the last #easlstudio of #easlcongress 2025 "Tot ziens Amsterdam, hola Barcelona" starting in 2 minutes at the Hepatology Arena!
EASL Education
@EASLedu
#easlstudio is starting soon in the Hepatology Arena!🤩
@EASLnews
#easlcongress #liverx -
EASLnews reposted
EASL Education
@EASLedu
📢 The first-ever EASL Clinical Practice Guidelines on #tips in #cirrhosis have just been presented by @VirginiaHdezGea & Christophe Bureau
Covered in the guidelines:
✔️ When to use preemptive TIPS
✔️ Guideline-supported use in: refractory ascites, hepatic hydrothorax, variceal bleeding, Budd–Chiari syndrome
✔️ Rescue TIPS: improves survival in early rebleeding (<5 days) despite standard care – LoE 3, strong rec.
✔️ Post-TIPS: guidance on HE prevention, imaging follow-up, anticoagulation
📲 Available now in the EASL Guidelines App: easlcampus.eu/easl-guidelines-app
@EASLnews @JHepatology
#easlcongress #liverx
Journal of Hepatology
@JHepatology
🆕CPG❕
EASL Clinical Practice Guidelines on TIPS
✅Addresses all aspects of #tips in patients with #cirrhosis
Full text here: www.journal-of-hepatology.eu/article/S0168-8278(25)00066-…
#livertwitter
@EASLnews
@EASLedu -
EASLnews reposted
Jin Ge
@egnij
So honored that our @HepCommJournal special article from when ChatGPT was new thing(!) is still getting plenty of mileage even today at @EASLnews @EASLedu.
EASL Education
@EASLedu
ChatGPT-4 shows strong potential in liver pathology:
✅ Accurately stages #mash fibrosis, outperforming pathologists when given context
✅ 81% diagnostic accuracy
⚠️ Still limited by lack of FOV-awareness, hallucinations & outdated training
#ai tools already assist us in our daily lives, why not move towards an era where they assist us in the medical field?
@EASLnews
#easlcongress #liverx -
EASLnews reposted
Pierre Gholam
@pgholam
Wonderful summary of immunomodulatory approaches to #hbv functional cure by @mmaini6 @EASLedu #easlcongress
This summary slide pretty much says it all
#livertwitter -
EASLnews reposted
Arndt Vogel
@ArndtVogel
🔥EASL Clinical Practice Guidelines on the management of extrahepatic cholangiocarcinoma🔥
@JHepatology
doi.org/10.1016/j.jhep.2025.03.007
👉get the lastest update on the diagnosis and management of eCCA
@myESMO @EASLedu @ILCAnews #livertwitter -
EASLnews reposted
Laura Sererols Viñas
@SererolsLaura
Such an honor to present our work at the #easlcongress2025 with @SilviaAffo !🔝✨
Always inspiring to reconnect with friends and collaborators and to build new networks within such a brilliant scientific community! -
EASLnews reposted
Ben Mullish
@bhmullish
Well - for one - looking forward to the results of the FARGO trial @CholestasisDoc @PSCSupportUK :
Imperial Hepatology
@IHepatology
Pleased that #fargo - a randomised, multicentre, placebo-controlled phase IIa trial of #fmt to treat #psc - is running and recruiting. Have a look at the protocol paper out now in @BMJ_Open: doi.org/10.1136/bmjopen-2024-095392 @lifearc1 @PSCSupportUK @CholestasisDoc @ImperialMDR
-
EASLnews reposted
Ben Mullish
@bhmullish
Honoured to be part of this Future of Hepatology session at #easl2025, discussing the promise of #microbiome related therapies in #psc #cholestatic liver disease - where have we come since the original #fmt #psc pilot study by @DrAllegrettiIBD: 10.14309/ajg.0000000000000115
-
EASLnews reposted
Lucy Charlotte
@lucy_charlottep
Superb abstract by Dr Dhiraj Tripathi at #easlcongress @EASLedu #amsterdam @CalibreTrial
-
EASLnews reposted
-
EASLnews reposted
EASL Education
@EASLedu
📢 Just presented by @MattiasMandorf1 and Dominique Thabut at #easlcongress 2025:
🔥🔥First-ever EASL CPGs on extrahepatic abdominal surgery in patients with #cirrhosis & #acld
Key recommendations:
✔️ Go beyond MELD/Child: assess VO₂peak, HVPG, frailty
✔️ Use VOCAL-Penn to stratify surgical risk (LoE 3, strong rec.)
✔️ Exclude CSPH via NITs; consider HVPG if decision-altering
✔️ Pre-op EGD unless CSPH ruled out
✔️ Cardio-pulm & functional testing essential
✔️ High-risk Child C? Consider pre-op TIPS in select cases
📲Available now in the EASL Guidelines App!
easlcampus.eu/easl-guidelines-app
@Jhepatology @EASLnews
#liverx
EASLnews
@EASLnews
⭐️New EASL CPGs on extrahepatic abdominal surgery in patients with cirrhosis and advanced chronic liver disease.
Read here👉 authors.elsevier.com/a/1l3v1cOnAYPTl -
EASLnews reposted
Marta Alonso Peña, PhD
@DraMartaAlonsoP
Saturday morning in Amsterdam and #easlcongress still going on!
In this session, faculty providing guidance to YIs about How to prepare a Clinical Practice Guideline in Hepatology @IsraelsenMads @a_zanetto -
EASLnews reposted
EASLnews
@EASLnews
At General Session II, Pedro Miguel Rodrigues presents a Novel “3-in-1” Blood Metabolomic Test for Early Diagnosis and Risk Stratification of Primary Sclerosing Cholangitis (PSC) and Cholangiocarcinoma
This innovative metabolomic-based test offers a single-platform solution for:
✔️ Early diagnosis of PSC
✔️ Detection of cholangiocarcinoma
✔️ Risk stratification in at-risk patients
A promising advancement toward non-invasive, precision diagnostics in cholestatic liver disease and hepatobiliary cancer.
@DebbieShawcros1 @AleksanderKrag -
EASLnews reposted
Tom Marjot
@tom_marjot
📢11:45 today: MASLD non-invasive tests poster tour.
5 excellent posters:
- Longitudinal NITs
- LITMUS biomarkers
- LSM and cardiac events
- Dynamic changes & liver outcomes
- Pi*MZ variants in MASH
Get stuck in. Track Hub 7.
#easlcongress #liverx -
EASLnews
@EASLnews
Inspiring and practical discussions at the #easlcongress YI Workshop on preparing Clinical Practice Guidelines in hepatology.
Participants explored how to frame clinical questions using the PICO model, understood the Delphi method for building consensus, and learned the process of systematic literature review and evidence grading. A vital skill set for shaping the future of hepatology standards and improving patient care worldwide.
@IsraelsenMads @EASLedu -
EASLnews
@EASLnews
Diving into complex challenges this morning at #easlcongress Meet-the-Experts sessions.
A major focus on immunotherapy and liver transplantation explored the patient populations that could benefit, the crucial washout periods before transplant, and how to manage post-transplant immunosuppression safely.
Another lively discussion tackled the management of cholangiocarcinoma, stressing the importance of early MDT involvement, optimising molecular profiling, and improving access to emerging therapies through international collaboration.
Meanwhile, in the metabolic liver disease field, experts debated GLP1 receptor agonists versus bariatric surgery for patients with compensated MASH cirrhosis, weighing efficacy, safety and the future role of these therapies. Vital insights for shaping patient care across hepatology.
@EASLedu -
EASLnews reposted
BCLC GROUP
@BCLC_group
Session about the challenges around systemic therapy just finished @EASLnews Our very own @MarcoSanduzzi exposed his BCLC thinking about how to navigate treatment sequencing. Clinical expertise is an important asset @hospitalclinic @idibaps @CIBERehd @ContraCancerEs
-
EASLnews reposted
Lorenza Rimassa
@LorenzaRimassa
Great talk and discussion by @graokane on #immunotherapy before #livertransplant for #hcc at #easl2025 @SherrieBhoori @A_DAlessioMD @EASLnews @EASLedu
EASLnews
@EASLnews
This afternoon at #easlcongress, experts are taking on the complexities of hepatocellular carcinoma management in a fast-evolving therapeutic landscape.
Discussion is centred around how to select patients for immune checkpoint inhibitors before liver transplantation, when systemic therapies can be safely and effectively used despite impaired liver function, and why locoregional treatments still have a key role even in advanced-stage disease.
Personalised, stage-adapted, and highly strategic approaches are critical to improving outcomes — and today's session is providing essential real-world guidance to get it right. -
EASLnews
@EASLnews
Exciting discussions today at #easlcongress on the future of HBV treatment. With new antivirals like CAMs, ASOs, iRNA, and secretion inhibitors advancing through trials, alongside immune-based approaches such as TLR agonists, checkpoint inhibitors, and therapeutic vaccines, the field is moving rapidly.
Experts explored how different phases of HBV infection may demand tailored treatment strategies, and how newer endpoints could redefine therapeutic success.
As we move towards combinations of antivirals and immune therapies, hopes are high for achieving functional cure in broader patient populations.
@EASLedu -
EASLnews
@EASLnews
Advances in MASLD clinical research on display at #easlcongress.
AI-driven digital pathology is reshaping histological assessment, with PathAI and HistoIndex models rivalling expert scoring in the LITMUS cohort. New data from the HARMONY trial show that non-invasive biomarkers can align well with histological improvements, providing a roadmap for drug trials.
Real-world analyses highlight how non-invasive strategies can select MASH patients for therapies like resmetirom. Exciting results from phase 2 trials of survodutide show benefits beyond weight loss, while dynamic use of fibrosis biomarkers could soon personalise risk prediction and improve long-term patient management.
@AlinaAllenMD @EASLedu -
EASLnews
@EASLnews
Innovative research on liver transplantation today at #easlcongress. New cfChIP-seq liquid biopsy methods show promise for diagnosing acute cellular rejection, while AI-generated synthetic data could revolutionise privacy-preserving transplant research.
We presented new findings that transcriptomic profiles of antibody-mediated rejection may be independent of donor-specific antibodies. Important data were also shared on inequalities in liver transplantation across Europe, and new US results show donor-derived cell-free DNA could personalise immunosuppression after transplant. A session full of future-facing science!
@JulieHeimbach @ACoilly @EASLedu -
EASLnews reposted
Sara Della Torre
@SDT_Coach
Great session on the future of drug discovery in SLD led by @lucavalenti75. Great talks by @stefano_romeo76 and @MikeVacca1979 #easl #easlcongress @EASLnews @EASLedu
-
EASLnews reposted
Andreas
@Andreas_0711Stg
Great presentations, thank you @sandulescu_oana
-
EASLnews reposted
Yujun_Wong
@Yujun__Wong
Impressive 🩸 based biomarker for cholangioCA #cca #easlcongress #liverx #livertwitter
Jesus Bañales
@JesusMBanales
So proud of @PMRodrigues19 !!💫😊
EASL Meeting, Amsterdam🇳🇱
🏆Best Oral Clinical presentation
🍀Plenary session
👉novel 3-in-1🩸metabolomic test for PSC and CCA early diagnosis & risk stratification
🙏@PSCPartnersCa @PSCSupportUK #rubiometabolomics -
EASLnews reposted
EASL Education
@EASLedu
🆕 New EASL Clinical Practice Guidelines on #ecca launched at #easlcongress 2025 and presented by @JulieHeimbach
✅ Classification of eCCA: malignancies arising from hepatic ducts and the bile duct
✅ Epidemiology: data should be routinely recorded for CCA cases; germline mutations testing and genetic counselling cannot currently be recommended for all patients
✅ Surveillance: who, when and what
✅ Diagnosis: the use of CA19-9 is not recommended but can be used as a prognostic biomarker; contrast-enhanced CT and contrast-enhanced MRI should be used
✅ Therapy - operable vs inoperable disease - and follow up
Available as of now, also in the Guidelines App!
Get the App: easlcampus.eu/easl-guidelines-app
#liverx
EASLnews
@EASLnews
⭐️ New EASL CPGs on the management of extrahepatic cholangiocarcinoma.
👉Read here: authors.elsevier.com/a/1l3v3_3rhKGFL2 -
EASLnews reposted
Mattias Mandorfer
@MattiasMandorf1
📢 First EASL CPG on surgery in cirrhosis presented today together with the one on TIPS!
🤝 See you at 10:30 Erlinger Room!
@EASLnews @EASLedu @BavenoCoop #livertwitter
Journal of Hepatology
@JHepatology
🆕CPG in press❕
EASL Clinical Practice Guidelines on extrahepatic abdominal surgery in patients with cirrhosis and advanced chronic liver disease
Find it here👉www.journal-of-hepatology.eu/article/S0168-8278(25)00235-…
@EASLnews
@EASLedu -
EASLnews reposted
EASL Education
@EASLedu
📢 The updated #hbv guidelines were just presented by @CornbergMarkus @ #easlcongress.
✔️ Focus on shared decision-making
✔️ Simplified treatment algorithm
✔️ Clear answers to key questions:
👉Who to treat?
👉When to start?
👉What are the #hcc risk factors?
👉What if ALT is normal but HBV DNA is high?
@JHepatology @EASLnews
#liverx
EASLnews
@EASLnews
⭐️ New EASL CPGs on the management of hepatitis B virus infection.
👉Read here: authors.elsevier.com/a/1l3v2cOnAYPKI -
EASLnews reposted
Decision4Liver
@Decision4Liver
Is the etiological work-up of #psvd a one-size-fits-all?
DECISION consortium member Lucile Moga from APHP takes part in EASL/ VALDIG's session on "Do's and Don'ts in the management of Porto-Sinusoidal Vascular Disease".
#easlcongress #easl2025 #liverresearch
@EASLnews -
EASLnews reposted
Dina Tiniakos
@DinaTiniakos
After 🔟 years, the new @EASLnews CPG on AutoImmune Hepatitis are here! 👉www.journal-of-hepatology.eu/article/S0168-8278(25)00173-… Liver biopsy 🔬 remains a pillar for diagnosis🎯! Congratulations to the author team 🇬🇷 🇳🇱🇬🇧 🇩🇰 🇩🇪🇪🇸🇮🇹🇭🇺 &EASL @ESP_Pathology @my_ueg @eemh_hasl @UKLiverPath @LiverPath_HPHS
Journal of Hepatology
@JHepatology
🆕CPG in press❕
EASL Clinical Practice Guidelines on the management of autoimmune hepatitis
Find it here👉www.journal-of-hepatology.eu/article/S0168-8278(25)00173-…
@EASLnews
@EASLedu -
EASLnews reposted
Angelo Lozada MD
@ablozadamd
Rebooting the Microbiome of Cirrhotics:
✅ Diet
✅ Probiotics
✅ Rifaximin
✅ Fecal Transplant
🗣️ Debbie L. Shawcross
@EASLedu @EASLnews #easlcongress #easl2025 #amsterdam #rai -
EASLnews
@EASLnews
The networking session with @thalassaemiaTIF will start soon! Head over Track Hub 1 (Public Health) at 09:45!
Meet Alessandra Mangia!
#easlcongress -
EASLnews
@EASLnews
The networking session with A-TANGO will start soon! Head over Track Hub 4 (Cirrhosis & Complications) at 09:45!
Meet @RajivJalan1 and Young Investigators of A-TANGO!
#easlcongress -
EASLnews reposted
@ESGVH
@esgvh_escmid
@JasmohanBajaj brilliantly presenting the epidemiology of #mdr infections in patients with #liver #cirrhosis at #easlcongress
@EASLnews @ESCMID @esgvh_escmid -
EASLnews reposted
EASL Education
@EASLedu
New EASL Clinical Practice Guidelines on #aih released at #easlcongress 2025 and presented by @AnaLleo
✅ Updated guidance for adults & children
✅ Clear diagnostic criteria (IgG, autoantibodies, histology)
✅ When to suspect AIH (including in cirrhosis)
✅ First-line treatments: prednisolone + azathioprine/MMF
✅ When (and how) to taper or stop immunosuppression
✅Well-being of patients
Available as of now, also in the Guidelines App!
Get the App: easlcampus.eu/easl-guidelines-app
#liverx
EASLnews
@EASLnews
⭐️ New EASL CPGs on the management of autoimmune hepatitis.
👉Read here: authors.elsevier.com/a/1l3v1cOnAYPK6
Journal of Hepatology
@JHepatology
🆕CPG in press❕
EASL Clinical Practice Guidelines on the management of autoimmune hepatitis
Find it here👉www.journal-of-hepatology.eu/article/S0168-8278(25)00173-…
@EASLnews
@EASLedu -
EASLnews
@EASLnews
📃5 new EASL CPGs released today at #easlcongress!
👉Make sure to attend the much awaited sessions listed below!
Access the publications:
📃 EASL Clinical Practice Guidelines on extrahepatic abdominal surgery in patients with cirrhosis and advanced chronic liver disease
authors.elsevier.com/a/1l3v1cOnAYPTl
📃 EASL Clinical Practice Guidelines on the management of hepatitis B virus infection
authors.elsevier.com/a/1l3v2cOnAYPKI
📃 EASL Clinical Practice Guidelines on the management of autoimmune hepatitis
authors.elsevier.com/a/1l3v1cOnAYPK6
📃 EASL Clinical Practice Guidelines on the management of extrahepatic cholangiocarcinoma
authors.elsevier.com/a/1l3v3_3rhKGFL2
@EASLedu @JHepatology -
EASLnews reposted
Rui Castro
@RuiCastroHD
#easlcongress day 4️⃣ (last day!)
But still lots to see and off to a great start with the microbiome and liver health session chaired by @DebbieShawcros1 & Max Nieuwdorp
@EASLnews @Bernd_Schnabl @meijnikman -
EASLnews
@EASLnews
⭐️ New EASL CPGs on the management of extrahepatic cholangiocarcinoma.
👉Read here: authors.elsevier.com/a/1l3v3_3rhKGFL2 -
EASLnews
@EASLnews
⭐️ New EASL CPGs on the management of autoimmune hepatitis.
👉Read here: authors.elsevier.com/a/1l3v1cOnAYPK6
Journal of Hepatology
@JHepatology
🆕CPG in press❕
EASL Clinical Practice Guidelines on the management of autoimmune hepatitis
Find it here👉www.journal-of-hepatology.eu/article/S0168-8278(25)00173-…
@EASLnews
@EASLedu -
EASLnews
@EASLnews
⭐️ New EASL CPGs on the management of hepatitis B virus infection.
👉Read here: authors.elsevier.com/a/1l3v2cOnAYPKI -
EASLnews
@EASLnews
⭐️New EASL CPGs on extrahepatic abdominal surgery in patients with cirrhosis and advanced chronic liver disease.
Read here👉 authors.elsevier.com/a/1l3v1cOnAYPTl -
EASLnews reposted
EASL Education
@EASLedu
Don't miss the final episode of #easlstudio live from #easlcongress 2025!
📅Saturday 10 Mayat 11:45 CEST
📍Onsite: Hepatology Arena
💻Online: : easl.eu/studio-at-easl-congress-2025/
@EASLNews @DebbieShawcros1 @AleksanderKrag @etrepo @analleo
#liverx -
EASLnews reposted
BHPG
@heppharm
Pharmacist Rachel Mcgaw presenting her audit on HSV prophylaxis and monitoring after LTx at the @RoyalFreeNHS
#easlcongress #easl2025 -
EASLnews reposted
Marta Alonso Peña, PhD
@DraMartaAlonsoP
Full room at the Clinical YI Poster Tour!
So many young clinical scientist sharing their research at #easlcongress
@IsraelsenMads @C_V_Schneider -
EASLnews reposted
Marta Alonso Peña, PhD
@DraMartaAlonsoP
How to move from a postdoc position to embrace the challenges of being a new PI?
YIs receiving great advice from great PIs! @ljpally19 @RautouE @b_maasoumy
#easlcongress -
EASLnews reposted
BHPG
@heppharm
Our education pharmacist, Naz presents the impact of her local HBV reactivation guidelines on improving surveillance and treatment at @RoyalFreeNHS
#easl2025 #easlcongress -
EASLnews reposted
BHPG
@heppharm
Our 🏴 team @alisonboyle_1 @FionaMarra @stephentbarclay presenting their success in improving patient assessment and management in their #pharmacist-led PBC clinic
#easlcongress -
EASLnews reposted
Pierre Gholam
@pgholam
@docberza concluding slide on NITs. A fantastic presentation which is most definitely required viewing for trainees or anyone trying to get familiar with NITs
@EASLedu #easlcongress
#livertwitter -
EASLnews reposted
Lorenza Rimassa
@LorenzaRimassa
Congrats to @analleo elected vice-secretary of @EASLnews 👏🏻👏🏻👏🏻
#easlcongress #easl2025 in Amsterdam @HUNIMED @HumanitasMilano @EASLedu -
EASLnews reposted
Cristina Alonso
@CAlonso_OWL
Amazing presentation of @PMRodrigues19 this morning in the General Session 2 at #easlcongress: Novel 3-in-1 metabolomic test for early diagnosis & risk stratification of PSC & CCA.
Well deserved Best Oral Clinical presentation! 👏👏
Big congrats to all the team & collaborators. -
EASLnews reposted
Joost PH Drenth
@joostphdrenth
🔝Takeaways from #easlcongress today, may 9
👩⚕️@DebbieShawcros1 and @analleo at the helm of @EASLnews
💪🏽 Bart Takkenberg member Policy Public Health Advocacy committee
🙏 @AleksanderKrag he carried @EASLedu through testing times -
EASLnews reposted
Grace Wong
@wonglaihung
Great Job in presenting this landmark study in #easlcongress #amsterdam @TerryYip12 👏🏻👏🏻👏🏻
@VWSWong @JimmyLaiCT @CUHKMedicine @CUHKGI @EASLnews @EASLedu
Terry Cheuk-Fung Yip
@TerryYip12
Grateful to represent the #vcte-Prognosis Study Group to discuss how non-invasive 2-step algorithm can be used to identify patients with #masld at high risk of developing hepatic decompensation! @EASLnews #easlcongress #easl2025 @CUHKMedicine
-
EASLnews reposted
EASL Education
@EASLedu
In hepatology, how should we assess AI tools like ChatGPT?
🧑⚕️Clinicians focus on accuracy, context & regulation.
🧑🦱Patients are more open, using AI for second opinions, clarity, & reassurance.
⚠️But beware: AI may lack precision, context awareness & over-recommend imaging.
@EASLnews
#easlcongress #liverx #ai -
EASLnews reposted
Madrigal Pharmaceuticals
@MadrigalPharma
At this year’s @EASLNews Congress, we’re driving innovative research, scientific advancements & important dialogue to help improve care for people living with metabolic dysfunction-associated steatohepatitis (#mash). Learn more about new Phase 3 data at our oral presentation.
-
EASLnews reposted
EASL Education
@EASLedu
Next up, #easlstudio is bringing you a curated overview of landmark studies and breakthrough data presented at #easlcongress 2025.
📅Starting at 16:15 CEST
📍Onsite: Hepatology Arena
💻Online: : easl.eu/studio-at-easl-congress-2025/
@Rajmookerjee @ThomasBerg24
@EASLNews @Jhepatology @aelsharkawy75
#liverx -
EASLnews reposted
EASL Education
@EASLedu
@Rajmookerjee, @ThomasBerg24, @KeitelVerena, and Hannes Hagström are ready to reveal which studies are making waves at #easlcongress 2025
Don't miss it!
💻easl.eu/studio-at-easl-congress-2025/
@EASLnews
#easlstudio #liverx -
EASLnews reposted
Antonio D'Alessio
@A_DAlessioMD
The calm before the storm... 🎙️
What a pleasure to share the stage with a stellar panel to talk about the challenges of ICI in HCC patients with impaired liver function at #easl25 @EASLedu @EASLnews -
EASLnews reposted
The Baveno Cooperation: an EASL Consortium
@BavenoCoop
🎓 Jean-Pierre Benhamou Clinical State-of-the-Art
🗣️ @docberza on The promise & pitfalls of non-invasive testing – #easl2025
🧪 NITs: from fibrosis staging ➡️ to prognosis
📈 Last LSM value matters
🔬 OMICS + evolving algorithms = the future
⏳ Baveno VIII will guide next steps -
EASLnews reposted
Pierre Gholam
@pgholam
If you read this post in isolation, you would conclude that this is a negative study. If you read the actual paper, you would conclude that is is a positive study.
The moral of the story. Read the paper not the tweet.
@EASLnews #easlcongress
#livertwitter
NEJM
@NEJM
In patients with compensated cirrhosis from metabolic dysfunction–associated steatohepatitis, efruxifermin did not significantly reduce fibrosis at 36 weeks. Full SYMMETRY trial results: www.nejm.org/doi/full/10.1056/NEJMoa2502242
@EASLnews | #easlcongress -
EASLnews reposted
The Baveno Cooperation: an EASL Consortium
@BavenoCoop
Do we need to treat cirrhotic PVT, and how? – #easl2025
🗣️ @jcgarciapagan
📍 LT candidate → anticoagulate if >25%
🚫 No LT → consider if >50%
🔍 Anticoagulation may help beyond recanalization
🛠️ Radiological Rx: for LT candidates not responding or with refractory CSPH -
EASLnews reposted
The Baveno Cooperation: an EASL Consortium
@BavenoCoop
🩸 Haemostatic management during procedures in cirrhosis
🗣️ N. Intagliata – #easl2025
✅ Bleeding is rare, but serious
🚫 Standard tests ≠ bleeding risk
📌 Consider procedure risk, cirrhosis stage & BMI
📋 Have a bleeding plan
🧪 Viscoelastic tests: promising future tool -
EASLnews reposted
The Baveno Cooperation: an EASL Consortium
@BavenoCoop
🩸 Managing acute bleeding in cirrhosis
🗣️ Lara Roberts (London) – #easl2025
✅ Restrictive transfusion
🚫 No FFP, no tranexamic acid
❓ Platelets & fibrinogen: no clear evidence
🔮 Future: viscoelastic tests to guide therapy? -
EASLnews reposted
The Baveno Cooperation: an EASL Consortium
@BavenoCoop
💊 DOACs in cirrhosis
🗣️ Cindy Pereira Portela (Lausanne) – #easl2025
✅ Child A/B: ok (⚠️ no rivaroxaban in B)
🚫 Child C: not recommended
⭐ Apixaban might be the winner — but more data needed
🧩 Case-by-case decision
🤝 Multidisciplinary approach is essential -
EASLnews reposted
Jasmohan Bajaj
@JasmohanBajaj
was a great session!
It was a pleasure to presented on #pros behalf of @AASLDtweets @AASLDPresident
@ISHENliver
EASLnews
@EASLnews
🌎Important global perspectives are being shared this morning at #easlcongress during the Global Liver Forum on tailored approaches to hepatic encephalopathy.
Experts from Europe, Latin America, Asia and beyond are reflecting on the latest guidelines, real-world management challenges, and future strategies to improve care for patients living with cirrhosis and hepatic encephalopathy.
The session also emphasises the need to prioritise quality of life indicators in clinical care, ensuring a more holistic, patient-centred approach.
A powerful reminder that tackling hepatic encephalopathy demands both local adaptation and global collaboration.
@drshivsarin @DebbieShawcros1 @spearman_wendy
@mariogpessoa @EASLedu -
EASLnews reposted
gloria s. antolin
@gsanchezantolin
Day 3 at #easlcongress: a day of awards, transplantation, acute-on-chronic, and hepatitis. @natmarcosc and @mamenalonso_doc presented our work. Thanks to the whole team that make it possible and to @EASLnews for the opportunity to share it!
-
EASLnews reposted
Yujun_Wong
@Yujun__Wong
Thank you @BavenoCoop & @docberza for highlighting our study. 🙂🙏🏻
⭐ When lastest LSM (LMSc) is known, prior LSM trajectories adds little to prognostic value in cACLD patients.
#nit #easlcongress
The Baveno Cooperation: an EASL Consortium
@BavenoCoop
🎓 Jean-Pierre Benhamou Clinical State-of-the-Art
🗣️ @docberza on The promise & pitfalls of non-invasive testing – #easl2025
🧪 NITs: from fibrosis staging ➡️ to prognosis
📈 Last LSM value matters
🔬 OMICS + evolving algorithms = the future
⏳ Baveno VIII will guide next steps -
EASLnews reposted
-
EASLnews reposted
Terry Cheuk-Fung Yip
@TerryYip12
Grateful to represent the #vcte-Prognosis Study Group to discuss how non-invasive 2-step algorithm can be used to identify patients with #masld at high risk of developing hepatic decompensation! @EASLnews #easlcongress #easl2025 @CUHKMedicine
-
EASLnews reposted
Manuel Mendizabal
@MMendizabalMD
It is always nice to present your research in big meetings. Thanks @EASLnews for the opportunity to share our work and specially to all my co-authors.
@fedepfc @MEOFAR
#easl2025 -
EASLnews reposted
Mapi Ballester
@mapibafe
Join us at the poster tour: cirrhosis and its complications. Track Hub 4, Friday 16:15-17:00 CEST. #ammon to predict liver-related complications 🎯 @EASLnews @ReibergerThomas @RajivJalan1
-
EASLnews
@EASLnews
Day 3 of #easlcongress 2025 has come to a close! 📅 Don’t miss the highlights—check out our gallery of photos capturing the energy, science, and community: easl.smugmug.com/EASL-Congress-2025-
-
EASLnews reposted
-
EASLnews reposted
EASLDHILIconsortium
@easldhili
#live ▶️Dra. Miren García Cortes chairing a General Hepatology Session & talking about diagnosis of DILI & the usefulness of causality assessment scales 🙂
#easlcongress Day 3️⃣ @EASLnews
@_ibima @DigestivoHuvv @CIBERehd -
EASLnews reposted
EASL Education
@EASLedu
ChatGPT-4 shows strong potential in liver pathology:
✅ Accurately stages #mash fibrosis, outperforming pathologists when given context
✅ 81% diagnostic accuracy
⚠️ Still limited by lack of FOV-awareness, hallucinations & outdated training
#ai tools already assist us in our daily lives, why not move towards an era where they assist us in the medical field?
@EASLnews
#easlcongress #liverx -
EASLnews reposted
EASL Education
@EASLedu
😲60% of people struggle with health literacy, not due to language, but info overload & poor quality.
🫂Trust remains a key issue: people frequently turn to the internet over healthcare providers for answers, especially in younger age groups.
⛰️The major challenge is ensuring accuracy, transparency, and alignment with clinical practice when AI interfaces directly with patients.
@EASLNews
#easlcongress #liverx -
EASLnews
@EASLnews
Last quiz of #easlcongress happening at 16:00 at the Community Hub in Hall 12!
Get ready - this is your chance to win BIG prizes: a free EASL membership, or a registration for EASL Congress 2026 in Barcelona!
❓⁉️❤️
@EASLedu -
EASLnews reposted
-
EASLnews
@EASLnews
The networking session with @Hep_Alliance will start soon! Head over Track Hub 1 (Public Health) at 16:15!
#easlcongress -
EASLnews reposted
EASL Education
@EASLedu
Multidisciplinary care: dream or reality? 🤝
Evidence shows integrated care models can deliver more impact than drug investment alone.
Perhaps it's time to shift the spotlight..🧐
@EASLNews
#easlstudio #easlcongress #liverx -
EASLnews reposted
Luca Valenti
@lucavalenti75
Honored to receive the @JHepatology reviewer recognition award 2025 #easl2025 @EASLnews
-
EASLnews reposted
-
EASLnews reposted
Tom Marjot
@tom_marjot
Seminar from the @EASLnews AI Taskforce at 15:00 in Hepatology Arena.
'Integrating AI Large Language Models into Liver Disease Care'
This session has something for everybody - AI experts, clinicians, young investigators, & pathologists. Great speakers & dynamic discussions✅ -
EASLnews reposted
Manuel D. Gahete
@ManuelDGahete
🔥Impressive high level of the presented posters at the #livertumor Track #easlcongress @EASLnews ‼️
🎤 @SilviaAffo
🗣️#matiasavila
🗣️ @NataliasNutri @aspichuetaLab
🔝 Great results and presentations! 👏🏼
@AEEHLiver -
EASLnews reposted
Jasmohan Bajaj
@JasmohanBajaj
Excited to hear the wonderful @docberza give the JP Benhammou lecture @EASLnews #easlcongress @DebbieShawcros1 @AleksanderKrag @RuiCastroHD
-
EASLnews reposted
Pierre Gholam
@pgholam
@docberza reminds us of the concept of cACLD vs. Cirrhosis as predictor of adverse liver events vs. histology which Baveno 6 endorsed 10 years ago.
LSM<10 kPa exclude
LSM>15 kPa include
@EASLnews #easlcongress
Still unfortunately not widely adopted stateside
#livertwitter -
EASLnews reposted
EASL Education
@EASLedu
🙏🏽✨ Thank you to the fantastic chairs of this educational session: @KeitelVerena and Richard Thompson!
@EASLnews @FrancqueSven @JesusMBanales @analleo @CholestasisDoc @PBCFoundation
#easlggr -
EASLnews reposted
Angelo Lozada MD
@ablozadamd
❌Pitfalls in assessing liver fibrosis❌
✅Congestion-⬆️ venous pressure
✅Hepatocytes edema-hepatitis
✅Mechanical Cholestasis
✅Infiltration-amiloidosis;
solid,hematological tumours, fat
✅Food
🗣️ Annalisa Berzigotti
@EASLedu @EASLnews #easlcongress #easl2025 #amsterdam #rai -
EASLnews
@EASLnews
This afternoon at #easlcongress, experts are taking on the complexities of hepatocellular carcinoma management in a fast-evolving therapeutic landscape.
Discussion is centred around how to select patients for immune checkpoint inhibitors before liver transplantation, when systemic therapies can be safely and effectively used despite impaired liver function, and why locoregional treatments still have a key role even in advanced-stage disease.
Personalised, stage-adapted, and highly strategic approaches are critical to improving outcomes — and today's session is providing essential real-world guidance to get it right. -
EASLnews
@EASLnews
The networking session with @ValdigGroup will start soon! Head over Track Hub 6 (Immune-mediated & Cholestatic Diseases) at 16:15!
Meet @VirginiaHdezGea & @RautouE!
#easlcongress -
EASLnews
@EASLnews
This afternoon at #easlcongress, experts looked into the critical role of animal models in advancing MASLD research.
Discussion focused on which features of the human MASLD spectrum animal models must replicate for true translational relevance, how to select the best validated models, and how to balance scientific rigour with ethical principles under the 3Rs framework.
@AleksanderKrag @EASLedu -
EASLnews
@EASLnews
At #easlcongress, advocacy leaders had a practical Meet-the-Experts session focused on equipping all with the tools needed to reduce alcohol-related harms across Europe and beyond.
We learnt from Markus Peck-Radosavljevic, Peter Rice, and Frank Murray how to make our voice heard for public health. @SagiZelber @EASLedu -
EASLnews reposted
The Liver Dude
@MichaelHenegha8
A thorn amongst the roses. @DebbieShawcros1 @TheBileDoc @CholestasisDoc Great to be with the team @EASLnews @KingsCollegeLon @f4liverresearch
-
EASLnews reposted
EASL Education
@EASLedu
Picking endpoints in #aclf trials is not easy.
🟤Mortality is often the default, but stabilising a patient enough for transplant could be a win.
🟤For #decompensation, it’s even tougher: patients decompensate for different reasons, so one-size-fits-all doesn’t work.
@EASLnews
#easlstudio #easlcongress #liverx -
EASLnews reposted
EASL Education
@EASLedu
Unmet needs remain in liver disease`
👉Different phenotypes, like portal hypertension & systemic inflammation, that require tailored approaches.
To develop effective treatments, we must understand the pathophys & target therapies to the right subpopulations.
@EASLnews
#easlstudio #easlcongress #liverx -
EASLnews reposted
EASL Education
@EASLedu
#decompensation was once seen as the end of the road.🛣️
Now we know that even patients with decompensated liver disease can improve, and sometimes even reverse cirrhosis.
💡We are starting to understand the mechanisms driving this shift.
@EASLnews
#easlstudio #easlcongress #liverx #aclf -
EASLnews reposted
EASL Education
@EASLedu
#aclf remains a major unmet need with no approved therapy, and only 15% of patients are seen by a hepatologist. 😲
What do we need to do?
✅Better characterise the condition
✅Harmonise definitions
✅Simplify diagnosis
✅Improve care
@EASLnews
#easlstudio #easlcongress #liverx -
EASLnews reposted
Annalisa Berzigotti
@docberza
What an incredible moment receiving this award today! Thank you so much dear EASL and thank you to my dearest colleagues, mentors, family and friends - this award is yours as well🙏🏻
-
EASLnews reposted
Jörn Schattenberg
@schattenbergJ
Did you know that #compensated #cirrhosis in MASH can be reversed from pharmacological treatment ⁉️
Shown at @EASLedu @EASLnews today in the General Session and Published online by @NoureddinMD
www.nejm.org/doi/full/10.1056/NEJMoa2502242 -
EASLnews reposted
Sagnik Biswas
@JustSagnik
Poster tour at EASL Congress 2025!
EASLnews
@EASLnews
Don't miss the sessions at the track hubs at the exhibition at #easlcongress happening now! Meet with peers with your interests and listen to important updates!
-
EASLnews reposted
EASL Education
@EASLedu
From systemic inflammation to portal hypertension, this episode will explore the drivers of decompensation and #aclf.
📅Starting at 12:45 CEST
📍Onsite: Hepatology Arena
💻Online: : easl.eu/studio-at-easl-congress-2025/
@EASLNews @DebbieShawcros1 @ReibergerThomas @ThomasBerg24 @aelsharkawy75 @Yujun__Wong @Apichatka
#easlstudio #easlnews #liverx -
EASLnews reposted
BHPG
@heppharm
Lovely to see a 🇬🇧 trial validating the cost effectiveness of carvedilol for primary prevention of varices in cirrhosis
#easl2025
EASLnews
@EASLnews
📢 Presenting the long-awaited results from the CALIBRE trial at #easlcongress General Session I:
A multicentre RCT comparing carvedilol vs variceal band ligation in the primary prevention of variceal bleeding in cirrhosis.
🩸 Variceal bleeding is a major tipping point in cirrhosis, with 30% bleeding risk in medium/large varices and up to 20% 6-week mortality. Prevention is critical.
💡 Dr. Dhiraj Tripathi (UK) shares vital insights that could reshape first-line management in cirrhosis care. -
EASLnews reposted
SMC Media
@smcmediasrl
📸 Standing room at yesterday’s #easl2025 Track Hub on cirrhosis & portal hypertension!
🎯 Mission: Update global recommendations on portal hypertension, grounded in the latest evidence & expert consensus.
The Baveno Coop shared big news: the #baveno8 Consensus Conference is set for 27–28 March 2026! 🗓️
🚨 Want in?
👉 Join the @BavenoCoop at bavenocoop.net
👉 Sign up for #baveno8 alerts & program: baveno8.org
Hosted by @EASLnews
#easl2025 #easlcongress #baveno8 #bavenocoop #hepatology #portalhypertension #liverdisease #liverhealth #gastroenterology #smcmedia -
EASLnews reposted
SMC Media
@smcmediasrl
🚨 Ever heard of Endohepatology? A new frontier in liver care is emerging! 🩺
At #easl2025, in collaboration with @BavenoCoop experts explored this evolving field bridging endoscopy & hepatology.
We're just getting started—follow the conversation.
🔗 baveno8.org
🔗 bavenocoop.net
@EASLnews #easl2025 #easlcongress #baveno8 #bavenocoop #smcmedia -
EASLnews
@EASLnews
MARCH Study: 48-Week Therapy and 24-Week Follow-Up of Tobevibart (VIR-3434) + Elebsiran (VIR-2218) ± Pegylated Interferon Alfa-2a in Chronic Hepatitis B, presented at #easlcongress General Session II.
This Phase 2 trial explores the potential of finite treatment regimens to achieve a functional cure in chronic hepatitis B virus (HBV) infection—addressing a critical gap in current long-term, non-curative management strategies.
🧬 The study investigates combination therapy with tobevibart and elebsiran, with or without pegylated interferon alfa-2a, over a 48-week treatment period followed by 24 weeks of post-treatment follow-up.
🗣️ ““Despite available treatment options, people living with chronic hepatitis B face a significant unmet medical need, as the current standard of care entails life-long treatment that doesn’t eliminate the risk of disease progression or liver cancer. We, in the field, continue to work towards a potential functional cure following a finite treatment.”
— Prof. Edward J. Gane, University of Auckland & NZ Liver Transplant Unit
@AleksanderKrag @DebbieShawcros1 @EASLedu -
EASLnews reposted
Dr.Bornie
@Apichatka
Congratulations 🎉 @Yujun__Wong #easlcongress
-
EASLnews reposted
Marta Alonso Peña, PhD
@DraMartaAlonsoP
@PMRodrigues19 presenting the BEST Clinical oral communication at #easlcongress You rock!! 💫💫
@GrupoJovenAEEH @AEEHLiver -
EASLnews reposted
José Presa
@JosPresa3
Congratulations @docberza
-
EASLnews reposted
Alejandro Forner
@Alexfornergon
Very well deserved award! Amazing scientific but better person!❤️❤️@docberza
-
EASLnews
@EASLnews
Latest Liver Stiffness Measurements Predict Liver-Related Outcomes in PBC Patients with Discordant Responses, presented by Yu Jun Wong at #easlcongress General Session II.
🔍 In this multinational cohort study, discordance between biochemical and liver stiffness measurement (LSM) responses was common—observed in 47% of patients.
📈 Crucially, an LSM corrected value (LSMc) >10 kPa emerged as the strongest predictor of the first liver-related outcome in patients with primary biliary cholangitis (PBC), regardless of biochemical response or LSM trajectory.
These findings emphasise the prognostic power of current LSM values in risk stratification and clinical decision-making for PBC patients.
@AleksanderKrag @DebbieShawcros1 @yujun__wong @EASLedu -
EASLnews
@EASLnews
🏆We wish to warmly congratulate Professor Ajay Duseja (Chandigarh, India), who has been honoured with a prestigious EASL Recognition Award for his exceptional contributions to the field of hepatology, particularly in the area of metabolic dysfunction-associated steatotic liver disease (MASLD).
In his words:
"It is a proud moment for me, my family, my department, and my country to receive this award. I am deeply grateful to EASL for this honour. My four decades of service with INASL have enabled me to advance the discipline of hepatology, and I remain committed to working even harder for my country, my institution, my department, and INASL."
@ajay_duseja @AleksanderKrag @DebbieShawcros1 -
EASLnews
@EASLnews
Best Poster Presentation Awards proudly celebrate the most outstanding and innovative research contributions showcased during the poster sessions, highlighting excellence, scientific rigour, and emerging talent in hepatology - Congratulations to all of our poster awardees at #easlcongress!
@AleksanderKrag @DebbieShawcros1 -
EASLnews
@EASLnews
🏆Professor Annalisa Berzigotti has been honoured with the EASL Community Award at #easlcongress, recognising her exceptional commitment to the hepatology community and her deep impact on patients, peers, and the profession at large.
Known as a model of intelligence, dedication, and kindness, Professor Berzigotti is celebrated not only for her academic and clinical contributions, but also for the way she uplifts those around her. As one colleague described: “the woman, the wonder, the legacy.”
In her own words:
"It is important for me to be here – it means a great deal both personally and professionally. I feel at home at EASL. As a true European who has lived and worked in several countries, EASL represents what I value most: connection, inclusion, and a shared commitment to the full spectrum of hepatology. Being part of this community enables us to build a better world, support one another, and grow together." - @docberza
@AleksanderKrag @DebbieShawcros1 @EASLedu -
EASLnews
@EASLnews
At General Session II, Pedro Miguel Rodrigues presents a Novel “3-in-1” Blood Metabolomic Test for Early Diagnosis and Risk Stratification of Primary Sclerosing Cholangitis (PSC) and Cholangiocarcinoma
This innovative metabolomic-based test offers a single-platform solution for:
✔️ Early diagnosis of PSC
✔️ Detection of cholangiocarcinoma
✔️ Risk stratification in at-risk patients
A promising advancement toward non-invasive, precision diagnostics in cholestatic liver disease and hepatobiliary cancer.
@DebbieShawcros1 @AleksanderKrag -
EASLnews reposted
Federación Española del Hígado - FEH
@fehigado
Un espacio esta mañana en el @EASLnews en el que hemos visualizado un vídeo por los 20 años de @EuropeLiver 🥳
Por más años de trabajo, tratamientosy lucha por los pacientes hepáticos ✊ -
EASLnews reposted
Angelo Lozada MD
@ablozadamd
Day 3 EASL. Just enjoying the Hall rooms at RAI
@EASLedu @EASLnews #easlcongress #easl2025 #amsterdam #rai -
EASLnews reposted
-
EASLnews
@EASLnews
📢 Presented at General Session II by Charlotte Mouliade at #easlcongress 2025
Elexacaftor-Tezacaftor-Ivacaftor (ETI) Era and Cystic Fibrosis Liver Disease Progression: A 10-Year National Study
This large-scale national study demonstrates that ETI therapy is associated with a greater than 60% reduction in the risk of cystic fibrosis liver disease (CFLD) progression.
Importantly, ETI appears to improve liver health without an associated increase in the risk of acute liver failure.
These findings underscore the need to further assess the therapeutic impact of ETI at the individual patient level, particularly among those with existing CFLD.
A significant step forward in understanding liver outcomes in the CF population.
@AleksanderKrag @DebbieShawcros1 -
EASLnews reposted
Rebecca West
@electricdreamz
Volixibat for treatment of Cholestatic pruritus-
Prof Heneghan presenting some very encouraging treatment improvements in burden of symptoms for patients with #pbc
@PBCFoundation @EASLnews #easl2025 -
EASLnews reposted
EASL Education
@EASLedu
🤔If inflammation is too variable to measure consistently, does that make it irrelevant?
🧐A good biomarker could change the game but would it replace fibrosis as the gold standard?
Even pathologists don’t always agree with themselves ... 😅
@EASLnews
#easlstudio #easlcongress #liverx -
EASLnews reposted
EASL Education
@EASLedu
The #sld burden paradox: many patients also have alcohol-related liver disease.
📊 Siloing by a single variable may reduce variability but risks leading clinical irrelevance.
⚠️Alcohol intake is a moving target and must be taken into account.
@EASLnews
#easlstudio #easlcongress #liverx -
EASLnews reposted
L. Marie Asad
@LmarieAsad
We're in Amsterdam bringing PBC Into Focus Through Art of Patient Stories via @GileadSciences @PBCFoundation @FriendsofPBC @EASLnews
#easlcongress
#primarybiliarycholangitis
#liverhealth #easl2025
www.gilead.com/stories/bringing-pbc-into-focus-through-ar… via @Gilead -
EASLnews
@EASLnews
📢 Presenting the long-awaited results from the CALIBRE trial at #easlcongress General Session I:
A multicentre RCT comparing carvedilol vs variceal band ligation in the primary prevention of variceal bleeding in cirrhosis.
🩸 Variceal bleeding is a major tipping point in cirrhosis, with 30% bleeding risk in medium/large varices and up to 20% 6-week mortality. Prevention is critical.
💡 Dr. Dhiraj Tripathi (UK) shares vital insights that could reshape first-line management in cirrhosis care. -
EASLnews reposted
EASL Education
@EASLedu
Whether you’re just getting started or looking to sharpen your skills, the Skills Learning Centre 1 at #easlcongress has you covered!
🔎Discover how integrating multiparametric ultrasound into your daily hepatology practice can elevate diagnostics and improve patient care.
@EASLnews @docberza @aelsharkawy75 @FrancqueSven @Yujun__Wong @Apichatka
#liverx
Patricia Pochelon-Faubert
@FaubertPochelon
How are your sonography skills? Come and learn at the skills learning center 1 at 10:00, 12:30, 14:00 or 16:15 today! You will get to play with both simulators and real US machines. #easlcongress
-
EASLnews reposted
Paula Boeira, PhD
@Paula__Boeira
We need better markers to predict mortality and infection in AH patients @HepatoPlymouth @RDInUHP @PlymUni #easl2025 #easl @EASLnews
-
EASLnews reposted
EASL Education
@EASLedu
🔦With treatments for SLD around the corner, the spotlight is on #nits.
Emerging data linking NITs to outcomes is helping us answer the key question: who should be treated?
@EASLNews
#easlstudio #easlcongress #liverx -
EASLnews
@EASLnews
Browse through the posters before General Session II at #easlcongress! Discover all the newest research being showcased in Amsterdam.
-
EASLnews
@EASLnews
Don't miss the sessions at the track hubs at the exhibition at #easlcongress happening now! Meet with peers with your interests and listen to important updates!
-
EASLnews reposted
Decision4Liver
@Decision4Liver
Kicking off our #easl2025 Networking Session with an intro to the DECISION project by Pierre-Emmanuel Rautou - Let’s talk systems medicine, cirrhosis, and precision care!
@RautouE
@ef_clif
@EASLnews
#liverdisease -
EASLnews reposted
WHO/Europe
@WHO_Europe
We are proud to announce that today, WHO/Europe & @EASLnews launched the European Health Alliance on Alcohol at the EASL Congress.
This alliance of health professionals met for the first time last year in December, and will accelerate work to reduce alcohol-related harms! -
EASLnews
@EASLnews
Policy and advocacy are under the spotlight this morning at #easlcongress with an important session on shaping the future direction of global NCD strategies for liver health.
Speakers are discussing how to elevate liver disease within the broader non-communicable disease agenda, and how World Liver Day, observed on 19 April, and the World Health Assembly can be leveraged to drive meaningful change.
The focus is on uniting clinicians, researchers, advocates and policymakers to create more inclusive, impactful and sustainable liver health initiatives across the globe.
A vital conversation recognising that tackling liver disease must be part of the global NCD effort.
@SagiZelber -
EASLnews
@EASLnews
Important new data are being presented this morning at #easlcongress during the Abstract Session on Viral Hepatitis B and D in current clinical practice.
Today's studies are highlighting strategies to achieve functional cure in hepatitis B surface antigen carriers, predictors of HDV RNA suppression following bulevirtide treatment, and outcomes after nucleos(t)ide analogue cessation.
Speakers are also sharing long-term analyses of chronic hepatitis delta outcomes and results from a randomised trial exploring strategies to promote HBsAg clearance in HBeAg-negative patients.
A vital session offering fresh perspectives for optimising hepatitis B and D management in real-world settings. -
EASLnews
@EASLnews
New frontiers in immune-mediated and cholestatic liver diseases are being explored at #easlcongress during theAbstract Session on immune mediated and cholestatic diseases.
Today's presentations highlight exciting developments, from novel dual-acting modulators targeting ABC transporters and potential new therapies for PSC, to updates on intrahepatic cholestasis of pregnancy management based on the 2023 EASL guidelines.
Speakers are also examining the utility of brush cytology in PSC for biliary dysplasia screening and presenting promising new phase 2b trial results on volixibat for treating cholestatic pruritus in PBC.
An inspiring session showcasing how scientific advances are translating into new therapeutic opportunities. -
EASLnews
@EASLnews
Complex clinical questions are under discussion this morning at #easlcongress during the EASL/SALVE Symposium on managing patients with alcohol use disorder.
Today's session is examining how ongoing alcohol consumption impacts treatment decisions in advanced liver disease, including therapeutic options for alcohol use disorder, TIPS placement considerations, and liver transplantation eligibility.
Speakers are sharing practical strategies for navigating these controversial and often challenging decisions, ensuring that patient care is both evidence-based and compassionate. -
EASLnews reposted
Decision4Liver
@Decision4Liver
Good morning!
DECISION coordinator Pierre-Emmanuel Rautou just started the early morning abstract session on #cirrhosis at the #easlcongress in Amsterdam. You can still join in the Benhamou Room until 09.45am! @EASLnews @ef_clif -
EASLnews reposted
Rui Castro
@RuiCastroHD
#easlcongress Day 3️⃣!
Abstract sessions are always very popular and I am starting the day @ the Gut Microbiota one, chaired by @MinnekeC & @JasmohanBajaj
@MFdezFondevila presents on gut permeability & ALD
@EASLnews @DebbieShawcros1 -
EASLnews reposted
Amalia Gastaldelli
@gastaldelli_amy
It was a privilege to chair this session with @FrancqueSven at #easlcongress yesterday
EASLnews
@EASLnews
Kicking off Day 2 at #easlcongress with a crucial look at #mash therapy: should we target metabolic dysfunction or fibrogenesis?
Today's session explores how metabolic dysfunction and chronic low-grade inflammation, driven by dysfunctional adiposity, fuel MASLD/MASH progression — alongside impaired hepatic repair mechanisms.
Through real-world case discussions, experts are examining whether therapies should focus on extrahepatic drivers like adipose tissue and gut-liver axis changes, or intrahepatic pathways of fibrogenesis and inflammation.
Understanding this complex, multidirectional disease process is vital to interpreting clinical trial results and tailoring future treatments according to disease stage.
@FrancqueSven @gastaldelli_amy -
EASLnews
@EASLnews
The networking session with @EuropeLiver will start soon! Head over Track Hub 1 (Public Health) at 10:00!
#easlcongress -
EASLnews
@EASLnews
The networking session with @CcaEns will start soon! Head over Track Hub 3 (Liver Tumours) at 10:00!
Meet Luke Boulter and Pedro Rodrigues!
#easlcongress -
EASLnews
@EASLnews
The networking session with @LEOPARD_EU will start soon! Head over Track Hub 8 (General Hepatology) at 10:00!
Meet Marina Berenguer, Felix Braun, Minneke Coenrad, Christophe Duvoux, @Marko_Korenjak & Xavier Verhselst!
#easlcongress -
EASLnews
@EASLnews
The networking session with @Decision4Liver will start soon! Head over Track Hub 4 (Cirrhosis & Complications) at 10:00!
Meet Richard Moreau, @RautouE & Theresa Wirtz!
#easlcongress -
EASLnews
@EASLnews
The networking session with the Consortium for Regenerative Hepatology will start soon! Head over Track Hub 2 (Basic Science) at 10:00!
Meet Pedro Baptista!
#easlcongress -
EASLnews reposted
Robert Mitchell-Thain💙💛
@PBCRobert
Quite possibly the busiest PBC academic session ever.
I mean ever.
Ever ever.
Dr Gideon Hirshfield sharing linerixabat data on itch in #pbc at @EASLedu congress in #amsterdam
@PBCFoundation @LiverPatients @Collettepbc @PBCMo @adyeoman @GSK @josewillemse -
EASLnews reposted
Aleksandra Gruevska
@Gruevska_A
Excited to present our work at #easlcongress (THU-036-YI). See you tomorrow on the Track Hub 2 - Basic science at 1pm to check how we use #massspecimaging and IMC for metabolic profiling of #liver fibrosis. Special thanks to our collaborators and funders @zoehall_ICL @ImperialMDR
-
EASLnews reposted
stephen barclay
@stephentbarclay
Congratulations to Hua, 4th year medical student @UofGMVLS presenting her SSC project on long term MASLD outcomes relative to criteria for Resmetirom therapy at #easlcongress
-
EASLnews reposted
Ajay Duseja
@ajay_duseja
Thanks EASL
@EASLnews
@EASLedu
@AleksanderKrag
@DebbieShawcros1
For the INASL presence at
#easl2025
You can visit INASL Booth no S4 at the EASL Congress #easlcongress
Get details about INASL-2025.
www.inasl2025.com
And become an INASL member.
www.inasl.org.in -
EASLnews reposted
EASL Education
@EASLedu
This #easlstudio episode will brings you expert highlights from #easlcongress.
📅Friday, 9 May at 16:15 CEST
📍Onsite: Hepatology Arena
💻Online: : easl.eu/studio-at-easl-congress-2025/
@EASLNews @ThomasBerg24 @Rajmookerjee @KeitelVerena @Jhepatology @aelsharkaway75 -
EASLnews reposted
Graciela Castro Narro
@GCastro_NarroMD
Today, the LATAM Consensus on Hepatic Encephalopathy was presented @alehlatam and Mario Pessoa represented us #easlcongress 2025 Thanks for the space. A great discussion panel, look forward to its publication soon. @DebbieShawcros1 @JasmohanBajaj @FATIMAHiguera8 @velardemd
-
EASLnews reposted
Mansoor Bangash
@bangash_mansoor
Resident Intensivist Dr Gladson Thomas showcasing his work looking at antimicrobials and infections in acute liver failure - doing @uhbtrust, @UHBCriticalCare and the Birmingham Liver Unit proud at #easlcongress 2025
-
EASLnews reposted
A. Digestivo HURH
@AparatoDigesti1
Our colleagues are attending the #easlcongress this week. Great to see our team engaged and up to date with the latest in the field!! 🙌🏼
#riohortega #hepatology #easl -
EASLnews reposted
EASL Education
@EASLedu
There's a very interesting Meet-the-Expert session 2 on plastic pollution & liver disease at #easlcongress:
Experts include:
✨@ProfRThompson: coined “microplastics” & named to @TIME’s 100 most influential list
time.com/collections/100-most-influential-people-2025/727…
✨Matthew Cramp:(@uniplymouth): studies micro/nanoplastics in human tissue
✨Guiseppe Paolisso: linked plastic exposure to heart disease & stroke
@EASLnews
#liverx -
EASLnews reposted
EASL Education
@EASLedu
The news is littered with info on micro- & nanoplastics.
Did you know? 🤯
🧫 They are even found in the liver.
🩸 The liver filters blood making it vulnerable to particle exposure.
💧 A 1L bottle can contain 250K particles this can increase 4x more if left in the sun.
🍽️ 3 mins microwaving at 800W = 1.2 billion nanoplastics/cm² released into ready-made meals.
It's not just waste, it's overproduction of single-use plastics.
@EASLnews -
EASLnews reposted
Thomas Reiberger
@ReibergerThomas
The @BavenoCoop TrackHub at @EASLnews congress #2025 was packed. 🔥 news on #portalhypertension
🔗 www.bavenocoop.net
🆕 BavenoVIII consensus in #2026: 27-28 March
➡️ baveno8.org -
EASLnews reposted
Grace Wong
@wonglaihung
Very well received #hbv #cure symposium #easlcongress
@CUHKMedicine @CUHKGI @VWSWong @TerryYip12 @JimmyLaiCT @EASLnews @EASLedu -
EASLnews reposted
EASL Education
@EASLedu
🧠 Scientists are trained to share discoveries but early disclosure can block future innovation.
To bring your ideas to market, you must learn what to keep confidential.🤫
Anselm Kamperman Sanders is sharing his insight in the #yiseminar.
@EASLnews
#easlcongress #liverx -
EASLnews reposted
Angelo Lozada MD
@ablozadamd
✅❌ Do’s and Don’t in abdominal surgery of Cirrhotics
practical and insightful tips
🗣️@nadimmahmud
@EASLedu @EASLnews #easlcongress #easl2025 #amsterdam #rai -
EASLnews reposted
EASL Education
@EASLedu
Bringing innovations from lab to clinic is an exciting journey but it comes with hurdles.
Prof. @RajivJalan1 has spent 24 years shaping the definition of #aclf, resulting in patents, clinical trials, and novel therapeutics.
At the #yiseminar, he highlights how financial or personal interests can challenge research integrity.
💡Academia doesn’t limit innovation it empowers meaningful stories. But you must know when a conflict becomes significant, and how to manage it.
@EASLnews
#easlcongress #liverx -
EASLnews reposted
The Baveno Cooperation: an EASL Consortium
@BavenoCoop
Do’s & Don’ts: How do you assess & prepare patients with cirrhosis for abdominal surgery?
🩺 Nadim Mahmud – #easl2025
✅ Risk stratification is key – use VPS & a multimodal approach
🛠️ Optimize decompensation events
⚖️ TIPS? -> Case-by-case decision -> More data!
👇 Final slide -
EASLnews reposted
EASL Education
@EASLedu
Join us tomorrow onsite at #easlcongress 2025!
🧬EASL Genetic Grand Round
📅 Friday 9 May, 12:45 - 13:45 CEST
📍 Hall 12 - Track Hub 8: General hepatology
🔗 events-apps.easl.eu/easl2025/en-GB/pag/session/103989
Take part in this educational session to explore clinical cases of patients with cholestasis and learn how to interpret genetic results for diagnosis, clinical decision-making, and potential treatment options.
@EASLnews @KeitelVerena @FrancqueSven @JesusMBanales @analleo @CholestasisDoc @PBCFoundation
#easlggr -
EASLnews
@EASLnews
🌎Important global perspectives are being shared this morning at #easlcongress during the Global Liver Forum on tailored approaches to hepatic encephalopathy.
Experts from Europe, Latin America, Asia and beyond are reflecting on the latest guidelines, real-world management challenges, and future strategies to improve care for patients living with cirrhosis and hepatic encephalopathy.
The session also emphasises the need to prioritise quality of life indicators in clinical care, ensuring a more holistic, patient-centred approach.
A powerful reminder that tackling hepatic encephalopathy demands both local adaptation and global collaboration.
@drshivsarin @DebbieShawcros1 @spearman_wendy
@mariogpessoa @EASLedu -
EASLnews
@EASLnews
Kicking off Day 2 at #easlcongress with a crucial look at #mash therapy: should we target metabolic dysfunction or fibrogenesis?
Today's session explores how metabolic dysfunction and chronic low-grade inflammation, driven by dysfunctional adiposity, fuel MASLD/MASH progression — alongside impaired hepatic repair mechanisms.
Through real-world case discussions, experts are examining whether therapies should focus on extrahepatic drivers like adipose tissue and gut-liver axis changes, or intrahepatic pathways of fibrogenesis and inflammation.
Understanding this complex, multidirectional disease process is vital to interpreting clinical trial results and tailoring future treatments according to disease stage.
@FrancqueSven @gastaldelli_amy -
EASLnews
@EASLnews
Today’s #readoftheweek📚highlights the significant variability of virologic responses to NA therapy in patients with #chronichepatitisb.
Read here this @JHEP_Reports article: www.jhep-reports.eu/article/S2589-5559(24)00233-7/fulltext
🙏@pippa_matt @borage_tina @EleanorBarnesOx et al.
#livertwitter #liverx -
EASLnews
@EASLnews
📢 New EASL Clinical Practice Guidelines for #hcc 📢
Liver cancer remains the third leading cause of cancer-related deaths worldwide, with hepatocellular carcinoma (HCC) representing 90% of cases. To address the evolving landscape of diagnostics and therapies, EASL has released updated Clinical Practice Guidelines to support clinicians and improve patient care.
🔑 What’s new?
✅ Personalised surveillance based on individual risk assessment
✅ Standardisation of liver imaging and diagnostic criteria
✅ Updates on minimally invasive surgery and liver transplantation
✅ Clear transitions between surgical, locoregional, and systemic therapies
✅ Integration of radiation therapies and combination immunotherapies at various disease stages
✅ Emphasis on multidisciplinary care and patient-centered risk assessment
These guidelines reflect the latest evidence to transform HCC management and optimise patient outcomes.
📖 Read more and access the guidelines here 👉easl.eu/news/easl-cpgs-hcc/
@JHepatology @valerieparadis @ma5RN @EASLedu -
EASLnews
@EASLnews
📢New release: Updated EASL Clinical Practice Guidelines on Liver Transplantation (LT) .
These guidelines, last updated in 2016, have undergone a major overhaul to incorporate the latest advancements in the field.
🔍 New assessment techniques: Better tools to evaluate liver transplant candidates, aiming for more accurate and individualised care.
🌱 Organ preservation insights: Cutting-edge strategies to improve organ viability, helping more patients receive life-saving transplants.
❤️ Enhanced post-transplant care: Emphasis on improving patient outcomes and quality of life post-surgery.
👉Read them now! easl.eu/news/easl-cpgs-liver-transplantation/
@JHepatology @EASLedu @AleksanderKrag -
EASLnews
@EASLnews
The authors in today's #readoftheweek📚 discuss how hepatic estrogen receptor alpha drives masculinization in post-menopausal women with metabolic dysfunction-associated #steatoticliverdisease.
Read here this @JHEP_Reports article: www.jhep-reports.eu/article/S2589-5559(24)00147-2/fulltext
🙏@SDT_Coach, @lucavalenti75, et al.
#livertwitter -
EASLnews
@EASLnews
Today's #readoftheweek📚 highlights the differential role of senescence in relevant cell types in the gut-liver axis, which should be considered when proposing senolytics as therapeutic approaches to treat cholestatic disease.
Read here this @JHEP_Reports article: www.jhep-reports.eu/article/S2589-5559(24)00163-0/fulltext
@BerazaLab @TheQuadram #livertwitter -
EASLnews
@EASLnews
In today’s #readoftheweek📚, the authors’ findings highlight the role of liver biopsy in elucidating the underlying pathology and aiding in the diagnosis of patients with persistent and unexplained GGT elevation.
Read here this @JHEP_Reports article: www.jhep-reports.eu/article/S2589-5559(24)00154-X/fulltext
🙏 @nicolapugliese_, @FRPonziani, @lucavalenti75, @AghemoAlessio et al. -
EASLnews
@EASLnews
#easlcongress delegates, you can now watch the Congress sessions on demand, on #easlcampus🔥
Catch up now: easlcampus.eu/list-search-taxonomy-sub/481
#livertwitter -
EASLnews
@EASLnews
🤔What do we expect from a good reviewer? How to plan a solid observational study? At the @JHepatology workshop at #easlcongress 2024 we are discussing insights into practical aspects of experimental design, data analysis, and findings dissemination in hepatology!
@RuiCastroHD @PatriziaBurra -
EASLnews
@EASLnews
Register for the conference: Challenging big industry narratives: alcohol, tobacco, unhealthy food and drinks - population measures and policies!
🗓️27-28 June, Ljubljana, Slovenia
👉yho.network/events/challenging-big-industry-narratives/
🔍 Explore critical issues such as pricing policies and marketing restrictions, and discuss solutions with diverse stakeholders.
🗣️ Engage in debates, network, and question industry narratives.
💡 Discover effective strategies for NCD prevention and community action.
This conference is part of the FILTERED Project – From Siloes to Synergies to Prevent NCDs, co-funded by the European Union (Action Grant, EU4Health Programme).
@EUROCAREBRUSSEL @sara_saracerdas @EASLEUAffairs -
EASLnews
@EASLnews
The liver community mourns the loss of Dr. Stephen Harrison, a friend and a visionary in MASLD clinics and clinical research, whose contributions have shaped the current state of the field.
We extend our deepest condolences to Dr. Harrison’s family and colleagues during this difficult time. 🩶
easl.eu/news/obituarystephenharrison/
@AleksanderKrag @DebbieShawcros1 @FrancqueSven @VladRatziu @phil_newsome7 @marurinella @NoureddinMD @AlkhouriNaim @ebtapper @AlinaAllenMD -
EASLnews
@EASLnews
In today's #readoftheweek📚, learn how soluble urokinase plasminogen activator receptor, as a surrogate of hepatic inflammation, may be used to stratify care in patients following TIPS insertion.
Read here this #openaccess @JHEP_Reports article: www.jhep-reports.eu/article/S2589-5559(24)00055-7/fulltext
🙏 @tony_bruns @JonelTrebicka et al.
#livertwitter -
EASLnews
@EASLnews
Liver cancer cases have doubled in Europe over the past 30 years, with chronic liver disease as a major risk factor. Today, on #worldliverday, we call for screening, prevention, and access to care to combat this growing health challenge.
👉Read the policy statement: easl.eu/publication/easl-policy-statement-on-liver-cancer…
#liverhealth #liverawareness #liverdisease #livercancer #hcc #cca #stepupforliverhealth #livertwitter
@WorldLiverDay @AleksanderKrag @EASLEdu @EASLEUAffairs @AASLDtweets
@alehlatam @Solda_Society @APASLnews @CCR_AACR @NCIResearchCtr @CNIOStopCancer @eaonc @EuropeanCancer @CDC_Cancer @WHO -
EASLnews
@EASLnews
🍺❌EASL's recommendations for reducing alcohol harms align with the spirit of #worldliverday.
We must prioritise public health over profit and protect our communities from harmful alcohol consumption.
💰🔞We advocate for evidence-based policies, from minimum unit pricing to strict enforcement of legal purchasing age.
We renew our commitment to advancing key EU initiatives like 'Healthier Together' and 'Europe’s Beating Cancer Plan' to address alcohol-related liver diseases.
Read the new op-ed on Euractiv:
www.euractiv.com/section/health-consumers/opinion/evidenc…
@WorldLiverDay @WHO @AleksanderKrag @EASLedu @EASLEUAffairs @AASLDtweets @alehlatam @Solda_Society @APASLnews @AwarhEurope @fscarfe @alcohol_review -
EASLnews
@EASLnews
On #worldliverday, watch the latest EASL Policy Dialogue featuring esteemed speakers Eduardo Lopez and Prof. Shira Zelber-Sagi.
Together, they shed light on crucial aspects of liver health, from rare diseases to nutrition and prevention strategies.
👉Watch here: easlcampus.eu/videos/easl-policy-dialogues-s3-e2-world-li…
@SagiZelber @WorldLiverDay @EASLedu @EASLEUAffairs -
EASLnews
@EASLnews
In today’s #readoftheweek, learn how a weakly supervised learning method is able to extract specific morphological features of HCC and iCCA from tumour biopsy.
Read here this🔓 #openaccess @JHEP_Reports article: www.jhep-reports.eu/article/S2589-5559(24)00009-0/fulltext
🙏@A_Beaufrere @valerie_paradis et al.
#livertwitter -
EASLnews
@EASLnews
Today’s #readoftheweek📚explores how alcohol-related severe liver disease is characterised by low lipid levels progressing with severity of liver disease, especially low sphingomyelins, which also associate to poor prognoses.
Read here this🔓 #openaccess @JHEP_Reports article: www.jhep-reports.eu/article/S2589-5559(23)00284-7/fulltext
🙏 @MaleneOConnell @liselottegluud @NKimer et al.
#livertwitter -
EASLnews
@EASLnews
⏰Only a month left until the EASL #livercancersummit 2024 in Rotterdam!
Join a global community of experts and contribute to shaping the future of liver cancer treatment and research.
🤝 Network, learn, and share your experiences in an environment buzzing with innovation and collaboration.
Register today!
📢easl.eu/event/liver-cancer-summit-2023/registration/ -
EASLnews
@EASLnews
Today’s #readoftheweek📚 explores the diagnosis and treatment of progressive familial intrahepatic cholestasis.
Read here this🔓 #openaccess @JHEP_Reports article: www.jhep-reports.eu/article/S2589-5559(23)00280-X/fulltext
🙏 @lurz_eberhard @CholestasisDoc et al.
#livertwitter -
EASLnews
@EASLnews
We are looking for our next EASL Nurses & AHPs Rising Star🤩
With this award, we honour a talented emerging nurse or a AHP whose focus is on putting people with, or at risk of, liver disease at the heart of practice.
Do you know this person? Send your nomination by 14 March on easl.eu/news/rising-star-2024/
#livertwitter @EASLNurses_AHPs @FpNuria
@KathrynJackNHS @liver_dietitian @analleo -
EASLnews
@EASLnews
#livertwitter, how well do you know your #cpgs on alcohol-related liver disease management?🤔
Take today's #easlquiz and find out!
🎲 easlcampus.eu/quiz/question/q88
@MarkThursz @MATHURINPHILIP1 @hlcortezpinto -
EASLnews
@EASLnews
In today’s #readoftheweek📚, learn to what extent traditional lifestyle factors mediate the relationship between SEP and IHL content, independent of aetiology, and #nafld.
Read here this🔓 #openaccess @JHEP_Reports article: www.jhep-reports.eu/article/S2589-5559(23)00186-6/fulltext
🙏 @ElineKooi @AnnemarieKo @MCGJBrouwers et al.
#livertwitter -
EASLnews
@EASLnews
The authors of today’s #readoftheweek📚 evaluate the predictive value of the liver frailty index in outpatients in the European #livertransplant setting.
Read here this🔓 #openaccess @JHEP_Reports article: www.jhep-reports.eu/article/S2589-5559(23)00171-4/fulltext
🙏 @goncrespo1 @Rod_Peralvarez et al.
@IISLaFe @hospitalclinic -
EASLnews
@EASLnews
➖ Alcohol = ➖ risk for: 200 diseases, mental disorders, cirrhosis and cancer.#alcoholrighttoknow ➡️ www.awarh.eu/better-societies-less-alcohol-17/
@AwarhEurope @EASLEUAffairs @spietikainen @fritzon_h @woelken @sara_saracerdas @delarabur @ale_moretti @SchaldemoseMEP @nicospapandreou @nicogoncas @AMALRICCatheri1 @Frederiqueries @MicheleRivasi @nicustefanuta @silviamodig @MalinBjork_EU @toni_comin @kaisaJuuso @1Hildegarde @jakobforssmed @SKyriakidesEU @FitzgeraldFrncs @andreykovatchev @CristianSBusoi @DeirdreCluneMEP -
EASLnews
@EASLnews
How well do you know your EASL CPGs on sclerosing cholangitis? Take today's quiz and find out😉
🎲 easlcampus.eu/quiz/question/q87
#livertwitter @EASLedu @tomhemmingk @DrCynthiaLevy -
EASLnews
@EASLnews
Alcohol-related harm affects us all. Europe leads in alcohol consumption and harm, with over 200 diseases and 740,000 new cancer cases yearly.
Let's choose health over industry profits.
Join #easl and @EUROCAREBRUSSEL in rejecting harmful amendments and misinformation.
👉🏻easl.eu/press-release/ncds-nov-2023/
@istvan_ujhelyi @skyttedal @MicheleRivasi @GreensEFA @FBEurocare @engerer @FiocchiPietro @CristianSBusoi @sara_saracerdas @DeirdreCluneMEP @rmkanev @spietikainen @RenewEurope @EASLEUAffairs -
EASLnews
@EASLnews
How will the new nomenclature affect healthcare pathways for those suffering with alcohol-related liver diseases?🤔
Faculty @AleksanderKrag, @juanpabloarab, Alexandre Louvet & @marurinella are looking forward to discuss this crucial topic!
📺 easl.eu/easl-studio-episode/s5e9/
#livertwitter -
EASLnews
@EASLnews
Tune in tomorrow 18:00 CET for this 🆕 #easlstudio episode on #hepatitisdelta as our faculty sheds light on the controversies surrounding this disease, as well as the latest and most hotly debated recommendations.
📺 easl.eu/easl-studio-episode/s5e8/
@ThomasBerg24 #livertwitter -
EASLnews
@EASLnews
Register to not miss the upcoming #easljc!
Authors @Cmontironi and Josep Llovet will present & discuss a revised immunogenomic classification of #hcc👩🏫👨🏫
📰gut.bmj.com/content/72/1/129
🖊easl-eu.zoom.us/webinar/register/2016926948831/WN_QW0qolX…
#livertwitter -
EASLnews
@EASLnews
The authors of today’s #readoftheweek📚 explore the metabolic profile, genetic basis, causal risk factors, and clinical sequelae underlying lean NAFLD.
Read here this🔓 #openaccess @JHEP_Reports article: www.jhep-reports.eu/article/S2589-5559(23)00075-7/fulltext
🙏 @HG_Peng et al.
@UMich @wsuapplebaum #livertwitter -
EASLnews
@EASLnews
Today’s #readoftheweek📚 explores why standardization of therapeutic strategies for combined hepatocellular-cholangiocarcinoma (cHCC-CCA) is necessary.
Read here this🔓#openaccess @JHEP_Reports article: www.jhep-reports.eu/article/S2589-5559(23)00076-9/fulltext
🙏 @claasen_m @sapisochin
@CcaEns @curecc
#livertwitter -
EASLnews
@EASLnews
In today’s #readoftheweek📚, learn about the effects of increased hydrodynamic pressure on liver sinusoidal endothelial cells and the endothelial-derived biomarkers of #portalhypertension.
Read here this🔓#openaccess @JHEP_Reports article: www.jhep-reports.eu/article/S2589-5559(23)00053-8/fulltext
🙏 @MartiOR92 @JSGracia
#livertwitter -
EASLnews
@EASLnews
📱 Get ready for an exceptional experience at #easlcongress 2023 by downloading the EASL Events App for free.
Whether you're attending in person or virtually, this app will enhance your participation with effortless scheduling and convenient program browsing.
Scan the QR code! -
EASLnews
@EASLnews
The authors of today’s #readoftheweek📚 discuss novel viral and immune markers in predicting #hbv treatment endpoints.
Read here this🔓#openaccess @JHEP_Reports article: www.jhep-reports.eu/article/S2589-5559(23)00051-4/fulltext
🙏 @georgiazeng @loeymak @druppygill @DrPKennedy
#livertwitter -
EASLnews
@EASLnews
Pleased to announce our journal @JHepatology w/ @alehlatam @annalsofhepatol & @AASLDtweets @Hep_Journal released a co-authored editorial, 'A call for unity: The path towards a more precise and patient-centric nomenclature for NAFLD'. www.journal-of-hepatology.eu/article/S0168-8278(23)00331-…
-
EASLnews
@EASLnews
In today’s #readoftheweek📚learn how ammonia predicts liver-related outcomes, independently of established prognostic indicators.
Read here this🔓#openaccess @JHEP_Reports article: www.jhep-reports.eu/article/S2589-5559(23)00013-7/fulltext
🙏@balcar_lorenz @ReibergerThomas @MattiasMandorf1 @Phil_Schwabl et al. -
EASLnews
@EASLnews
The @EASLnews & @ESPGHANSociety joint statement on MAFLD is now available!
Learn about clear criteria for diagnosis & the importance of investigating for other causes of chronic liver disease in children & young people.
🔗easl.eu/news/easlespghanstatement/
#fattyliver #mafld #healthcare -
EASLnews
@EASLnews
#livertwitter: 🎯 Register for the #easlcongress 2023 by 17 April to take advantage of the early fees and save up to 50% on the registration fee. 👉www.easlcongress.eu/registration/
The 🌍 world's leading hepatology faculty is looking forward to meeting you in Vienna! -
EASLnews
@EASLnews
In today’s #readoftheweek📚learn how increased SMOC2 in plasma appears to reflect HSC activation & may serve as a non-invasive biomarker of #nash.
👉Read here this #openaccess @JHEP_Reports article: www.jhep-reports.eu/article/S2589-5559(22)00187-2/fulltext
🙏@FTibertLarsen @AleksanderKrag @ravnskjaer_lab et al. -
EASLnews
@EASLnews
#livertwitter: ⏰Hurry up! This is your last chance ⏳ to save up to 60% with early fees registration for the #easl #livercancersummit 2023.
📌Deadline 14 March! Register now 👉 easl.eu/LCS23 -
EASLnews
@EASLnews
Interested in building the future of #hepatology with us?💡
We're🔎for:
1️⃣Vice-Secretary
1️⃣Treasurer
1️⃣Public Health Councillor
1️⃣Scientific Committee Member
2️⃣Young Investigators Task Force Members
2️⃣Nurses & AHPs Task Force Members
👉easl.eu/governance
🗓 26 March -
EASLnews
@EASLnews
How to identify unmet clinical needs and address them by basic research? How to write a successful research grant application?🤔
This and more in next Thursday's YI Afterwork Series webinar on translational research!
Register today on easl.eu/event/yi-afterwork-series-liver-translational-res…
#basicscience -
EASLnews
@EASLnews
In today’s special #readoftheweek📚feat. #easljc, read this study on the developmental trajectories of various cell types in the human liver at a single-cell level.
Next week, 14 March 18:00CET on easlcampus.eu/webinars/single-cell-atlas-human-liver-deve…
@VallierLab @Saskia_van_Mil @aelsharkawy75 @Phil_Schwabl -
EASLnews
@EASLnews
The 2021 #easlmono on Bleeding, Thrombosis, and Vascular Diseases is now open access on #easlcampus!
(Re)discover freely the conference's ePosters & webcasts💡
🔗easlcampus.eu/list-search-taxonomy-sub/274
@VirginiaHdezGea @RautouE #livertwitter
@EASLedu -
EASLnews
@EASLnews
Today’s #readoftheweek📚 explores the causal effect of waiting time on post-transplant survival for patients with #hcc.
Read here this🔓#openaccess @JHEP_Reports article: www.jhep-reports.eu/article/S2589-5559(22)00201-4/fulltext
🙏 to @dewojt et al.
@ErasmusMC @UNOSNews
@aelsharkawy75 #livertwitter -
EASLnews
@EASLnews
MEP @JerkovicRomana, Member of @EP_BeatCancer:
Political will! We can achieve *real* change if we all work together: EU Institutions, all Member States, NGOs & healthcare institutions.
Tweeting live, today with @cancereu @ACHIEVE_hep @ChallengeCAN




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































